U.S. patent application number 13/550872 was filed with the patent office on 2012-11-08 for molecular in vitro diagnosis of breast cancer.
This patent application is currently assigned to INSTITUT GUSTAVE ROUSSY. Invention is credited to Fabrice ANDRE, Suzette DELALOGE, Philippe DESSEN, Stefan MICHIELS, Marc SPIELMANN, Philippe VIELH.
Application Number | 20120283132 13/550872 |
Document ID | / |
Family ID | 39361311 |
Filed Date | 2012-11-08 |
United States Patent
Application |
20120283132 |
Kind Code |
A1 |
ANDRE; Fabrice ; et
al. |
November 8, 2012 |
MOLECULAR IN VITRO DIAGNOSIS OF BREAST CANCER
Abstract
A method for determining the benign or malignant state of a
breast tumor in a biological sample is presented. The benign or
malignant state is determined by measuring the variation of
expression of twelve genes and at least one variant of each of the
twelve genes when the variants exist, using a combination of 50
polynucleotide probe sets. An expression profile of the sample is
then compared with reference expression profiles of control benign
and malignant breast tissues. The probe sets can be arranged in a
microarray.
Inventors: |
ANDRE; Fabrice; (Sceaux,
FR) ; MICHIELS; Stefan; (Paris, FR) ;
DELALOGE; Suzette; (Longjumeau, FR) ; SPIELMANN;
Marc; (Cachan, FR) ; DESSEN; Philippe; (Ivry
Sur Seine, FR) ; VIELH; Philippe; (Sceaux,
FR) |
Assignee: |
INSTITUT GUSTAVE ROUSSY
Villejuif Cedex
FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Paris Cedex 16
FR
|
Family ID: |
39361311 |
Appl. No.: |
13/550872 |
Filed: |
July 17, 2012 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
12811792 |
Sep 29, 2010 |
|
|
|
PCT/EP2009/050060 |
Jan 5, 2009 |
|
|
|
13550872 |
|
|
|
|
Current U.S.
Class: |
506/9 |
Current CPC
Class: |
C12Q 1/6886 20130101;
C12Q 2600/156 20130101; C12Q 2600/112 20130101 |
Class at
Publication: |
506/9 |
International
Class: |
C40B 30/04 20060101
C40B030/04 |
Foreign Application Data
Date |
Code |
Application Number |
Jan 4, 2008 |
EP |
08100106.7 |
Claims
1. A method for determining a benign or malignant state of a breast
tumor in a biological sample from a subject, by determining a
variation of expression of at least 12 determined genes belonging
to a group of determined genes selected from the nucleotide
sequences of SEQ ID NO: 5419 to SEQ ID NO: 5693 and at least one
variant of each of said at least 12 determined genes, when said
variants exist, said at least 12 genes being represented by the
following nucleotide sequences: SEQ ID NOs 5421; 5423; 5432; 5434;
5486; 5491; 5525; 5552; 5599; 5652; 5654 and 5683, the method
comprising: (1) contacting nucleic acid molecules obtained from
said biological sample to a combination of 50 polynucleotide probe
sets to allow formation of a nucleic acid complex, and detecting
said formation; (2) determining a sample expression profile of said
12 genes and of variants of said 12 genes from the detection of the
nucleic acid complexes; (3) comparing said sample expression
profile with a reference expression profile of a control benign
breast tumor, and/or a reference expression profile of a control
malignant tumor, and (4) determining, from the comparison, that:
(a) when said profile of expression is similar to the reference
expression profile of a control benign breast tumor, then the
breast cancer is benign, and (b) when said profile of expression is
similar to the reference expression profile of a control malignant
breast tumor, then the breast cancer is malignant, wherein, said 50
polynucleotide probe sets comprise: probe set #1 consisting of the
nucleic acids consisting of SEQ ID NO: 333, 335 and 334; probe set
#2 consisting of the nucleic acids consisting of SEQ ID NO: 364,
365 and 366; probe set #3 consisting of the nucleic acids
consisting of SEQ ID NO: 364, 366 and 365; probe set #4 consisting
of the nucleic acids consisting of SEQ ID NO: 312, 348 and 313;
probe set #5 consisting of the nucleic acids consisting of SEQ ID
NO: 312, 314 and 313; probe set #6 consisting of the nucleic acids
consisting of SEQ ID NO: 171, 172 and 173; probe set #7 consisting
of the nucleic acids consisting of SEQ ID NO: 315, 336 and 331;
probe set #8 consisting of the nucleic acids consisting of SEQ ID
NO: 1198, 1199 and 1200; probe set #9 consisting of the nucleic
acids consisting of SEQ ID NO: 315, 317 and 316; probe set #10
consisting of the nucleic acids consisting of SEQ ID NO: 1522, 1523
and 1524; probe set #11 consisting of the nucleic acids consisting
of SEQ ID NO: 339, 341 and 340; probe set #12 consisting of the
nucleic acids consisting of SEQ ID NO: 353, 361 and 360; probe set
#13 consisting of the nucleic acids consisting of SEQ ID NO: 1185,
1186 and 1194; probe set #14 consisting of the nucleic acids
consisting of SEQ ID NO: 315, 370 and 316; probe set #15 consisting
of the nucleic acids consisting of SEQ ID NO: 324, 326 and 325;
probe set #16 consisting of the nucleic acids consisting of SEQ ID
NO: 1165 and 1166; probe set #17 consisting of the nucleic acid
consisting of SEQ ID NO: 177; probe set #18 consisting of the
nucleic acids consisting of SEQ ID NO: 1551, 1552 and 1553; probe
set #19 consisting of the nucleic acids consisting of SEQ ID NO:
315, 316 and 370; probe set #20 consisting of the nucleic acids
consisting of SEQ ID NO: 1185, 1186 and 1194; probe set #21
consisting of the nucleic acids consisting of SEQ ID NO: 1523, 1524
and 1557; probe set #22 consisting of the nucleic acid consisting
of SEQ ID NO: 1158; probe set #23 consisting of the nucleic acids
consisting of SEQ ID NO: 345, 347 and 346; probe set #24 consisting
of the nucleic acids consisting of SEQ ID NO: 367, 369 and 368;
probe set #25 consisting of the nucleic acids consisting of SEQ ID
NO: 315, 331 and 330; probe set #26 consisting of the nucleic acids
consisting of SEQ ID NO: 327, 329 and 328; probe set #27 consisting
of the nucleic acid consisting of SEQ ID NO: 1203; probe set #28
consisting of the nucleic acids consisting of SEQ ID NO: 1262, 1263
and 1264; probe set #29 consisting of the nucleic acids consisting
of SEQ ID NO: 1534, 1535 and 1536; probe set #30 consisting of the
nucleic acids consisting of SEQ ID NO: 2179, 2180 and 2181; probe
set #31 consisting of the nucleic acids consisting of SEQ ID NO:
1159, 1160 and 1161; probe set #32 consisting of the nucleic acids
consisting of SEQ ID NO: 327, 329 and 328; probe set #33 consisting
of the nucleic acids consisting of SEQ ID NO: 157, 158 and 159;
probe set #34 consisting of the nucleic acids consisting of SEQ ID
NO: 1267, 1268 and 1269; probe set #35 consisting of the nucleic
acids consisting of SEQ ID NO: 167, 168 and 169; probe set #36
consisting of the nucleic acids consisting of SEQ ID NO: 167, 168
and 177; probe set #37 consisting of the nucleic acids consisting
of SEQ ID NO: 1167, 1168 and 1169; probe set #38 consisting of the
nucleic acids consisting of SEQ ID NO: 1544, 1545 and 1546; probe
set #39 consisting of the nucleic acids consisting of SEQ ID NO:
969, 972 and 981; probe set #40 consisting of the nucleic acids
consisting of SEQ ID NO: 1162, 1170 and 1171; probe set #41
consisting of the nucleic acids consisting of SEQ ID NO: 790, 791
and 792; probe set #42 consisting of the nucleic acids consisting
of SEQ ID NO: 368, 374 and 375; probe set #43 consisting of the
nucleic acids consisting of SEQ ID NO: 1551, 1552 and 1553; probe
set #44 consisting of the nucleic acids consisting of SEQ ID NO:
1554, 1555 and 1556; probe set #45 consisting of the nucleic acids
consisting of SEQ ID NO: 2026, 2027 and 2028; probe set #46
consisting of the nucleic acids consisting of SEQ ID NO: 1081, 1082
and 1083; probe set #47 consisting of the nucleic acids consisting
of SEQ ID NO: 1129, 1140 and 1141; probe set #48 consisting of the
nucleic acids consisting of SEQ ID NO: 1519, 1520 and 1521; probe
set #49 consisting of the nucleic acids consisting of SEQ ID NO:
136, 137 and 138; and probe set #50 consisting of the nucleic acids
consisting of SEQ ID NO: 793, 794 and 795, as specified as probe
set #1 to probe set #50 in Table 7.
2. The method according to claim 1, comprising determining the
variation of expression of: at least 20 determined genes belonging
to a group of determined genes selected from the nucleotide
sequences of SEQ ID NO: 5419 to SEQ ID NO: 5693, and at least one
variant of each of said at least 20 determined genes, when said
variants exist, said at least 20 determined genes being represented
by the following nucleotide sequences: SEQ ID Nos 5421; 5423; 5432;
5434; 5457; 5486; 5491; 5513; 5516; 5525; 5532; 5552; 5599; 5616;
5624; 5643; 5652; 5654; 5673 and 5683, said method comprising: (1)
contacting the nucleic acid molecules obtained from said biological
sample to a combination of at least 100 polynucleotide probe sets
to allow the formation of the nucleic acid complex, wherein said
100 polynucleotide probe sets comprise probe set #1 to probe set
#100 as specified in Table 7.
3. The method according to claim 1, comprising determining the
variation of expression of: at least 35 determined genes belonging
to a group of determined genes selected from the nucleotide
sequences of SEQ ID NO: 5419 to SEQ ID NO: 5693, and at least one
variant of each of said at least 35 determined genes, when said
variants exist, said at least 35 determined genes being represented
by the following nucleotide sequences: SEQ ID Nos 5421; 5423; 5431;
5432; 5434; 5440; 5457; 5462; 5470; 5486; 5491; 5505; 5513; 5516;
5525; 5532; 5546; 5552; 5594; 5599; 5601; 5603; 5616; 5618; 5624;
5627; 5630; 5643; 5645; 5652; 5654; 5660; 5669; 5673 and 5683, said
method comprising: (1) contacting the nucleic acid molecules
obtained from said biological sample to a combination of at least
150 polynucleotide probe sets to allow the formation of the nucleic
acid complex, wherein said 150 polynucleotide probe sets comprise
probe set #1 to probe set #150 as specified in Table 7.
4. The method according to claim 1, comprising determining the
variation of expression of: at least 43 determined genes belonging
to a group of determined genes selected from the nucleotide
sequences of SEQ ID NO: 5419 to SEQ ID NO: 5693, and at least one
variant of each of said at least 43 determined genes, when said
variants exist, said at least 43 determined genes being represented
by the following nucleotide sequences: SEQ ID Nos 5421; 5423; 5431;
5432; 5434; 5440; 5455; 5457; 5462; 5470; 5475; 5486; 5491; 5499;
5505; 5513; 5516; 5520; 5525; 5532; 5546; 5549; 5552; 5594; 5599;
5601; 5603; 5616; 5618; 5623; 5624; 5627; 5630; 5643; 5645; 5651;
5652; 5654; 5660; 5669; 5673; 5683 and 5686, said method
comprising: (1) contacting the nucleic acid molecules obtained from
said biological sample to a combination of at least 200
polynucleotide probe sets to allow the formation of the nucleic
acid complex, wherein said 200 polynucleotide probe sets comprise
probe set #1 to probe set #200 as specified in Table 7.
5. The method according to claim 1, comprising determining the
variation of expression of: at least 206 determined genes belonging
to a group of determined genes selected from the nucleotide
sequences of SEQ ID NO: 5419 to SEQ ID NO: 5693, and at least one
variant of each of said at least 206 determined genes, when said
variants exist, said at least 206 determined genes being
represented by the following nucleotide sequences: SEQ ID Nos 5420;
5421; 5422; 5423; 5425; 5426; 5427; 5428; 5429; 5430; 5431; 5432;
5434; 5435; 5436; 5437; 5438; 5439; 5440; 5441; 5442; 5443; 5444;
5445; 5446; 5447; 5449; 5450; 5451; 5452; 5453; 5454; 5455; 5456;
5457; 5459; 5460; 5461; 5462; 5463; 5465; 5467; 5468; 5470; 5473;
5475; 5476; 5479; 5480; 5482; 5484; 5485; 5486; 5487; 5488; 5489;
5490; 5491; 5492; 5493; 5495; 5496; 5497; 5498; 5499; 5502; 5503;
5505; 5506; 5507; 5508; 5509; 5511; 5512; 5513; 5515; 5516; 5517;
5518; 5519; 5520; 5523; 5524; 5525; 5526; 5528; 5529; 5530; 5531;
5532; 5533; 5534; 5536; 5538; 5539; 5540; 5543; 5544; 5545; 5546;
5547; 5549; 5550; 5552; 5553; 5554; 5556; 5558; 5559; 5560; 5562;
5563; 5564; 5565; 5566; 5567; 5568; 5569; 5570; 5571; 5573; 5574;
5575; 5576; 5577; 5578; 5581; 5582; 5585; 5587; 5588; 5590; 5591;
5593; 5594; 5595; 5597; 5598; 5599; 5600; 5601; 5602; 5603; 5604;
5605; 5606; 5608; 5609; 5610; 5611; 5612; 5613; 5615; 5616; 5617;
5618; 5622; 5623; 5624; 5625; 5627; 5629; 5630; 5631; 5632; 5633;
5634; 5635; 5637; 5638; 5639; 5640; 5641; 5642; 5643; 5644; 5645;
5647; 5648; 5649; 5651; 5652; 5653; 5654; 5656; 5657; 5658; 5660;
5661; 5665; 5667; 5669; 5672; 5673; 5675; 5676; 5677; 5678; 5680;
5681; 5683; 5684; 5686; 5687; 5689 and 5692, said method
comprising: (1) contacting the nucleic acid molecules obtained from
said biological sample to a combination of at least 1228
polynucleotide probe sets to allow the formation of the nucleic
acid complex, wherein said 1228 polynucleotide probe sets comprise
probe set #1 to probe set #1228 as specified in Table 7.
6. The method according to claim 1, comprising determining the
variation of expression of: at least 275 determined genes belonging
to a group of determined genes selected from the nucleotide
sequences of SEQ ID NO: 5419 to SEQ ID NO: 5693, and at least one
variant of each of said at least 275 determined genes, when said
variants exist, said method comprising: (1) contacting the nucleic
acid molecules obtained from said biological sample to a
combination of at least 1640 polynucleotide probe sets to allow the
formation of the nucleic acid complex, wherein said 1640
polynucleotide probe sets comprise probe set #1 to probe set #1640
as specified in Table 7.
7. The method according to claim 1, wherein determining the
variation of expression comprises, determining an over
representation or an under representation for each of said at least
12 determined genes and at least one variant of each of said at
least 12 determined genes when said variants exist.
8. The method according to claim 1, wherein the nucleic acid
molecules obtained from said biological sample are mRNA or cDNA
prepared from said mRNA, the mRNA resulting from the expression of
the genes represented by the nucleotide sequences of SEQ ID NO:
5419 to SEQ ID NO: 5693, and/or at least one of said variants when
present represented by the nucleotide sequences of SEQ ID NO: 4579
to SEQ ID NO: 5418 and SEQ ID NO: 5694.
9. The method according to claim 1, wherein the 50 polynucleotide
probe sets are arranged in a microarray.
Description
[0001] The present invention describes a molecular in vitro
diagnosis of breast cancers. More particularly, the invention
relates to the use of molecular probes for the diagnosis evaluation
of breast tumors.
[0002] Breast Cancer is the most frequent cancer in women in
western countries (40 000 new cases in France/year). Although
several advances have been achieved in the last 10 years the
mortality rates remain high (11 000 death/year in France). There is
therefore a need for a new generation of advances in this disease.
Two axes have allowed improvement of breast cancer survival rates:
i. an earlier and more accurate diagnosis, ii. the development of
adjuvant therapies.
[0003] Breast Cancer diagnosis is currently performed in a vast
majority of cases by a preoperative core needle biopsy. This exam
is currently considered as a level 1 recommendation in France
(www.has-sante.fr). In selected centers that are experts in this
field, a fine needle aspiration is used to perform breast cancer
diagnosis. Overall, the preoperative diagnosis of breast cancer is
currently allowed by microscopic assessment of samples obtained
either fine needle aspiration (FNA) or core needle biopsy (CNB).
Each of this approach presents some limitations that hamper the
quality of care in patients who present a breast lesion. FNA is
associated with an unacceptable rate of misdiagnosis. The rate of
uncertain diagnosis is indeed around 30% (Oyama T, Koibuchi Y,
McKee G. Core needle biopsy (CNB) as a diagnostic method for breast
lesions: comparison with fine needle aspiration cytology (FNA).
Breast Cancer. 2004; 11(4):339-42; Orell S R, Farshid G.
False-positive reports in fine needle biopsy of breast lesions.
Pathology. 2001 November; 33(4):428-36; Meunier M, Clough K. Fine
needle aspiration cytology versus percutaneous biopsy of
nonpalpable breast lesions. Eur J Radiol. 2002 April; 42(1):10-6).
CNB exhibits better performance for diagnosis but is associated
with some major limitations. First, since CNB is a complex
procedure, the appointments are usually given several weeks after
detection of breast lesions. This induces a delayed diagnosis and
therefore treatment. With the increase of mass screening, this
delay will probably increase over time. Second, the CNB is
associated with clinical side effects. The rate of hematoma related
to the procedure indeed range between 0.6 and 4% (Barreau B, Tastet
S, Lakdja F, Henriques C, Valentin F, Labat M J, Dilhuydy M H.
[Patients' information in percutaneous core breast biopsy] Bull
Cancer. 2005 March; 92(3):257-65). In addition, CNB is associated
is a more painful procedure as compared to FNA. Finally, CNB is an
expensive procedure for a frequent disease (200 Euros/procedure).
Overall, from these considerations rises the need for a diagnostic
test performed on FNA samples that would be accurate, quick and
cost-saving. This test could either substitute cytological exam of
FNA sample or be performed in complement to this one. This test
would allow an earlier, safer and cost-saving diagnosis
procedure.
[0004] Regarding mass screening, mammogram is currently considered
as the gold standard for mass screening. Nevertheless, this
approach is limited by a high rate of false negative results,
especially in young women and in aggressive tumors. In addition,
mammogram is limited by the fact that a significant proportion of
women do not perform the test. These considerations point out the
need for a screening test that would be better or complementary to
mammogram and that would be based on an easier procedure.
[0005] So, there is a need to provide test for the patients to
diagnose and give a diagnosis of the status of the breast tumor
detected.
[0006] Many methods based on the knowledge of the molecular
mechanism of the breast tumor evolution have been extensively
described. These methods describe in particular large-scale process
for the determination of variation of expression of genes, or
proteins, which can define a hallmark of the breast tumor
evolution.
[0007] WO 2007/048978 describes methods and compositions for the
detection of molecular markers in order to diagnose cancer. In
particular, this document describes methods and compositions that
can be used to detect the presence or evolution of a breast tumor
in a patient.
[0008] However, this document discloses in particular micro-arrays
for the evaluation of miss-regulated expressed genes, without
interest for the expression of variants of genes.
[0009] WO 2004/065545 discloses a diagnostic and prognostic method
of the breast cancer tumor status, wherein said method consists to
compare the expression profile of at least 5 genes of a determined
list of 70 genes to the expression profile of said at least 5 genes
of a determined list of 70 genes of a control tumor.
[0010] However, this document never teaches that the disclosed
method can detect splicing variant of the mentioned at least 5
genes chosen among the list of 70 genes to determine the breast
cancer status of a tumor.
[0011] The setting-up of new arrays to analyse the large-scale
expression of exons allows a highly accurate identification of
differential molecular events between two conditions. This approach
not only analyzes genes differentially expressed (as it is the case
with conventional DNA array) but also the differential splicing
events. Applied to breast cancer, this large scale analysis could
identify differential expression of gene sequences between cancer
and benign lesions. Based on these data, it would be possible to
set-up molecular assays that could allow a molecular diagnosis of
breast cancer based on FNA samples, that would allow a quick,
accurate and cost-saving diagnosis. In addition, this approach
could allow to set-up a molecular test for breast cancer screening
based on blood samples, ductal lavage or breast sampling by
FNA.
[0012] One aim of the invention is to provide a molecular diagnosis
to determine the status of a breast tumor.
[0013] Another aim of the invention provides micro-arrays to
determine the benign or malignant status of a breast tumor.
[0014] Another aim of the invention provides a method using the
micro-array to determine the benign or malignant status of a breast
tumor.
[0015] The invention also provides a kit for the breast cancer
diagnosis.
[0016] The invention discloses the use of a multiplicity of
polynucleotide probe sets, said multiplicity of polynucleotide
probe sets consisting in a combination of pools of polynucleotide
probe sets, each polynucleotide probe set containing at least one
polynucleotide probe chosen among a library of nucleic acid
sequences, each nucleic acid sequence specifically hybridizing with
a gene, and/or at least one of its variants when present, said gene
being chosen among the group of genes consisting in SEQ ID NO 5419
to SEQ ID NO 5693, [0017] each given gene, when it presents NO
variant, comprising at least one target region, the nucleic acid
sequence of which is chosen among SEQ ID NO 2939 TO SEQ ID NO 4578,
said target region characterizing said gene, [0018] each given
gene, when it presents at least one variant, comprising at least
two target regions such that: [0019] at least one of the respective
nucleic acid sequences of said target region chosen among SEQ ID NO
2939 to SEQ ID NO 4578 is present in a given variant of said gene,
[0020] at least one of the respective nucleic acid sequences of
said target region chosen among SEQ ID NO 2939 to SEQ ID NO 4578 is
either absent in a given variant or is present in a configuration
that differs from the one of said gene, [0021] said two target
regions characterizing said gene, [0022] each variant of a given
gene presenting at least one target region, said target region
being such that its respective nucleic acid sequence is chosen
among SEQ ID NO 2939 to SEQ ID NO 4578, [0023] each variant is
characterized by: [0024] either the combination of the presence of
at least one target region also present in the gene, the respective
nucleic acid sequence of which being chosen among SEQ ID NO 2939 to
SEQ ID NO 4578, and the absence of at least one target region
present in the gene the respective nucleic acid sequence of which
being chosen among SEQ ID NO 2939 to SEQ ID NO 4578, [0025] or the
presence of a target region, the respective nucleic acid sequence
of which being chosen among SEQ ID NO 2939 to SEQ ID NO 4578, said
target region presenting a configuration that does not naturally
exist in the gene, [0026] each polynucleotide probe of a
polynucleotide probe set hybridizes with a specific nucleic acid
sequence contained in a given target region of the target regions
characterizing a given gene, and/or at least one of its variants
when present, [0027] each given gene, and its variants when
present, is specifically recognized by the polynucleotide probes of
at least a given polynucleotide probe set, [0028] each
polynucleotide probe of a given pool of polynucleotide probe set
being such that it hybridizes with a given gene, and/or at least
one of its variants when present, and cannot hybridize with any
other gene different from said given gene, and cannot hybridize
with any other variants of a gene different from said given gene,
[0029] the polynucleotide probes involved in the combination of
pools of polynucleotide probe sets of said multiplicity of
polynucleotide probe sets being such that each polynucleotide probe
specifically hybridizes with one gene, and/or at least one of its
variants when present, of a sub-group comprising 12 genes among the
genes of the group consisting in SEQ ID NO 5419 to SEQ ID NO 5693,
for determining the variation of expression a gene, and its
variants when present, of said sub-group in order to diagnose the
benign or malignant state of a breast tumor. The invention
discloses the use of a multiplicity of polynucleotide probe sets,
[0030] each polynucleotide probe set containing at least one
polynucleotide probe chosen among a library of nucleic acid
sequences, said library compring or consisting of at least one copy
each of the nucleic acids consisting of SEQ ID NO 1 to SEQ ID NO
2938, [0031] said polynucleotide probes being such that the nucleic
acid sequence of each polynucleotide probe specifically hybridizes
with the nucleotidic sequence of one target region of one gene,
and/or of at least one of its variants when present, for
determining the variation of the expression of [0032] at least 12
determined genes belonging to a group of determined genes
represented by the nucleotidic sequences SEQ ID NO: 5419 to SEQ ID
NO: 5693 and [0033] at least one variant of said genes at least 12
determined genes, when they exist,
[0034] said 12 determined genes being represented by the following
nucleotidic sequences:
[0035] SEQ ID NOs 5421; 5423; 5432; 5434; 5486; 5491; 5525; 5552;
5599; 5652; 5654 and 5683,
in order to diagnose in vitro or ex vivo the benign or malignant
state of a breast tumor,
[0036] wherein [0037] a) each given gene, [0038] a. when it
presents no variant, comprises at least one target region, said
target region characterizing said gene, [0039] b. when it presents
one variant, comprises at least one target region, said target
region characterizing said gene and its variant, and preferably
said variant being characterized by the fact that its nucleic acid
sequence is shorter than the nucleic acid sequence of said gene,
[0040] c. when it presents at least two variants, comprises at
least two target regions, said two target regions characterizing
said gene, such that: [0041] i. at least one of the respective
polynucleotidic sequences of said target region is present in a
given variant of said gene, and [0042] ii. at least one of the
respective polynucleotidic sequences of said target region is
either [0043] absent in a given variant, or [0044] present in a
given variant in a configuration that differs from the one of said
gene, [0045] preferably said variant being characterized such that
its nucleic acid sequence is shorter than the nucleic acid of said
gene, [0046] b) each variant of a given gene presents at least one
target region, and [0047] if said variant is the unique variant of
a gene, said variant has the same target as said gene, and [0048]
if said variant is one of the variants of a gene that has at least
two variants, each variant of said gene is characterized by either:
[0049] a. the combination of the presence of at least one target
region also present in the gene, and the absence of at least one
target region present in the gene, or [0050] b. the combination of
the presence of at least one target region also present in the
gene, and the presence of a target region, said target region
presenting a configuration that does not naturally exist in the
gene, [0051] c) the nucleotidic sequence of each given gene, and
its variants when present, is specifically recognized by the
nucleic acid sequences of polynucleotide probes contained in at
least one given polynucleotide probe set, [0052] d) the nucleic
acid sequence of each polynucleotide probe of a polynucleotide
probe set hybridizes with a specific polynucleotidic sequence
contained in a given target region of the target regions which
characterize a given gene, and/or at least one of its variants when
present, [0053] e) the nucleic acid sequence of each polynucleotide
probe of a given pool of polynucleotide probe set being such that
[0054] a. it hybridizes with the nucleotidic sequence of a given
gene, and/or of at least one of its variants when present, and
[0055] b. cannot hybridize with [0056] i. the nucleotidic sequence
of any other gene different from said given gene, and [0057] ii.
the nucleotidic sequence of any other variants of a gene different
from said given gene, [0058] with the proviso that said gene, and
its variants when present, is not KRT17, LOC440421, KRT6C and
KRT6A, said genes being respectively represented by SEQ ID NO 5431;
5689; 5651 and 5682.
[0059] In the case of KRT17, LOC440421, KRT6C and KRT6A genes, said
genes being respectively represented by SEQ ID NO 5431; 5689; 5651
and 5682, the above mentioned definition of the nucleic acid
sequence of each polynucleotide probe of a given pool of
polynucleotide probe set applies with the exception that: [0060]
1--polynucleotide probes of a given pool of polynucleotide probe
set recognizing KRT17 can hybridize with LOC440421 and at least one
of its variant when present, [0061] 2--polynucleotide probes of a
given pool of polynucleotide probe set recognizing LOC440421 can
hybridize with KRT17 and at least one of its variant when present,
[0062] 3--polynucleotide probes of a given pool of polynucleotide
probe set recognizing KRT6C can hybridize with KRT6A and at least
one of its variant when present, and [0063] 4--polynucleotide
probes of a given pool of polynucleotide probe set recognizing
KRT6A can hybridize with KRT6C and at least one of its variant when
present.
[0064] The invention is based on the unexpected observation made by
the inventors that the variation of expression of some genes, and
their variants when they exist, may characterize the evolution of a
diagnosed breast tumor. More particularly, the variants of the
invention are the products of a differential splicing, or
alternative splicing.
[0065] The inventors have demonstrated that the variation of
expression of at least 12 determined genes of a group of 275
determined genes, and of variants of said at least 12 determined
genes when they exist, hallmarks the benign or malignant status of
a breast tumor.
[0066] Then, the invention describes the use of polynucleotide
probes to characterize a benign versus malignant hallmark of a
breast tumor, each polynucleotide probe hybridizing specifically
with one gene, and at least one of its splicing variants when they
exist, said gene splicing variant being able to be recognized by at
least one polynucleotide probe.
[0067] In genetics, splicing is a modification of genetic
information after transcription, in which introns of precursor
messenger RNA (pre-mRNA) are removed and exons of precursor
messenger RNA are joined. The splicing prepares the pre-mRNA to
produce the mature messenger RNA (mRNA), which then undergoes
translation as part of the protein synthesis to produce
proteins.
[0068] Alternative splicing, in the sense of the invention, is the
RNA splicing variation mechanism, in which the exons of the
pre-mRNA are separated and reconnected so as to produce alternative
ribonucleotide arrangements. In this way, alternative splicing uses
genetic expression to facilitate the synthesis of a greater variety
of transcripts.
[0069] When the pre-mRNA has been transcribed from the DNA, it
includes several introns and exons. The exons which are retained in
the mRNA are determined during the splicing process. The use of
alternative splicing factors leads to a modification of the
definition of a "gene" and imposes the variant notion.
[0070] For example a pre-mRNA containing 3 exons, if it is
considered that variants must contain at least one exon of the gene
and at least one exon missing of said gene, can hypothetically
produce 6 different variants, as the result of alternative
splicing.
[0071] In the invention, a gene is defined by the fact that it
comprises the deoxyribonucleic acid sequence corresponding to the
mRNA which results of the transcription of the DNA sequence, and
after the splicing process. Then, the gene is characterized in that
it comprises all the exons present in the genomic sequence of said
gene.
[0072] All the 275 genes considered in the invention present a
nucleic acid sequence chosen among the group consisting in SEQ ID
NO 5419 to SEQ ID NO 5693.
[0073] In the invention, there are two alternatives for a gene:
[0074] said gene is not submitted to alternative splicing, and
presents no variants, or [0075] said gene presents at least one
variant.
[0076] In the case of a gene having no variant, this gene can is
characterized in the invention by the presence of a target region.
This target region corresponds to a nucleic acid sequence contained
in the total nucleic acid sequence of the said gene.
[0077] In the case of a gene having one variant, this gene is
defined by a target region, and its variant is defined by the same
target region. The difference between the gene and its variant is
preferably determined by the fact that the nucleic acid sequence of
said gene is longer than the nucleic acid sequence of its
variant.
[0078] This recognizing by one target region allows a redundancy of
the representativity of said gene. Indeed, the target region
contained in a gene having one variant is thus recognized at least
twice, i.e. when the gene is present and when the variant of this
gene is present. This redundancy enhances the specificity of
detection of the gene expression variation.
[0079] In the case of a gene having at least two variants, this
gene is defined by at least two regions, these two regions
characterizing the gene. These regions are therefore present in
gene. These regions, also called target regions correspond to
nucleic acid sequences contained in the total nucleic acid sequence
of said gene. Moreover, these target regions of said gene are
located at a different position in the sequence of said gene.
[0080] The targets regions that are involved in the invention
present a nucleic acid sequence chosen among the group consisting
in SEQ ID NO 2939 to SEQ ID NO 4578.
[0081] According to the invention, a "variant" is defined as a
polynucleotide molecule that differs from the reference
polynucleotide molecule (the gene), but retains essential
properties. The gene and its variants share similar polynucleotide
sequences with, for example, 70% of nucleic acids identity,
preferably 80% of nucleic acids identity, preferably 90% of nucleic
acids identity and more preferably 95% of nucleic acids identity.
The variants of the invention can be also considered as
isoforms.
[0082] To be considered as a variant of a given gene, a
polynucleotide sequence must contain at least one nucleotide
sequence present in the said gene, this sequence corresponding to
the target sequence defined above.
[0083] If a variant is the unique variant of a gene, this variant
has the same target region as its gene, preferably with a nucleic
acid sequence with a size that is shorter than the size of the
nucleic acid sequence of said gene. Since said variant corresponds
to a splicing product of a gene, it generally has one or more exons
lacking that are present in said gene. Nevertheless, it is
possible, in some rare examples, that a variant of a gene has a
nucleic acid sequence with a size which is higher than the size of
the nucleic acid sequence of said gene.
[0084] If a variant is a variant of a gene that has at least two
variants, said variant has at least one difference in the presence
of a nucleic acid sequence with respect to the given gene nucleic
acid sequence. The specific combination of the presence of at least
one target sequence and the absence of at least one target sequence
defines the specific characteristic of a given variant. Therefore,
each variant is defined by a "bar code" corresponding to the
diversity of the presence and absence of all the target sequences
present in a gene.
[0085] For example, if a gene contains 3 exons, all the nucleic
acid sequences consisting in least one exon of said gene, and
missing at least one of the other 2 exons of the said given gene,
are considered as variants of said given gene.
[0086] FIG. 1A illustrates this example.
[0087] In the invention, a variant of a gene is characterized in
that it comprises at least on target region. These target regions
corresponds to polynucleotidic sequences chosen among the group
consisting in SEQ ID NO 2939 to SEQ ID NO 4578.
[0088] So, a given variant of a gene can be characterized with
respect to the target sequence by the fact it contains at least a
target region, present in the gene corresponding to said variant,
and must is devoid of at least one target region, present in the
gene corresponding to said variant, only in the case of a gene that
has at least two variants.
[0089] As defined above, a variant of a gene having at least two
variants is then characterized by a bar code which corresponds to a
combination of the presence of at least one target region of the
gene, corresponding to the variant, and the absence of at least one
target region of the gene corresponding to the variant.
[0090] A variant can also be alternatively defined. This other
definition is supported by the feature of the invention: the
alternative splicing.
[0091] When a gene, constituted by at least 3 exons, is
differentially spliced, in the corresponding variants, some exons
are fused to exons which are not naturally fused in the sequence of
the gene. For example, in a gene constituted by 3 exons E1, E2 and
E3, one variant can be constituted by the fusion of E1 and E3. In
the gene, the natural configuration corresponds to the sequence
E1-E2-E3. Then the configuration observed in the variant, E1-E3, is
considered as a non natural configuration.
[0092] In this case, variant presents a sequence that does not
exist in the natural configuration of the gene. It generally
corresponds to a junction of to distant exons, separated by at
least one other exon. If the target region characterizing the
variant corresponds to the junction between two exons, naturally
distant in the normal configuration in the gene, said target region
characterizes specifically said variant. This example is
illustrated by FIG. 1B.
[0093] Example of genes having, or not, at least one variant are
represented in FIG. 3.
[0094] According to the invention, polynucleotide probes are used
to detect the variation of expression of a gene, and/or its
variants when they exist, to determine the status of a breast
tumor.
[0095] Artificially, polynucleotide probes are grouped to form a
polynucleotide probe set. The term "polynucleotide probe set" used
in the invention defines a group of polynucleotide probes as
described above. A given set of polynucleotide probe contains from
one polynucleotide probe to several polynucleotide probes.
Preferably, the polynucleotide probe set of the invention contains
one polynucleotide probe to three or four polynucleotide probes.
Thereby, polynucleotide probes regrouped in a polynucleotide probe
set of the invention are able to hybridize to the same target
region.
[0096] The polynucleotides probes are also brought together to form
a "pool of polynucleotide probe sets". The polynucleotides probes
contained in the polynucleotide probe sets of a pool are able to
specifically hybridize with nucleic acid sequences of a gene,
and/or variants of said gene when they exist.
[0097] Alternatively, the polynucleotide probes contained in the
polynucleotide probe sets of a pool are able to specifically
hybridize neither with nucleic acid sequences of a different gene,
nor with nucleic acid sequences of variants of said different gene,
when they exist.
[0098] However, in few cases, the above definition should be
modulated. In the case of genes KRT17 (SEQ ID NO 5431) and
LOC440421 (SEQ ID NO 5689), these genes are two different genes,
but share a high similarity/identity in their nucleic acid
sequence. Thus, these two genes present some gene regions in their
nucleic acid sequence which can be identical. If a target region is
present in said gene region, therefore, the polynucleotide probe
that recognize the target region contained in said gene region will
be able to recognize the two genes.
[0099] A similar example applies with genes KRT6A (SEQ ID NO 5682)
and KRT6C (SEQ ID NO 5651).
[0100] Then, polynucleotide probes of a pool of polynucleotide
probe sets are able to characterize a gene and its variants.
Moreover, a given gene, and its variants when they exist, can be
detected only by the polynucleotide probes of the same pool of
polynucleotide probe sets.
[0101] According to the invention, each gene, and its variants when
present, can be detected by all the polynucleotide probes of a
probe set. Moreover, each gene can be recognized by all the
polynucleotide probes of at least one polynucleotide probe set,
i.e. each gene and its variants can be defined by at least one
polynucleotide probe set.
[0102] A variant can be detected by two polynucleotide probes
belonging to two different polynucleotide probe sets, provided that
they belong to the same pool of polynucleotide probe set.
[0103] The multiplicity, pool, polynucleotide probe set, and
polynucleotide probe interconnection are represented in FIG. 2.
Terms "library compring or consisting of at least one copy each of
the nucleic acids consisting of SEQ ID NO 1 to SEQ ID NO 2938"
means that the library can contain one, or two, or three, or four,
or five or six or seven or eight, or nine or ten copies of each
polynucleotide probes represented by the nucleic acids consisting
of SEQ ID NO 1 to SEQ ID NO 2938. Thus, the minimal library
contains 2938 polynucleotides probes, and the maximal library
contains 29380 polynucleotides probes. Preferably the preferred
library of the invention contains 4582 polynucleotides probes.
[0104] In the invention, a "benign breast tumor" is any
non-cancerous breast abnormality. Some (not all) benign conditions
can signal an increased risk for breast cancer. The most common
benign breast conditions include fibrocystic breast condition,
benign breast tumors, and breast inflammation. Depending on the
type of benign breast condition and the patient's medical
situation, treatment may or may not be necessary.
[0105] In the invention, a "malignant breast tumor refers" to a
malignant tumor that has developed from cells in the breast.
Malignant tumors penetrate and destroy healthy body tissues. A
group of cells within a tumor may also break away and spread to
other parts of the body. Cells that spread from one region of the
body into another are called metastases.
[0106] The term "base" is used to define the components of the DNA
or RNA, i.e. deoxyribonucleotides and ribonucleotides
respectively.
[0107] Terms "nucleic acids", "nucleic acid molecule", "nucleic
acid sequence", "polynucleotidic sequence", and "polynucleotide"
are uniformly used to define a chain of bases that characterizing a
DNA or an RNA molecule.
[0108] In the invention, "polynucleotide probe" represent a
fragment of nucleic acid molecule, corresponding to DNA or RNA,
with a variable length. The length of the polynucleotide probe is
commonly comprised between 15 bases to 1000 bases, and preferably
between 20 bases to 500 bases. Advantageously, the polynucleotide
probes defined in the invention comprise from 20 bases to 30 bases.
These polynucleotide probes are defined by their nucleic acid
sequence.
[0109] In the invention, terms "multiplicity" and "combination" are
used to define a group of polynucleotide probes sets and
polynucleotide probes, respectively. Theses groups correspond to an
ensemble of probes, or sets of probes, characterized in that they
contains similar information.
[0110] According to the invention, each nucleic acid sequence
corresponding to nucleic acid probe "specifically hybridizes with"
a target region of the said gene. These terms mean that each
polynucleotide probe is able to hybridize with a gene, and/or its
variants when they exist, defined above. The polynucleotide probe
thereby hybridizes to single-stranded nucleic acid molecule (gene
and/or its variants, which are DNA or RNA) whose nucleic acid
sequence allows base pairing due to complementarity between the
nucleic acid sequence of the probe and the nucleic acid sequence of
the gene and/or variants of said gene. The base pairing (A-T;G-C)
is a concept well known by the skilled man in the art.
[0111] Each polynucleotide probe is able to hybridize with one gene
and/or at least one variant of said gene, in a specific region of
said variant called target region.
[0112] Said target region is then defined as the region allowing
the base pairing between polynucleotide probe and a gene and/or its
variants, when they exist.
[0113] Thereby, each polynucleotide probe is able to define a gene
and/or at least one variant of said gene, when they exist.
[0114] According to the invention, each polynucleotide probe
specifically hybridizes with a specific nucleic acid sequence
contained in the target region. Moreover, each polynucleotide
probes can recognizes a sequence overlapping partially with the
sequence recognized by another probe of the same polynucleotide
probe set.
[0115] To sum up, in the invention each gene, or reference
transcript, can be expressed differentially in the form of
variants. These variants differ from each other by the presence or
absence or the variation of a sequence of a specific region: the
target region. This region is liable to be recognized by one to
three polynucleotide probes, said polynucleotide probes hybridizing
with the same target region being brought together in a
polynucleotide probe set.
[0116] Then, the use of the multiplicity of polynucleotide probe
sets of the invention allows to detect the variation of expression
of at least 12 determined genes consisting in SEQ ID NO 5421, SEQ
ID NO 5423, SEQ ID NO 5432, SEQ ID NO 5434, SEQ ID NO 5486, SEQ ID
NO 5491, SEQ ID NO 5525, SEQ ID NO 5552, SEQ ID NO 5599, SEQ ID NO
5652, SEQ ID NO 5654 and SEQ ID NO 5683, and their variants when
they exist, of the group of determined genes constituted by genes
of the group constituted by SEQ ID NO 5419 to SEQ ID NO 5693, and a
skill man in the art can determine if the breast tumor is malignant
or benign.
[0117] Thereby, if the expression of a given gene and/or at least
one of its variants belonging to the group of 12 determined genes
corresponds to a "profile" similar to that of a benign tumor, the
tumor of the patient will be considered as evolving to a benign
status. In contrast, the expression of a gene and/or at least one
of its variant belonging to the group of 12 genes corresponds to
that of a "profile" similar to a malignant tumor, it will be
considered that the tumor is a malignant tumor.
[0118] In one embodiment, the invention discloses the use of a
multiplicity of polynucleotide probe sets, wherein the multiplicity
of polynucleotide probe sets consisting in a combination of pools
of polynucleotide probe sets chosen among 1640 probe sets of
polynucleotides, each polynucleotide probe set containing at least
one polynucleotide probe chosen among a library of nucleic acid
sequences consisting in SEQ ID NO 1 to SEQ ID NO 2938, each nucleic
acid sequence hybridizing with a gene, and/or at least one of its
variants when present, said gene being chosen among the group of
genes consisting in SEQ ID NO 5419 to SEQ ID NO 5693, [0119] each
given gene, when it presents NO variant, comprising at least one
target region, the nucleic acid sequence of which is chosen among
SEQ ID NO 2939 TO SEQ ID NO 4578, said target region characterizing
said gene, [0120] each given gene, when it presents at least one
variant, comprising at least two target regions such that: [0121]
at least one of the respective nucleic acid sequences of said
target region chosen among SEQ ID NO 2939 to SEQ ID NO 4578 is
present in a given variant of said gene, [0122] at least one of the
respective nucleic acid sequences of said target region chosen
among SEQ ID NO 2939 to SEQ ID NO 4578 is either absent in a given
variant or is present in a configuration that differs from the one
of said gene, [0123] said two target regions characterizing said
gene, [0124] each variant of a given gene presenting at least one
target region, said target region being such that its respective
nucleic acid sequence is chosen among SEQ ID NO 2939 to SEQ ID NO
4578, [0125] each variant is characterized by: [0126] either the
combination of the presence of at least one target region also
present in the gene, the respective nucleic acid sequence of which
being chosen among SEQ ID NO 2939 to SEQ ID NO 4578, and the
absence of at least one target region present in the gene the
respective nucleic acid sequence of which being chosen among SEQ ID
NO 2939 to SEQ ID NO 4578, [0127] or the presence of a target
region, the respective nucleic acid sequence of which being chosen
among SEQ ID NO 2939 to SEQ ID NO 4578, said target region
presenting a configuration that does not naturally exist in the
gene, [0128] each polynucleotide probe of a polynucleotide probe
set hybridizes with a specific nucleic acid sequence contained in a
given target region of the target regions which characterize a
given gene, and/or at least one of its variants when present,
[0129] each given gene, and its variants when present, is
specifically recognized by at least a given polynucleotide probe
set, [0130] each polynucleotide probe of a given pool of
polynucleotide probe set being such that it hybridizes with a given
gene, and/or at least one of its variants when present, and cannot
hybridize with any other gene different from said given gene, and
cannot hybridize with any other variants of a gene different from
said given gene, [0131] the polynucleotide probes involved in the
combination of pools of polynucleotide probe sets of said
multiplicity of polynucleotide probe sets being such that each
polynucleotide probe specifically hybridizes with one gene, and/or
at least one of its variants when present, of a sub-group
comprising 12 genes among the genes of the group consisting in SEQ
ID NO 5419 to SEQ ID NO 5693,
[0132] for determining the variation of expression a gene, and its
variants when present, of said sub-group in order to diagnose the
benign or malignant state of a breast tumor.
[0133] In one preferred embodiment, the invention discloses the use
of a multiplicity of polynucleotide probe sets defined above, for
determining the variation of the expression of at least 20
determined genes of a group of genes represented by the nucleotidic
sequences SEQ ID NO: 5419 to SEQ ID NO: 5693, [0134] said 20
determined genes being represented by the following nucleotidic
sequences: [0135] SEQ ID Nos 5421; 5423; 5432; 5434; 5457; 5486;
5491; 5513; 5516; 5525; 5532; 5552; 5599; 5616; 5624; 5643; 5652;
5654; 5673 and 5683.
[0136] The invention resides in the unexpected observation that the
variation of expression of a group of at least 20 determined genes
chosen among 275 determined genes is sufficient to determine the
malignant or the benign status of a breast tumor.
[0137] In another preferred embodiment the invention discloses the
use of a multiplicity of polynucleotide probe sets as above
defined, for determining the variation of the expression of at
least 35 determined genes of a group of determined genes
represented by the nucleotidic sequences SEQ ID NO: 5419 to SEQ ID
NO: 5693 [0138] said 35 determined genes being represented by the
following nucleotidic sequences:
SEQ ID Nos 5421; 5423; 5431; 5432; 5434; 5440; 5457; 5462; 5470;
5486; 5491; 5505; 5513; 5516; 5525; 5532; 5546; 5552; 5594; 5599;
5601; 5603; 5616; 5618; 5624; 5627; 5630; 5643; 5645; 5652; 5654;
5660; 5669; 5673 and 5683.
[0139] The invention also resides in the unexpected observation
that the variation of expression of a group of at least 35
determined genes chosen among 275 determined genes is sufficient to
determine the malignant or the benign status of a breast tumor.
[0140] In another preferred embodiment the invention discloses the
use of a multiplicity of polynucleotide probe sets previously
defined, for determining the variation of the expression of at
least 43 determined genes of a group of determined genes
represented by the nucleotidic sequences SEQ ID NO: 5419 to SEQ ID
NO: 5693, [0141] said 43 determined genes being represented by the
following nucleotidic sequences: [0142] SEQ ID Nos 5421; 5423;
5431; 5432; 5434; 5440; 5455; 5457; 5462; 5470; 5475; 5486; 5491;
5499; 5505; 5513; 5516; 5520; 5525; 5532; 5546; 5549; 5552; 5594;
5599; 5601; 5603; 5616; 5618; 5623; 5624; 5627; 5630; 5643; 5645;
5651; 5652; 5654; 5660; 5669; 5673; 5683 and 5686.
[0143] The invention also resides in the unexpected observation
that the variation of expression of a group of at least 43
determined genes chosen among 275 determined genes is sufficient to
determine the malignant or the benign status of a breast tumor.
[0144] In another preferred embodiment the invention discloses the
use of a multiplicity of polynucleotide probe sets such as defined
above, for determining the variation of the expression of at least
206 determined genes of a group of determined genes represented by
the nucleotidic sequences SEQ ID NO: 5419 to SEQ ID NO: 5693 [0145]
said 206 determined genes being represented by the following
nucleotidic sequences: SEQ ID Nos 5420; 5421; 5422; 5423; 5425;
5426; 5427; 5428; 5429; 5430; 5431; 5432; 5434; 5435; 5436; 5437;
5438; 5439; 5440; 5441; 5442; 5443; 5444; 5445; 5446; 5447; 5449;
5450; 5451; 5452; 5453; 5454; 5455; 5456; 5457; 5459; 5460; 5461;
5462; 5463; 5465; 5467; 5468; 5470; 5473; 5475; 5476; 5479; 5480;
5482; 5484; 5485; 5486; 5487; 5488; 5489; 5490; 5491; 5492; 5493;
5495; 5496; 5497; 5498; 5499; 5502; 5503; 5505; 5506; 5507; 5508;
5509; 5511; 5512; 5513; 5515; 5516; 5517; 5518; 5519; 5520; 5523;
5524; 5525; 5526; 5528; 5529; 5530; 5531; 5532; 5533; 5534; 5536;
5538; 5539; 5540; 5543; 5544; 5545; 5546; 5547; 5549; 5550; 5552;
5553; 5554; 5556; 5558; 5559; 5560; 5562; 5563; 5564; 5565; 5566;
5567; 5568; 5569; 5570; 5571; 5573; 5574; 5575; 5576; 5577; 5578;
5581; 5582; 5585; 5587; 5588; 5590; 5591; 5593; 5594; 5595; 5597;
5598; 5599; 5600; 5601; 5602; 5603; 5604; 5605; 5606; 5608; 5609;
5610; 5611; 5612; 5613; 5615; 5616; 5617; 5618; 5622; 5623; 5624;
5625; 5627; 5629; 5630; 5631; 5632; 5633; 5634; 5635; 5637; 5638;
5639; 5640; 5641; 5642; 5643; 5644; 5645; 5647; 5648; 5649; 5651;
5652; 5653; 5654; 5656; 5657; 5658; 5660; 5661; 5665; 5667; 5669;
5672; 5673; 5675; 5676; 5677; 5678; 5680; 5681; 5683; 5684; 5686;
5687; 5689 and 5692.
[0146] The invention also resides in the unexpected observation
that the variation of expression of a group of at least 206
determined genes chosen among 275 determined genes is sufficient to
determine the malignant or the benign status of a breast tumor, and
provide the best results.
[0147] In another preferred embodiment the invention discloses the
use of a multiplicity of polynucleotide probe sets such as above
defined, for determining the variation of the expression of 275
determined genes represented by the nucleotidic sequences SEQ ID
NO: 5419 to SEQ ID NO: 5693.
[0148] The invention also resides in the unexpected observation
that the variation of expression of 275 determined genes is
sufficient to determine the malignant or the benign status of a
breast tumor.
[0149] Then, in an advantageous embodiment, the invention describes
the use of a multiplicity of polynucleotide probe sets that allow
the detection of variation of expression 12 genes, and their
variants when they exist, said variation defining the benign or
malignant hallmark of the breast tumor.
[0150] More particularly, the 12 genes, and their variants when
they exist, are represented by their nucleic acid sequences
consisting in SEQ ID NO 5421, SEQ ID NO 5423, SEQ ID NO 5432, SEQ
ID NO 5434, SEQ ID NO 5486, SEQ ID NO 5491, SEQ ID NO 5525, SEQ ID
NO 5552, SEQ ID NO 5599, SEQ ID NO 5652, SEQ ID NO 5654 and SEQ ID
NO 5683 and are specifically recognized by their target
sequences.
[0151] In one preferred embodiment, the invention relates to the
use of a multiplicity of polynucleotide probe sets for determining
the variation the gene expression as defined above, and of at least
one variant of said genes when present, said variant being
represented by the nucleic acid sequences SEQ ID NO 4579 to SEQ ID
NO 5418 and SEQ ID NO 5694, the correspondence between each variant
and its corresponding gene being represented in Table 1A-E and in
Table 6.
[0152] Thus, according to the invention the inventors have
demonstrated that the determination of the variation of expression
of at least 12 genes chosen among a group of 275 genes, and of at
least one variant of each at least 12 genes give a good information
about the benign or malignant status of a breast tumor, without
important false positives.
[0153] Also, others aspects of the invention demonstrate that the
study of the variation of expression of: [0154] at least 20
determined genes, or [0155] at least 35 determined genes, or [0156]
at least 43 determined genes or [0157] at least 206 determined
genes [0158] of a group of 275 determined genes, and the expression
of at least one variant of said at least 20 determined genes, or
[0159] of said at least 35 determined genes, or [0160] of said at
least 43 determined genes, or [0161] of said at least 206
determined genes allows to the pathologist to clearly and without
ambiguity determine if a breast tumor is, or will be, benign or
malignant.
[0162] In one particular embodiment, the variation of expression of
all the 275 determined genes and at least one of their variant
allows the diagnostic.
[0163] In another particular embodiment, the invention relates to
the use as defined above, for the determination of the variation of
expression of at least 12 determined genes of the group of 275
determined genes represented by SEQ ID NO 5419 to SEQ ID NO 5693,
and of at least one of the variants of said at least 12 determined
genes, wherein the correspondence between genes and their variants
is indicated in the following table 1A.
[0164] Table 1A represents the correspondences between the group of
12 determined genes and their corresponding variants.
TABLE-US-00001 Gene Name Gene SEQ ID Variants SEQ ID AK5 SEQ ID NO
5654 SEQ ID NO 4620 COL17A1 SEQ ID NO 5683 SEQ ID NO 4739; SEQ ID
NO 4784; SEQ ID NO 5242; SEQ ID NO 5384 DMD SEQ ID NO 5421 SEQ ID
NO 4664; SEQ ID NO 4860; SEQ ID NO 5058; SEQ ID NO 5095; SEQ ID NO
5150; SEQ ID NO 5381; SEQ ID NO 5410; KIT SEQ ID NO 5423 SEQ ID NO
5107 KRT14 SEQ ID NO 5434 SEQ ID NO 4819; SEQ ID NO 4825; SEQ ID NO
4845; SEQ ID NO 4877; SEQ ID NO 4891; SEQ ID NO 4969 KRT16 SEQ ID
NO 5525 SEQ ID NO 4826; SEQ ID NO 4881 KRT5 SEQ ID NO 5432 SEQ ID
NO 5279 MYH11 SEQ ID NO 5599 SEQ ID NO 4697; SEQ ID NO 4870; SEQ ID
NO 5361; SEQ ID NO 5365 NRG1 SEQ ID NO 5552 SEQ ID NO 5084 PTN SEQ
ID NO 5486 SEQ ID NO 4666 SFRP1 SEQ ID NO 5491 SEQ ID NO 5161 TSHZ2
SEQ ID NO 5652 SEQ ID NO 4962
[0165] In another particular embodiment, the invention relates to
the use as defined above, for the determination of the variation of
expression of at least 20 determined genes of the group of 275
genes represented by SEQ ID NO 5419 to SEQ ID NO 5693, and of at
least one of the variants of said at least 20 determined genes,
wherein the correspondence between genes and their variants is
indicated in the following table 1B.
[0166] Table 1B represents the correspondences between the group of
20 determined genes and their corresponding variants.
TABLE-US-00002 Gene Name Gene SEQ ID Variants SEQ ID AK5 SEQ ID NO
5654 SEQ ID NO 5224 C2orf40 SEQ ID NO 5616 SEQ ID NO 4832 C9orf61
SEQ ID NO 5516 SEQ ID NO 4661 CNN1 SEQ ID NO 5457 SEQ ID NO 5181;
SEQ ID NO 4666 COL17A1 SEQ ID NO 5683 SEQ ID NO 4739; SEQ ID NO
4784; SEQ ID NO 5242; SEQ ID NO 5384 DMD SEQ ID NO 5421 SEQ ID NO
4664; SEQ ID NO 4860; SEQ ID NO 4908; SEQ ID NO 5058; SEQ ID NO
5095; SEQ ID NO 5150; SEQ ID NO 5381; SEQ ID NO 5410; SEQ ID NO
5107 DMN SEQ ID NO 5643 SEQ ID NO 4610; SEQ ID NO 5120 EDN3 SEQ ID
NO 5673 SEQ ID NO 5405 IL33 SEQ ID NO 5624 SEQ ID NO 4927 KIT SEQ
ID NO 5423 SEQ ID NO 5177; SEQ ID NO 4748; SEQ ID NO 4817; SEQ ID
NO 4821; SEQ ID NO 5152 KRT14 SEQ ID NO 5434 SEQ ID NO 4969 KRT16
SEQ ID NO 5525 SEQ ID NO 4826; SEQ ID NO 4881 KRT5 SEQ ID NO 5432
SEQ ID NO 5279; SEQ ID NO 4740; SEQ ID NO 4819; SEQ ID NO 4825; SEQ
ID NO 4845; SEQ ID NO 4877; SEQ ID NO 4878; SEQ ID NO 4891 MYH11
SEQ ID NO 5599 SEQ ID NO 4697; SEQ ID NO 4870; SEQ ID NO 4972; SEQ
ID NO 5103; SEQ ID NO 5323; SEQ ID NO 5361; SEQ ID NO 5365 NRG1 SEQ
ID NO 5552 SEQ ID NO 5084; SEQ ID NO 5413 NTRK2 SEQ ID NO 5532 SEQ
ID NO 5121 PIK3C2G SEQ ID NO 5513 SEQ ID NO 5109 PTN SEQ ID NO 5486
SEQ ID NO 5317; SEQ ID NO 4909 SFRP1 SEQ ID NO 5491 SEQ ID NO 5161
TSHZ2 SEQ ID NO 5652 SEQ ID NO 4962; SEQ ID NO 4620; SEQ ID NO
4694; SEQ ID NO 4786; SEQ ID NO 4794
[0167] In another preferred embodiment, the invention relates to
the use as defined above, for the determination of the variation of
expression of at least 35 determined genes of the group of 275
determined genes represented by SEQ ID NO 5419 to SEQ ID NO 5693,
and of at least one of the variants of said at least 35 determined
genes, wherein the correspondence between genes and their variants
is indicated in the following table 1C.
[0168] Table 1C represents the correspondences between the group of
35 determined genes and their corresponding variants.
TABLE-US-00003 Gene Name Gene SEQ ID Variants SEQ ID ACTA2 SEQ ID
NO 5462 -- AK5 SEQ ID NO 5654 SEQ ID NO 4586; SEQ ID NO 4620; SEQ
ID NO 4658; SEQ ID NO 4694; SEQ ID NO 4786; SEQ ID NO 4794; SEQ ID
NO 4856; SEQ ID NO 5078; SEQ ID NO 5224; SEQ ID NO 5391 C2orf40 SEQ
ID NO 5616 SEQ ID NO 4832 C9orf61 SEQ ID NO 5516 SEQ ID NO 4661
CNN1 SEQ ID NO 5457 SEQ ID NO 5181 CNTNAP3 SEQ ID NO 5627 SEQ ID NO
4675 COL14A1 SEQ ID NO 5594 SEQ ID NO 5102 COL17A1 SEQ ID NO 5683
SEQ ID NO 4739; SEQ ID NO 4784; SEQ ID NO 5242; SEQ ID NO 5384
CRYAB SEQ ID NO 5470 SEQ ID NO 4858 DMD SEQ ID NO 5421 SEQ ID NO
4664; SEQ ID NO 4860; SEQ ID NO 4908; SEQ ID NO 5058; SEQ ID NO
5095; SEQ ID NO 5150; SEQ ID NO 5381; SEQ ID NO 5387; SEQ ID NO
5410 DMN SEQ ID NO 5643 SEQ ID NO 4610; SEQ ID NO 5120 DST SEQ ID
NO 5660 SEQ ID NO 5309 EDN3 SEQ ID NO 5673 SEQ ID NO 5405 FAM126A
SEQ ID NO 5618 SEQ ID NO 5157 FBXL7 SEQ ID NO 5546 SEQ ID NO 4932
GRAMD3 SEQ ID NO 5601 SEQ ID NO 4857 IL33 SEQ ID NO 5624 SEQ ID NO
4927 IRX1 SEQ ID NO 5603 SEQ ID NO 5140 KIT SEQ ID NO 5423 SEQ ID
NO 5107; SEQ ID NO 5177 KRT14 SEQ ID NO 5434 SEQ ID NO 4740; SEQ ID
NO 4819; SEQ ID NO 4825; SEQ ID NO 4845; SEQ ID NO 4877; SEQ ID NO
4878; SEQ ID NO 4891; SEQ ID NO 4969 KRT16 SEQ ID NO 5525 SEQ ID NO
4826; SEQ ID NO 4881 KRT17 SEQ ID NO 5431 SEQ ID NO 4876; SEQ ID NO
4992 KRT5 SEQ ID NO 5432 SEQ ID NO 4748; SEQ ID NO 4817; SEQ ID NO
4821; SEQ ID NO 4919; SEQ ID NO 5152; SEQ ID NO 5279 MME SEQ ID NO
5440 SEQ ID NO 4579; SEQ ID NO 5054 MYH11 SEQ ID NO 5599 SEQ ID NO
4697; SEQ ID NO 4870; SEQ ID NO 4972; SEQ ID NO 5053; SEQ ID NO
5103; SEQ ID NO 5323; SEQ ID NO 5361; SEQ ID NO 5365 MYLK SEQ ID NO
5630 SEQ ID NO 5376 NDRG2 SEQ ID NO 5669 SEQ ID NO 4868; SEQ ID NO
4911 NRG1 SEQ ID NO 5552 SEQ ID NO 5084; SEQ ID NO 5148; SEQ ID NO
5413 NTRK2 SEQ ID NO 5532 SEQ ID NO 5121 PIK3C2G SEQ ID NO 5513 SEQ
ID NO 5109 PTN SEQ ID NO 5486 SEQ ID NO 4666; SEQ ID NO 5317 SFRP1
SEQ ID NO 5491 SEQ ID NO 4909; SEQ ID NO 5161 TANK SEQ ID NO 5505
SEQ ID NO 5069 TSHZ2 SEQ ID NO 5652 SEQ ID NO 4962 WIF1 SEQ ID NO
5645 SEQ ID NO 5397
[0169] In other preferred embodiment, the invention relates to the
use as defined above, for the determination of the variation of
expression of at least 43 determined genes of the group of 275
determined genes represented by SEQ ID NO 5419 to SEQ ID NO 5693,
and of at least one of the variants of said at least 43 determined
genes, wherein the correspondence between genes and their variant s
is indicated in the following table 1D.
[0170] Table 1D represents the correspondences between the group of
43 determined genes and their corresponding variants.
TABLE-US-00004 Gene Name Gene SEQ ID Variants SEQ ID ACTA2 SEQ ID
NO 5462 SEQ ID NO 4633; SEQ ID NO 4795; SEQ ID NO 4956; SEQ ID NO
5052; SEQ ID NO 5093; SEQ ID NO AK5 SEQ ID NO 5654 SEQ ID NO 4586;
SEQ ID NO 4620; SEQ ID NO 4658; SEQ ID NO 4694; SEQ ID NO 4786; SEQ
ID NO 4794; SEQ ID NO 4856; SEQ ID NO 5078; SEQ ID NO 5224; SEQ ID
NO 5391 C2orf40 SEQ ID NO 5616 SEQ ID NO 4832; SEQ ID NO 4862
C9orf61 SEQ ID NO 5516 SEQ ID NO 4661 CNN1 SEQ ID NO 5457 SEQ ID NO
5181; SEQ ID NO 5185 CNTNAP3 SEQ ID NO 5627 SEQ ID NO 4597; SEQ ID
NO 4675 COL14A1 SEQ ID NO 5594 SEQ ID NO 5102 COL17A1 SEQ ID NO
5683 SEQ ID NO 4739; SEQ ID NO 4784; SEQ ID NO 5242; SEQ ID NO 5384
CRYAB SEQ ID NO 5470 SEQ ID NO 4858 DKK3 SEQ ID NO 5549 SEQ ID NO
4933; SEQ ID NO 5208 DMD SEQ ID NO 5421 SEQ ID NO 4664; SEQ ID NO
4860; SEQ ID NO 4908; SEQ ID NO 5058; SEQ ID NO 5095; SEQ ID NO
5150; SEQ ID NO 5381; SEQ ID NO 5387; SEQ ID NO 5410 DMN SEQ ID NO
5643 SEQ ID NO 4610; SEQ ID NO 5120; SEQ ID NO 5396 DST SEQ ID NO
5660 SEQ ID NO 5309 EDN3 SEQ ID NO 5673 SEQ ID NO 5405 FAM126A SEQ
ID NO 5618 SEQ ID NO 5126; SEQ ID NO 5157 FBXL7 SEQ ID NO 5546 SEQ
ID NO 4932 GRAMD3 SEQ ID NO 5601 SEQ ID NO 4857 IL33 SEQ ID NO 5624
SEQ ID NO 4927 IRX1 SEQ ID NO 5603 SEQ ID NO 5140 KIT SEQ ID NO
5423 SEQ ID NO 5107; SEQ ID NO 5177 KRT14 SEQ ID NO 5434 SEQ ID NO
4740; SEQ ID NO 4819; SEQ ID NO 4825; SEQ ID NO 4845; SEQ ID NO
4877; SEQ ID NO 4878; SEQ ID NO 4891; SEQ ID NO 4969 KRT15 SEQ ID
NO 5475 SEQ ID NO 4619; SEQ ID NO 4867; SEQ ID NO 4967 KRT16 SEQ ID
NO 5525 SEQ ID NO 4826; SEQ ID NO 4881 KRT17 SEQ ID NO 5431 SEQ ID
NO 4876; SEQ ID NO 4992; SEQ ID NO 5036 KRT5 SEQ ID NO 5432 SEQ ID
NO 4748; SEQ ID NO 4782; SEQ ID NO 4817; SEQ ID NO 4821; SEQ ID NO
4827; SEQ ID NO 4919; SEQ ID NO 4970; SEQ ID NO 5152; SEQ ID NO
5279; SEQ ID NO 5406 KRT6C SEQ ID NO 5651 SEQ ID NO 4840 MGC70870
SEQ ID NO 5686 SEQ ID NO 5201 MID1 SEQ ID NO 5623 SEQ ID NO 4706
MME SEQ ID NO 5440 SEQ ID NO 4579; SEQ ID NO 4607; SEQ ID NO 5054
MYH11 SEQ ID NO 5599 SEQ ID NO 4697; SEQ ID NO 4870; SEQ ID NO
4972; SEQ ID NO 5053; SEQ ID NO 5103; SEQ ID NO 5323; SEQ ID NO
5361; SEQ ID NO 5365 MYLK SEQ ID NO 5630 SEQ ID NO 5376 NDRG2 SEQ
ID NO 5669 SEQ ID NO 4868; SEQ ID NO 4898; SEQ ID NO 4911; SEQ ID
NO 5010 NRG1 SEQ ID NO 5552 SEQ ID NO 5084; SEQ ID NO 5085; SEQ ID
NO 5148; SEQ ID NO 5395; SEQ ID NO 5412; SEQ ID NO 5413 NTRK2 SEQ
ID NO 5532 SEQ ID NO 5121 PDE1C SEQ ID NO 5520 SEQ ID NO 4657
PIK3C2G SEQ ID NO 5513 SEQ ID NO 5109 PTN SEQ ID NO 5486 SEQ ID NO
4666; SEQ ID NO 5317 SFRP1 SEQ ID NO 5491 SEQ ID NO 4909; SEQ ID NO
5161 TANK SEQ ID NO 5505 SEQ ID NO 5069 TOP2A SEQ ID NO 5455 SEQ ID
NO 5153 TP63 SEQ ID NO 5499 SEQ ID NO 4588 TSHZ2 SEQ ID NO 5652 SEQ
ID NO 4962 WIF1 SEQ ID NO 5645 SEQ ID NO 5397
[0171] In another preferred embodiment, the invention relates to
the use as defined above, for the determination of the variation of
expression of at least 206 determined genes of the group of 275
determined genes represented by SEQ ID NO 5419 to SEQ ID NO 5693,
and of at least one of the variants of said at least 206 determined
genes, wherein the correspondence between genes and their variants
is indicated in the following table 1E.
[0172] Table 1E represents the correspondences between the group of
206 determined genes and their corresponding variants.
TABLE-US-00005 Gene Name Gene SEQ ID Variants SEQ ID A2M SEQ ID NO
5420 SEQ ID NO 4855; SEQ ID NO 4945; SEQ ID NO 5092; SEQ ID NO
5248; SEQ ID NO 5328; SEQ ID NO 5363; SEQ ID NO 5364 ACTA2 SEQ ID
NO 5462 SEQ ID NO 4632; SEQ ID NO 4633; SEQ ID NO 4795; SEQ ID NO
4956; SEQ ID NO 4959; SEQ ID NO 4981; SEQ ID NO 5052; SEQ ID NO
5057; SEQ ID NO 5093; SEQ ID NO 5316; SEQ ID NO 5350; SEQ ID NO
5369 ACTG2 SEQ ID NO 5463 SEQ ID NO 4774; SEQ ID NO 4777; SEQ ID NO
4940 ADD3 SEQ ID NO 5588 SEQ ID NO 4629 AK5 SEQ ID NO 5654 SEQ ID
NO 4586; SEQ ID NO 4620; SEQ ID NO 4658; SEQ ID NO 4694; SEQ ID NO
4786; SEQ ID NO 4794; SEQ ID NO 4856; SEQ ID NO 5071; SEQ ID NO
5078; SEQ ID NO 5224; SEQ ID NO 5391 ALDH7A1 SEQ ID NO 5456 SEQ ID
NO 4836 ALKBH3 SEQ ID NO 5641 SEQ ID NO 4756 ANLN SEQ ID NO 5587
SEQ ID NO 4734; SEQ ID NO 4792; SEQ ID NO 5210 ANXA1 SEQ ID NO 5436
SEQ ID NO 4651; SEQ ID NO 4760; SEQ ID NO 4888; SEQ ID NO 5066; SEQ
ID NO 5343 ANXA8L2 SEQ ID NO 5465 SEQ ID NO 4901; SEQ ID NO 5018;
SEQ ID NO 5246 APCDD1 SEQ ID NO 5647 SEQ ID NO 4871; SEQ ID NO
5001; SEQ ID NO 5081; SEQ ID NO 5182 AQP1 SEQ ID NO 5661 SEQ ID NO
4676; SEQ ID NO 4865 ARHGAP26 SEQ ID NO 5560 SEQ ID NO 5215 ARL4A
SEQ ID NO 5453 SEQ ID NO 4793; SEQ ID NO 5002; SEQ ID NO 5004
ARRDC3 SEQ ID NO 5591 SEQ ID NO 4642; SEQ ID NO 4973 ASPM SEQ ID NO
5581 SEQ ID NO 5050 ASPN SEQ ID NO 5573 SEQ ID NO 4854 ATP8B4 SEQ
ID NO 5608 SEQ ID NO 4814 B4GALNT4 SEQ ID NO 5656 SEQ ID NO 5007
BCL11A SEQ ID NO 5577 SEQ ID NO 5204 BUB1 SEQ ID NO 5509 SEQ ID NO
5082 C1orf112 SEQ ID NO 5582 SEQ ID NO 5268 C2orf40 SEQ ID NO 5616
SEQ ID NO 4832; SEQ ID NO 4862 C3orf64 SEQ ID NO 5653 SEQ ID NO
4626 C9orf61 SEQ ID NO 5516 SEQ ID NO 4661; SEQ ID NO 4788; SEQ ID
NO 5034; SEQ ID NO 5290 CCNB1 SEQ ID NO 5615 SEQ ID NO 5138 CCNE2
SEQ ID NO 5631 SEQ ID NO 4656 CDKN3 SEQ ID NO 5523 SEQ ID NO 4837
CENPA SEQ ID NO 5467 SEQ ID NO 4637 CENPE SEQ ID NO 5468 SEQ ID NO
5097 CENPF SEQ ID NO 5568 SEQ ID NO 4843; SEQ ID NO 5130 CFI SEQ ID
NO 5422 SEQ ID NO 4719; SEQ ID NO 5105 CHST9 SEQ ID NO 5613 SEQ ID
NO 4582 CLDN8 SEQ ID NO 5667 SEQ ID NO 4720; SEQ ID NO 4953 CLIP4
SEQ ID NO 5606 SEQ ID NO 5314 CNN1 SEQ ID NO 5457 SEQ ID NO 5079;
SEQ ID NO 5181; SEQ ID NO 5185 CNTNAP3 SEQ ID NO 5627 SEQ ID NO
4597; SEQ ID NO 4675 CNTNAP3B SEQ ID NO 5692 SEQ ID NO 5399 COL14A1
SEQ ID NO 5594 SEQ ID NO 4727; SEQ ID NO 4936; SEQ ID NO 5102; SEQ
ID NO 5326; SEQ ID NO 5382; SEQ ID NO 5418 COL17A1 SEQ ID NO 5683
SEQ ID NO 4739; SEQ ID NO 4747; SEQ ID NO 4784; SEQ ID NO 4897; SEQ
ID NO 5008; SEQ ID NO 5242; SEQ ID NO 5384 CRK SEQ ID NO 5571 SEQ
ID NO 4757 CRYAB SEQ ID NO 5470 SEQ ID NO 4611; SEQ ID NO 4685; SEQ
ID NO 4688; SEQ ID NO 4689; SEQ ID NO 4773; SEQ ID NO 4858; SEQ ID
NO 4863; SEQ ID NO 4894; SEQ ID NO 4975; SEQ ID NO 5407; SEQ ID NO
5416 CTHRC1 SEQ ID NO 5639 SEQ ID NO 4598 CX3CL1 SEQ ID NO 5490 SEQ
ID NO 4630; SEQ ID NO 4951 DHCR7 SEQ ID NO 5459 SEQ ID NO 5025; SEQ
ID NO 5339 DKK3 SEQ ID NO 5549 SEQ ID NO 4624; SEQ ID NO 4831; SEQ
ID NO 4933; SEQ ID NO 4989; SEQ ID NO 5049; SEQ ID NO 5184; SEQ ID
NO 5205; SEQ ID NO 5207; SEQ ID NO 5208; SEQ ID NO 5378 DMD SEQ ID
NO 5421 SEQ ID NO 4593; SEQ ID NO 4664; SEQ ID NO 4860; SEQ ID NO
4908; SEQ ID NO 5058; SEQ ID NO 5095; SEQ ID NO 5150; SEQ ID NO
5381; SEQ ID NO 5387; SEQ ID NO 5388; SEQ ID NO 5389; SEQ ID NO
5410 DMN SEQ ID NO 5643 SEQ ID NO 4610; SEQ ID NO 5120; SEQ ID NO
5396 DOCK8 SEQ ID NO 5672 SEQ ID NO 4623; SEQ ID NO 4728; SEQ ID NO
5118 DST SEQ ID NO 5660 SEQ ID NO 4587; SEQ ID NO 4679; SEQ ID NO
5236; SEQ ID NO 5309; SEQ ID NO 5336 EDN3 SEQ ID NO 5673 SEQ ID NO
4714; SEQ ID NO 5405 EGR2 SEQ ID NO 5429 SEQ ID NO 5020; SEQ ID NO
5356 ETV1 SEQ ID NO 5518 SEQ ID NO 4730; SEQ ID NO 5080; SEQ ID NO
5197; SEQ ID NO 5209; SEQ ID NO 5214; SEQ ID NO 5218; SEQ ID NO
5241; SEQ ID NO 5329; SEQ ID NO 5417 ETV5 SEQ ID NO 5511 SEQ ID NO
4999; SEQ ID NO 5330 FAM126A SEQ ID NO 5618 SEQ ID NO 4641; SEQ ID
NO 4646; SEQ ID NO 5126; SEQ ID NO 5157 FAM130A2 SEQ ID NO 5609 SEQ
ID NO 5149; SEQ ID NO 5281 FAM13A1 SEQ ID NO 5559 SEQ ID NO 4680;
SEQ ID NO 4804; SEQ ID NO 5293 FBXL7 SEQ ID NO 5546 SEQ ID NO 4932
FDXR SEQ ID NO 5503 SEQ ID NO 5318 FLJ25770 SEQ ID NO 5684 SEQ ID
NO 4735 FMO2 SEQ ID NO 5460 SEQ ID NO 4600; SEQ ID NO 5065 FN1 SEQ
ID NO 5675 SEQ ID NO 4608; SEQ ID NO 4609; SEQ ID NO 4636; SEQ ID
NO 4649; SEQ ID NO 4842; SEQ ID NO 5015; SEQ ID NO 5022; SEQ ID NO
5098; SEQ ID NO 5141; SEQ ID NO 5164; SEQ ID NO 5165; SEQ ID NO
5183; SEQ ID NO 5186; SEQ ID NO 5258; SEQ ID NO 5307 FRZB SEQ ID NO
5461 SEQ ID NO 5174 FTO SEQ ID NO 5687 SEQ ID NO 4971; SEQ ID NO
5151; SEQ ID NO 5257 FZD1 SEQ ID NO 5497 SEQ ID NO 4652 GABRP SEQ
ID NO 5554 SEQ ID NO 4614; SEQ ID NO 5031; SEQ ID NO 5061; SEQ ID
NO 5067; SEQ ID NO 5347 GALE SEQ ID NO 5446 SEQ ID NO 4618 GJB3 SEQ
ID NO 5602 SEQ ID NO 5262 GLTSCR2 SEQ ID NO 5566 SEQ ID NO 4775;
SEQ ID NO 4834; SEQ ID NO 4872 GPM6B SEQ ID NO 5443 SEQ ID NO 5104
GPR177 SEQ ID NO 5444 SEQ ID NO 5051; SEQ ID NO 5267; SEQ ID NO
5298 GRAMD3 SEQ ID NO 5601 SEQ ID NO 4587; SEQ ID NO 4857; SEQ ID
NO 4926; SEQ ID NO 4934; SEQ ID NO 5087; SEQ ID NO 5088; SEQ ID NO
5240; SEQ ID NO 5291; SEQ ID NO 5354 GRIA4 SEQ ID NO 5437 SEQ ID NO
4772; SEQ ID NO 5238 GSTA1 SEQ ID NO 5644 SEQ ID NO 4655 GUCY1A3
SEQ ID NO 5438 SEQ ID NO 4716; SEQ ID NO 4886; SEQ ID NO 4913; SEQ
ID NO 5044; SEQ ID NO 5070 GYPC SEQ ID NO 5473 SEQ ID NO 5133
HNRNPA1 SEQ ID NO 5612 SEQ ID NO 5273 HOXA7 SEQ ID NO 5538 SEQ ID
NO 5005 IFNGR1 SEQ ID NO 5430 SEQ ID NO 4925 IGF1 SEQ ID NO 5435
SEQ ID NO 5414 IL33 SEQ ID NO 5624 SEQ ID NO 4927 IMPAD1 SEQ ID NO
5574 SEQ ID NO 5360 INTS8 SEQ ID NO 5575 SEQ ID NO 4724 IRX1 SEQ ID
NO 5603 SEQ ID NO 5140 ITM2A SEQ ID NO 5517 SEQ ID NO 4592 KCTD12
SEQ ID NO 5638 SEQ ID NO 5162 KIAA0101 SEQ ID NO 5556 SEQ ID NO
4648; SEQ ID NO 4808; SEQ ID NO 4809; SEQ ID NO 4904 KIAA2013 SEQ
ID NO 5637 SEQ ID NO 4990 KIF11 SEQ ID NO 5512 SEQ ID NO 4988 KIF23
SEQ ID NO 5640 SEQ ID NO 4725; SEQ ID NO 4732; SEQ ID NO 4899 KIF4A
SEQ ID NO 5547 SEQ ID NO 4964 KIT SEQ ID NO 5423 SEQ ID NO 5107;
SEQ ID NO 5177 KLHL13 SEQ ID NO 5625 SEQ ID NO 4979 KMO SEQ ID NO
5498 SEQ ID NO 4653 KRT13 SEQ ID NO 5648 SEQ ID NO 5261; SEQ ID NO
5351 KRT14 SEQ ID NO 5434 SEQ ID NO 4740; SEQ ID NO 4818; SEQ ID NO
4819; SEQ ID NO 4825; SEQ ID NO 4845; SEQ ID NO 4877; SEQ ID NO
4878; SEQ ID NO 4891; SEQ ID NO 4969 KRT15 SEQ ID NO 5475 SEQ ID NO
4619; SEQ ID NO 4645; SEQ ID NO 4737; SEQ ID NO 4844; SEQ ID NO
4849; SEQ ID NO 4866; SEQ ID NO 4867; SEQ ID NO 4869; SEQ ID NO
4882; SEQ ID NO 4890; SEQ ID NO 4967; SEQ ID NO 4978; SEQ ID NO
5147 KRT16 SEQ ID NO 5525 SEQ ID NO 4826; SEQ ID NO 4881 KRT17 SEQ
ID NO 5431 SEQ ID NO 4820; SEQ ID NO 4824; SEQ ID NO 4873; SEQ ID
NO 4876; SEQ ID NO 4920; SEQ ID NO 4992; SEQ ID NO 5036; SEQ ID NO
5048 KRT19 SEQ ID NO 5476 SEQ ID NO 4750; SEQ ID NO 4941 KRT28 SEQ
ID NO 5657 SEQ ID NO 5154 KRT5 SEQ ID NO 5432 SEQ ID NO 4748; SEQ
ID NO 4782; SEQ ID NO 4817; SEQ ID NO 4821; SEQ ID NO 4823; SEQ ID
NO 4827; SEQ ID NO 4919; SEQ ID NO 4970; SEQ ID NO 5152; SEQ ID NO
5179; SEQ ID NO 5277; SEQ ID NO 5279; SEQ ID NO 5406 KRT6C SEQ ID
NO 5651 SEQ ID NO 4840; SEQ ID NO 5310 KRT7 SEQ ID NO 5524 SEQ ID
NO 4896; SEQ ID NO 4995 KRT72 SEQ ID NO 5633 SEQ ID NO 5311 LGR4
SEQ ID NO 5585 SEQ ID NO 4764; SEQ ID NO 5116 LMOD1 SEQ ID NO 5544
SEQ ID NO 4710 LMOD1 SEQ ID NO SEQ ID NO 5280 LMOD1 SEQ ID NO SEQ
ID NO 5302 LOC147804 SEQ ID NO 5680 SEQ ID NO 5211 LOC440421 SEQ ID
NO 5689 SEQ ID NO 5006 LPHN2 SEQ ID NO 5545 SEQ ID NO 4625; SEQ ID
NO 5160 LPHN3 SEQ ID NO 5562 SEQ ID NO 5187 MAF SEQ ID NO 5451 SEQ
ID NO 4850; SEQ ID NO 5390 MAGED4B SEQ ID NO 5611 SEQ ID NO 5284
MAML2 SEQ ID NO 5617 SEQ ID NO 4862; SEQ ID NO 5156 MAP2K6 SEQ ID
NO 5485 SEQ ID NO 4722; SEQ ID NO 4917 MATN2 SEQ ID NO 5479 SEQ ID
NO 4677; SEQ ID NO 4861; SEQ ID NO 5017; SEQ ID NO 5100 MED20 SEQ
ID NO 5507 SEQ ID NO 4830 MERTK SEQ ID NO 5536 SEQ ID NO 5124 MFGE8
SEQ ID NO 5530 SEQ ID NO 4580; SEQ ID NO 4711; SEQ ID NO 4765; SEQ
ID NO 4839; SEQ ID NO 5301 MGC70870 SEQ ID NO 5686 SEQ ID NO 5201
MID1 SEQ ID NO 5623 SEQ ID NO 4698; SEQ ID NO 4699; SEQ ID NO 4700;
SEQ ID NO 4701; SEQ ID NO 4702; SEQ ID NO 4703; SEQ ID NO 4705; SEQ
ID NO 4706; SEQ ID NO 5074 MKI67 SEQ ID NO 5480 SEQ ID NO 4754; SEQ
ID NO 4790; SEQ ID NO 4884; SEQ ID NO 4921; SEQ ID NO 4954 MME SEQ
ID NO 5440 SEQ ID NO 4579; SEQ ID NO 4607; SEQ ID NO 5054 MXI1 SEQ
ID NO 5635 SEQ ID NO 5269 MYH11 SEQ ID NO 5599 SEQ ID NO 4602; SEQ
ID NO 4697; SEQ ID NO 4870; SEQ ID NO 4972; SEQ ID NO 5053; SEQ ID
NO 5103; SEQ ID NO 5323; SEQ ID NO 5361; SEQ ID NO 5365 MYLK SEQ ID
NO 5630 SEQ ID NO 4682; SEQ ID NO 4687; SEQ ID NO 4931; SEQ ID NO
5358; SEQ ID NO 5376; SEQ ID NO 5400; SEQ ID NO 5401 MYO18A SEQ ID
NO 5632 SEQ ID NO 4907 NCAPG SEQ ID NO 5597 SEQ ID NO 4630 NDRG2
SEQ ID NO 5669 SEQ ID NO 4601; SEQ ID NO 4715; SEQ ID NO 4766; SEQ
ID NO 4781; SEQ ID NO 4822; SEQ ID NO 4859; SEQ ID NO 4868; SEQ ID
NO 4898; SEQ ID NO 4911; SEQ ID NO 4914; SEQ ID NO 4947; SEQ ID NO
4977; SEQ ID NO 4986; SEQ ID NO 5010; SEQ ID NO 5027; SEQ ID NO
5028; SEQ ID NO 5030; SEQ ID NO 5062; SEQ ID NO 5194; SEQ ID NO
5198; SEQ ID NO 5200; SEQ ID NO 5212; SEQ ID NO 5222; SEQ ID NO
5227; SEQ ID NO 5229; SEQ ID NO 5234; SEQ ID NO 5235; SEQ ID NO
5252; SEQ ID NO 5256; SEQ ID NO 5292; SEQ ID NO 5304; SEQ ID NO
5342; SEQ ID NO 5344; SEQ ID NO 5346; SEQ ID NO 5348; SEQ ID NO
5367 NECAB1 SEQ ID NO 5598 SEQ ID NO 4797 NEFH SEQ ID NO 5593 SEQ
ID NO 4976; SEQ ID NO 5266 NEK2 SEQ ID NO 5482 SEQ ID NO 4976 NFIB
SEQ ID NO 5526 SEQ ID NO 4628; SEQ ID NO 4767; SEQ ID NO 4833; SEQ
ID NO 5271; SEQ ID NO 5370; SEQ ID NO 5371 NME4 SEQ ID NO 5519 SEQ
ID NO 4806; SEQ ID NO 5372 NR3C2 SEQ ID NO 5439 SEQ ID NO 4606 NRG1
SEQ ID NO 5552 SEQ ID NO 4713; SEQ ID NO 5084; SEQ ID NO 5085; SEQ
ID NO 5086; SEQ ID NO 5148; SEQ ID NO 5393; SEQ ID NO 5394; SEQ ID
NO 5395; SEQ ID NO 5412; SEQ ID NO 5413 NTRK2 SEQ ID NO 5532 SEQ ID
NO 4946; SEQ ID NO 5056; SEQ ID NO 5121; SEQ ID NO 5178; SEQ ID NO
5385; SEQ ID NO 5386 NUSAP1 SEQ ID NO 5570 SEQ ID NO 4639; SEQ ID
NO 4768; SEQ ID NO 4929; SEQ ID NO 5335 ODZ2 SEQ ID NO 5677 SEQ ID
NO 4665; SEQ ID NO 5176 OGFRL1 SEQ ID NO 5605 SEQ ID NO 5040 OSR1
SEQ ID NO 5642 SEQ ID NO 4937 P2RY13 SEQ ID NO 5600 SEQ ID NO 4993
PDE1C SEQ ID NO 5520 SEQ ID NO 4657 PDGFRA SEQ ID NO 5533 SEQ ID NO
4918; SEQ ID NO 4938 PELI1 SEQ ID NO 5590 SEQ ID NO 5014 PFKM SEQ
ID NO 5425 SEQ ID NO 5380 PIGR SEQ ID NO 5484 SEQ ID NO 4663; SEQ
ID NO 4916; SEQ ID NO 5345 PIK3C2G SEQ ID NO 5513 SEQ ID NO 5109;
SEQ ID NO 5345 PKD2 SEQ ID NO 5426 SEQ ID NO 5111; SEQ ID NO 5128
PPP1R14A SEQ ID NO 5622 SEQ ID NO 4592; SEQ ID NO 4721; SEQ ID NO
5137 PRC1 SEQ ID NO 5502 SEQ ID NO 4631; SEQ ID NO 4744; SEQ ID NO
4785; SEQ ID NO 4994; SEQ ID NO 5075; SEQ ID NO 5188; SEQ ID NO
5191; SEQ ID NO 5312 PRNP SEQ ID NO 5427 SEQ ID NO 4644; SEQ ID NO
4915 PROS1 SEQ ID NO 5428 SEQ ID NO 5206 PTN SEQ ID NO 5486 SEQ ID
NO 4666; SEQ ID NO 5317 PTPRZ1 SEQ ID NO 5487 SEQ ID NO 5064; SEQ
ID NO 5112; SEQ ID NO 5125 PTTG1 SEQ ID NO 5506 SEQ ID NO 4885; SEQ
ID NO 5073; SEQ ID NO 5136 PZP SEQ ID NO 5488 SEQ ID NO 4673; SEQ
ID NO 4738; SEQ ID NO 4851; SEQ ID NO 5313 RACGAP1 SEQ ID NO 5550
SEQ ID NO 4589; SEQ ID NO 5237; SEQ ID NO 5283; SEQ ID NO 5288; SEQ
ID NO 5322 RBMS3 SEQ ID NO 5445 SEQ ID NO 4980 RIC3 SEQ ID NO 5604
SEQ ID NO 4612; SEQ ID NO 5140; SEQ ID NO 5155; SEQ
ID NO 5270 ROPN1B SEQ ID NO 5447 SEQ ID NO 4718; SEQ ID NO 5144
RPL3 SEQ ID NO 5441 SEQ ID NO 4763; SEQ ID NO 4963 RRM2 SEQ ID NO
5452 SEQ ID NO 4691; SEQ ID NO 4798 S100B SEQ ID NO 5534 SEQ ID NO
4798; SEQ ID NO 4948; SEQ ID NO 4974 S100P SEQ ID NO 5531 SEQ ID NO
4835 SAA1 SEQ ID NO 5665 SEQ ID NO 4690; SEQ ID NO 4813 SAA2 SEQ ID
NO 5610 SEQ ID NO 4584; SEQ ID NO 4813; SEQ ID NO 4816; SEQ ID NO
5170; SEQ ID NO 5409 SAMD5 SEQ ID NO 5450 SEQ ID NO 5158 SATB1 SEQ
ID NO 5489 SEQ ID NO 4709; SEQ ID NO 4815; SEQ ID NO 4852; SEQ ID
NO 4950; SEQ ID NO 5249; SEQ ID NO 5337 SFRP1 SEQ ID NO 5491 SEQ ID
NO 4674; SEQ ID NO 4909; SEQ ID NO 5161 SFTPD SEQ ID NO 5492 SEQ ID
NO 4674 SIRPA SEQ ID NO 5634 SEQ ID NO 4880; SEQ ID NO 4997; SEQ ID
NO 5131; SEQ ID NO 5379 SLC25A27 SEQ ID NO 5508 SEQ ID NO 5253
SLC26A8 SEQ ID NO 5629 SEQ ID NO 4672 SMARCA2 SEQ ID NO 5493 SEQ ID
NO 4810 SMC4 SEQ ID NO 5678 SEQ ID NO 4998; SEQ ID NO 5244; SEQ ID
NO 5320 SORBS1 SEQ ID NO 5564 SEQ ID NO 4681 SPARCL1 SEQ ID NO 5515
SEQ ID NO 4585; SEQ ID NO 4693; SEQ ID NO 4832; SEQ ID NO 4910; SEQ
ID NO 4924; SEQ ID NO 4935; SEQ ID NO 4939; SEQ ID NO 4960; SEQ ID
NO 4961; SEQ ID NO 5029; SEQ ID NO 5035; SEQ ID NO 5055; SEQ ID NO
5059; SEQ ID NO 5090; SEQ ID NO 5127; SEQ ID NO 5199; SEQ ID NO
5202; SEQ ID NO 5228; SEQ ID NO 5230; SEQ ID NO 5232; SEQ ID NO
5254; SEQ ID NO 5276; SEQ ID NO 5325; SEQ ID NO 5353 SPG3A SEQ ID
NO 5567 SEQ ID NO 4966 SPRY2 SEQ ID NO 5529 SEQ ID NO 4742; SEQ ID
NO 4982; SEQ ID NO 5233 TAGLN SEQ ID NO 5442 SEQ ID NO 4594; SEQ ID
NO 4662; SEQ ID NO 4906; SEQ ID NO 5024; SEQ ID NO 5082; SEQ ID NO
5355 TANK SEQ ID NO 5505 SEQ ID NO 4895; SEQ ID NO 5069 TESC SEQ ID
NO 5576 SEQ ID NO 5360 TF SEQ ID NO 5454 SEQ ID NO 4654; SEQ ID NO
4668; SEQ ID NO 4669; SEQ ID NO 4758; SEQ ID NO 4892; SEQ ID NO
5032; SEQ ID NO 5099; SEQ ID NO 5411 TLE4 SEQ ID NO 5539 SEQ ID NO
4595; SEQ ID NO 4616; SEQ ID NO 4635; SEQ ID NO 4729; SEQ ID NO
4733; SEQ ID NO 4889; SEQ ID NO 5122 TMEM16A SEQ ID NO 5578 SEQ ID
NO 4708 TMPRSS2 SEQ ID NO 5528 SEQ ID NO 5231; SEQ ID NO 5247; SEQ
ID NO 5296 TOP2A SEQ ID NO 5455 SEQ ID NO 4686; SEQ ID NO 5153 TP63
SEQ ID NO 5499 SEQ ID NO 4588; SEQ ID NO 4590; SEQ ID NO 4653; SEQ
ID NO 4828; SEQ ID NO 5043 TPM1 SEQ ID NO 5449 SEQ ID NO 5319 TPM2
SEQ ID NO 5676 SEQ ID NO 4581; SEQ ID NO 4638; SEQ ID NO 4789; SEQ
ID NO 4800; SEQ ID NO 4983; SEQ ID NO 5366 TPM3 SEQ ID NO 5649 SEQ
ID NO 4634; SEQ ID NO 4741; SEQ ID NO 4769; SEQ ID NO 4771; SEQ ID
NO 4799; SEQ ID NO 4800; SEQ ID NO 4803; SEQ ID NO 4875; SEQ ID NO
4985; SEQ ID NO 4987; SEQ ID NO 5264; SEQ ID NO 5265; SEQ ID NO
5274; SEQ ID NO 5299; SEQ ID NO 5308; SEQ ID NO 5315 TPX2 SEQ ID NO
5543 SEQ ID NO 4596; SEQ ID NO 5129 TRIM2 SEQ ID NO 5563 SEQ ID NO
5119 TRIM29 SEQ ID NO 5681 SEQ ID NO 4847; SEQ ID NO 4848; SEQ ID
NO 5333; SEQ ID NO 5357; SEQ ID NO 5392 TSHZ2 SEQ ID NO 5652 SEQ ID
NO 4962 UBAP2L SEQ ID NO 5558 SEQ ID NO 5072 UBE2C SEQ ID NO 5658
SEQ ID NO 5077; SEQ ID NO 5172; SEQ ID NO 5173; SEQ ID NO 5403; SEQ
ID NO 5404 UBE2T SEQ ID NO 5553 SEQ ID NO 4660; SEQ ID NO 5041 UTRN
SEQ ID NO 5540 SEQ ID NO 5091 VIM SEQ ID NO 5495 SEQ ID NO 4643
WIF1 SEQ ID NO 5645 SEQ ID NO 5142; SEQ ID NO 5397; SEQ ID NO 5415
YWHAZ SEQ ID NO 5496 SEQ ID NO 4749 ZDHHC2 SEQ ID NO 5569 SEQ ID NO
4768; SEQ ID NO 5106; SEQ ID NO 5260 ZNF462 SEQ ID NO 5595 SEQ ID
NO 4851 ZNF521 SEQ ID NO 5565 SEQ ID NO 4723; SEQ ID NO 5195; SEQ
ID NO 5196; SEQ ID NO 5219; SEQ ID NO 5321; SEQ ID NO 5359
[0173] In another particular embodiment, the invention relates to
the use as defined above, for the determination of the variation of
expression of 275 determined genes represented by SEQ ID NO 5419 to
SEQ ID NO 5693, and of at least one of their variants when they
exist, wherein the correspondence between genes and their variants
is indicated in the following table 6.
[0174] Table 6 summarizes the correspondence between all the
sequences disclosed in the invention. In this table: [0175] SEQ ID
NOs 1-2938 represent polynucleotide probes, and targets, variants
and genes they can recognize, [0176] SEQ ID NOs 2939-4578 represent
target regions, and variant and genes containing them, and
polynucleotide probes recognizing them, [0177] SEQ ID NOs 4579-5418
and SEQ ID NO 5694 represent variants and their corresponding gene,
and target they comprises, and also polynucleotide probes
recognizing them, [0178] SEQ ID NOs 5419-5493 represent genes.
[0179] In another preferred embodiment, the invention relates to
the use of a multiplicity of polynucleotide probe sets for
determining the variation of the gene expression as defined above,
and of its variants when present, wherein target regions are
characterized by the polynucleotide sequences SEQ ID NO 2939 to
4578, each target region of each gene, and of each variant when
they exist, being represented in Table 6.
[0180] For example, in the invention, for detecting the variation
of expression of the group of at least 12 determined genes of the
group of 275 genes, each of the 12 genes has the following target
region: [0181] AK5 (SEQ ID NO 5654) contains the following target
regions: SEQ ID NO 2979 and 2988 [0182] COL17A1 (SEQ ID NO 5683)
contains the following target regions: SEQ ID NO 2944; 2955; 2971;
2973 and 2974, [0183] DMD (SEQ ID NO 5421) contains the following
target regions: SEQ ID NO 2939; 2940; 2941; 2942; 2943; 2945; 2947;
2949; 2950; 2952; 2953; 2957; 2961; 2962; 2963; 2964; 2970 and
2980, [0184] KIT (SEQ ID NO 5423) contains the following target
regions: SEQ ID NO 2984; 2946; 2951; 2954; 2958; 2960; 2965; 2969;
2975 and 2978 [0185] KRT16 (SEQ ID NO 5525) contains the following
target regions: SEQ ID NO 2966 and 2972, [0186] KRT14 (SEQ ID NO
5434) contains the following target regions: SEQ ID NO 2946; 2951;
2954; 2958; 2960; 2965; 2969; 2975 and 2978, [0187] KRT5 (SEQ ID NO
5432) contains the following target regions: SEQ ID NO 2985, [0188]
MYH11 (SEQ ID NO 5599) contains the following target regions: SEQ
ID NO 2948; 2956; 2959; 2967; 2976; 2981; 2982 and 2986, [0189]
NRG1 (SEQ ID NO 5552) contains the following target regions: SEQ ID
NO 2977, [0190] PTN (SEQ ID NO 5486) contains the following target
regions: SEQ ID NO 2983, [0191] SFRP1 (SEQ ID NO 5491) contains the
following target regions: SEQ ID NO 2968, and [0192] TSHZ2 (SEQ ID
NO 5652) contains the following target regions: SEQ ID NO 2987.
[0193] With Table 6, knowing gene and variants, it is easy to
identify the sequence of the corresponding target region.
[0194] In another particular embodiments, the invention discloses
the use of a multiplicity of polynucleotide probe sets for
determining the variation of the gene expression as defined above,
and/or of their variants when present, wherein each polynucleotide
probe contained in a polynucleotide probe set is represented by the
nucleic acid sequence of the library consisting in SEQ ID NO 1 to
SEQ ID NO 2938, the correspondence between each polynucleotide
probe and its corresponding target region, said target region
corresponding to a gene and its variants when present, being
represented in Table 6.
[0195] For example, in the invention, for detecting the variation
of expression of the group of at least 12 determined genes of the
group of 275 genes, each of the 12 genes is recognized by the
following polynucleotide probes: [0196] AK5 (SEQ ID NO 5654) is
recognized by the polynucleotide probes SEQ ID NO 790; 791; 792;
793; 794 and 795, [0197] COL17A1 (SEQ ID NO 5683) is recognized by
the polynucleotide probes SEQ ID NO 157; 158; 159; 167; 168; 169;
171; 172; 173 and 177, [0198] DMD (SEQ ID NO 5421) is recognized by
the polynucleotide probes SEQ ID NO 312; 313; 314; 315; 316; 317;
324; 325; 326; 327; 328; 329; 330; 331; 333; 334; 335; 336; 339;
340; 341; 345; 346; 347; 348; 353; 360; 361; 364; 365; 366; 367;
368; 369; 370; 374 and 375, [0199] KIT (SEQ ID NO 5423) is
recognized by the polynucleotide probes SEQ ID NO 1081; 1082 and
1083, [0200] KRT14 (SEQ ID NO 5434) is recognized by the
polynucleotide probes SEQ ID NO 1165; 1158; 1159; 1160; 1161; 1162;
1166; 1167; 1168; 1169; 1170; 1171; 1185; 1186; 1194; 1198; 1199;
1200 and 1203, [0201] KRT16 (SEQ ID NO 5525) is recognized by the
polynucleotide probes SEQ ID NO 1262; 1263; 1264; 1267; 1268 and
1269, [0202] KRT5 (SEQ ID NO 5432) is recognized by the
polynucleotide probes SEQ ID NO 1129; 1140 and 1141, [0203] MYH11
(SEQ ID NO 5599) is recognized by the polynucleotide probes SEQ ID
NO 1522; 1519; 1520; 1521; 1523; 1524; 1534; 1535; 1536; 1544;
1545; 1546; 1551; 1552; 1553; 1554; 1555; 1556 and 1557, [0204]
NRG1 (SEQ ID NO 5552) is recognized by the polynucleotide probes
SEQ ID NO 969; 972 and 981, [0205] PTN (SEQ ID NO 5486) is
recognized by the polynucleotide probes SEQ ID NO 2026; 2027 and
2028, [0206] SFRP1 (SEQ ID NO 5491) is recognized by the
polynucleotide probes SEQ ID NO 2179; 2180 and 2181, and [0207]
TSHZ2 (SEQ ID NO 5652) is recognized by the polynucleotide probes
SEQ ID NO 136; 137 and 138. [0208] To summarize, for the same
example of at least 12 determined genes of the group of 275 genes,
the correspondences are the following ones: [0209] NRG1 (SEQ ID NO
5552) and one of its variants (SEQ ID 5084) both contain the target
region SEQ ID 2977, said target region being recognized by
polynucleotide probes SEQ ID NO 969, 972 and 981, [0210] PTN (SEQ
ID NO 5486) and one of its variants (SEQ ID 4666) both contain the
target region SEQ ID 2983, said target region being recognized by
polynucleotide probes SEQ ID NO 2026, 2027 and 2028, [0211] SFRP1
(SEQ ID NO 5491) and one of its variants (SEQ ID 5161) both contain
the target region SEQ ID 2968, said target region being recognized
by polynucleotide probes SEQ ID NO 2179, 2180 and 2181, [0212]
TSHZ2 (SEQ ID NO 5652) and one of its variants (SEQ ID 4962) both
contain the target region SEQ ID 2987, said target region being
recognized by polynucleotide probes SEQ ID NO 136, 137 and 138,
[0213] KIT (SEQ ID NO 5423) and one of its variants (SEQ ID 5107)
both contain the target region SEQ ID 2984, said target region
being recognized by polynucleotide probes SEQ ID NO 1081, 1082 and
1083, [0214] KRT16 (SEQ ID NO 5525) and two of its variants (SEQ ID
4826 and 4881) are such as [0215] KRT5 and SEQ ID 4826 both contain
the target region SEQ ID 2972, said target region being recognized
by polynucleotide probes SEQ ID NO 1267, 1268 and 1269, and [0216]
KRT5 and SEQ ID 4881 both contain the target region SEQ ID 2966,
said target region being recognized by polynucleotide probes SEQ ID
NO 1262, 1263 and 1264, [0217] KRT5 (SEQ ID NO 5432) and one of its
variants (SEQ ID 5279) both contain the target region SEQ ID 2985,
said target region being recognized by polynucleotide probes SEQ ID
NO 1129, 1140 and 1141, [0218] KRT14 (SEQ ID NO 5434) and six of
its variants (SEQ ID 4819, 4825, 4845, 4877, 4891 and 4969) are
such as: [0219] KRT14 and SEQ ID 4819 both contain the target
regions SEQ ID 2954, 2960 and 2969, said target regions being
recognized respectively by polynucleotide probes SEQ ID NO 116 and
1166, SEQ ID NO 1158 and SEQ ID NO 1159, 1160 and 1161 [0220] KRT14
and SEQ ID 4825 both contain the target regions SEQ ID 2975 and
2978, said target regions being recognized respectively by
polynucleotide probes SEQ ID NO 1167, 1168 and 1169 and SEQ ID NO
1162, 1170 and 1171, [0221] KRT14 and SEQ ID 4845 both contain the
target region SEQ ID 2965, said target region being recognized by
polynucleotide probes SEQ ID NO 1203, [0222] KRT14 and SEQ ID 4877
both contain the target region SEQ ID 2946, said target region
being recognized by polynucleotide probes SEQ ID NO 1198, 1199 and
1200, [0223] KRT14 and SEQ ID 4891 both contain the target region
SEQ ID 2958, said target region being recognized by polynucleotide
probes SEQ ID NO 1185, 1186 and 1194, and [0224] KRT14 and SEQ ID
4969 both contain the target region SEQ ID 2951, said target region
being recognized by polynucleotide probes SEQ ID NO 1185, 1186 and
1194, [0225] MYH11 (SEQ ID NO 5599) and four of its variants (SEQ
ID 4697, 4870, 5361 and 5365) are such as: [0226] MYH11 and SEQ ID
4697 both contain the target regions SEQ ID NO 2948 and 2986, said
target regions being recognized respectively by polynucleotide
probes SEQ ID NO 1522; 1523 and 1524, and SEQ ID NO 1519; 1520 and
1521 [0227] MYH11 and SEQ ID 4870 both contain the target regions
SEQ ID 2956, 2959, 2981 and 2982, said target regions being
recognized respectively by polynucleotide probes SEQ ID 1551, 1552
and 1553, SEQ ID NO 1523, 1524 and 1557, SEQ ID NO 1551, 1552 and
1553 and SEQ ID NO 1554, 1555 and 1556, [0228] MYH11 and SEQ ID
5361 both contain the target region SEQ ID 2967, said target region
being recognized by polynucleotide probes SEQ ID NO 1534, 1535 and
1536, [0229] MYH11 and SEQ ID 5365 both contain the target region
SEQ ID 2976, said target region being recognized by polynucleotide
probes SEQ ID NO 1544, 1545 and 1546, [0230] AK5 (SEQ ID NO 5654)
and one of its variants (SEQ ID 4654) both contain the target
regions SEQ ID 2979 and 2988, said target regions being
respectively recognized by polynucleotide probes SEQ ID NO 790, 791
and 792, and SEQ ID NO 793, 794 and 795, [0231] COL17A1 (SEQ ID NO
5599) and four of its variants (SEQ ID 4739, 4784, 5242 and 5384)
are such as: [0232] COL17A1 and SEQ ID 4739 both contain the target
regions SEQ ID NO 2944 and 2955, said target regions being
recognized respectively by polynucleotide probes SEQ ID NO 171; 172
and 173, and SEQ ID NO 177, [0233] COL17A1 and SEQ ID 4784 both
contain the target region SEQ ID NO 2973, said target region being
recognized by polynucleotide probes SEQ ID NO 167, 168 and 169,
[0234] COL17A1 and SEQ ID 5242 both contain the target region SEQ
ID 2974, said target region being recognized by polynucleotide
probes SEQ ID NO 167, 168 and 177, [0235] COL17A1 and SEQ ID 5384
both contain the target region SEQ ID 2971, said target region
being recognized by polynucleotide probes SEQ ID NO 157, 158 and
159, [0236] DMD (SEQ ID NO 5421) and seven of its variants (SEQ ID
NO 4664, 4860, 5058, 5095, 5150, 5381 and 5410) are such as: [0237]
DMD and SEQ ID 4664 both contain the target regions SEQ ID NO 294
and 2947, said target regions being recognized respectively by
polynucleotide probes SEQ ID NO 312, 313 and 314, and SEQ ID NO
315, 316 and 317 [0238] DMD and SEQ ID 4860 both contain the target
region SEQ ID 2940, said target region being recognized by
polynucleotide probes SEQ ID NO 364, 365 and 366, [0239] DMD and
SEQ ID 5058 both contain the target region SEQ ID 2950, said target
region being recognized by polynucleotide probes SEQ ID NO 353, 360
and 361, [0240] DMD and SEQ ID 5095 both contain the target regions
SEQ ID 2939, 2942, 2945, 2949, 2953, 2961, 2963, 2964 and 2970,
said target region being respectively recognized by polynucleotide
probes [0241] SEQ ID NO 333, 334 and 335, [0242] SEQ ID NO 312, 313
and 348, [0243] SEQ ID NO 315, 331 and 336, [0244] SEQ ID NO 339,
340 and 341, [0245] SEQ ID NO 324, 325 and 326, [0246] SEQ ID NO
345, 346 and 347, [0247] SEQ ID NO 315, 330 and 331, [0248] SEQ ID
NO 327, 328 and 329, and [0249] SEQ ID NO 327, 328 and 329, [0250]
DMD and SEQ ID 5150 both contain the target region SEQ ID 2980,
said target region being recognized by polynucleotide probes SEQ ID
NO 368, 374 and 375, [0251] DMD and SEQ ID 5381 both contain the
target regions SEQ ID 2941, 2952 and 2962, said target regions
being respectively recognized by polynucleotide probes SEQ ID NO
364, 365 and 366, SEQ ID NO 315, 316 and 370, and SEQ ID NO 367,
368 and 369, [0252] DMD and SEQ ID 5410 both contain the target
region SEQ ID 2957, said target region being recognized by
polynucleotide probes SEQ ID NO 315, 316 and 370.
[0253] Using Table 6, and knowing genes and variants, it is easy to
identify the sequence of the corresponding target region and
probes.
[0254] The invention also relates to the use of a multiplicity of
at least 50 polynucleotide probe sets chosen among 1640
polynucleotide probe sets, the nucleic acid sequences of the
polynucleotide probes contained in said 50 polynucleotide probe
sets being the following nucleic acid sequences: SEQ ID NOs 136;
137; 138; 157; 158; 159; 167; 168; 169; 171; 172; 173; 177; 312;
313; 313; 314; 315; 316; 317; 324; 325; 326; 327; 328; 329; 330;
331; 333; 334; 335; 336; 339; 340; 341; 345; 346; 347; 348; 353;
360; 361; 364; 365; 366; 367; 368; 369; 370; 374; 375; 790; 791;
792; 793; 794; 795; 969; 972; 981; 1081; 1082; 1083; 1129; 1140;
1141; 1158; 1159; 1160; 1161; 1162; 1165; 1166; 1167; 1168; 1169;
1170; 1171; 1185; 1186; 1194; 1198; 1199; 1200; 1203; 1262; 1263;
1264; 1267; 1268; 1269; 1519; 1520; 1521; 1522; 1523; 1524; 1534;
1535; 1536; 1544; 1545; 1546; 1551; 1552; 1553; 1554; 1555; 1556;
1557; 2026; 2027; 2028; 2179; 2180 and 2181,
each polynucleotide probe set containing from 1 to 4 of said
polynucleotide probes, for the determination of the variation of
expression of: [0255] at least 12 determined genes belonging to a
group of genes represented by the nucleotidic sequences SEQ ID NO:
5419 to SEQ ID NO: 5693 and [0256] at least one variant of said
genes of at least 12 determined genes, when they exist, [0257] said
12 determined genes being represented by the following nucleotidic
sequences: [0258] SEQ ID NOs 5421; 5423; 5432; 5434; 5486; 5491;
5525; 5552; 5599; 5652; 5654 and 5683 and the corresponding
variants being represented in table 1A in order to diagnose in
vitro or ex vivo the benign or malignant state of a breast
tumor.
[0259] In one preferred embodiment, the invention relates to the
use as defined above, wherein the polynucleotide probes contained
in said at least 50 polynucleotide probe sets are as mentioned
above and wherein SEQ ID NOs 167; 168; 177; 312; 313; 327; 328;
329; 331; 364; 365; 366; 368; 370; 1185; 1186; 1194; 1523; 1524;
1551; 1552 and 1553 are present twice, SEQ ID NO 316 is present in
three copies and SEQ ID NO 315 is present in 5 copies.
[0260] Thus, in all the 50 polynucleotide probe sets mentioned
above, 143 polynucleotide probes are present, the above mentioned
polynucleotide probes being present at least once, and in
particular SEQ ID NOs 167; 168; 177; 312; 313; 327; 328; 329; 331;
364; 365; 366; 368; 370; 1185; 1186; 1194; 1523; 1524; 1551; 1552
and 1553 are present twice, SEQ ID NO 316 is present in three
copies and SEQ ID NO 315 is present in 5 copies.
[0261] The above mentioned polynucleotide probes contained in the
50 nucleotides probe sets specifically recognized the above
mentioned gene and their variant when present via target region,
the correspondence being deduced from Table 6.
[0262] In one preferred embodiment, the invention relates to the
use of a multiplicity of at least 100 polynucleotide probe sets as
defined above, the nucleic acid sequence of the polynucleotides
probes contained in said 100 polynucleotide probe sets being the
following nucleic acid sequences: SEQ ID NO 120; 136; 137; 138;
154; 155; 156; 157; 158; 159; 167; 168; 169; 171; 172; 173; 174;
175; 176; 177; 312; 313; 314; 315; 316; 316; 317; 324; 325; 326;
327; 328; 329; 330; 331; 332; 333; 334; 335; 336; 337; 338; 339;
340; 341; 345; 346; 347; 348; 349; 350; 351; 352; 353; 354; 355;
356; 360; 361; 363; 364; 365; 366; 367; 368; 369; 370; 371; 374;
375; 376; 378; 379; 380; 381; 555; 556; 557; 558; 560; 561; 562;
566; 567; 788; 789; 790; 791; 792; 793; 794; 795; 800; 801; 802;
821; 822; 823; 969; 971; 972; 981; 1056; 1057; 1058; 1075; 1076;
1077; 1081; 1082; 1083; 1087; 1088; 1089; 1103; 1104; 1105; 1114;
1115; 1116; 1123; 1124; 1125; 1129; 1130; 1131; 1140; 1141; 1158;
1159; 1160; 1161; 1162; 1163; 1164; 1165; 1166; 1167; 1168; 1169;
1170; 1171; 1172; 1180; 1181; 1185; 1186; 1187; 1188; 1189; 1190;
1191; 1192; 1193; 1194; 1195; 1196; 1198; 1199; 1200; 1201; 1202;
1203; 1207; 1262; 1263; 1264; 1267; 1268; 1269; 1509; 1510; 1511;
1519; 1520; 1521; 1522; 1523; 1524; 1528; 1529; 1534; 1535; 1536;
1544; 1545; 1546; 1551; 1552; 1553; 1554; 1555; 1556; 1557; 1561;
1562; 1682; 1683; 1684; 1776; 1777; 1778; 2023; 2024; 2025; 2026;
2027; 2028; 2173; 2174; 2175; 2176; 2177; 2178; 2179; 2180; 2181;
2762; 2763; 2764; 2860; 2861; 2862; 2883; 2884 and 2885,
each polynucleotide probe set containing from 1 to 4 of said
polynucleotide probes, for the determination of the variation of
expression of [0263] at least 20 determined genes belonging to a
group of determined genes represented by the nucleotidic sequences
SEQ ID NO: 5419 to SEQ ID NO: 5693 and [0264] at least one variant
of said genes at least 20 determined genes, when they exist, [0265]
said 20 determined genes being represented by the following
nucleotidic sequences: [0266] SEQ ID Nos 5421; 5423; 5432; 5434;
5457; 5486; 5491; 5513; 5516; 5525; 5532; 5552; 5599; 5616; 5624;
5643; 5652; 5654; 5673 and 5683 and the corresponding variants
being represented in table 1B in order to diagnose in vitro or ex
vivo the benign or malignant state of a breast tumor.
[0267] In one preferred embodiment, the invention relates to the
use as defined above, wherein the polynucleotide probes contained
in said at least 100 polynucleotide probe sets are as mentioned
above and wherein SEQ ID NOs 167; 168; 177; 312; 313; 316; 317;
327; 329; 330; 353; 361; 364; 365; 366; 367; 368; 369; 370; 821;
822; 823; 1129; 1164; 1185; 1186; 1187; 1188; 1189; 1203; 1523;
1551; 1552 and 1553 are present twice, SEQ ID NOs 328; 331; 1162;
1194; 1519; 1520; 1521 and 1524 are present in three copies and SEQ
ID NO 315 is present in 6 copies.
[0268] Thus, in all the 100 polynucleotide probe sets mentioned
above, 282 polynucleotide probes are present, the above mentioned
polynucleotide probes being present at least once, and in
particular SEQ ID NOs 167; 168; 177; 312; 313; 316; 317; 327; 329;
330; 353; 361; 364; 365; 366; 367; 368; 369; 370; 821; 822; 823;
1129; 1164; 1185; 1186; 1187; 1188; 1189; 1203; 1523; 1551; 1552
and 1553 are present twice, SEQ ID NOs 328; 331; 1162; 1194; 1519;
1520; 1521 and 1524 are present in three copies and SEQ ID NO 315
is present in 6 copies.
[0269] The above mentioned polynucleotide probes contained in the
100 nucleotides probe sets specifically recognized the above
mentioned gene and their variant when present via target region,
the correspondence being deduced from Table 6.
[0270] In another preferred embodiment, the invention relates to
the use of a multiplicity of at least 150 polynucleotide probe sets
as previously defined, the nucleic acid sequence of the
polynucleotides probes contained in said 150 polynucleotide probe
sets being the following nucleic acid sequences: SEQ ID NOs 4; 5;
6; 120; 136; 137; 138; 154; 155; 156; 157; 158; 159; 167; 168; 169;
171; 172; 173; 174; 175; 176; 177; 197; 248; 254; 255; 305; 306;
307; 312; 313; 314; 315; 316; 317; 324; 325; 326; 327; 328; 329;
330; 331; 332; 333; 334; 335; 336; 337; 338; 339; 340; 341; 345;
346; 347; 348; 349; 350; 351; 352; 353; 354; 355; 356; 360; 361;
362; 363; 364; 365; 366; 367; 367; 368; 369; 370; 371; 374; 375;
376; 377; 378; 379; 380; 381; 513; 514; 515; 552; 553; 554; 555;
556; 557; 558; 559; 560; 561; 562; 566; 567; 783; 784; 785; 788;
789; 790; 791; 792; 793; 794; 795; 796; 797; 798; 799; 800; 801;
802; 803; 804; 805; 806; 807; 808; 812; 813; 814; 818; 821; 822;
823; 968; 969; 970; 971; 972; 981; 1056; 1057; 1058; 1061; 1062;
1063; 1064; 1065; 1066; 1067; 1068; 1069; 1070; 1071; 1075; 1076;
1077; 1080; 1081; 1082; 1083; 1087; 1088; 1089; 1103; 1104; 1105;
1114; 1115; 1116; 1123; 1124; 1125; 1129; 1130; 1131; 1139; 1140;
1141; 1158; 1159; 1160; 1161; 1162; 1163; 1164; 1165; 1166; 1167;
1168; 1169; 1170; 1171; 1172; 1174; 1175; 1176; 1180; 1181; 1185;
1186; 1187; 1188; 1189; 1190; 1191; 1192; 1193; 1194; 1195; 1196;
1197; 1198; 1199; 1200; 1201; 1202; 1203; 1204; 1205; 1206; 1207;
1262; 1263; 1264; 1267; 1268; 1269; 1284; 1285; 1315; 1469; 1470;
1471; 1509; 1510; 1511; 1515; 1516; 1517; 1519; 1520; 1521; 1522;
1523; 1524; 1528; 1529; 1534; 1535; 1536; 1537; 1538; 1539; 1544;
1545; 1546; 1550; 1551; 1552; 1553; 1554; 1555; 1556; 1557; 1558;
1559; 1560; 1561; 1562; 1580; 1581; 1582; 1671; 1682; 1683; 1684;
1685; 1686; 1690; 1691; 1692; 1776; 1777; 1778; 1788; 1789; 1790;
1890; 1891; 1892; 1952; 1953; 1954; 1963; 2023; 2024; 2025; 2026;
2027; 2028; 2065; 2067; 2088; 2089; 2090; 2091; 2173; 2174; 2175;
2176; 2177; 2178; 2179; 2180; 2181; 2196; 2201; 2229; 2230; 2231;
2536; 2537; 2538; 2576; 2577; 2578; 2599; 2600; 2762; 2763; 2764;
2774; 2775; 2776; 2860; 2861; 2862; 2883; 2884 and 2885,
each polynucleotide probe set containing from 1 to 4 of said
polynucleotide probes, for the determination of the variation of
expression of [0271] at least 35 determined genes belonging to a
group of determined genes represented by the nucleotidic sequences
SEQ ID NO: 5419 to SEQ ID NO: 5693 and [0272] at least one variant
of said genes at least 35 determined genes, when they exist, [0273]
said 35 determined genes being represented by the following
nucleotidic sequences: [0274] SEQ ID Nos 5421; 5423; 5431; 5432;
5434; 5440; 5457; 5462; 5470; 5486; 5491; 5505; 5513; 5516; 5525;
5532; 5546; 5552; 5594; 5599; 5601; 5603; 5616; 5618; 5624; 5627;
5630; 5643; 5645; 5652; 5654; 5660; 5669; 5673 and 5683, and the
corresponding variants being represented in table 1C in order to
diagnose in vitro or ex vivo the benign or malignant state of a
breast tumor.
[0275] In one preferred embodiment, the invention relates to the
use as defined above, wherein the polynucleotide probes contained
in said at least 150 polynucleotide probe sets are as mentioned
above and wherein SEQ ID NOs 167; 168; 177; 312; 313; 317; 327;
329; 330; 353; 361; 363; 364; 365; 366; 369; 370; 371; 558; 567;
796; 797; 801; 806; 807; 808; 813; 814; 821; 822; 823; 969; 1056;
1057; 1058; 1129; 1141; 1163; 1164; 1185; 1186; 1187; 1188; 1189;
1199; 1203; 1469; 1470; 1471; 1523; 1551; 1552 and 1553 are present
twice, SEQ ID NOs 316; 328; 331; 368; 788; 1194; 1519; 1520; 1521;
1524 are present in three copies, SEQ ID NO 1162 is present in 4
copies and SEQ ID NO 315 is present in 6 copies.
[0276] Thus, in all the 150 polynucleotide probe sets mentioned
above, 422 polynucleotide probes are present, the above mentioned
polynucleotide probes being present at least once, and in
particular SEQ ID NOs 167; 168; 177; 312; 313; 317; 327; 329; 330;
353; 361; 363; 364; 365; 366; 369; 370; 371; 558; 567; 796; 797;
801; 806; 807; 808; 813; 814; 821; 822; 823; 969; 1056; 1057; 1058;
1129; 1141; 1163; 1164; 1185; 1186; 1187; 1188; 1189; 1199; 1203;
1469; 1470; 1471; 1523; 1551; 1552 and 1553 are present twice, SEQ
ID NOs 316; 328; 331; 368; 788; 1194; 1519; 1520; 1521; 1524 are
present in three copies, SEQ ID NO 1162 is present in 4 copies and
SEQ ID NO 315 is present in 6 copies.
[0277] The above mentioned polynucleotide probes contained in the
150 nucleotides probe sets specifically recognized the above
mentioned gene and their variant when present via target region,
the correspondence being deduced from Table 6.
[0278] A preferred embodiment of the invention relates to the use
of a multiplicity of at least 200 polynucleotide probe sets as
defined above, the nucleic acid sequence of the polynucleotide
probes contained in said 200 polynucleotide probe sets being the
following nucleic acid sequences: SEQ ID NOs 4; 5; 6; 120; 121;
122; 123; 130; 131; 132; 136; 137; 138; 154; 155; 156; 157; 158;
159; 167; 168; 169; 171; 172; 173; 174; 175; 176; 177; 195; 196;
197; 198; 199; 200; 248; 254; 255; 305; 306; 307; 312; 313; 314;
315; 316; 317; 324; 325; 326; 327; 328; 329; 330; 331; 332; 333;
334; 335; 336; 337; 338; 339; 340; 341; 345; 346; 347; 348; 349;
350; 351; 352; 353; 354; 355; 356; 360; 361; 362; 363; 364; 365;
366; 367; 368; 369; 370; 371; 374; 375; 376; 377; 378; 379; 380;
381; 513; 514; 515; 552; 553; 554; 555; 556; 557; 558; 559; 560;
561; 562; 563; 564; 565; 566; 567; 783; 784; 785; 788; 789; 790;
791; 792; 793; 794; 795; 796; 797; 798; 799; 800; 801; 802; 803;
804; 805; 806; 807; 808; 809; 810; 811; 812; 813; 814; 815; 816;
817; 818; 821; 822; 823; 824; 825; 826; 840; 841; 845; 846; 847;
868; 968; 969; 970; 971; 972; 973; 974; 975; 976; 977; 981; 1056;
1057; 1058; 1059; 1060; 1061; 1062; 1063; 1064; 1065; 1066; 1067;
1068; 1069; 1070; 1071; 1075; 1076; 1077; 1080; 1081; 1082; 1083;
1084; 1085; 1086; 1087; 1088; 1089; 1094; 1095; 1096; 1103; 1104;
1105; 1110; 1111; 1112; 1114; 1115; 1116; 1123; 1124; 1125; 1126;
1127; 1128; 1129; 1130; 1131; 1139; 1140; 1141; 1158; 1159; 1160;
1161; 1162; 1163; 1164; 1165; 1166; 1167; 1168; 1169; 1170; 1171;
1172; 1174; 1175; 1176; 1180; 1181; 1185; 1186; 1187; 1188; 1189;
1190; 1191; 1192; 1193; 1194; 1195; 1196; 1197; 1198; 1199; 1200;
1201; 1202; 1203; 1204; 1205; 1206; 1207; 1229; 1230; 1242; 1243;
1244; 1245; 1250; 1251; 1252; 1262; 1263; 1264; 1265; 1266; 1267;
1268; 1269; 1270; 1271; 1272; 1284; 1285; 1315; 1335; 1407; 1408;
1469; 1470; 1471; 1509; 1510; 1511; 1512; 1513; 1514; 1515; 1516;
1517; 1519; 1520; 1521; 1522; 1523; 1524; 1528; 1529; 1534; 1535;
1536; 1537; 1538; 1539; 1544; 1545; 1546; 1550; 1551; 1552; 1553;
1554; 1555; 1556; 1557; 1558; 1559; 1560; 1561; 1562; 1563; 1564;
1580; 1581; 1582; 1586; 1587; 1588; 1671; 1682; 1683; 1684; 1685;
1686; 1687; 1688; 1689; 1690; 1691; 1692; 1743; 1744; 1745; 1776;
1777; 1778; 1788; 1789; 1790; 1890; 1891; 1892; 1896; 1897; 1898;
1952; 1953; 1954; 1963; 1974; 2023; 2024; 2025; 2026; 2027; 2028;
2061; 2062; 2063; 2065; 2067; 2068; 2072; 2083; 2084; 2085; 2088;
2089; 2090; 2091; 2092; 2173; 2174; 2175; 2176; 2177; 2178; 2179;
2180; 2181; 2196; 2201; 2229; 2230; 2231; 2381; 2382; 2383; 2536;
2537; 2538; 2576; 2577; 2578; 2599; 2600; 2601; 2602; 2603; 2762;
2763; 2764; 2774; 2775; 2776; 2778; 2779; 2783; 2794; 2860; 2861;
2862; 2883; 2884 and 2885,
for the determination of the variation of expression of [0279] at
least 43 determined genes belonging to a group of determined genes
represented by the nucleotidic sequences SEQ ID NO: 5419 to SEQ ID
NO: 5693 and [0280] at least one variant of said determined genes
at least 43 genes, when they exist, [0281] said 43 determined genes
being represented by the following nucleotidic sequences: [0282]
SEQ ID Nos 5421; 5423; 5431; 5432; 5434; 5440; 5455; 5457; 5462;
5470; 5475; 5486; 5491; 5499; 5505; 5513; 5516; 5520; 5525; 5532;
5546; 5549; 5552; 5594; 5599; 5601; 5603; 5616; 5618; 5623; 5624;
5627; 5630; 5643; 5645; 5651; 5652; 5654; 5660; 5669; 5673; 5683
and 5686, and the corresponding variants being represented in table
1D, in order to diagnose in vitro or ex vivo the benign or
malignant state of a breast tumor.
[0283] In one preferred embodiment, the invention relates to the
use as defined above, wherein the polynucleotide probes contained
in said at least 200 polynucleotide probe sets are as mentioned
above and wherein SEQ ID NOs 167; 168; 177; 312; 313; 317; 327;
329; 330; 353; 361; 363; 364; 365; 366; 367; 369; 370; 371; 558;
567; 796; 797; 801; 806; 807; 808; 813; 814; 821; 822; 823; 845;
968; 970; 972; 1056; 1057; 1058; 1085; 1114; 1115; 1116; 1123;
1124; 1125; 1129; 1141; 1163; 1164; 1185; 1186; 1187; 1188; 1189;
1199; 1203; 1523; 1551; 1552; 1553; 1557; 1586; 1587; 1588; 1952;
1953; 1954; 2088; 2090; 2091; 2762; 2763 and 2764 are present
twice, SEQ ID NOs 316; 328; 331; 368; 788; 1284; 1285; 1469; 1470;
1471; 1519; 1520; 1521; 1524; 2065; 2067 and 2089 are present in
three copies, SEQ ID NO 1194 is present in 4 copies and SEQ ID NOs
315 and 1162 are present in 6 copies.
[0284] Thus, in all the 200 polynucleotide probe sets mentioned
above, 565 polynucleotide probes are present, the above mentioned
polynucleotide probes being present at least once, and in
particular SEQ ID NOs 167; 168; 177; 312; 313; 317; 327; 329; 330;
353; 361; 363; 364; 365; 366; 367; 369; 370; 371; 558; 567; 796;
797; 801; 806; 807; 808; 813; 814; 821; 822; 823; 845; 968; 970;
972; 1056; 1057; 1058; 1085; 1114; 1115; 1116; 1123; 1124; 1125;
1129; 1141; 1163; 1164; 1185; 1186; 1187; 1188; 1189; 1199; 1203;
1523; 1551; 1552; 1553; 1557; 1586; 1587; 1588; 1952; 1953; 1954;
2088; 2090; 2091; 2762; 2763 and 2764 are present twice, SEQ ID NOs
316; 328; 331; 368; 788; 1284; 1285; 1469; 1470; 1471; 1519; 1520;
1521; 1524; 2065; 2067 and 2089 are present in three copies, SEQ ID
NO 1194 is present in 4 copies and SEQ ID NOs 315 and 1162 are
present in 6 copies.
[0285] The above mentioned polynucleotide probes contained in the
200 nucleotides probe sets specifically recognized the above
mentioned gene and their variant when present via target region,
the correspondence being deduced from Table 6.
[0286] The multiplicities mentioned above are considered as the
"Top Polynucleotide Probe Sets".
[0287] In another preferred embodiment, the invention relates to
the use of a multiplicity of at least 1228 polynucleotide probe
sets as defined above, containing 3985 polynucleotide probes, the
nucleic acid sequence of the polynucleotide probes contained in
said 1228 polynucleotide probe sets being represented in the first
1228 lines of the Table 7,
for the determination of the variation of expression of for
determining the variation of the expression of [0288] at least 206
determined genes belonging to a group of determined genes
represented by the nucleotidic sequences SEQ ID NO: 5419 to SEQ ID
NO: 5693 and [0289] at least one variant of said genes at least 206
genes, when they exist, [0290] said 206 genes being represented by
the following nucleotidic sequences:
[0291] SEQ ID Nos 5420; 5421; 5422; 5423; 5425; 5426; 5427; 5428;
5429; 5430; 5431; 5432; 5434; 5435; 5436; 5437; 5438; 5439; 5440;
5441; 5442; 5443; 5444; 5445; 5446; 5447; 5449; 5450; 5451; 5452;
5453; 5454; 5455; 5456; 5457; 5459; 5460; 5461; 5462; 5463; 5465;
5467; 5468; 5470; 5473; 5475; 5476; 5479; 5480; 5482; 5484; 5485;
5486; 5487; 5488; 5489; 5490; 5491; 5492; 5493; 5495; 5496; 5497;
5498; 5499; 5502; 5503; 5505; 5506; 5507; 5508; 5509; 5511; 5512;
5513; 5515; 5516; 5517; 5518; 5519; 5520; 5523; 5524; 5525; 5526;
5528; 5529; 5530; 5531; 5532; 5533; 5534; 5536; 5538; 5539; 5540;
5543; 5544; 5545; 5546; 5547; 5549; 5550; 5552; 5553; 5554; 5556;
5558; 5559; 5560; 5562; 5563; 5564; 5565; 5566; 5567; 5568; 5569;
5570; 5571; 5573; 5574; 5575; 5576; 5577; 5578; 5581; 5582; 5585;
5587; 5588; 5590; 5591; 5593; 5594; 5595; 5597; 5598; 5599; 5600;
5601; 5602; 5603; 5604; 5605; 5606; 5608; 5609; 5610; 5611; 5612;
5613; 5615; 5616; 5617; 5618; 5622; 5623; 5624; 5625; 5627; 5629;
5630; 5631; 5632; 5633; 5634; 5635; 5637; 5638; 5639; 5640; 5641;
5642; 5643; 5644; 5645; 5647; 5648; 5649; 5651; 5652; 5653; 5654;
5656; 5657; 5658; 5660; 5661; 5665; 5667; 5669; 5672; 5673; 5675;
5676; 5677; 5678; 5680; 5681; 5683; 5684; 5686; 5687; 5689 and
5692, and the corresponding variants being represented in table
1E,
in order to diagnose in vitro or ex vivo the benign or malignant
state of a breast tumor.
[0292] Thus, in all the 1228 polynucleotide probe sets mentioned
above, 3427 polynucleotide probes are present.
[0293] Also, a preferred embodiment of the invention discloses the
use of a multiplicity of 1640 polynucleotide probe sets as defined
above, the nucleic acid sequence of the polynucleotide probes
contained in said 1640 polynucleotide probe sets being represented
in Table 7,
for the determination of the variation of expression of [0294] 275
determined genes represented by the nucleotidic sequences SEQ ID
NO: 5419 to SEQ ID NO: 5693 and [0295] at least one variant of said
genes 275 determined genes, when they exist, the correspondence
being mentioned in table 6, [0296] in order to diagnose in vitro or
ex vivo the benign or malignant state of a breast tumor.
[0297] Thus, in all the 1640 polynucleotide probe sets mentioned
above, 4586 polynucleotide probes are present.
[0298] In another embodiment, the invention discloses the use of a
multiplicity of polynucleotide probe sets, wherein the sub-group of
genes is constituted by 12 to 259 genes chosen among the group of
genes consisting in SEQ ID NO 5419 to SEQ ID NO 5677.
[0299] The sub-groups of genes contain at least 12 genes, as
described above. The sub-group of genes can also contain
advantageously 19 genes, or advantageously 32 genes, or
advantageously 40 genes, or advantageously 214 genes or more
advantageously 259 genes.
[0300] According to the invention, each gene of the sub-groups of
genes, and/or its variants when they exist, are specifically
recognized by at least one polynucleotide probe belonging to a
polynucleotide probe set of a pool of polynucleotide probe
sets.
[0301] In a more particular embodiment, the invention relates to
the use of a multiplicity of polynucleotide probe sets, wherein the
sub-group of genes is constituted by the 259 genes of the group
consisting in SEQ ID NO 5419 to SEQ ID NO 5693.
[0302] The inventors have unexpectedly demonstrated that a group of
259 genes, and/or their variants when they exist, give some
powerful information to precisely determine the benign or malignant
status of a breast tumor.
[0303] In the group of 259 genes, each gene, and its variants when
they exist is specifically recognized by at least one
polynucleotide probe belonging to a polynucleotide probe set of a
pool of polynucleotide probe sets.
[0304] In another advantageous embodiment, the invention discloses
the use of a multiplicity of polynucleotide probe sets, wherein the
polynucleotide probe sets are chosen among at least 50
polynucleotide probe sets, particularly at least 100 polynucleotide
probe sets, more particularly at least 150 polynucleotide probe
sets, more particularly at least 200 polynucleotide probe sets,
more particularly at least 1228 polynucleotide probe sets, and more
particularly 1640 polynucleotide probe sets of the library of
nucleic acid sequences consisting in SEQ ID NO 1 to SEQ ID NO
2938.
[0305] The multiplicity of polynucleotide probe sets is of at least
50 polynucleotide probe sets, and particularly at least 100
polynucleotide probe sets, more particularly at least 150
polynucleotide probe sets, and more advantageously at least 200
polynucleotide probe sets.
[0306] These multiplicities are considered as the "Top
Polynucleotide Probe Sets".
[0307] The Top 50 polynucleotide probe sets contains a combination
of polynucleotide probes characterized by SEQ ID NO 138, SEQ ID NO
140, SEQ ID NO 157, SEQ ID NO 159, SEQ ID NO 167, SEQ ID NO 168,
SEQ ID NO 169, SEQ ID NO 171, SEQ ID NO 173, SEQ ID NO 177, SEQ ID
NO 312, SEQ ID NO 314, SEQ ID NO 315, SEQ ID NO 317, SEQ ID NO 324,
SEQ ID NO 326, SEQ ID NO 327, SEQ ID NO 329, SEQ ID NO 330, SEQ ID
NO 331 SEQ ID NO 333, SEQ ID NO 335, SEQ ID NO 336, SEQ ID NO 339,
SEQ ID NO 341, SEQ ID NO 345, SEQ ID NO 347, SEQ ID NO 353, SEQ ID
NO 360, SEQ ID NO 361, SEQ ID NO 364, SEQ ID NO 366, SEQ ID NO 367,
SEQ ID NO 369, SEQ ID NO 790, SEQ ID NO 792, SEQ ID NO 793, SEQ ID
NO 795, SEQ ID NO 969, SEQ ID NO 972, SEQ ID NO 981, SEQ ID NO
1081, SEQ ID NO 1083, SEQ ID NO 1129, SEQ ID NO 1140, SEQ ID NO
1141, SEQ ID NO 1151, SEQ ID NO 1158, SEQ ID NO 1159, SEQ ID NO
1162, SEQ ID NO 1165, SEQ ID NO 1166, SEQ ID NO 1167, SEQ ID NO
1169, SEQ ID NO 1170, SEQ ID NO 1171, SEQ ID NO 1185, SEQ ID NO
1186, SEQ ID NO 1194, SEQ ID NO 1198, SEQ ID NO 1200, SEQ ID NO
1203, SEQ ID NO 1262, SEQ ID NO 1264, SEQ ID NO 1267, SEQ ID NO
1269, SEQ ID NO 1520, SEQ ID NO 1522, SEQ ID NO 1523, SEQ ID NO
1524, SEQ ID NO 1534, SEQ ID NO 1536, SEQ ID NO 1544, SEQ ID NO
1546, SEQ ID NO 1551, SEQ ID NO 1553, SEQ ID NO 1554, SEQ ID NO
1556, SEQ ID NO 1557, SEQ ID NO 2026, SEQ ID NO 2028, SEQ ID NO
2179 and SEQ ID NO 2181.
[0308] The Top 100 polynucleotide probe set contains a combination
of polynucleotide probes characterized by SEQ ID NO 120, SEQ ID NO
138, SEQ ID NO 140, SEQ ID NO 154, SEQ ID NO 155, SEQ ID NO 156,
SEQ ID NO 157, SEQ ID NO 159, SEQ ID NO 166, SEQ ID NO 167, SEQ ID
NO 168, SEQ ID NO 169, SEQ ID NO 171, SEQ ID NO 173, SEQ ID NO 174,
SEQ ID NO 175, SEQ ID NO 176, SEQ ID NO 177, SEQ ID NO 312, SEQ ID
NO 314, SEQ ID NO 315, SEQ ID NO 317, SEQ ID NO 324, SEQ ID NO 326,
SEQ ID NO 327, SEQ ID NO 328, SEQ ID NO 329, SEQ ID NO 330, SEQ ID
NO 331, SEQ ID NO 331, SEQ ID NO 332, SEQ ID NO 333, SEQ ID NO 335,
SEQ ID NO 336, SEQ ID NO 337, SEQ ID NO 338, SEQ ID NO 339, SEQ ID
NO 341, SEQ ID NO 345, SEQ ID NO 347, SEQ ID NO 349, SEQ ID NO 350,
SEQ ID NO 351, SEQ ID NO 352, SEQ ID NO 353, SEQ ID NO 354, SEQ ID
NO 355, SEQ ID NO 356, SEQ ID NO 360, SEQ ID NO 361, SEQ ID NO 363,
SEQ ID NO 364, SEQ ID NO 364, SEQ ID NO 366, SEQ ID NO 367, SEQ ID
NO 369, SEQ ID NO 369, SEQ ID NO 371, SEQ ID NO 376, SEQ ID NO 378,
SEQ ID NO 379, SEQ ID NO 380, SEQ ID NO 381, SEQ ID NO 555, SEQ ID
NO 556, SEQ ID NO 557, SEQ ID NO 558, SEQ ID NO 560, SEQ ID NO 561,
SEQ ID NO 562, SEQ ID NO 566, SEQ ID NO 567, SEQ ID NO 788, SEQ ID
NO 789, SEQ ID NO 790, SEQ ID NO 792, SEQ ID NO 793, SEQ ID NO 795,
SEQ ID NO 800, SEQ ID NO 801, SEQ ID NO 802, SEQ ID NO 821, SEQ ID
NO 822, SEQ ID NO 823, SEQ ID NO 969, SEQ ID NO 971, SEQ ID NO 972,
SEQ ID NO 981, SEQ ID NO 1056, SEQ ID NO 1057, SEQ ID NO 1058, SEQ
ID NO 1075, SEQ ID NO 1076, SEQ ID NO 1077, SEQ ID NO 1081, SEQ ID
NO 1083, SEQ ID NO 1087, SEQ ID NO 1088, SEQ ID NO 1089, SEQ ID NO
1103, SEQ ID NO 1104, SEQ ID NO 1105, SEQ ID NO 1114, SEQ ID NO
1115, SEQ ID NO 1116, SEQ ID NO 1123, SEQ ID NO 1124, SEQ ID NO
1125, SEQ ID NO 1129, SEQ ID NO 1130, SEQ ID NO 1131, SEQ ID NO
1140, SEQ ID NO 1141, SEQ ID NO 1142, SEQ ID NO 1143, SEQ ID NO
1151, SEQ ID NO 1158, SEQ ID NO 1159, SEQ ID NO 1162, SEQ ID NO
1163, SEQ ID NO 1163, SEQ ID NO 1164, SEQ ID NO 1165, SEQ ID NO
1166, SEQ ID NO 1167, SEQ ID NO 1169, SEQ ID NO 1170, SEQ ID NO
1171, SEQ ID NO 1172, SEQ ID NO 1172, SEQ ID NO 1180, SEQ ID NO
1181, SEQ ID NO 1185, SEQ ID NO 1186, SEQ ID NO 1187, SEQ ID NO
1188, SEQ ID NO 1189, SEQ ID NO 1189, SEQ ID NO 1190, SEQ ID NO
1191, SEQ ID NO 1192, SEQ ID NO 1193, SEQ ID NO 1194, SEQ ID NO
1195, SEQ ID NO 1196, SEQ ID NO 1198, SEQ ID NO 1200, SEQ ID NO
1201, SEQ ID NO 1202, SEQ ID NO 1203, SEQ ID NO 1207, SEQ ID NO
1262, SEQ ID NO 1264, SEQ ID NO 1267, SEQ ID NO 1269, SEQ ID NO
1509, SEQ ID NO 1510, SEQ ID NO 1511, SEQ ID NO 1519, SEQ ID NO
1520, SEQ ID NO 1520, SEQ ID NO 1521, SEQ ID NO 1522, SEQ ID NO
1523, SEQ ID NO 1524, SEQ ID NO 1524, SEQ ID NO 1528, SEQ ID NO
1529, SEQ ID NO 1534, SEQ ID NO 1536, SEQ ID NO 1544, SEQ ID NO
1546, SEQ ID NO 1551, SEQ ID NO 1553, SEQ ID NO 1554, SEQ ID NO
1556, SEQ ID NO 1557, SEQ ID NO 1561, SEQ ID NO 1562, SEQ ID NO
1682, SEQ ID NO 1683, SEQ ID NO 1684, SEQ ID NO 1776, SEQ ID NO
1777, SEQ ID NO 1778, SEQ ID NO 2023, SEQ ID NO 2024, SEQ ID NO
2025, SEQ ID NO 2026, SEQ ID NO 2028, SEQ ID NO 2173, SEQ ID NO
2174, SEQ ID NO 2175, SEQ ID NO 2176, SEQ ID NO 2177, SEQ ID NO
2178, SEQ ID NO 2179, SEQ ID NO 2181, SEQ ID NO 2762, SEQ ID NO
2763, SEQ ID NO 2764, SEQ ID NO 2860, SEQ ID NO 2861, SEQ ID NO
2862, SEQ ID NO 2883, SEQ ID NO 2884 and SEQ ID NO 2885.
[0309] The Top 150 polynucleotide probe set contains a combination
of polynucleotide probes characterized by polynucleotide probes
chosen among SEQ ID NO 1 to SEQ ID NO 2938.
[0310] The Top 200 polynucleotide probe set contains a combination
of polynucleotide probes characterized by polynucleotide probes
chosen among SEQ ID NO 1 to SEQ ID NO 2938.
[0311] According to the invention, the multiplicities used can also
be represented by a number of at least 300 polynucleotide probe
sets, more particularly at least 400 polynucleotide probe sets,
more particularly at least 500 polynucleotide probe sets, more
particularly at least 600 polynucleotide probe sets, more
particularly at least 700 polynucleotide probe sets, more
particularly at least 800 polynucleotide probe sets, more
particularly at least 900 polynucleotide probe sets, more
particularly at least 1000 polynucleotide probe sets, more
particularly at least 1100 polynucleotide probe sets, more
particularly at least 1228 polynucleotide probe sets, more
particularly at least 1400 polynucleotide probe sets, and more
particularly 1640 polynucleotide probe sets.
[0312] All the above-mentioned multiplicities of polynucleotide
probe sets contain polynucleotides probes chosen among the library
of nucleic acid sequences consisting in SEQ ID NO 1 to SEQ ID NO
2938.
[0313] According to the invention, the 1228 polynucleotide probe
sets are an advantageous multiplicity of probe sets defined to
diagnose the benign versus malignant status of a breast tumor.
[0314] In another embodiment, the invention also relates to the use
of a multiplicity of polynucleotide probe sets, wherein
polynucleotide probe sets are chosen among at least 50
polynucleotide probe sets, particularly at least 100 polynucleotide
probe sets, more particularly at least 150 polynucleotide probe
sets, more particularly at least 200 polynucleotide probe sets,
more particularly at least 1228 polynucleotide probe sets, and more
particularly 1640 polynucleotide probe sets of the library of
nucleic acid sequences consisting in SEQ ID NO 1 to SEQ ID NO
2938,
[0315] and wherein the sub-group of genes is constituted by the 259
genes of the group consisting in SEQ ID NO 5419 to SEQ ID NO
5677.
[0316] According to the invention, the benign versus malignant
status of a breast tumor can be determined by the use of 2938
polynucleotide probes.
[0317] In an advantageous embodiment, the invention describes the
use of a multiplicity of polynucleotide probe sets, wherein a
variant of a given gene is chosen among the group of variants
consisting in SEQ ID NO 4579 to SEQ ID NO 5418.
[0318] According to the invention, each gene can have: [0319] no
variant [0320] at least one variant, as defined above.
[0321] In an advantageous embodiment, the invention discloses the
use of a multiplicity of polynucleotide probe sets, each
polynucleotide probe set containing at least one polynucleotide
probe, each probe being able to specifically hybridize with at
least one gene, and/or its variants when they exist, to determine
the benign or malignant status of a breast tumor.
[0322] More particularly, the invention discloses the use of 2938
polynucleotides probes, assembled in polynucleotide probe sets,
said polynucleotides probes being able to detect the variation of
expression of at least one gene chosen among 259 genes, and/or its
variants when present. According to the invention, the variation of
expression of at least 839 variants and the variation of expression
259 genes can be detected by the use of the multiplicities of
polynucleotide probe sets described above.
[0323] The invention also discloses a library of nucleic acid
sequences consisting in SEQ ID NO 1 to SEQ ID NO 2938.
[0324] This library consists in all the polynucleotide probes that
can be regrouped in 1640 representative probe sets of the
invention. Then, the library consists in a group that contains 2938
polynucleotide probes.
[0325] The invention advantageously discloses a multiplicity of
polynucleotide probes sets chosen among the nucleic acid sequences
of the library described above, wherein the multiplicity of
polynucleotide probe sets represents a combination of pool of
polynucleotide probe sets able to specifically hybridize with 214
genes, and/or their variants when they exist, chosen among SEQ ID
NO 5419 to SEQ ID NO 5677.
[0326] The group of polynucleotide probes represents a combination
of 1228 polynucleotide probe sets. The group allows to detect the
variation of expression of 214 genes and/or their variants when
they exist.
[0327] The invention advantageously discloses a multiplicity of
polynucleotide probe sets chosen among the nucleic acid sequences
of the library according to claim 8, wherein the multiplicity of
polynucleotide probe sets represents a combination of pool of
polynucleotide probe sets able to specifically hybridize with 40
genes, and/or their variants when they exist, chosen among SEQ ID
NO 5419 to SEQ ID NO 5677.
[0328] The group of polynucleotide probes represents a combination
of 200 polynucleotide probe sets. The group allows to detect the
variation of expression of 40 genes and/or their variants when they
exist.
[0329] The invention more advantageously discloses a multiplicity
of polynucleotide probe sets chosen among the nucleic acid
sequences of the library according to claim 8, wherein the
multiplicity of polynucleotide probe sets represents a combination
of pool of polynucleotide probe sets able to specifically hybridize
with 32 genes, and/or their variants when they exist, chosen among
SEQ ID NO 5419 to SEQ ID NO 5677.
[0330] The group of polynucleotide probes represents a combination
of 150 polynucleotide probe sets. The group allows to detect the
variation of expression of 32 genes and/or their variants when they
exist.
[0331] The invention more advantageously discloses multiplicity of
polynucleotide probe sets chosen among the nucleic acid sequences
of the library according to claim 8, wherein the multiplicity of
polynucleotide probe sets represents a combination of pool of
polynucleotide probe sets able to specifically hybridize with 19
genes, and/or their variants when they exist, chosen among SEQ ID
NO 5419 to SEQ ID NO 5677.
[0332] According to the invention, the set of polynucleotide probe
being able to specifically hybridize with 19 genes, and/or their
variants when they exist, comprises the polynucleotide probes
consisting in SEQ ID NO 120, SEQ ID NO 138, SEQ ID NO 140, SEQ ID
NO 154, SEQ ID NO 155, SEQ ID NO 156, SEQ ID NO 157, SEQ ID NO 159,
SEQ ID NO 166, SEQ ID NO 167, SEQ ID NO 168, SEQ ID NO 169, SEQ ID
NO 171, SEQ ID NO 173, SEQ ID NO 174, SEQ ID NO 175, SEQ ID NO 176,
SEQ ID NO 177, SEQ ID NO 312, SEQ ID NO 314, SEQ ID NO 315, SEQ ID
NO 317, SEQ ID NO 324, SEQ ID NO 326, SEQ ID NO 327, SEQ ID NO 328,
SEQ ID NO 329, SEQ ID NO 330, SEQ ID NO 331, SEQ ID NO 331, SEQ ID
NO 332, SEQ ID NO 333, SEQ ID NO 335, SEQ ID NO 336, SEQ ID NO 337,
SEQ ID NO 338, SEQ ID NO 339, SEQ ID NO 341, SEQ ID NO 345, SEQ ID
NO 347, SEQ ID NO 349, SEQ ID NO 350, SEQ ID NO 351, SEQ ID NO 352,
SEQ ID NO 353, SEQ ID NO 354, SEQ ID NO 355, SEQ ID NO 356, SEQ ID
NO 360, SEQ ID NO 361, SEQ ID NO 363, SEQ ID NO 364, SEQ ID NO 364,
SEQ ID NO 366, SEQ ID NO 367, SEQ ID NO 369, SEQ ID NO 369, SEQ ID
NO 371, SEQ ID NO 376, SEQ ID NO 378, SEQ ID NO 379, SEQ ID NO 380,
SEQ ID NO 381, SEQ ID NO 555, SEQ ID NO 556, SEQ ID NO 557, SEQ ID
NO 558, SEQ ID NO 560, SEQ ID NO 561, SEQ ID NO 562, SEQ ID NO 566,
SEQ ID NO 567, SEQ ID NO 788, SEQ ID NO 789, SEQ ID NO 790, SEQ ID
NO 792, SEQ ID NO 793, SEQ ID NO 795, SEQ ID NO 800, SEQ ID NO 801,
SEQ ID NO 802, SEQ ID NO 821, SEQ ID NO 822, SEQ ID NO 823, SEQ ID
NO 969, SEQ ID NO 971, SEQ ID NO 972, SEQ ID NO 981, SEQ ID NO
1056, SEQ ID NO 1057, SEQ ID NO 1058, SEQ ID NO 1075, SEQ ID NO
1076, SEQ ID NO 1077, SEQ ID NO 1081, SEQ ID NO 1083, SEQ ID NO
1087, SEQ ID NO 1088, SEQ ID NO 1089, SEQ ID NO 1103, SEQ ID NO
1104, SEQ ID NO 1105, SEQ ID NO 1114, SEQ ID NO 1115, SEQ ID NO
1116, SEQ ID NO 1123, SEQ ID NO 1124, SEQ ID NO 1125, SEQ ID NO
1129, SEQ ID NO 1130, SEQ ID NO 1131, SEQ ID NO 1140, SEQ ID NO
1141, SEQ ID NO 1142, SEQ ID NO 1143, SEQ ID NO 1151, SEQ ID NO
1158, SEQ ID NO 1159, SEQ ID NO 1162, SEQ ID NO 1163, SEQ ID NO
1163, SEQ ID NO 1164, SEQ ID NO 1165, SEQ ID NO 1166, SEQ ID NO
1167, SEQ ID NO 1169, SEQ ID NO 1170, SEQ ID NO 1171, SEQ ID NO
1172, SEQ ID NO 1172, SEQ ID NO 1180, SEQ ID NO 1181, SEQ ID NO
1185, SEQ ID NO 1186, SEQ ID NO 1187, SEQ ID NO 1188, SEQ ID NO
1189, SEQ ID NO 1189, SEQ ID NO 1190, SEQ ID NO 1191, SEQ ID NO
1192, SEQ ID NO 1193, SEQ ID NO 1194, SEQ ID NO 1195, SEQ ID NO
1196, SEQ ID NO 1198, SEQ ID NO 1200, SEQ ID NO 1201, SEQ ID NO
1202, SEQ ID NO 1203, SEQ ID NO 1207, SEQ ID NO 1262, SEQ ID NO
1264, SEQ ID NO 1267, SEQ ID NO 1269, SEQ ID NO 1509, SEQ ID NO
1510, SEQ ID NO 1511, SEQ ID NO 1519, SEQ ID NO 1520, SEQ ID NO
1520, SEQ ID NO 1521, SEQ ID NO 1522, SEQ ID NO 1523, SEQ ID NO
1524, SEQ ID NO 1524, SEQ ID NO 1528, SEQ ID NO 1529, SEQ ID NO
1534, SEQ ID NO 1536, SEQ ID NO 1544, SEQ ID NO 1546, SEQ ID NO
1551, SEQ ID NO 1553, SEQ ID NO 1554, SEQ ID NO 1556, SEQ ID NO
1557, SEQ ID NO 1561, SEQ ID NO 1562, SEQ ID NO 1682, SEQ ID NO
1683, SEQ ID NO 1684, SEQ ID NO 1776, SEQ ID NO 1777, SEQ ID NO
1778, SEQ ID NO 2023, SEQ ID NO 2024, SEQ ID NO 2025, SEQ ID NO
2026, SEQ ID NO 2028, SEQ ID NO 2173, SEQ ID NO 2174, SEQ ID NO
2175, SEQ ID NO 2176, SEQ ID NO 2177, SEQ ID NO 2178, SEQ ID NO
2179, SEQ ID NO 2181, SEQ ID NO 2762, SEQ ID NO 2763, SEQ ID NO
2764, SEQ ID NO 2860, SEQ ID NO 2861, SEQ ID NO 2862, SEQ ID NO
2883, SEQ ID NO 2884 and SEQ ID NO 2885.
[0333] The group of polynucleotide probes represents a combination
of 100 polynucleotide probe sets. The group allows to detect the
variation of expression of 19 genes and/or their variants when they
exist.
[0334] The invention advantageously discloses a multiplicity of
polynucleotide probe sets chosen among the nucleic acid sequences
of the library according to claim 8, wherein the multiplicity of
polynucleotide probe sets represents a combination of pool of
polynucleotide probe sets able to specifically hybridize with 12
genes, and/or their variants when they exist, chosen among SEQ ID
NO 5419 to SEQ ID NO 5677.
[0335] According to the invention, the set of polynucleotide probe
being able to specifically hybridize with 12 genes, and/or their
variants when they exist, comprises the polynucleotide probes
consisting in SEQ ID NO 138, SEQ ID NO 140, SEQ ID NO 157, SEQ ID
NO 159, SEQ ID NO 167, SEQ ID NO 168, SEQ ID NO 169, SEQ ID NO 171,
SEQ ID NO 173, SEQ ID NO 177, SEQ ID NO 312, SEQ ID NO 314, SEQ ID
NO 315, SEQ ID NO 317, SEQ ID NO 324, SEQ ID NO 326, SEQ ID NO 327,
SEQ ID NO 329, SEQ ID NO 330, SEQ ID NO 331 SEQ ID NO 333, SEQ ID
NO 335, SEQ ID NO 336, SEQ ID NO 339, SEQ ID NO 341, SEQ ID NO 345,
SEQ ID NO 347, SEQ ID NO 353, SEQ ID NO 360, SEQ ID NO 361, SEQ ID
NO 364, SEQ ID NO 366, SEQ ID NO 367, SEQ ID NO 369, SEQ ID NO 790,
SEQ ID NO 792, SEQ ID NO 793, SEQ ID NO 795, SEQ ID NO 969, SEQ ID
NO 972, SEQ ID NO 981, SEQ ID NO 1081, SEQ ID NO 1083, SEQ ID NO
1129, SEQ ID NO 1140, SEQ ID NO 1141, SEQ ID NO 1151, SEQ ID NO
1158, SEQ ID NO 1159, SEQ ID NO 1162, SEQ ID NO 1165, SEQ ID NO
1166, SEQ ID NO 1167, SEQ ID NO 1169, SEQ ID NO 1170, SEQ ID NO
1171, SEQ ID NO 1185, SEQ ID NO 1186, SEQ ID NO 1194, SEQ ID NO
1198, SEQ ID NO 1200, SEQ ID NO 1203, SEQ ID NO 1262, SEQ ID NO
1264, SEQ ID NO 1267, SEQ ID NO 1269, SEQ ID NO 1520, SEQ ID NO
1522, SEQ ID NO 1523, SEQ ID NO 1524, SEQ ID NO 1534, SEQ ID NO
1536, SEQ ID NO 1544, SEQ ID NO 1546, SEQ ID NO 1551, SEQ ID NO
1553, SEQ ID NO 1554, SEQ ID NO 1556, SEQ ID NO 1557, SEQ ID NO
2026, SEQ ID NO 2028, SEQ ID NO 2179 and SEQ ID NO 2181.
[0336] The group of polynucleotide probes represents a combination
of 50 polynucleotide probe sets. The group allows to detect the
variation of expression of 12 genes and/or their variants when they
exist.
[0337] The invention also discloses a multiplicity of 50
polynucleotide probe sets chosen among 1640 polynucleotide probe
sets as defined above.
[0338] Also, the invention relates to a multiplicity of at least 50
polynucleotide probe sets chosen among 1640 polynucleotide probe
sets, the nucleic acid sequences of the polynucleotide probes
contained in said 50 polynucleotide probe sets being the following
nucleic acid sequences: SEQ ID NOs 136; 137; 138; 157; 158; 159;
167; 168; 169; 171; 172; 173; 177; 312; 313; 313; 314; 315; 316;
317; 324; 325; 326; 327; 328; 329; 330; 331; 333; 334; 335; 336;
339; 340; 341; 345; 346; 347; 348; 353; 360; 361; 364; 365; 366;
367; 368; 369; 370; 374; 375; 790; 791; 792; 793; 794; 795; 969;
972; 981; 1081; 1082; 1083; 1129; 1140; 1141; 1158; 1159; 1160;
1161; 1162; 1165; 1166; 1167; 1168; 1169; 1170; 1171; 1185; 1186;
1194; 1198; 1199; 1200; 1203; 1262; 1263; 1264; 1267; 1268; 1269;
1519; 1520; 1521; 1522; 1523; 1524; 1534; 1535; 1536; 1544; 1545;
1546; 1551; 1552; 1553; 1554; 1555; 1556; 1557; 2026; 2027; 2028;
2179; 2180 and 2181,
each polynucleotide probe set containing from 1 to 4 of said
polynucleotide probes,
[0339] preferably, wherein SEQ ID NOs 167; 168; 177; 312; 313; 327;
328; 329; 331; 364; 365; 366; 368; 370; 1185; 1186; 1194; 1523;
1524; 1551; 1552 and 1553 are present twice, SEQ ID NO 316 is
present in three copies and SEQ ID NO 315 is present in 5
copies.
[0340] In one preferred embodiment, the invention also discloses a
multiplicity of 100 polynucleotide probe sets chosen among 1640
polynucleotide probe sets as defined above.
[0341] Also, the invention relates to a multiplicity of at least
100 polynucleotide probe sets as above defined, the nucleic acid
sequences of the polynucleotides probes contained in said 100
polynucleotide probe sets being the following nucleic acid
sequences: SEQ ID NO 120; 136; 137; 138; 154; 155; 156; 157; 158;
159; 167; 168; 169; 171; 172; 173; 174; 175; 176; 177; 312; 313;
314; 315; 316; 316; 317; 324; 325; 326; 327; 328; 329; 330; 331;
332; 333; 334; 335; 336; 337; 338; 339; 340; 341; 345; 346; 347;
348; 349; 350; 351; 352; 353; 354; 355; 356; 360; 361; 363; 364;
365; 366; 367; 368; 369; 370; 371; 374; 375; 376; 378; 379; 380;
381; 555; 556; 557; 558; 560; 561; 562; 566; 567; 788; 789; 790;
791; 792; 793; 794; 795; 800; 801; 802; 821; 822; 823; 969; 971;
972; 981; 1056; 1057; 1058; 1075; 1076; 1077; 1081; 1082; 1083;
1087; 1088; 1089; 1103; 1104; 1105; 1114; 1115; 1116; 1123; 1124;
1125; 1129; 1130; 1131; 1140; 1141; 1158; 1159; 1160; 1161; 1162;
1163; 1164; 1165; 1166; 1167; 1168; 1169; 1170; 1171; 1172; 1180;
1181; 1185; 1186; 1187; 1188; 1189; 1190; 1191; 1192; 1193; 1194;
1195; 1196; 1198; 1199; 1200; 1201; 1202; 1203; 1207; 1262; 1263;
1264; 1267; 1268; 1269; 1509; 1510; 1511; 1519; 1520; 1521; 1522;
1523; 1524; 1528; 1529; 1534; 1535; 1536; 1544; 1545; 1546; 1551;
1552; 1553; 1554; 1555; 1556; 1557; 1561; 1562; 1682; 1683; 1684;
1776; 1777; 1778; 2023; 2024; 2025; 2026; 2027; 2028; 2173; 2174;
2175; 2176; 2177; 2178; 2179; 2180; 2181; 2762; 2763; 2764; 2860;
2861; 2862; 2883; 2884 and 2885,
each polynucleotide probe set containing from 1 to 4 of said
polynucleotide probes,
[0342] preferably, wherein SEQ ID NOs 167; 168; 177; 312; 313; 316;
317; 327; 329; 330; 353; 361; 364; 365; 366; 367; 368; 369; 370;
821; 822; 823; 1129; 1164; 1185; 1186; 1187; 1188; 1189; 1203;
1523; 1551; 1552 and 1553 are present twice, SEQ ID NOs 328; 331;
1162; 1194; 1519; 1520; 1521 and 1524 are present in three copies
and SEQ ID NO 315 is present in 6 copies.
[0343] In another preferred embodiment, the invention also
discloses a multiplicity of 150 polynucleotide probe sets chosen
among 1640 polynucleotide probe sets as defined above.
[0344] In other word, the invention relates to a multiplicity of at
least 150 polynucleotide probe sets previously defined, the nucleic
acid sequences of the polynucleotides probes contained in said 150
polynucleotide probe sets being the following nucleic acid
sequences: SEQ ID NOs 4; 5; 6; 120; 136; 137; 138; 154; 155; 156;
157; 158; 159; 167; 168; 169; 171; 172; 173; 174; 175; 176; 177;
197; 248; 254; 255; 305; 306; 307; 312; 313; 314; 315; 316; 317;
324; 325; 326; 327; 328; 329; 330; 331; 332; 333; 334; 335; 336;
337; 338; 339; 340; 341; 345; 346; 347; 348; 349; 350; 351; 352;
353; 354; 355; 356; 360; 361; 362; 363; 364; 365; 366; 367; 367;
368; 369; 370; 371; 374; 375; 376; 377; 378; 379; 380; 381; 513;
514; 515; 552; 553; 554; 555; 556; 557; 558; 559; 560; 561; 562;
566; 567; 783; 784; 785; 788; 789; 790; 791; 792; 793; 794; 795;
796; 797; 798; 799; 800; 801; 802; 803; 804; 805; 806; 807; 808;
812; 813; 814; 818; 821; 822; 823; 968; 969; 970; 971; 972; 981;
1056; 1057; 1058; 1061; 1062; 1063; 1064; 1065; 1066; 1067; 1068;
1069; 1070; 1071; 1075; 1076; 1077; 1080; 1081; 1082; 1083; 1087;
1088; 1089; 1103; 1104; 1105; 1114; 1115; 1116; 1123; 1124; 1125;
1129; 1130; 1131; 1139; 1140; 1141; 1158; 1159; 1160; 1161; 1162;
1163; 1164; 1165; 1166; 1167; 1168; 1169; 1170; 1171; 1172; 1174;
1175; 1176; 1180; 1181; 1185; 1186; 1187; 1188; 1189; 1190; 1191;
1192; 1193; 1194; 1195; 1196; 1197; 1198; 1199; 1200; 1201; 1202;
1203; 1204; 1205; 1206; 1207; 1262; 1263; 1264; 1267; 1268; 1269;
1284; 1285; 1315; 1469; 1470; 1471; 1509; 1510; 1511; 1515; 1516;
1517; 1519; 1520; 1521; 1522; 1523; 1524; 1528; 1529; 1534; 1535;
1536; 1537; 1538; 1539; 1544; 1545; 1546; 1550; 1551; 1552; 1553;
1554; 1555; 1556; 1557; 1558; 1559; 1560; 1561; 1562; 1580; 1581;
1582; 1671; 1682; 1683; 1684; 1685; 1686; 1690; 1691; 1692; 1776;
1777; 1778; 1788; 1789; 1790; 1890; 1891; 1892; 1952; 1953; 1954;
1963; 2023; 2024; 2025; 2026; 2027; 2028; 2065; 2067; 2088; 2089;
2090; 2091; 2173; 2174; 2175; 2176; 2177; 2178; 2179; 2180; 2181;
2196; 2201; 2229; 2230; 2231; 2536; 2537; 2538; 2576; 2577; 2578;
2599; 2600; 2762; 2763; 2764; 2774; 2775; 2776; 2860; 2861; 2862;
2883; 2884 and 2885,
each polynucleotide probe set containing from 1 to 4 of said
polynucleotide probes,
[0345] preferably, wherein SEQ ID NOs 167; 168; 177; 312; 313; 317;
327; 329; 330; 353; 361; 363; 364; 365; 366; 369; 370; 371; 558;
567; 796; 797; 801; 806; 807; 808; 813; 814; 821; 822; 823; 969;
1056; 1057; 1058; 1129; 1141; 1163; 1164; 1185; 1186; 1187; 1188;
1189; 1199; 1203; 1469; 1470; 1471; 1523; 1551; 1552 and 1553 are
present twice, SEQ ID NOs 316; 328; 331; 368; 788; 1194; 1519;
1520; 1521; 1524 are present in three copies, SEQ ID NO 1162 is
present in 4 copies and SEQ ID NO 315 is present in 6 copies.
[0346] Another preferred embodiment of the invention relates to a
multiplicity of 200 polynucleotide probe sets chosen among 1640
polynucleotide probe sets as defined above.
[0347] Indeed, a preferred embodiment of the invention discloses a
multiplicity of at least 200 polynucleotide probe sets defined
above, the nucleic acid sequences of the polynucleotide probes
contained in said 200 polynucleotide probe sets being the following
nucleic acid sequences: SEQ ID NOs 4; 5; 6; 120; 121; 122; 123;
130; 131; 132; 136; 137; 138; 154; 155; 156; 157; 158; 159; 167;
168; 169; 171; 172; 173; 174; 175; 176; 177; 195; 196; 197; 198;
199; 200; 248; 254; 255; 305; 306; 307; 312; 313; 314; 315; 316;
317; 324; 325; 326; 327; 328; 329; 330; 331; 332; 333; 334; 335;
336; 337; 338; 339; 340; 341; 345; 346; 347; 348; 349; 350; 351;
352; 353; 354; 355; 356; 360; 361; 362; 363; 364; 365; 366; 367;
368; 369; 370; 371; 374; 375; 376; 377; 378; 379; 380; 381; 513;
514; 515; 552; 553; 554; 555; 556; 557; 558; 559; 560; 561; 562;
563; 564; 565; 566; 567; 783; 784; 785; 788; 789; 790; 791; 792;
793; 794; 795; 796; 797; 798; 799; 800; 801; 802; 803; 804; 805;
806; 807; 808; 809; 810; 811; 812; 813; 814; 815; 816; 817; 818;
821; 822; 823; 824; 825; 826; 840; 841; 845; 846; 847; 868; 968;
969; 970; 971; 972; 973; 974; 975; 976; 977; 981; 1056; 1057; 1058;
1059; 1060; 1061; 1062; 1063; 1064; 1065; 1066; 1067; 1068; 1069;
1070; 1071; 1075; 1076; 1077; 1080; 1081; 1082; 1083; 1084; 1085;
1086; 1087; 1088; 1089; 1094; 1095; 1096; 1103; 1104; 1105; 1110;
1111; 1112; 1114; 1115; 1116; 1123; 1124; 1125; 1126; 1127; 1128;
1129; 1130; 1131; 1139; 1140; 1141; 1158; 1159; 1160; 1161; 1162;
1163; 1164; 1165; 1166; 1167; 1168; 1169; 1170; 1171; 1172; 1174;
1175; 1176; 1180; 1181; 1185; 1186; 1187; 1188; 1189; 1190; 1191;
1192; 1193; 1194; 1195; 1196; 1197; 1198; 1199; 1200; 1201; 1202;
1203; 1204; 1205; 1206; 1207; 1229; 1230; 1242; 1243; 1244; 1245;
1250; 1251; 1252; 1262; 1263; 1264; 1265; 1266; 1267; 1268; 1269;
1270; 1271; 1272; 1284; 1285; 1315; 1335; 1407; 1408; 1469; 1470;
1471; 1509; 1510; 1511; 1512; 1513; 1514; 1515; 1516; 1517; 1519;
1520; 1521; 1522; 1523; 1524; 1528; 1529; 1534; 1535; 1536; 1537;
1538; 1539; 1544; 1545; 1546; 1550; 1551; 1552; 1553; 1554; 1555;
1556; 1557; 1558; 1559; 1560; 1561; 1562; 1563; 1564; 1580; 1581;
1582; 1586; 1587; 1588; 1671; 1682; 1683; 1684; 1685; 1686; 1687;
1688; 1689; 1690; 1691; 1692; 1743; 1744; 1745; 1776; 1777; 1778;
1788; 1789; 1790; 1890; 1891; 1892; 1896; 1897; 1898; 1952; 1953;
1954; 1963; 1974; 2023; 2024; 2025; 2026; 2027; 2028; 2061; 2062;
2063; 2065; 2067; 2068; 2072; 2083; 2084; 2085; 2088; 2089; 2090;
2091; 2092; 2173; 2174; 2175; 2176; 2177; 2178; 2179; 2180; 2181;
2196; 2201; 2229; 2230; 2231; 2381; 2382; 2383; 2536; 2537; 2538;
2576; 2577; 2578; 2599; 2600; 2601; 2602; 2603; 2762; 2763; 2764;
2774; 2775; 2776; 2778; 2779; 2783; 2794; 2860; 2861; 2862; 2883;
2884 and 2885,
each polynucleotide probe set containing from 1 to 4 of said
polynucleotide probes,
[0348] preferably, wherein SEQ ID NOs 167; 168; 177; 312; 313; 317;
327; 329; 330; 353; 361; 363; 364; 365; 366; 367; 369; 370; 371;
558; 567; 796; 797; 801; 806; 807; 808; 813; 814; 821; 822; 823;
845; 968; 970; 972; 1056; 1057; 1058; 1085; 1114; 1115; 1116; 1123;
1124; 1125; 1129; 1141; 1163; 1164; 1185; 1186; 1187; 1188; 1189;
1199; 1203; 1523; 1551; 1552; 1553; 1557; 1586; 1587; 1588; 1952;
1953; 1954; 2088; 2090; 2091; 2762; 2763 and 2764 are present
twice, SEQ ID NOs 316; 328; 331; 368; 788; 1284; 1285; 1469; 1470;
1471; 1519; 1520; 1521; 1524; 2065; 2067 and 2089 are present in
three copies, SEQ ID NO 1194 is present in 4 copies and SEQ ID NOs
315 and 1162 are present in 6 copies.
[0349] Another particular embodiment of the invention relates to a
multiplicity of 1228 polynucleotide probe sets chosen among 1640
polynucleotide probe sets as defined above.
[0350] The invention, in a particular embodiment, relates to a
multiplicity of at least 1228 polynucleotide probe sets as defined
above, containing 3985 polynucleotide probes, the nucleic acid
sequences of the polynucleotide probes contained in said 1228
polynucleotide probe sets being represented in the first 1228 lines
of the Table 7.
[0351] The invention discloses, in another preferred embodiment, a
multiplicity 1640 polynucleotide probe sets as defined above.
[0352] The invention related to a multiplicity of 1640
polynucleotide probe sets as previously defined, the nucleic acid
sequences of the polynucleotide probes contained in said 1640
polynucleotide probe sets being represented in Table 7.
[0353] The invention also discloses a micro-array comprising or
consisting in a multiplicity of polynucleotide probe sets as
defined above.
[0354] Thus, the invention discloses a micro-array comprising the
library of nucleic acid sequences consisting in SEQ ID NO 1 to SEQ
ID NO 2938, or a multiplicity of polynucleotide probe sets: [0355]
corresponding to a multiplicity of 1228 polynucleotide probe sets
comprising nucleic acid sequences chosen among the group consisting
in SEQ ID NO 1 to SEQ ID NO 2938, or [0356] corresponding to a
multiplicity of 200 polynucleotide probe sets comprising nucleic
acid sequences consisting in SEQ ID NO 1 to SEQ ID NO 2938, or
[0357] corresponding to a multiplicity of 150 polynucleotide probe
sets comprising nucleic acid sequences consisting in SEQ ID NO 1 to
SEQ ID NO 2938, or [0358] corresponding to a multiplicity of 100
polynucleotide probe sets comprising nucleic acid sequences
consisting in SEQ ID NO 1 to SEQ ID NO 2938, and in particular
consisting in SEQ ID NO 120, SEQ ID NO 138, SEQ ID NO 140, SEQ ID
NO 154, SEQ ID NO 155, SEQ ID NO 156, SEQ ID NO 157, SEQ ID NO 159,
SEQ ID NO 166, SEQ ID NO 167, SEQ ID NO 168, SEQ ID NO 169, SEQ ID
NO 171, SEQ ID NO 173, SEQ ID NO 174, SEQ ID NO 175, SEQ ID NO 176,
SEQ ID NO 177, SEQ ID NO 312, SEQ ID NO 314, SEQ ID NO 315, SEQ ID
NO 317, SEQ ID NO 324, SEQ ID NO 326, SEQ ID NO 327, SEQ ID NO 328,
SEQ ID NO 329, SEQ ID NO 330, SEQ ID NO 331, SEQ ID NO 331, SEQ ID
NO 332, SEQ ID NO 333, SEQ ID NO 335, SEQ ID NO 336, SEQ ID NO 337,
SEQ ID NO 338, SEQ ID NO 339, SEQ ID NO 341, SEQ ID NO 345, SEQ ID
NO 347, SEQ ID NO 349, SEQ ID NO 350, SEQ ID NO 351, SEQ ID NO 352,
SEQ ID NO 353, SEQ ID NO 354, SEQ ID NO 355, SEQ ID NO 356, SEQ ID
NO 360, SEQ ID NO 361, SEQ ID NO 363, SEQ ID NO 364, SEQ ID NO 364,
SEQ ID NO 366, SEQ ID NO 367, SEQ ID NO 369, SEQ ID NO 369, SEQ ID
NO 371, SEQ ID NO 376, SEQ ID NO 378, SEQ ID NO 379, SEQ ID NO 380,
SEQ ID NO 381, SEQ ID NO 555, SEQ ID NO 556, SEQ ID NO 557, SEQ ID
NO 558, SEQ ID NO 560, SEQ ID NO 561, SEQ ID NO 562, SEQ ID NO 566,
SEQ ID NO 567, SEQ ID NO 788, SEQ ID NO 789, SEQ ID NO 790, SEQ ID
NO 792, SEQ ID NO 793, SEQ ID NO 795, SEQ ID NO 800, SEQ ID NO 801,
SEQ ID NO 802, SEQ ID NO 821, SEQ ID NO 822, SEQ ID NO 823, SEQ ID
NO 969, SEQ ID NO 971, SEQ ID NO 972, SEQ ID NO 981, SEQ ID NO
1056, SEQ ID NO 1057, SEQ ID NO 1058, SEQ ID NO 1075, SEQ ID NO
1076, SEQ ID NO 1077, SEQ ID NO 1081, SEQ ID NO 1083, SEQ ID NO
1087, SEQ ID NO 1088, SEQ ID NO 1089, SEQ ID NO 1103, SEQ ID NO
1104, SEQ ID NO 1105, SEQ ID NO 1114, SEQ ID NO 1115, SEQ ID NO
1116, SEQ ID NO 1123, SEQ ID NO 1124, SEQ ID NO 1125, SEQ ID NO
1129, SEQ ID NO 1130, SEQ ID NO 1131, SEQ ID NO 1140, SEQ ID NO
1141, SEQ ID NO 1142, SEQ ID NO 1143, SEQ ID NO 1151, SEQ ID NO
1158, SEQ ID NO 1159, SEQ ID NO 1162, SEQ ID NO 1163, SEQ ID NO
1163, SEQ ID NO 1164, SEQ ID NO 1165, SEQ ID NO 1166, SEQ ID NO
1167, SEQ ID NO 1169, SEQ ID NO 1170, SEQ ID NO 1171, SEQ ID NO
1172, SEQ ID NO 1172, SEQ ID NO 1180, SEQ ID NO 1181, SEQ ID NO
1185, SEQ ID NO 1186, SEQ ID NO 1187, SEQ ID NO 1188, SEQ ID NO
1189, SEQ ID NO 1189, SEQ ID NO 1190, SEQ ID NO 1191, SEQ ID NO
1192, SEQ ID NO 1193, SEQ ID NO 1194, SEQ ID NO 1195, SEQ ID NO
1196, SEQ ID NO 1198, SEQ ID NO 1200, SEQ ID NO 1201, SEQ ID NO
1202, SEQ ID NO 1203, SEQ ID NO 1207, SEQ ID NO 1262, SEQ ID NO
1264, SEQ ID NO 1267, SEQ ID NO 1269, SEQ ID NO 1509, SEQ ID NO
1510, SEQ ID NO 1511, SEQ ID NO 1519, SEQ ID NO 1520, SEQ ID NO
1520, SEQ ID NO 1521, SEQ ID NO 1522, SEQ ID NO 1523, SEQ ID NO
1524, SEQ ID NO 1524, SEQ ID NO 1528, SEQ ID NO 1529, SEQ ID NO
1534, SEQ ID NO 1536, SEQ ID NO 1544, SEQ ID NO 1546, SEQ ID NO
1551, SEQ ID NO 1553, SEQ ID NO 1554, SEQ ID NO 1556, SEQ ID NO
1557, SEQ ID NO 1561, SEQ ID NO 1562, SEQ ID NO 1682, SEQ ID NO
1683, SEQ ID NO 1684, SEQ ID NO 1776, SEQ ID NO 1777, SEQ ID NO
1778, SEQ ID NO 2023, SEQ ID NO 2024, SEQ ID NO 2025, SEQ ID NO
2026, SEQ ID NO 2028, SEQ ID NO 2173, SEQ ID NO 2174, SEQ ID NO
2175, SEQ ID NO 2176, SEQ ID NO 2177, SEQ ID NO 2178, SEQ ID NO
2179, SEQ ID NO 2181, SEQ ID NO 2762, SEQ ID NO 2763, SEQ ID NO
2764, SEQ ID NO 2860, SEQ ID NO 2861, SEQ ID NO 2862, SEQ ID NO
2883, SEQ ID NO 2884 and SEQ ID NO 2885, or [0359] corresponding to
a multiplicity of 50 polynucleotide probe sets comprising nucleic
acid sequences consisting in SEQ ID NO 1 to SEQ ID NO 2938, and in
particular consisting in SEQ ID NO 138, SEQ ID NO 140, SEQ ID NO
157, SEQ ID NO 159, SEQ ID NO 167, SEQ ID NO 168, SEQ ID NO 169,
SEQ ID NO 171, SEQ ID NO 173, SEQ ID NO 177, SEQ ID NO 312, SEQ ID
NO 314, SEQ ID NO 315, SEQ ID NO 317, SEQ ID NO 324, SEQ ID NO 326,
SEQ ID NO 327, SEQ ID NO 329, SEQ ID NO 330, SEQ ID NO 331 SEQ ID
NO 333, SEQ ID NO 335, SEQ ID NO 336, SEQ ID NO 339, SEQ ID NO 341,
SEQ ID NO 345, SEQ ID NO 347, SEQ ID NO 353, SEQ ID NO 360, SEQ ID
NO 361, SEQ ID NO 364, SEQ ID NO 366, SEQ ID NO 367, SEQ ID NO 369,
SEQ ID NO 790, SEQ ID NO 792, SEQ ID NO 793, SEQ ID NO 795, SEQ ID
NO 969, SEQ ID NO 972, SEQ ID NO 981, SEQ ID NO 1081, SEQ ID NO
1083, SEQ ID NO 1129, SEQ ID NO 1140, SEQ ID NO 1141, SEQ ID NO
1151, SEQ ID NO 1158, SEQ ID NO 1159, SEQ ID NO 1162, SEQ ID NO
1165, SEQ ID NO 1166, SEQ ID NO 1167, SEQ ID NO 1169, SEQ ID NO
1170, SEQ ID NO 1171, SEQ ID NO 1185, SEQ ID NO 1186, SEQ ID NO
1194, SEQ ID NO 1198, SEQ ID NO 1200, SEQ ID NO 1203, SEQ ID NO
1262, SEQ ID NO 1264, SEQ ID NO 1267, SEQ ID NO 1269, SEQ ID NO
1520, SEQ ID NO 1522, SEQ ID NO 1523, SEQ ID NO 1524, SEQ ID NO
1534, SEQ ID NO 1536, SEQ ID NO 1544, SEQ ID NO 1546, SEQ ID NO
1551, SEQ ID NO 1553, SEQ ID NO 1554, SEQ ID NO 1556, SEQ ID NO
1557, SEQ ID NO 2026, SEQ ID NO 2028, SEQ ID NO 2179 and SEQ ID NO
2181.
[0360] The microarray refers to nucleic acid molecule covalently
attached to an inert chemical surface, such as coated glass slides
or gene chips, and to which a mobile DNA target is hybridized. All
the commonly used surfaces can also serve as a support.
[0361] The invention discloses a method for the in vitro and/or ex
vivo determination of the benign or malignant state of a breast
tumor in a biological sample from a subject, by determining the
variation of the expression of a gene, and/or at least one of its
variants when present, of a sub-group comprising at least 12 genes
among the genes of the group consisting in SEQ ID NO 5419 to SEQ ID
NO 5677, comprising: [0362] a) contacting nucleic acid molecules
from said biological sample a multiplicity of polynucleotide probe
sets, said multiplicity of polynucleotide probe sets consisting in
a combination of pools of polynucleotide probe sets, each
polynucleotide probe set containing at least one polynucleotide
probe chosen among a library of nucleic acid sequences, each
nucleic acid sequence specifically hybridizing with a gene, and/or
at least one of its variants when present, said gene being chosen
among the group of genes consisting in SEQ ID NO 5419 to SEQ ID NO
5677, [0363] each given gene, when it presents no variant,
comprising at least one target region, the nucleic acid sequence of
which is chosen among SEQ ID NO 2939 to SEQ ID NO 4578, said target
region characterizing said gene, [0364] each given gene, when it
presents at least one variant, comprising at least two target
regions such that: [0365] at least one of the respective nucleic
acid sequences of said target region chosen among SEQ ID NO 2939 to
SEQ ID NO 4578 is present in a given variant of said gene, [0366]
at least one of the respective nucleic acid sequences of said
target region chosen among SEQ ID NO 2939 to SEQ ID NO 4578 is
either absent in a given variant or is present in a configuration
that differs from the one of said gene, [0367] said two target
regions characterizing said gene, [0368] each variant of a given
gene presenting at least one target region, said target region
being such that its respective nucleic acid sequence is chosen
among SEQ ID NO 2939 to SEQ ID NO 4578, [0369] each variant is
characterized by: [0370] either the combination of the presence of
at least one target region also present in the gene, the respective
nucleic acid sequence of which being chosen among SEQ ID NO 2939 to
SEQ ID NO 4578, and the absence of at least one target region
present in the gene the respective nucleic acid sequence of which
being chosen among SEQ ID NO 2939 to SEQ ID NO 4578, [0371] or the
presence of a target region, the respective nucleic acid sequence
of which being chosen among SEQ ID NO 2939 to SEQ ID NO 4578, said
target region presenting a configuration that does not naturally
exist in the gene, [0372] each polynucleotide probe of a
polynucleotide probe set hybridizes with a specific nucleic acid
sequence contained in a given target region of the target regions
which characterize a given gene, and/or at least one of its
variants when present, [0373] each given gene, and its variants
when present, is specifically recognized by at least a given
polynucleotide probe set, [0374] each polynucleotide probe of a
given pool of polynucleotide probe set being such that it
hybridizes with a given gene, and/or at least one of its variants
when present, and cannot hybridize with any other gene different
from said given gene, and cannot hybridize with any other variants
of a gene different from said given gene, [0375] b) determining a
profile of expression variants of said genes from the detection of
the nucleic acid complexes formed in the previous step, [0376] c)
comparing said profile with a reference gene expression variant
profile of a control subject, [0377] d) concluding, from the
previous comparison, the benign or malignant state of the breast
cancer in the subject.
[0378] Also, the invention relates to a method for the
determination, preferably in vitro and/or ex vivo, of the benign or
malignant state of a breast tumor in a biological sample from a
subject, by determining the variation of the expression of [0379]
at least 12 determined genes belonging to a group of determined
genes represented by the nucleotidic sequences SEQ ID NO: 5419 to
SEQ ID NO: 5693 and [0380] at least one variant of said genes at
least 12 determined genes, when they exist, [0381] said 12
determined genes being represented by the following nucleotidic
sequences: [0382] SEQ ID NOs 5421; 5423; 5432; 5434; 5486; 5491;
5525; 5552; 5599; 5652; 5654 and 5683,
[0383] comprising: [0384] (1) contacting nucleic acid molecules
from said biological sample to a multiplicity of polynucleotide
probe sets, said multiplicity of polynucleotide probe sets
consisting in a combination of pools of polynucleotide probe sets,
to allow the formation of a nucleic acid complexe, [0385] each
polynucleotide probe set containing at least one polynucleotide
probe chosen among a library of nucleic acid sequences, said
library compring or consisting of at least one copy each of the
nucleic acids consisting of SEQ ID NO 1 to SEQ ID NO 2938, [0386]
said polynucleotide probes being such that the nucleic acid
sequence of each polynucleotide probe specifically hybridizes with
the nucleotidic sequence of one target region of one gene, and/or
of at least one of its variants when present,
[0387] wherein [0388] a) each given gene, [0389] a. when it
presents no variant, comprises at least one target region, said
target region characterizing said gene, [0390] b. when it presents
one variant, comprises at least one target region, said target
region characterizing said gene and its variant, and said variant
being characterized by the fact that its nucleic acid sequence is
shorter than the nucleic acid sequence of said gene, [0391] c. when
it presents at least two variants, comprises at least two target
regions, said two target regions characterizing said gene, such
that: [0392] iii. at least one of the respective polynucleotidic
sequences of said target region is present in a given variant of
said gene, and [0393] iv. at least one of the respective
polynucleotidic sequences of said target region is either [0394]
absent in a given variant, or [0395] present in a given variant in
a configuration that differs from the one of said gene, [0396] said
variant being characterized by the fact that its nucleic acid
sequence is shorter than the nucleic acid sequence of said gene,
[0397] b) each variant of a given gene presents at least one target
region, and [0398] if said variant is the unique variant of a gene,
said variant has the same target than said gene, and [0399] if said
variant is one of the variants of a gene that has at least two
variants, each variant of said gene is characterized by either:
[0400] a. the combination of the presence of at least one target
region also present in the gene, and the absence of at least one
target region present in the gene, or [0401] b. the combination of
the presence of at least one target region also present in the
gene, and the presence of a target region, said target region
presenting a configuration that does not naturally exist in the
gene, [0402] c) the nucleotidic sequence of each given gene, and
its variants when present, is specifically recognized by the
nucleic acid sequences of polynucleotide probes contained in at
least one given polynucleotide probe set, [0403] d) the nucleic
acid sequence of each polynucleotide probe of a polynucleotide
probe set hybridizes with a specific polynucleotidic sequence
contained in a given target region of the target regions which
characterize a given gene, and/or at least one of its variants when
present, [0404] e) the nucleic acid sequence of each polynucleotide
probe of a given pool of polynucleotide probe set being such that
[0405] a. it hybridizes with the nucleotidic sequence of a given
gene, and/or of at least one of its variants when present, and
[0406] b. cannot hybridize with [0407] i. the nucleotidic sequence
of any other gene different from said given gene, and [0408] ii.
the nucleotidic sequence of any other variants of a gene different
from said given gene, [0409] (2) determining a profile of
expression of said genes and of variants of said genes from the
detection of the nucleic acid complexes formed in the previous
step, [0410] (3) comparing said profile with a reference expression
profile of a control benign breast tumor, and/or a reference
expression profile of a control malignant tumor, and [0411] (4)
concluding, from the previous comparison, that: [0412] if said
profile of expression is similar to the reference expression
profile of a control benign breast tumor, then the breast cancer is
benign, and [0413] if said profile of expression is similar to the
reference expression profile of a control malignant breast tumor,
then the breast cancer is malignant, [0414] with the proviso that
said gene, and its variants when present, is not KRT17, LOC440421,
KRT6C and KRT6A, said genes being respectively represented by SEQ
ID NO 5431; 5689; 5651 and 5682.
[0415] The invention also describes a method that allows the
determination of the status, benign or malignant, of a breast
tumor.
[0416] In the method of the invention, a biological sample
corresponding to a breast tumor is used as a source of nucleic acid
molecule. Said biological sample refers to a sample obtained from
an organism or from components (e.g., cells) of an organism. The
sample may be one of any biological tissue. Frequently the sample
could be a "clinical sample" which is a sample derived from a
patient. Such samples include, but are not limited to, FNA sample,
CNB sample, ductal lavage and blood sample. Biological samples may
also include sections of tissues such as frozen sections taken for
histological purposes.
[0417] The subject from which biological sample is provided is
commonly a woman, afflicted, or suspected to be afflicted by a
breast tumor. The subject can also be a man, with, or suspected to
have, a breast cancer. By extension, all the mammals can be
diagnosed by the method provides by the invention, with the proviso
that they could develop a breast tumor.
[0418] The extraction of the nucleic acid molecules of the samples
is managed by a routine protocol used in the art. Advantageously,
nucleic acid molecules extracted from the biological sample are
RNA.
[0419] Then, the method of the invention consists in contacting
nucleic acid molecules extracted from the biological sample of a
subject, with a multiplicity of polynucleotide probe sets. Each
polynucleotide probe set contains at least one polynucleotide
probe.
[0420] The contact between the polynucleotide probe set, and more
particularly the polynucleotide probes contained in each
polynucleotide probe set, allows to form a nucleic acid complex
between the nucleic acid molecule corresponding to a gene, and/or
its variants when they exist, and a polynucleotide probe.
[0421] Preferably, before contacting the polynucleotide probes with
the nucleic acid molecules, nucleic acid molecules are labeled with
any know labeling agents (radioisotopes, enzymes, fluorescent
molecule . . . ). The hybridization is made according a standard
procedure, by modulating if necessary saline concentration and
temperature. The protocol used for hybridization is well known by
the skilled man in the art.
[0422] The presence and amount of the formed nucleic acid complex
is detected, by the detection of hybridized nucleic acid molecules
which have been labeled with labeling agent, with a specific
detection method fitting to the used labeled agent.
[0423] According to the invention, each probe set that have
hybridized with labeled nucleic acid molecules allows to attribute
a value of hybridization. The given value is dependant of the
labeling agent.
[0424] The compilation of all the values of hybridization allows to
establish a profile that corresponds to the specific feature of the
tumor assayed. This result is considered as a hallmark of the tumor
assayed.
[0425] The tumor profile is compared to a reference profile, in
particular profile of tumors deriving from biological sample of non
afflicted by breast cancer subjects, or derived from biological
sample of a subject afflicted by a benign or a malignant breast
tumor. Alternatively, the tumor profile assayed can be compared
with tumor profile of patients afflicted by benign breast tumor or
malignant breast tumor. Typically, the comparison is made by using
software commonly used in this type of comparison, and well known
and described in the art.
[0426] From the comparison between tumor profile and reference
profile, it is possible to determine if the breast tumor derived
from the biological sample of a patient is a benign tumor or a
malignant tumor.
[0427] In an advantageous embodiment, the invention discloses a
method for the in vitro and/or ex vivo determination of the benign
or malignant state of a breast tumor in a biological sample from a
subject, wherein the determination of the variation of the
expression of a gene, and/or at least one of its variants when
present, of a sub-group comprising at least 12 genes among the
genes of the group consisting in SEQ ID NO 5419 to SEQ ID NO 5677,
comprises: [0428] a) contacting nucleic acid molecules from said
biological sample with a multiplicity of polynucleotide probe sets
consisting in a combination of pools of polynucleotide probe sets
chosen among 1640 probe sets of polynucleotides, each
polynucleotide probe set containing at least one polynucleotide
probe chosen among a library of nucleic acid sequences consisting
in SEQ ID NO 1 to SEQ ID NO 2938, each nucleic acid sequence
hybridizing with a gene, and/or at least one of its variants when
present, said gene being chosen among the group of genes consisting
in SEQ ID NO 5419 to SEQ ID NO 5677, [0429] each given gene, when
it presents NO variant, comprising at least one target region, the
nucleic acid sequence of which is chosen among SEQ ID NO 2939 TO
SEQ ID NO 4578, said target region characterizing said gene, [0430]
each given gene, when it presents at least one variant, comprising
at least two target regions such that: [0431] at least one of the
respective nucleic acid sequences of said target region chosen
among SEQ ID NO 2939 to SEQ ID NO 4578 is present in a given
variant of said gene, [0432] at least one of the respective nucleic
acid sequences of said target region chosen among SEQ ID NO 2939 to
SEQ ID NO 4578 is either absent in a given variant or is present in
a configuration that differs from the one of said gene, [0433] said
two target regions characterizing said gene, [0434] each variant of
a given gene presenting at least one target region, said target
region being such that its respective nucleic acid sequence is
chosen among SEQ ID NO 2939 to SEQ ID NO 4578, [0435] each variant
is characterized by: [0436] either the combination of the presence
of at least one target region also present in the gene, the
respective nucleic acid sequence of which being chosen among SEQ ID
NO 2939 to SEQ ID NO 4578, and the absence of at least one target
region present in the gene the respective nucleic acid sequence of
which being chosen among SEQ ID NO 2939 to SEQ ID NO 4578, [0437]
or the presence of a target region, the respective nucleic acid
sequence of which being chosen among SEQ ID NO 2939 to SEQ ID NO
4578, said target region presenting a configuration that does not
naturally exist in the gene, [0438] each polynucleotide probe of a
polynucleotide probe set hybridizes with a specific nucleic acid
sequence contained in a given target region of the target regions
which characterize a given gene, and/or at least one of its
variants when present, [0439] each given gene, and its variants
when present, is specifically recognized by at least a given
polynucleotide probe set, [0440] each polynucleotide probe of a
given pool of polynucleotide probe set being such that it
hybridizes with a given gene, and/or at least one of its variants
when present, and cannot hybridize with any other gene different
from said given gene, and cannot hybridize with any other variants
of a gene different from said given gene, [0441] b) determining a
profile of expression variants of said genes from the detection of
the nucleic acid complexes formed in the previous step, [0442] c)
comparing said profile with a reference gene expression variant
profile of a control subject, [0443] d) concluding, from the
previous comparison, the benign or malignant state of the breast
cancer in the subject.
[0444] In one preferred embodiment, the invention relates to a
method for the in vitro and/or ex vivo determination of the benign
or malignant state of a breast tumor in a biological sample from a
subject as defined above, by determining the variation of the
expression of at least 20 determined genes of a group of determined
genes represented by the nucleotidic sequences SEQ ID NO: 5419 to
SEQ ID NO: 5693
said 20 determined genes being represented by the following
nucleotidic sequences: SEQ ID Nos 5421; 5423; 5432; 5434; 5457;
5486; 5491; 5513; 5516; 5525; 5532; 5552; 5599; 5616; 5624; 5643;
5652; 5654; 5673 and 5683.
[0445] In one other preferred embodiment, the invention relates to
a method for the in vitro and/or ex vivo determination of the
benign or malignant state of a breast tumor in a biological sample
from a subject such as defined above, by 35 determined genes of a
group of determined genes represented by the nucleotidic sequences
SEQ ID NO: 5419 to SEQ ID NO: 5693 [0446] said 35 determined genes
being represented by the following nucleotidic sequences:
[0447] SEQ ID Nos 5421; 5423; 5431; 5432; 5434; 5440; 5457; 5462;
5470; 5486; 5491; 5505; 5513; 5516; 5525; 5532; 5546; 5552; 5594;
5599; 5601; 5603; 5616; 5618; 5624; 5627; 5630; 5643; 5645; 5652;
5654; 5660; 5669; 5673 and 5683.
[0448] Another preferred embodiment of the invention relates to a
method for the in vitro and/or ex vivo determination of the benign
or malignant state of a breast tumor in a biological sample from a
subject as previously defined, by determining the variation of the
expression of at least 43 determined genes of a group of determined
genes represented by the nucleotidic sequences SEQ ID NO: 5419 to
SEQ ID NO: 5693 [0449] said 43 determined genes being represented
by the following nucleotidic sequences: [0450] 5486; 5491; 5499;
5505; 5513; 5516; 5520; 5525; 5532; 5546; 5549; 5552; 5594; 5599;
5601; 5603; 5616; 5618; 5623; 5624; 5627; 5630; 5643; 5645; 5651;
5652; 5654; 5660; 5669; 5673; 5683 and 5686.
[0451] Another particular embodiment of the invention relates to a
method for the in vitro and/or ex vivo determination of the benign
or malignant state of a breast tumor in a biological sample from a
subject as defined above, by determining the variation of the
expression of at least 206 determined genes of a group of
determined genes represented by the nucleotidic sequences SEQ ID
NO: 5419 to SEQ ID NO: 5693 [0452] said 206 determined genes being
represented by the following nucleotidic sequences: [0453] SEQ ID
Nos 5420; 5421; 5422; 5423; 5425; 5426; 5427; 5428; 5429; 5430;
5431; 5432; 5434; 5435; 5436; 5437; 5438; 5439; 5440; 5441; 5442;
5443; 5444; 5445; 5446; 5447; 5449; 5450; 5451; 5452; 5453; 5454;
5455; 5456; 5457; 5459; 5460; 5461; 5462; 5463; 5465; 5467; 5468;
5470; 5473; 5475; 5476; 5479; 5480; 5482; 5484; 5485; 5486; 5487;
5488; 5489; 5490; 5491; 5492; 5493; 5495; 5496; 5497; 5498; 5499;
5502; 5503; 5505; 5506; 5507; 5508; 5509; 5511; 5512; 5513; 5515;
5516; 5517; 5518; 5519; 5520; 5523; 5524; 5525; 5526; 5528; 5529;
5530; 5531; 5532; 5533; 5534; 5536; 5538; 5539; 5540; 5543; 5544;
5545; 5546; 5547; 5549; 5550; 5552; 5553; 5554; 5556; 5558; 5559;
5560; 5562; 5563; 5564; 5565; 5566; 5567; 5568; 5569; 5570; 5571;
5573; 5574; 5575; 5576; 5577; 5578; 5581; 5582; 5585; 5587; 5588;
5590; 5591; 5593; 5594; 5595; 5597; 5598; 5599; 5600; 5601; 5602;
5603; 5604; 5605; 5606; 5608; 5609; 5610; 5611; 5612; 5613; 5615;
5616; 5617; 5618; 5622; 5623; 5624; 5625; 5627; 5629; 5630; 5631;
5632; 5633; 5634; 5635; 5637; 5638; 5639; 5640; 5641; 5642; 5643;
5644; 5645; 5647; 5648; 5649; 5651; 5652; 5653; 5654; 5656; 5657;
5658; 5660; 5661; 5665; 5667; 5669; 5672; 5673; 5675; 5676; 5677;
5678; 5680; 5681; 5683; 5684; 5686; 5687; 5689 and 5692.
[0454] In another preferred embodiment, the invention discloses a
method for the in vitro and/or ex vivo determination of the benign
or malignant state of a breast tumor in a biological sample from a
subject such as defined above, by determining the variation of the
expression of 275 determined genes represented by the nucleotidic
sequences SEQ ID NO: 5419 to SEQ ID NO: 5693.
[0455] Another particular embodiment of the invention relates to a
method for the in vitro and/or ex vivo determination of the benign
or malignant state of a breast tumor in a biological sample from a
subject such as defined above, wherein said variant being
represented by the nucleic acid sequences SEQ ID NO 4579 to SEQ ID
NO 5418 and SEQ ID NO 5694, the correspondence between each variant
and its corresponding gene being represented in Table 1A-E and
Table 6.
[0456] In still another embodiment, the invention relates to a
method for the in vitro and/or ex vivo determination of the benign
or malignant state of a breast tumor in a biological sample from a
subject as defined above, wherein target regions are characterized
by the polynucleotide sequences SEQ ID NO 2939 to 4578, the each
target region of each gene, and of each variant when they exist,
being represented in Table 6.
[0457] In one other preferred embodiment, the invention relates to
a method for the in vitro and/or ex vivo determination of the
benign or malignant state of a breast tumor in a biological sample
from a subject such as previously defined, wherein each
polynucleotide probe contained in a polynucleotide probe set is
represented by the nucleic acid sequence of the library consisting
in SEQ ID NO 1 to SEQ ID NO 2938,
the correspondence between each polynucleotide probe and its
corresponding target region, said target region corresponding to a
gene and its variants when present, being represented in Table
6.
[0458] In another advantageous embodiment, the invention relates to
a method for the in vitro and/or ex vivo determination of the
benign or malignant state of a breast tumor in a biological sample
from a subject, wherein the sub-group of genes is constituted by 12
to 259 genes chosen among the group consisting in SEQ ID NO 5419 to
SEQ ID NO 5677.
[0459] In another embodiment, the invention discloses a method for
the in vitro and/or ex vivo determination of the benign or
malignant state of a breast tumor described above, wherein the
sub-group of genes is constituted by the 259 genes of the group
consisting in SEQ ID NO 5419 to SEQ ID NO 5677.
[0460] In a more particular embodiment, the invention relates to a
method for the in vitro and/or ex vivo determination of the benign
or malignant state of a breast tumor in a biological sample from a
subject, wherein said set of polynucleotide probes are chosen among
the group consisting in:
[0461] at least 50 polynucleotide probe sets, particularly at least
100 polynucleotide probe sets, more particularly at least 150
polynucleotide probes sets, more particularly at least 200
polynucleotide probe sets, more particularly at least 1228
polynucleotide probe sets and more particularly 1640 polynucleotide
probe sets of the library of nucleic acid sequences consisting in
SEQ ID NO 1 to SEQ ID NO 2938.
[0462] The sub-groups of 50, 100, 150, 200 polynucleotide probe
sets are defined as the Top sub-groups allowing to determine the
benign or malignant status of the tumor.
[0463] It is also disclosed in the invention that the multiplicity
of probe sets can be constituted by at least 300 polynucleotide
probe sets, more particularly at least 400 polynucleotide probe
sets, more particularly at least 500 polynucleotide probe sets,
more particularly at least 600 polynucleotide probe sets, more
particularly at least 700 polynucleotide probe sets, more
particularly at least 800 polynucleotide probe sets, more
particularly at least 900 polynucleotide probe sets, more
particularly at least 1000 polynucleotide probe sets, more
particularly at least 1100 polynucleotide probe sets, more
particularly at least 1228 polynucleotide probe sets, more
particularly at least 1400 polynucleotide probe sets, and more
particularly 1640 polynucleotide probe sets.
[0464] All the polynucleotide probes contained in the
polynucleotide probe sets used in the method of the invention are
chosen among a library of nucleic acid sequences consisting SEQ ID
NO 1 to SEQ ID NO 2938.
[0465] In one embodiment, the invention discloses a method
described above, wherein a variant of a given gene is chosen among
the group of variants consisting in SEQ ID NO 4579 to SEQ ID NO
5418.
[0466] The method of the invention allows to detect the variation
of expression genes, and their variants when they exist, said genes
being characterized in that they consist in the nucleic acid
sequences chosen among the group consisting in SEQ ID NO 5419 to
SEQ ID NO 5677 and said variants being characterized in that they
consist in the nucleic acid sequence chosen among the group
consisting in SEQ ID NO 4579 to SEQ ID NO 5418.
[0467] In the invention, it is also disclosed a method for the in
vitro and/or ex vivo determination of the benign or malignant state
of a breast tumor, wherein the variation of expression of a gene,
and/or at least one of its variants when present, said gene being
chosen in the group consisting in SEQ ID NO 5419 to SEQ ID NO 5693,
is [0468] Over represented (Up-regulated), or [0469] Under
represented (Down-regulated).
[0470] Each gene expression, and expression of its variants if they
exist, revealed by the method of the invention corresponds to an
expression product of a gene of the group consisting in SEQ ID NO
5419 to SEQ ID NO 5693.
[0471] These variants are normally expressed in a subject non
afflicted by breast cancer. These variants are also expressed in
the biological of subject afflicted by benign breast cancer or
malignant breast cancer. Each variant have a specific expression
level corresponding to the state of the breast cancer. Each variant
can then be overexpressed compare to the same variant expressed in
a normal subject, or under expressed comparing to the same variant
expressed in a normal subject.
[0472] The genes, and/or their variants are up-regulated,
preferably when their expression levels are more than 1.7 fold
higher than the expression levels of said genes in a patient non
afflicted by a breast tumor, and significantly different
(preferably with a significant coefficient value of less than
0.05). The genes, and/or their variants are down-regulated,
preferably when their expression levels are less than 1.7 fold
lower than the expression levels of said genes in a patient non
afflicted by a breast tumor, and significantly different
(preferably with a significant coefficient value of less than
0.05).
[0473] In a particular embodiment, the invention discloses a method
described above, wherein the nucleic acid molecules from the
biological sample of the subject are mRNA/or cDNA, said mRNA
resulting from the expression of the genes consisting in SEQ ID NO
5419 to SEQ ID NO 5693, and/or at least one of their variants when
present, represented by the nucleotidic sequences SEQ ID NO 4579 to
SEQ ID NO 5418 and SEQ ID NO 5694.
[0474] In the invention, nucleic acid molecules are extracted from
the biological sample of the subject, prior to be contacted with
the set of polynucleotide probes, immobilized in a support.
[0475] The extraction and preparation of said nucleic acid
molecules from the biological sample of the subject is made with a
routine protocol commonly used by a skilled man in the art.
[0476] More particularly, the RNA are extracted from the biological
sample, eventually, mRNA are isolated from the total RNA. In the
case of the use of cDNA, mRNA are reverse-transcripted with a
standard procedure.
[0477] The invention relates to a kit for the in vitro and/or ex
vivo determination of benign or malignant status of a breast tumor,
comprising: [0478] a multiplicity as defined above, or [0479] a
microarray as defined above.
[0480] The invention relates to a kit for the in vitro and/or ex
vivo determination of benign or malignant status of a breast tumor,
comprising the following group of polynucleotide probes: [0481] SEQ
ID NOs 136; 137; 138; 157; 158; 159; 167; 168; 169; 171; 172; 173;
177; 312; 313; 313; 314; 315; 316; 317; 324; 325; 326; 327; 328;
329; 330; 331; 333; 334; 335; 336; 339; 340; 341; 345; 346; 347;
348; 353; 360; 361; 364; 365; 366; 367; 368; 369; 370; 374; 375;
790; 791; 792; 793; 794; 795; 969; 972; 981; 1081; 1082; 1083;
1129; 1140; 1141; 1158; 1159; 1160; 1161; 1162; 1165; 1166; 1167;
1168; 1169; 1170; 1171; 1185; 1186; 1194; 1198; 1199; 1200; 1203;
1262; 1263; 1264; 1267; 1268; 1269; 1519; 1520; 1521; 1522; 1523;
1524; 1534; 1535; 1536; 1544; 1545; 1546; 1551; 1552; 1553; 1554;
1555; 1556; 1557; 2026; 2027; 2028; 2179; 2180 and 2181,
[0482] preferably, wherein SEQ ID NOs 167; 168; 177; 312; 313; 327;
328; 329; 331; 364; 365; 366; 368; 370; 1185; 1186; 1194; 1523;
1524; 1551; 1552 and 1553 are present twice, [0483] SEQ ID NO 316
is present in three copies and SEQ ID NO 315 is present in 5
copies, or SEQ ID NO 120; 136; 137; 138; 154; 155; 156; 157; 158;
159; 167; 168; 169; 171; 172; 173; 174; 175; 176; 177; 312; 313;
314; 315; 316; 316; 317; 324; 325; 326; 327; 328; 329; 330; 331;
332; 333; 334; 335; 336; 337; 338; 339; 340; 341; 345; 346; 347;
348; 349; 350; 351; 352; 353; 354; 355; 356; 360; 361; 363; 364;
365; 366; 367; 368; 369; 370; 371; 374; 375; 376; 378; 379; 380;
381; 555; 556; 557; 558; 560; 561; 562; 566; 567; 788; 789; 790;
791; 792; 793; 794; 795; 800; 801; 802; 821; 822; 823; 969; 971;
972; 981; 1056; 1057; 1058; 1075; 1076; 1077; 1081; 1082; 1083;
1087; 1088; 1089; 1103; 1104; 1105; 1114; 1115; 1116; 1123; 1124;
1125; 1129; 1130; 1131; 1140; 1141; 1158; 1159; 1160; 1161; 1162;
1163; 1164; 1165; 1166; 1167; 1168; 1169; 1170; 1171; 1172; 1180;
1181; 1185; 1186; 1187; 1188; 1189; 1190; 1191; 1192; 1193; 1194;
1195; 1196; 1198; 1199; 1200; 1201; 1202; 1203; 1207; 1262; 1263;
1264; 1267; 1268; 1269; 1509; 1510; 1511; 1519; 1520; 1521; 1522;
1523; 1524; 1528; 1529; 1534; 1535; 1536; 1544; 1545; 1546; 1551;
1552; 1553; 1554; 1555; 1556; 1557; 1561; 1562; 1682; 1683; 1684;
1776; 1777; 1778; 2023; 2024; 2025; 2026; 2027; 2028; 2173; 2174;
2175; 2176; 2177; 2178; 2179; 2180; 2181; 2762; 2763; 2764; 2860;
2861; 2862; 2883; 2884 and 2885,
[0484] preferably, wherein SEQ ID NOs 167; 168; 177; 312; 313; 316;
317; 327; 329; 330; 353; 361; 364; 365; 366; 367; 368; 369; 370;
821; 822; 823; 1129; 1164; 1185; 1186; 1187; 1188; 1189; 1203;
1523; 1551; 1552 and 1553 are present twice, SEQ ID NOs 328; 331;
1162; 1194; 1519; 1520; 1521 and 1524 are present in three copies
and SEQ ID NO 315 is present in 6 copies, or [0485] SEQ ID NOs 4;
5; 6; 120; 136; 137; 138; 154; 155; 156; 157; 158; 159; 167; 168;
169; 171; 172; 173; 174; 175; 176; 177; 197; 248; 254; 255; 305;
306; 307; 312; 313; 314; 315; 316; 317; 324; 325; 326; 327; 328;
329; 330; 331; 332; 333; 334; 335; 336; 337; 338; 339; 340; 341;
345; 346; 347; 348; 349; 350; 351; 352; 353; 354; 355; 356; 360;
361; 362; 363; 364; 365; 366; 367; 367; 368; 369; 370; 371; 374;
375; 376; 377; 378; 379; 380; 381; 513; 514; 515; 552; 553; 554;
555; 556; 557; 558; 559; 560; 561; 562; 566; 567; 783; 784; 785;
788; 789; 790; 791; 792; 793; 794; 795; 796; 797; 798; 799; 800;
801; 802; 803; 804; 805; 806; 807; 808; 812; 813; 814; 818; 821;
822; 823; 968; 969; 970; 971; 972; 981; 1056; 1057; 1058; 1061;
1062; 1063; 1064; 1065; 1066; 1067; 1068; 1069; 1070; 1071; 1075;
1076; 1077; 1080; 1081; 1082; 1083; 1087; 1088; 1089; 1103; 1104;
1105; 1114; 1115; 1116; 1123; 1124; 1125; 1129; 1130; 1131; 1139;
1140; 1141; 1158; 1159; 1160; 1161; 1162; 1163; 1164; 1165; 1166;
1167; 1168; 1169; 1170; 1171; 1172; 1174; 1175; 1176; 1180; 1181;
1185; 1186; 1187; 1188; 1189; 1190; 1191; 1192; 1193; 1194; 1195;
1196; 1197; 1198; 1199; 1200; 1201; 1202; 1203; 1204; 1205; 1206;
1207; 1262; 1263; 1264; 1267; 1268; 1269; 1284; 1285; 1315; 1469;
1470; 1471; 1509; 1510; 1511; 1515; 1516; 1517; 1519; 1520; 1521;
1522; 1523; 1524; 1528; 1529; 1534; 1535; 1536; 1537; 1538; 1539;
1544; 1545; 1546; 1550; 1551; 1552; 1553; 1554; 1555; 1556; 1557;
1558; 1559; 1560; 1561; 1562; 1580; 1581; 1582; 1671; 1682; 1683;
1684; 1685; 1686; 1690; 1691; 1692; 1776; 1777; 1778; 1788; 1789;
1790; 1890; 1891; 1892; 1952; 1953; 1954; 1963; 2023; 2024; 2025;
2026; 2027; 2028; 2065; 2067; 2088; 2089; 2090; 2091; 2173; 2174;
2175; 2176; 2177; 2178; 2179; 2180; 2181; 2196; 2201; 2229; 2230;
2231; 2536; 2537; 2538; 2576; 2577; 2578; 2599; 2600; 2762; 2763;
2764; 2774; 2775; 2776; 2860; 2861; 2862; 2883; 2884 and 2885,
[0486] preferably, wherein SEQ ID NOs 167; 168; 177; 312; 313; 317;
327; 329; 330; 353; 361; 363; 364; 365; 366; 369; 370; 371; 558;
567; 796; 797; 801; 806; 807; 808; 813; 814; 821; 822; 823; 969;
1056; 1057; 1058; 1129; 1141; 1163; 1164; 1185; 1186; 1187; 1188;
1189; 1199; 1203; 1469; 1470; 1471; 1523; 1551; 1552 and 1553 are
present twice, SEQ ID NOs 316; 328; 331; 368; 788; 1194; 1519;
1520; 1521; 1524 are present in three copies, SEQ ID NO 1162 is
present in 4 copies and SEQ ID NO 315 is present in 6 copies, or
[0487] SEQ ID NOs 4; 5; 6; 120; 121; 122; 123; 130; 131; 132; 136;
137; 138; 154; 155; 156; 157; 158; 159; 167; 168; 169; 171; 172;
173; 174; 175; 176; 177; 195; 196; 197; 198; 199; 200; 248; 254;
255; 305; 306; 307; 312; 313; 314; 315; 316; 317; 324; 325; 326;
327; 328; 329; 330; 331; 332; 333; 334; 335; 336; 337; 338; 339;
340; 341; 345; 346; 347; 348; 349; 350; 351; 352; 353; 354; 355;
356; 360; 361; 362; 363; 364; 365; 366; 367; 368; 369; 370; 371;
374; 375; 376; 377; 378; 379; 380; 381; 513; 514; 515; 552; 553;
554; 555; 556; 557; 558; 559; 560; 561; 562; 563; 564; 565; 566;
567; 783; 784; 785; 788; 789; 790; 791; 792; 793; 794; 795; 796;
797; 798; 799; 800; 801; 802; 803; 804; 805; 806; 807; 808; 809;
810; 811; 812; 813; 814; 815; 816; 817; 818; 821; 822; 823; 824;
825; 826; 840; 841; 845; 846; 847; 868; 968; 969; 970; 971; 972;
973; 974; 975; 976; 977; 981; 1056; 1057; 1058; 1059; 1060; 1061;
1062; 1063; 1064; 1065; 1066; 1067; 1068; 1069; 1070; 1071; 1075;
1076; 1077; 1080; 1081; 1082; 1083; 1084; 1085; 1086; 1087; 1088;
1089; 1094; 1095; 1096; 1103; 1104; 1105; 1110; 1111; 1112; 1114;
1115; 1116; 1123; 1124; 1125; 1126; 1127; 1128; 1129; 1130; 1131;
1139; 1140; 1141; 1158; 1159; 1160; 1161; 1162; 1163; 1164; 1165;
1166; 1167; 1168; 1169; 1170; 1171; 1172; 1174; 1175; 1176; 1180;
1181; 1185; 1186; 1187; 1188; 1189; 1190; 1191; 1192; 1193; 1194;
1195; 1196; 1197; 1198; 1199; 1200; 1201; 1202; 1203; 1204; 1205;
1206; 1207; 1229; 1230; 1242; 1243; 1244; 1245; 1250; 1251; 1252;
1262; 1263; 1264; 1265; 1266; 1267; 1268; 1269; 1270; 1271; 1272;
1284; 1285; 1315; 1335; 1407; 1408; 1469; 1470; 1471; 1509; 1510;
1511; 1512; 1513; 1514; 1515; 1516; 1517; 1519; 1520; 1521; 1522;
1523; 1524; 1528; 1529; 1534; 1535; 1536; 1537; 1538; 1539; 1544;
1545; 1546; 1550; 1551; 1552; 1553; 1554; 1555; 1556; 1557; 1558;
1559; 1560; 1561; 1562; 1563; 1564; 1580; 1581; 1582; 1586; 1587;
1588; 1671; 1682; 1683; 1684; 1685; 1686; 1687; 1688; 1689; 1690;
1691; 1692; 1743; 1744; 1745; 1776; 1777; 1778; 1788; 1789; 1790;
1890; 1891; 1892; 1896; 1897; 1898; 1952; 1953; 1954; 1963; 1974;
2023; 2024; 2025; 2026; 2027; 2028; 2061; 2062; 2063; 2065; 2067;
2068; 2072; 2083; 2084; 2085; 2088; 2089; 2090; 2091; 2092; 2173;
2174; 2175; 2176; 2177; 2178; 2179; 2180; 2181; 2196; 2201; 2229;
2230; 2231; 2381; 2382; 2383; 2536; 2537; 2538; 2576; 2577; 2578;
2599; 2600; 2601; 2602; 2603; 2762; 2763; 2764; 2774; 2775; 2776;
2778; 2779; 2783; 2794; 2860; 2861; 2862; 2883; 2884 and 2885,
[0488] preferably, wherein SEQ ID NOs 167; 168; 177; 312; 313; 317;
327; 329; 330; 353; 361; 363; 364; 365; 366; 367; 369; 370; 371;
558; 567; 796; 797; 801; 806; 807; 808; 813; 814; 821; 822; 823;
845; 968; 970; 972; 1056; 1057; 1058; 1085; 1114; 1115; 1116; 1123;
1124; 1125; 1129; 1141; 1163; 1164; 1185; 1186; 1187; 1188; 1189;
1199; 1203; 1523; 1551; 1552; 1553; 1557; 1586; 1587; 1588; 1952;
1953; 1954; 2088; 2090; 2091; 2762; 2763 and 2764 are present
twice, SEQ ID NOs 316; 328; 331; 368; 788; 1284; 1285; 1469; 1470;
1471; 1519; 1520; 1521; 1524; 2065; 2067 and 2089 are present in
three copies, SEQ ID NO 1194 is present in 4 copies and SEQ ID NOs
315 and 1162 are present in 6 copies, or [0489] the polynucleotide
probes contained in said 1228 polynucleotide probe sets being
represented in the first 1228 lines of the Table 7, or [0490] the
nucleic acid sequence of the polynucleotide probes contained in
said 1640 polynucleotide probe sets being represented in Table
7.
[0491] The invention also relates to [0492] a micro-array
comprising the library of nucleic acid sequences consisting in SEQ
ID NO 1 to SEQ ID NO 2938, or [0493] a multiplicity of
polynucleotide probe sets chosen among the group consisting in:
[0494] a multiplicity of 1228 polynucleotide probe sets comprising
nucleic acid sequences chosen among the group consisting in SEQ ID
NO 1 to SEQ ID NO 2938, or [0495] a multiplicity of 200
polynucleotide probe sets comprising nucleic acid sequences
consisting in SEQ ID NO 1 to SEQ ID NO 2938, or [0496] a
multiplicity of 150 polynucleotide probe sets comprising nucleic
acid sequences consisting in SEQ ID NO 1 to SEQ ID NO 2938, or
[0497] a multiplicity of 100 polynucleotide probe sets comprising
nucleic acid sequences consisting in SEQ ID NO 1 to SEQ ID NO 2938,
and in particular consisting in SEQ ID NO 120, SEQ ID NO 138, SEQ
ID NO 140, SEQ ID NO 154, SEQ ID NO 155, SEQ ID NO 156, SEQ ID NO
157, SEQ ID NO 159, SEQ ID NO 166, SEQ ID NO 167, SEQ ID NO 168,
SEQ ID NO 169, SEQ ID NO 171, SEQ ID NO 173, SEQ ID NO 174, SEQ ID
NO 175, SEQ ID NO 176, SEQ ID NO 177, SEQ ID NO 312, SEQ ID NO 314,
SEQ ID NO 315, SEQ ID NO 317, SEQ ID NO 324, SEQ ID NO 326, SEQ ID
NO 327, SEQ ID NO 328, SEQ ID NO 329, SEQ ID NO 330, SEQ ID NO 331,
SEQ ID NO 331, SEQ ID NO 332, SEQ ID NO 333, SEQ ID NO 335, SEQ ID
NO 336, SEQ ID NO 337, SEQ ID NO 338, SEQ ID NO 339, SEQ ID NO 341,
SEQ ID NO 345, SEQ ID NO 347, SEQ ID NO 349, SEQ ID NO 350, SEQ ID
NO 351, SEQ ID NO 352, SEQ ID NO 353, SEQ ID NO 354, SEQ ID NO 355,
SEQ ID NO 356, SEQ ID NO 360, SEQ ID NO 361, SEQ ID NO 363, SEQ ID
NO 364, SEQ ID NO 364, SEQ ID NO 366, SEQ ID NO 367, SEQ ID NO 369,
SEQ ID NO 369, SEQ ID NO 371, SEQ ID NO 376, SEQ ID NO 378, SEQ ID
NO 379, SEQ ID NO 380, SEQ ID NO 381, SEQ ID NO 555, SEQ ID NO 556,
SEQ ID NO 557, SEQ ID NO 558, SEQ ID NO 560, SEQ ID NO 561, SEQ ID
NO 562, SEQ ID NO 566, SEQ ID NO 567, SEQ ID NO 788, SEQ ID NO 789,
SEQ ID NO 790, SEQ ID NO 792, SEQ ID NO 793, SEQ ID NO 795, SEQ ID
NO 800, SEQ ID NO 801, SEQ ID NO 802, SEQ ID NO 821, SEQ ID NO 822,
SEQ ID NO 823, SEQ ID NO 969, SEQ ID NO 971, SEQ ID NO 972, SEQ ID
NO 981, SEQ ID NO 1056, SEQ ID NO 1057, SEQ ID NO 1058, SEQ ID NO
1075, SEQ ID NO 1076, SEQ ID NO 1077, SEQ ID NO 1081, SEQ ID NO
1083, SEQ ID NO 1087, SEQ ID NO 1088, SEQ ID NO 1089, SEQ ID NO
1103, SEQ ID NO 1104, SEQ ID NO 1105, SEQ ID NO 1114, SEQ ID NO
1115, SEQ ID NO 1116, SEQ ID NO 1123, SEQ ID NO 1124, SEQ ID NO
1125, SEQ ID NO 1129, SEQ ID NO 1130, SEQ ID NO 1131, SEQ ID NO
1140, SEQ ID NO 1141, SEQ ID NO 1142, SEQ ID NO 1143, SEQ ID NO
1151, SEQ ID NO 1158, SEQ ID NO 1159, SEQ ID NO 1162, SEQ ID NO
1163, SEQ ID NO 1163, SEQ ID NO 1164, SEQ ID NO 1165, SEQ ID NO
1166, SEQ ID NO 1167, SEQ ID NO 1169, SEQ ID NO 1170, SEQ ID NO
1171, SEQ ID NO 1172, SEQ ID NO 1172, SEQ ID NO 1180, SEQ ID NO
1181, SEQ ID NO 1185, SEQ ID NO 1186, SEQ ID NO 1187, SEQ ID NO
1188, SEQ ID NO 1189, SEQ ID NO 1189, SEQ ID NO 1190, SEQ ID NO
1191, SEQ ID NO 1192, SEQ ID NO 1193, SEQ ID NO 1194, SEQ ID NO
1195, SEQ ID NO 1196, SEQ ID NO 1198, SEQ ID NO 1200, SEQ ID NO
1201, SEQ ID NO 1202, SEQ ID NO 1203, SEQ ID NO 1207, SEQ ID NO
1262, SEQ ID NO 1264, SEQ ID NO 1267, SEQ ID NO 1269, SEQ ID NO
1509, SEQ ID NO 1510, SEQ ID NO 1511, SEQ ID NO 1519, SEQ ID NO
1520, SEQ ID NO 1520, SEQ ID NO 1521, SEQ ID NO 1522, SEQ ID NO
1523, SEQ ID NO 1524, SEQ ID NO 1524, SEQ ID NO 1528, SEQ ID NO
1529, SEQ ID NO 1534, SEQ ID NO 1536, SEQ ID NO 1544, SEQ ID NO
1546, SEQ ID NO 1551, SEQ ID NO 1553, SEQ ID NO 1554, SEQ ID NO
1556, SEQ ID NO 1557, SEQ ID NO 1561, SEQ ID NO 1562, SEQ ID NO
1682, SEQ ID NO 1683, SEQ ID NO 1684, SEQ ID NO 1776, SEQ ID NO
1777, SEQ ID NO 1778, SEQ ID NO 2023, SEQ ID NO 2024, SEQ ID NO
2025, SEQ ID NO 2026, SEQ ID NO 2028, SEQ ID NO 2173, SEQ ID NO
2174, SEQ ID NO 2175, SEQ ID NO 2176, SEQ ID NO 2177, SEQ ID NO
2178, SEQ ID NO 2179, SEQ ID NO 2181, SEQ ID NO 2762, SEQ ID NO
2763, SEQ ID NO 2764, SEQ ID NO 2860, SEQ ID NO 2861, SEQ ID NO
2862, SEQ ID NO 2883, SEQ ID NO 2884 and SEQ ID NO 2885, or [0498]
a multiplicity of 50 polynucleotide probe sets comprising nucleic
acid sequences consisting in SEQ ID NO 1 to SEQ ID NO 2938, and in
particular consisting in SEQ ID NO 138, SEQ ID NO 140, SEQ ID NO
157, SEQ ID NO 159, SEQ ID NO 167, SEQ ID NO 168, SEQ ID NO 169,
SEQ ID NO 171, SEQ ID NO 173, SEQ ID NO 177, SEQ ID NO 312, SEQ ID
NO 314, SEQ ID NO 315, SEQ ID NO 317, SEQ ID NO 324, SEQ ID NO 326,
SEQ ID NO 327, SEQ ID NO 329, SEQ ID NO 330, SEQ ID NO 331 SEQ ID
NO 333, SEQ ID NO 335, SEQ ID NO 336, SEQ ID NO 339, SEQ ID NO 341,
SEQ ID NO 345, SEQ ID NO 347, SEQ ID NO 353, SEQ ID NO 360, SEQ ID
NO 361, SEQ ID NO 364, SEQ ID NO 366, SEQ ID NO 367, SEQ ID NO 369,
SEQ ID NO 790, SEQ ID NO 792, SEQ ID NO 793, SEQ ID NO 795, SEQ ID
NO 969, SEQ ID NO 972, SEQ ID NO 981, SEQ ID NO 1081, SEQ ID NO
1083, SEQ ID NO 1129, SEQ ID NO 1140, SEQ ID NO 1141, SEQ ID NO
1151, SEQ ID NO 1158, SEQ ID NO 1159, SEQ ID NO 1162, SEQ ID NO
1165, SEQ ID NO 1166, SEQ ID NO 1167, SEQ ID NO 1169, SEQ ID NO
1170, SEQ ID NO 1171, SEQ ID NO 1185, SEQ ID NO 1186, SEQ ID NO
1194, SEQ ID NO 1198, SEQ ID NO 1200, SEQ ID NO 1203, SEQ ID NO
1262, SEQ ID NO 1264, SEQ ID NO 1267, SEQ ID NO 1269, SEQ ID NO
1520, SEQ ID NO 1522, SEQ ID NO 1523, SEQ ID NO 1524, SEQ ID NO
1534, SEQ ID NO 1536, SEQ ID NO 1544, SEQ ID NO 1546, SEQ ID NO
1551, SEQ ID NO 1553, SEQ ID NO 1554, SEQ ID NO 1556, SEQ ID NO
1557, SEQ ID NO 2026, SEQ ID NO 2028, SEQ ID NO 2179 and SEQ ID NO
2181.
[0499] Preferably in the kit of the invention, the micro-array
comprises 1228 polynucleotide probe sets that represent the best
multiplicity of polynucleotide probe sets to characterize
efficiently the benign or malignant status of the breast tumor of a
subject.
[0500] Optionally, the kit of the invention may contain protocol
and molecules to label nucleic acid molecules used to be contacted
with the micro-array. Also, the kit of the invention may contain
protocol and material for the extraction and purification of the
nucleic acid molecules from the biological sample of a subject.
[0501] The contain of the kit is not limited to the described
materials and protocols described above, and may contain any other
material or procedures that can help a skilled man in the art to
use the kit of the invention.
FIGS. 1 TO 6 ILLUSTRATE THE INVENTION
[0502] FIG. 1A represents a gene containing 3 exons, and its
variants that lack at least one exon. T represents a Target region.
The "bar code" associated to the presence or absence of a target
region is indicated: 1=present; 0=absent.
[0503] FIG. 1B represents a gene containing 3 exons, and its
variant that lacks one exon. T represents a Target region. The "bar
code" associated to the presence or absence of a target region is
indicated: 1=present; 0=absent.
[0504] FIG. 2 represents the notions of multiplicity, pool, probe
set and probes of the invention.
[0505] FIG. 3A to 3G represent the gene and its variant when they
exist and the corresponding target region.
[0506] FIG. 3A represents a gene having no variant and having one
target region.
[0507] FIG. 3B represents a gene having no variant and having two
target regions.
[0508] FIG. 3C represents a gene having one variant and having one
target region.
[0509] FIG. 3D represents a gene having one variant and having two
target regions.
[0510] FIG. 3E represents a gene having two variants and having two
target regions.
[0511] FIG. 3F represents a gene having two variants and having
three target regions.
[0512] FIG. 3G represents a gene having two variants and having
three target regions, one of its target regions being in a
configuration different in variant and gene.
[0513] FIG. 4 represents Heatmap of the 1656 exon-probes that
present a more than two fold higher intensity in malignant
condition. The FIG. 4 reports the intensities of exon-probes that
present more than a two-fold higher intensity in malignant tumors.
Each column represents a sample, and each raw represent an
exon-probe.
[0514] FIG. 5 represents the correlation of each specimen with the
average benign and malignant profiles. Each tumor is classified
according to its correlation with the average expressions of the
probes in the benign and malignant group respectively during one
leave-one-out-step. The bisecting line defines a region of benign
prediction (bottom right triangle) and malignant prediction (upper
left triangle). Tumors from the benign group are depicted in black,
and those from the malignant group, in grey. Any misclassifications
correspond to benign samples located in the malignant prediction
area and vice versa. Training set included 94 samples (benign
tumor, n=24, malignant tumor, n=70).
[0515] FIG. 6 represents the correlation of each specimen in the
validation set with the average benign and malignant profiles of
the preferred 1,228 signature polynucleotide probe sets obtained on
the patients in the training set. Validation set included 71
samples (benign tumor, n=21, malignant tumor, n=50). Each tumour is
classified according to its correlation with the average
expressions of the probes in the benign and malignant profiles. The
bisecting line defines a region of benign prediction (bottom right
triangle) and malignant prediction (upper left triangle). Tumours
from the benign group are depicted in black, and those from the
malignant group, in grey. Any misclassifications correspond to
benign samples located in the malignant prediction area and vice
versa.
[0516] The following examples illustrate the invention, but the
invention is not limited to these examples.
EXAMPLE I
Differentially Expressed Genes and Exons Between Malignant and
Benign Breast Diseases
[0517] 56652 probes (8%) presented a different intensity between
malignant and benign conditions (adjusted p value<0.05). Of
these, 37858 were exon-probes (B, T, and F) and 18794 were
junction-probes (C, D, E). Of the 37858 exon-probes (B, T, F),
17441 were higher in malignant as opposed to benign diseases. The
17441 exon-probes (B, T, F) that were found higher in malignant
condition referred to 12091 exons and 3391 genes. Of the 17441
exon-probes increased in malignant tumors, 1656 presented more than
a two fold increased intensity in malignant conditions as compared
to benign tumors. Heatmap of intensities for these 1656 probes is
reported in FIG. 4. These 1656 probe sets referred to 1178 exons
and 363 genes.
The level of gene expression was then determined as reported in
patients and methods section. Among the 11921 filtered genes, 3733
were differentially expressed between cancer and benign conditions
(adjusted p value <0.05). This accounts for 7% of the overall
genes included in the array and 31% of the filtered genes. Of
these, 1984 were overexpressed in malignant condition. Several of
these genes are currently being targeted in therapeutics including
TOP2A, VEGFA, AURKA, PARP1, RAS. Seventy-two genes presented more
than a two fold increase of the mean value in breast cancer. As
expected, a high proportion of these 72 highly overexpressed genes
related to cell cycle activation and mitosis, including cyclins
(CCNA2, CCNE2, CCNB2), cell division cycle family (CDC2, CKS1B,
CKS2, NUF2), kinesin family members (KIF23, NDC80, KIF4A, KIF18A,
MKLP2, KIF14) and centromere proteins (CENPF, CENPE). FIG. 3
reports the dot-plots for gene expression of the top 10
overexpressed genes. Two (PTTG1, NET1) of the 10 most overexpressed
genes were considered as potential new therapeutic targets given
their oncogenic properties. Pathways analyses using BioCarta
database identified 7 pathways that presented an enrichment of
genes differentially expressed in one or the other condition.
Interestingly, genes involved in spliceosome assembly were
significantly enriched in malignant condition (LS permutations,
p=0.001, KS permutations, p=0.002), suggesting an activation of
this phenomenon in breast cancer. Finally, the inventors identified
2675 exons (adjusted p value <0.05) overexpressed in malignant
condition who were not located within the 1984 filtered genes whose
geometric mean values differ between cancer and benign lesions.
These 2675 exon-probes were located in 1559 genes. The splice index
for the 2675 exon is reported in supplementary table 4. Numbers of
these over-expressed exons located within unchanged genes have
potential oncogenic properties. As illustration, probe sets for
exon 9 casein kinase 1 delta (CSNK1D), exon 5-6 retinoblastoma
binding protein 9 (RBBP9) and exon 21-22 Erbb2 interacting protein
(ERBB2IP/LAP2) presented a 1.67 (adjusted p=0.005), 1.45 (adjusted
p=0.006) and 1.6 (adjusted p=0.0005) fold increased intensity in
malignant as compared to benign tumors. At the opposite, the geo
mean ratio between cancer and benign tumors for gene expression
levels were 1.09 (p=0.95), 1.04 (p=0.61) and 1.00 (p=0.96) for
CSNK1D, RBBP9, ERBB2IP/LAP2 respectively. These findings suggest
that a significant proportion of genes identified as unchanged may
actually contain differentially expressed exons. These
considerations suggest that analyses at exon level provide
additional information to analyses at gene level, to decipher the
transcriptional program of breast malignancy. Based on the finding
that breast cancer and benign tumors present widely different
exonic profiles, the inventors developed a molecular classifier for
breast cancer diagnosis on FNA samples.
EXAMPLE II
Development of a Molecular Classifier for Breast Cancer
Diagnosis
[0518] Patients et Methods.
[0519] Patients.
[0520] 94 patients have been included in the present study. These
patients referred at the Institut Gustave Roussy for a clinical or
radiological breast lesion in 2006. FNA was performed in all of
these patients to assess the diagnosis of the breast lesion. A
breast adenocarcinoma was diagnosed in 70 patients, and a benign
lesion was diagnosed in 24 patients. Breast cancer diagnosis was
based on the identification of cancer cells on the CNB or surgical
specimen. The diagnosis of benign lesion was based on the
identification of non-malignant epithelial cells on CNB and the
identification of non-malignant epithelial cells in FNA sample
together with lack of radiological change after 3 or 6 months
follow-up. Patient characteristics are reported in Table 2.
TABLE-US-00006 TABLE 2 Table 2: patient characteristics Benign
lesions Malignant lesions (n = 24) (n = 70) Median Age (range) 41
(16-74) 59 (30-92) Median clinical size (range) 17 mm (7-35) 29 mm
(7-110) ACR classification ACR3 14 (58%) 0 ACR4 9 (37%) 13 (19%)
ACR5 1 (5%) 56 (81%) Not assessable 1 Palpable lesion Yes 15 (65%)
53 (78%) NO 8 (35%) 15 (22%) Not assessable 1 2 Pathological tumor
size (range) NA 28 mm (6-60) pTNM Stage Node negative disease 27
(45%) Node positive disease NA 20 (33%) Stage IV disease 1 (2%)
Preoperative medical treatment 12 (20%) Not assessable 10 Tumor
grade Grade 1 17 (27%) Grade 2 NA 24 (37%) Grade 3 23 (36%) Not
Assessable 6 Estogen receptor expression ER negative 17 (25%) ER
positive NA 50 (75%) Not assessable 3 Progesteron receptor
expression PR negative 29 (43%) PR positive NA 39 (57%) Not
assessable 3 Her2 status Overexpression 13 (20%) Not overexpressed
NA 53 (80%) Not assessable 4
Sample Processing and Hybridization
[0521] RNA was extracted using RNEasy kit (Qiagen) from FNA
specimen. Total RNA quality and quantity were evaluated using the
RNA 6000 Nano LabChip kit with the Agilent 2100 Bioanalyzer.
Sample amplification and labeling was performed using the
WT-Ovation Pico RNA Amplification System and the FL-Ovation cDNA
Biotin Module v2 (NuGen, Inc., part #'s 3300-60 and 4200-60)
according to manufacturer's instructions. Standard methods
following recommendations of the manufacturer were used to
hybridize the samples. A pan-genomic array has been designed to
detect 138,636 splicing events. 20,649 genes are analyzed using
this array. The overall number of probes included in this array was
6,079,562. The present study was focused on 703,680 Evidenced
probes. Once hybridized, the arrays were washed and stained using
the FS450-0001 Fluidics protocol prior to scanning using the
Affymetrix GeneChip.RTM. Scanner 3000 7G. .DAT and .CEL images were
visually inspected for anomalies and accurate grid placement. The
.CEL files were imported into Partek.RTM. Genomics Suite and the
data were processed using the Robust Multichip Average (RMA)
background correction method followed by GC content background
correction. Quantile normalization was performed across all arrays,
and then data was Log 2 transformed and mean probe summarization
was performed.
Normalization
[0522] Data were processed using the RMA background correction
method followed by guanine-cytosine content background correction.
Quantile normalization was performed across all arrays, and then
data was log 2 transformed and mean probe summarization was
performed.
Pre-Filtering
[0523] Starting from the 703,680 Evidenced probes, the inventors
filtered out probes whose expression varied little across the 94
patient training set as follows: first the inventors floored the
expression values at 10 (i.e. all expression values lower than 10
were replaced by 10), and secondly they deleted a probe from the
data set if the ratio of the maximum by minimum intensity across
the 94-patient set was higher or equal to 5 and if the difference
between the maximum and minimum intensity was higher or equal to
100. In total 176,832 probes were retained for analysis after the
pre-filtering step.
Statistical Analysis
[0524] The point biserial correlation coefficient was calculated
for each probe between probe expression and a binary indicator
which value was defined by the status of the patient (the indicator
took the value 0 in patients who had benign tissue and the value 1
in tissues from patients with tumors) (Kraemer H C: Biserial
correlation, in Encyclopedia of Statistical Science, Vol 1. Edited
by Kotz S, Read C B. New York, Wiley, 1982, pp 276-280). The probes
with the highest absolute correlation are those which are the most
likely correlated with the occurrence of a tumor. The inventors
used the t-test to test whether the point biserial correlation
values were significantly different from 0 (Kraemer H C: Biserial
correlation, in Encyclopedia of Statistical Science, Vol 1. Edited
by Kotz S, Read C B. New York, Wiley, 1982, pp 276-280). In order
to take the multiple testing issues into account they used a very
stringent cut-off for statistical significance: 10e-8 (1 out of 100
million).
[0525] In order to develop a prediction rule to classify tissues
from new patients with unknown status (benign vs. malignant), the
inventors chose the nearest centroid prediction rule, which has
been intensively studied on data from several microarray studies
(S. Michiels, S. Koscielny, C. Hill. Prediction of cancer outcome
with microarrays: a multiple random validation strategy. Lancet
2005; 365:488-92). This prediction rule classifies new patients
according to the Pearson correlation between the expression of
their signature probes and the average profiles in the two
categories (the average benign and malignant profiles are defined
as the vector of the average expression values of the signature
probes in patients with benign and malignant tissues of the 94
patient training set), the predicted category being the one with
the highest Pearson correlation. The signature probes were defined
as those probes for which the p-value of test of significance of
the point biserial correlation coefficient with the benign vs.
malignant status was below a particular threshold.
[0526] Leave-one-out cross-validation was used to estimate the
prediction accuracy of the prediction rule. One sample is left out,
and the remaining samples are used to build the prediction rule,
which is then used to classify the left-out sample. The entire
model-building process was repeated for each leave-one-out training
set to provide unbiased estimates of the prediction accuracy
(Ntzani E E, Ioannidis J P. Predictive ability of DNA microarrays
for cancer outcomes and correlates: an empirical assessment. Lancet
2003; 362: 1439-44; Simon R, Radmacher M D, Dobbin K, McShane L M.
Pitfalls in the use of DNA microarray data for diagnostic and
prognostic classification. J Natl Cancer Inst 2003; 95: 14-8):
correlation coefficients were recalculated, ordered according to
their absolute value, the signature probes defined and the nearest
centroid prediction rule was constructed. Then, the inventors
predicted the outcome of the one sample they left out in the first
place based on the highest correlation coefficient it had with the
average benign and the malignant profile from the 93 other samples.
At the end of the leave-one-out cross-validation procedure, the
inventors counted in how many cases the predictions were correct
and in how many cases the predictions were incorrect.
[0527] The inventors repeated the above performance evaluation
procedure based on leave-one-out cross-validation for different
p-value thresholds for signature genes in order to find an optimal
prediction rule yielding the lowest number of misclassified
patients. They tried the following four p-values thresholds to
define the signature genes: 10e-11, 10e-10, 10e-09 and 10e-8.
[0528] The inventors also provide subsets of 50, 100, 150 and 200
polynucleotide probe sets whose expression can be used to classify
the benign and malignant status of tissues of new patients.
Results:
[0529] The inventors found 1,640 Evidenced polynucleotide probe
sets that were significantly associated with malignancy at the
stringent p-value cut-off of p<10e-8 (see Table 3). The
polynucleotide probe sets with positive correlation are those which
have increased expression in malignant tissues, those with negative
correlation have increased expression in the benign tissues.
[0530] The inventors developed an optimal prediction rule based on
the methodology explained above. The preferred p-value threshold
for defining signature genes was p<10e-9. This p-value threshold
corresponds to the first 1228 polynucleotide probe sets in Table 3
(with identifier no 1 to no 1228). When using leave-one-out
cross-validation to estimated the prediction accuracy of the
prediction rule with this particular threshold, they obtained 0 out
of 24 patients (0%) with benign status that were misclassified and
0 out of 70 patients with malignant status that were misclassified
(0%). This corresponds to a sensitivity of 100% and a specificity
of 100%.
TABLE-US-00007 TABLE 3 variant No Probeset_ID correl abs_correl
tstat pvalue Event_ID reference_representative_accession
variant_representative_accession variant_representative_database nb
1 1756.022.2-C_at -0.91151 0.91150698 21.25746 <1e-16.sup.
1756.022. NM_000109.2 CQ714747.1 GENBANK_PATENT 1 2 1756.029.1-D_at
-0.89254 0.89253605 18.98306 <1e-16.sup. 1756.029. NM_000109.2
BI551231.1 EST 1 3 1756.026.1-C_at -0.89221 0.8922081 18.94884
<1e-16.sup. 1756.026. NM_000109.2 M63075.1 mRNA 1 4
1756.022.4-T_at -0.87666 0.87666398 17.47788 <1e-16.sup.
1756.022. NM_000109.2 CQ714747.1 GENBANK_PATENT 1 5 1756.011.1-B_at
-0.87581 0.87581182 17.40484 <1e-16.sup. 1756.011. NM_000109.2
AX114289.1 GENBANK_PATENT 1 6 1308.008.1-C_at -0.86492 0.86492412
16.52922 <1e-16.sup. 1308.008. NM_130778.1 BE148646.1 EST 1 7
1756.022.3-F_at -0.84937 0.84936983 15.43558 <1e-16.sup.
1756.022. NM_000109.2 CQ714747.1 GENBANK_PATENT 1 8 3861.020.1-D_at
-0.84359 0.84358795 15.06806 <1e-16.sup. 3861.020. NM_000526.3
BM018298.1 EST 1 9 1756.011.1-F_at -0.83903 0.83903098 14.7913
<1e-16.sup. 1756.011. NM_000109.2 AX114289.1 GENBANK_PATENT 1 10
4629.007.1-F_at -0.83653 0.83653075 14.64397 <1e-16.sup.
4629.007. NM_022844.1 AY520817.1 mRNA 16 11 1756.022.4-B_at
-0.83558 0.83557952 14.58872 <1e-16.sup. 1756.022. NM_000109.2
CQ714747.1 GENBANK_PATENT 1 12 1756.024.1-F_at -0.83305 0.83304555
14.44365 <1e-16.sup. 1756.024. NM_000109.2 CD299688.1 EST 1 13
3861.019.1-T_at -0.83092 0.83091678 14.32409 <1e-16.sup.
3861.019. NM_000526.3 BQ359236.1 EST 1 14 1756.026.1-T_at -0.83005
0.83004684 14.27581 <1e-16.sup. 1756.026. NM_000109.2 M63075.1
mRNA 1 15 1756.022.1-B_at -0.82986 0.8298586 14.26541
<1e-16.sup. 1756.022. NM_000109.2 CQ714747.1 GENBANK_PATENT 1 16
3861.001.1-T_at -0.82888 0.82888471 14.21185 <1e-16.sup.
3861.001. NM_000526.3 BG677893.1 EST 1 17 1308.008.1-T_at -0.82731
0.82731458 14.12635 <1e-16.sup. 1308.008. NM_130778.1 BE148646.1
EST 1 18 4629.020.1-C_at -0.82454 0.82453945 13.97781
<1e-16.sup. 4629.020. NM_022844.1 BI819760.1 EST 1 19
1756.027.1-T_at -0.82281 0.82280868 13.88676 <1e-16.sup.
1756.027. NM_000109.2 S60971.1 mRNA 1 20 3861.013.1-T_at -0.82153
0.82153279 13.82042 <1e-16.sup. 3861.013. NM_000526.3 BM563823.1
EST 1 21 4629.020.1-F_at -0.8194 0.81940128 13.71099 <1e-16.sup.
4629.020. NM_022844.1 BI819760.1 EST 1 22 3861.001.1-B_at -0.81782
0.8178189 13.63089 <1e-16.sup. 3861.001. NM_000526.3 BG677893.1
EST 1 23 1756.022.4-F_at -0.81687 0.81686612 13.5831 <1e-16.sup.
1756.022. NM_000109.2 CQ714747.1 GENBANK_PATENT 1 24
1756.026.1-F_at -0.81627 0.81626518 13.55314 <1e-16.sup.
1756.026. NM_000109.2 M63075.1 mRNA 1 25 1756.022.2-T_at -0.81571
0.815705 13.52532 <1e-16.sup. 1756.022. NM_000109.2 CQ714747.1
GENBANK_PATENT 1 26 1756.022.2-F_at -0.81498 0.8149825 13.48962
<1e-16.sup. 1756.022. NM_000109.2 CQ714747.1 GENBANK_PATENT 1 27
3861.022.1-B_at -0.81494 0.81494272 13.48766 <1e-16.sup.
3861.022. NM_000526.3 BI085500.1 EST 1 28 3868.004.1-D_at -0.81412
0.81412336 13.4474 <1e-16.sup. 3868.004. NM_005557.2 BM045170.1
EST 1 29 4629.015.1-C_at -0.81348 0.81347687 13.41581
<1e-16.sup. 4629.015. NM_022844.1 DB284318.1 EST 1 30
6422.002.1-E_at -0.81346 0.81346311 13.41514 <1e-16.sup.
6422.002. NM_003012.3 AX565729.1 GENBANK_PATENT 3 31
3861.001.1-D_at -0.81115 0.81115184 13.30339 <1e-16.sup.
3861.001. NM_000526.3 BG677893.1 EST 1 32 1756.022.1-F_at -0.81112
0.81111566 13.30165 <1e-16.sup. 1756.022. NM_000109.2 CQ714747.1
GENBANK_PATENT 1 33 1308.003.1-T_at -0.80635 0.80635142 13.07706
<1e-16.sup. 1308.003. NM_130778.1 NM_000494.2 REFSEQ 19 34
3868.005.1-B_at -0.8061 0.80610095 13.06545 <1e-16.sup.
3868.005. NM_005557.2 BG682632.1 EST 1 35 1308.007.1-F_at -0.8044
0.80440011 12.98719 <1e-16.sup. 1308.007. NM_130778.1 BF916393.1
EST 1 36 1308.009.1-F_at -0.8039 0.80390038 12.96437 <1e-16.sup.
1308.009. NM_130778.1 DA425187.1 EST 1 37 3861.007.1-E_at -0.8038
0.80380368 12.95997 <1e-16.sup. 3861.007. NM_000526.3 BG682207.1
EST 11 38 4629.016.1-D_at -0.80378 0.80377953 12.95887
<1e-16.sup. 4629.016. NM_022844.1 DB289769.1 EST 1 39
3084.007.1-F_at -0.80131 0.80130924 12.84728 <1e-16.sup.
3084.007. NM_013957.1 CN603653.1 EST 3 40 3861.007.1-F_at -0.79968
0.79968463 12.77489 <1e-16.sup. 3861.007. NM_000526.3 BG682207.1
EST 11 41 26289.003.1-E_at -0.79508 0.7950811 12.57397
<1e-16.sup. 26289.003 NM_174858.1 AK090967.1 mRNA 3 42
1756.028.1-T_at -0.79389 0.79388677 12.52282 <1e-16.sup.
1756.028. NM_000109.2 CQ733377.1 GENBANK_PATENT 1 43
4629.021.1-E_at -0.7935 0.79350334 12.50648 <1e-16.sup.
4629.021. NM_022844.1 CQ717811.1 GENBANK_PATENT 1 44
4629.020.1-D_at -0.78948 0.78947575 12.33726 <1e-16.sup.
4629.020. NM_022844.1 BI819760.1 EST 1 45 5764.001.1-F_at -0.78733
0.78733221 12.24894 <1e-16.sup. 5764.001. NM_002825.5 AX135902.1
GENBANK_PATENT 3 46 3815.002.3-F_at -0.78506 0.78505901 12.15655
<1e-16.sup. 3815.002. NM_000222.1 CQ719901.1 GENBANK_PATENT 1 47
3852.020.1-T_at -0.78181 0.78181405 12.02688 <1e-16.sup.
3852.020. NM_000424.2 DA764792.1 EST 1 48 4629.007.1-E_at -0.78063
0.78063131 11.98024 <1e-16.sup. 4629.007. NM_022844.1 AY520817.1
mRNA 16 49 128553.003.1-F -0.78062 0.78061872 11.97975
<1e-16.sup. 128553.00 NM_173485.2 BP394387.1 EST 1 50
26289.003.1-F_at -0.78004 0.78004 11.95705 <1e-16.sup. 26289.003
NM_174858.1 AK090967.1 mRNA 3 51 3815.002.2-F_at -0.77826
0.77825678 11.88761 <1e-16.sup. 3815.002. NM_000222.1 CQ719901.1
GENBANK_PATENT 1 52 1756.029.1-B_at -0.77795 0.77795132 11.87578
<1e-16.sup. 1756.029. NM_000109.2 BI551231.1 EST 1 53
4629.005.1-E_at -0.7779 0.77790413 11.87396 <1e-16.sup.
4629.005. NM_022844.1 CB963138.1 EST 3 54 4629.010.1-B_at -0.77786
0.77786129 11.8723 <1e-16.sup. 4629.010. NM_022844.1 AI285326.1
EST 1 55 6422.001.1-T_at -0.77686 0.77685589 11.83356
<1e-16.sup. 6422.001. NM_003012.3 CQ850220.1 GENBANK_PATENT 2 56
5764.001.1-E_at -0.77561 0.77560627 11.78573 <1e-16.sup.
5764.001. NM_002825.5 AX135902.1 GENBANK_PATENT 3 57
3861.008.1-F_at -0.77548 0.77547795 11.78084 <1e-16.sup.
3861.008. NM_000526.3 BE184532.1 EST 1 58 1756.030.2-T_at -0.77479
0.77478755 11.75458 <1e-16.sup. 1756.030. NM_000109.2 BM929495.1
EST 1 59 3084.009.1-B_at -0.77277 0.77277347 11.67858
<1e-16.sup. 3084.009. NM_013957.1 U02327.1 mRNA 2 60
26289.002.1-T_at -0.77207 0.7720739 11.65239 <1e-16.sup.
26289.002 NM_174858.1 BF966377.1 EST 1 61 1756.022.5-B_at -0.77137
0.77136743 11.62604 <1e-16.sup. 1756.022. NM_000109.2 CQ714747.1
GENBANK_PATENT 1 62 4629.007.1-D_at -0.77091 0.77091122 11.60908
<1e-16.sup. 4629.007. NM_022844.1 AY520817.1 mRNA 16 63
23336.001.1-C_at -0.76979 0.76978838 11.56754 <1e-16.sup.
23336.001 NM_145728.1 AJ697971.1 mRNA 1 64 1308.003.1-D_at -0.76831
0.7683088 11.5132 <1e-16.sup. 1308.003. NM_130778.1 NM_000494.2
REFSEQ 19 65 1756.022.3-T_at -0.76731 0.76730759 11.47668
<1e-16.sup. 1756.022. NM_000109.2 CQ714747.1 GENBANK_PATENT 1 66
3861.020.1-T_at -0.76715 0.76714705 11.47084 <1e-16.sup.
3861.020. NM_000526.3 BM018298.1 EST 1 67 3861.022.1-C_at -0.76448
0.76448457 11.37481 <1e-16.sup. 3861.022. NM_000526.3 BI085500.1
EST 1 68 3852.012.2-B_at -0.76294 0.76294046 11.31975
<1e-16.sup. 3852.012. NM_000424.2 CQ733668.1 GENBANK_PATENT 1 69
26289.012.1-E_at -0.76192 0.76191947 11.28361 <1e-16.sup.
26289.012 NM_174858.1 BG189938.1 EST 1 70 23336.003.1-T_at -0.76122
0.76122392 11.2591 <1e-16.sup. 23336.003 NM_145728.1 CQ723645.1
GENBANK_PATENT 1 71 26289.007.1-B_at -0.76082 0.76081931 11.24488
<1e-16.sup. 26289.007 NM_174858.1 DA259560.1 EST 1 72
84417.001.1-T_at -0.76076 0.76075848 11.24275 <1e-16.sup.
84417.001 NM_032411.1 BI561114.1 EST 1 73 3861.018.1-D_at -0.7605
0.76050387 11.23382 <1e-16.sup. 3861.018. NM_000526.3 BM019687.1
EST 1 74 3852.004.1-B_at -0.76039 0.76038766 11.22975
<1e-16.sup. 3852.004. NM_000424.2 BE715131.1 EST 1 75
90865.006.1-B_at -0.76035 0.76035315 11.22855 <1e-16.sup.
90865.006 NM_033439.2 AV707946.1 EST 1 76 4629.021.1-F_at -0.76012
0.7601167 11.22027 <1e-16.sup. 4629.021. NM_022844.1 CQ717811.1
GENBANK_PATENT 1 77 3861.018.1-T_at -0.76002 0.76001693 11.21679
<1e-16.sup. 3861.018. NM_000526.3 BM019687.1 EST 1 78
1756.022.1-T_at -0.75998 0.75998388 11.21563 <1e-16.sup.
1756.022. NM_000109.2 CQ714747.1 GENBANK_PATENT 1 79
1264.003.1-B_at -0.75956 0.75955538 11.20068 <1e-16.sup.
1264.003. NM_001299.4 CV811526.1 EST 1 80 26289.010.1-E_at -0.7591
0.75909546 11.18467 <1e-16.sup. 26289.010 NM_174858.1 AX988359.1
GENBANK_PATENT 1 81 3861.001.1-F_at -0.75842 0.75842235 11.16131
<1e-16.sup. 3861.001. NM_000526.3 BG677893.1 EST 1 82
1908.002.1-T_at -0.75841 0.75841175 11.16094 <1e-16.sup.
1908.002. NM_207032.1 NM_207033.1 REFSEQ 8 83 4629.007.1-C_at
-0.75757 0.75757437 11.132 <1e-16.sup. 4629.007. NM_022844.1
AY520817.1 mRNA 16 84 1756.022.5-T_at -0.75733 0.75732729 11.12348
<1e-16.sup. 1756.022. NM_000109.2 CQ714747.1 GENBANK_PATENT 1 85
3815.002.4-B_at -0.75611 0.75610941 11.08167 <1e-16.sup.
3815.002. NM_000222.1 CQ719901.1 GENBANK_PATENT 1 86
1756.022.2-B_at -0.75476 0.75476064 11.03568 <1e-16.sup.
1756.022. NM_000109.2 CQ714747.1 GENBANK_PATENT 1 87
1756.027.1-B_at -0.75441 0.75441365 11.0239 <1e-16.sup.
1756.027. NM_000109.2 S60971.1 mRNA 1 88 3852.008.2-T_at -0.75435
0.75434944 11.02172 <1e-16.sup. 3852.008. NM_000424.2 BG675837.1
EST 1 89 6422.001.1-E_at -0.75383 0.75383168 11.00419
<1e-16.sup. 6422.001. NM_003012.3 CQ850220.1 GENBANK_PATENT 2 90
3861.022.1-F_at -0.75247 0.75247162 10.95837 <1e-16.sup.
3861.022. NM_000526.3 BI085500.1 EST 1 91 4915.011.1-D_at -0.75125
0.75124983 10.91748 <1e-16.sup. 4915.011. NM_006180.3 CQ723929.1
GENBANK_PATENT 1 92 5288.001.1-F_at -0.75114 0.75113721 10.91373
<1e-16.sup. 5288.001. NM_004570.2 CQ720591.1 GENBANK_PATENT 1 93
3861.007.1-T_at -0.75024 0.75024416 10.88402 <1e-16.sup.
3861.007. NM_000526.3 BG682207.1 EST 11 94 3852.006.1-C_at -0.74966
0.74965968 10.86465 <1e-16.sup. 3852.006. NM_000424.2 BG679014.1
EST 1 95 9413.003.1-T_at -0.74954 0.74953975 10.86069
<1e-16.sup. 9413.003. NM_004816.2 BX641153.1 mRNA 10 96
3861.020.1-C_at -0.74922 0.74922185 10.85018 <1e-16.sup.
3861.020. NM_000526.3 BM018298.1 EST 1 97 1308.008.1-D_at -0.7468
0.746803 10.77082 <1e-16.sup. 1308.008. NM_130778.1 BE148646.1
EST 1 98 23336.001.1-T_at -0.74666 0.74665951 10.76614
<1e-16.sup. 23336.001 NM_145728.1 AJ697971.1 mRNA 1 99
3815.001.1-F_at -0.74657 0.74656536 10.76307 <1e-16.sup.
3815.001. NM_000222.1 CS237377.1 GENBANK_PATENT 1 100
1756.022.5-F_at -0.74654 0.74654247 10.76233 <1e-16.sup.
1756.022. NM_000109.2 CQ714747.1 GENBANK_PATENT 1 101
79937.001.1-T_at -0.74608 0.74607796 10.74722 <1e-16.sup.
79937.001 NM_033655.2 AF333769.2 mRNA 1 102 4915.012.1-E_at
-0.74575 0.74575052 10.73659 <1e-16.sup. 4915.012. NM_006180.3
CD103051.1 EST 1 103 3861.022.1-T_at -0.74356 0.74356005 10.66593
<1e-16.sup. 3861.022. NM_000526.3 BI085500.1 EST 1 104
26289.005.1-T_at -0.74355 0.74354601 10.66548 <1e-16.sup.
26289.005 NM_174858.1 BI546738.1 EST 1 105 3815.002.3-B_at -0.74306
0.74306109 10.64994 <1e-16.sup. 3815.002. NM_000222.1 CQ719901.1
GENBANK_PATENT 1 106 4311.009.1-F_at -0.74287 0.74287019 10.64383
<1e-16.sup. 4311.009. NM_000902.2 A30431.1 GENBANK_PATENT 1 107
26289.006.1-T_at -0.74283 0.74282989 10.64255 <1e-16.sup.
26289.006 NM_174858.1 CN356131.1 EST 1 108 5288.003.1-F_at -0.74231
0.74231399 10.62608 <1e-16.sup. 5288.003. NM_004570.2 CQ721655.1
GENBANK_PATENT 1 109 4629.020.1-B_at -0.7423 0.74230371 10.62575
<1e-16.sup. 4629.020. NM_022844.1 BI819760.1 EST 1 110
26289.007.1-D_at -0.74169 0.74168883 10.60617 <1e-16.sup.
26289.007 NM_174858.1 DA259560.1 EST 1 111 3815.002.1-B_at -0.74167
0.74166962 10.60556 <1e-16.sup. 3815.002. NM_000222.1 CQ719901.1
GENBANK_PATENT 1 112 26289.004.1-T_at -0.74153 0.74153045 10.60114
<1e-16.sup. 26289.004 NM_174858.1 NM_012093.2 REFSEQ 7 113
79192.002.2-T_at -0.74131 0.74131399 10.59427 <1e-16.sup.
79192.002 NM_024337.3 CQ731489.1 GENBANK_PATENT 1 114
4638.006.1-D_at -0.74126 0.74125872 10.59252 <1e-16.sup.
4638.006. NM_053025.2 DR005817.1 EST 2 115 3084.008.1-F_at -0.74052
0.74051659 10.56902 <1e-16.sup. 3084.008. NM_013957.1 CQ733299.1
GENBANK_PATENT 1 116 4311.001.2-T_at -0.73955 0.73955496 10.5387
<1e-16.sup. 4311.001. NM_000902.2 CB988534.1 EST 1 117
3815.002.1-D_at -0.73931 0.73930643 10.53089 <1e-16.sup.
3815.002. NM_000222.1 CQ719901.1 GENBANK_PATENT 1 118
4629.020.1-T_at -0.73906 0.73905518 10.523 <1e-16.sup. 4629.020.
NM_022844.1 BI819760.1 EST 1 119 1756.026.1-B_at -0.739 0.73899721
10.52119 <1e-16.sup. 1756.026. NM_000109.2 M63075.1 mRNA 1 120
3852.022.1-T_at -0.73857 0.73856714 10.50771 <1e-16.sup.
3852.022. NM_000424.2 BP226135.1 EST 1 121 4629.015.1-D_at -0.73849
0.73848689 10.5052 <1e-16.sup. 4629.015. NM_022844.1 DB284318.1
EST 1
122 26289.007.1-C_at -0.73826 0.73825579 10.49797 <1e-16.sup.
26289.007 NM_174858.1 DA259560.1 EST 1 123 23194.003.1-C_at
-0.73638 0.73638084 10.43964 <1e-16.sup. 23194.003 NM_012304.3
BP290286.1 EST 1 124 3815.002.1-F_at -0.73534 0.73534271 10.40757
<1e-16.sup. 3815.002. NM_000222.1 CQ719901.1 GENBANK_PATENT 1
125 26289.007.1-T_at -0.7346 0.73459701 10.38463 <1e-16.sup.
26289.007 NM_174858.1 DA259560.1 EST 1 126 65983.009.1-B_at
-0.73458 0.73457702 10.38401 <1e-16.sup. 65983.009 NM_023927.1
CQ413222.1 GENBANK_PATENT 2 127 23336.001.1-F_at -0.73393
0.73392505 10.36403 <1e-16.sup. 23336.001 NM_145728.1 AJ697971.1
mRNA 1 128 1410.007.2-B_at -0.73346 0.73346173 10.34986
<1e-16.sup. 1410.007. NM_001885.1 BI548180.1 EST 1 129
1756.029.1-F_at -0.73299 0.73298982 10.33546 <1e-16.sup.
1756.029. NM_000109.2 BI551231.1 EST 1 130 7373.003.6-C_at -0.73258
0.73257952 10.32297 <1e-16.sup. 7373.003. NM_021110.1 CQ716670.1
GENBANK_PATENT 1 131 10010.002.1-E_at -0.7322 0.73219822 10.31139
<1e-16.sup. 10010.002 NM_004180.2 CF242863.1 EST 1 132
59.026.1-B_at -0.73215 0.73215036 10.30993 <1e-16.sup. 59.026.1
-- -- -- -- 133 4915.011.1-F_at -0.73192 0.73191927 10.30292
<1e-16.sup. 4915.011. NM_006180.3 CQ723929.1 GENBANK_PATENT 1
134 3872.007.1-D_at -0.73192 0.73191502 10.30279 <1e-16.sup.
3872.007. NM_000422.1 BU155457.1 EST 1 135 26289.002.1-D_at
-0.73171 0.73171045 10.2966 <1e-16.sup. 26289.002 NM_174858.1
BF966377.1 EST 1 136 84668.002.1-C_at -0.73162 0.73162167 10.29391
<1e-16.sup. 84668.002 NM_032581.2 AL833296.1 mRNA 20 137
1756.002.2-T_at -0.73157 0.73156873 10.2923 <1e-16.sup.
1756.002. NM_000109.2 NM_004016.1 REFSEQ 30 138 57447.033.1-C_at
-0.73085 0.73084864 10.27055 <1e-16.sup. 57447.033 NM_201535.1
DA135222.1 EST 1 139 26289.009.1-E_at -0.7304 0.73039812 10.25697
<1e-16.sup. 26289.009 NM_174858.1 AA393277.1 EST 1 140
3872.006.1-F_at -0.73024 0.73023988 10.25221 <1e-16.sup.
3872.006. NM_000422.1 BM017443.1 EST 1 141 3861.022.1-D_at -0.72983
0.72982952 10.23988 <1e-16.sup. 3861.022. NM_000526.3 BI085500.1
EST 1 142 3861.020.1-B_at -0.72921 0.72920518 10.22116
<1e-16.sup. 3861.020. NM_000526.3 BM018298.1 EST 1 143
667.021.1-B_at -0.72908 0.72907922 10.21739 <1e-16.sup.
667.021.1 NM_183380.1 DB134537.1 EST 1 144 57447.027.1-F_at
-0.72812 0.72812186 10.18881 <1e-16.sup. 57447.027 NM_201535.1
BM810623.1 EST 9 145 56477.001.1-D_at -0.72775 0.72774687 10.17766
<1e-16.sup. 56477.001 NM_148672.1 NM_019846.3 REFSEQ 13 146
26289.008.1-F_at -0.72745 0.72744814 10.16878 <1e-16.sup.
26289.008 NM_174858.1 AV721097.1 EST 1 147 59.024.2-D_at -0.72739
0.72738851 10.16701 <1e-16.sup. 59.024.2 -- -- -- -- 148
4629.005.1-T_at -0.72738 0.7273826 10.16683 <1e-16.sup.
4629.005. NM_022844.1 CB963138.1 EST 3 149 3815.002.1-T_at -0.72727
0.72727235 10.16356 <1e-16.sup. 3815.002. NM_000222.1 CQ719901.1
GENBANK_PATENT 1 150 23336.001.1-B_at -0.72692 0.7269191 10.15309
<1e-16.sup. 23336.001 NM_145728.1 AJ697971.1 mRNA 1 151
3084.004.2-F_at -0.72617 0.72616697 10.13085 1E-16 3084.004.
NM_013957.1 NM_013964.1 REFSEQ 5 152 27122.014.2-T_at -0.72585
0.72585166 10.12156 1E-16 27122.014 NM_013253.4 DA180412.1 EST 1
153 26289.008.1-C_at -0.72537 0.72537026 10.10738 1E-16 26289.008
NM_174858.1 AV721097.1 EST 1 154 286887.003.2-B -0.72458 0.72457637
10.08408 1E-16 286887.00 NM_173086.2 BG876719.1 EST 1 155
4629.005.1-F_at -0.72437 0.72437411 10.07816 1E-16 4629.005.
NM_022844.1 CB963138.1 EST 3 156 3872.009.1-T_at -0.72329
0.72328551 10.04637 1E-16 3872.009. NM_000422.1 BX647923.1 mRNA 91
157 59.014.2-D_at -0.72287 0.72287431 10.0344 1E-16 59.014.2
NM_001613.1 CB962422.1 EST 1 158 403340.001.2-B -0.72269 0.72269253
10.02912 1E-16 403340.00 NM_203481.1 DA145754.1 EST 1 159
3852.014.1-F_at -0.72194 0.72194027 10.0073 1E-16 3852.014.
NM_000424.2 BF826002.1 EST 1 160 27122.001.1-T_at -0.72089
0.72088962 9.976959 1E-16 27122.001 NM_013253.4 BP290952.1 EST 1
161 3815.002.3-T_at -0.72077 0.72076825 9.973463 1E-16 3815.002.
NM_000222.1 CQ719901.1 GENBANK_PATENT 1 162 3852.008.1-E_at
-0.72074 0.72073551 9.97252 1E-16 3852.008. NM_000424.2 BG675837.1
EST 1 163 26289.012.1-T_at -0.72072 0.72072375 9.972181 1E-16
26289.012 NM_174858.1 BG189938.1 EST 1 164 26289.007.1-F_at
-0.72026 0.72026202 9.958901 1E-16 26289.007 NM_174858.1 DA259560.1
EST 1 165 4638.006.1-T_at -0.72019 0.72019094 9.956859 1E-16
4638.006. NM_053025.2 DR005817.1 EST 2 166 8626.005.1-B_at -0.71997
0.71997497 9.950658 1E-16 8626.005. NM_003722.3 AB042841.1 mRNA 1
167 3815.002.4-T_at -0.71955 0.71955195 9.938531 1E-16 3815.002.
NM_000222.1 CQ719901.1 GENBANK_PATENT 1 168 84668.004.1-F_at
-0.71918 0.71917508 9.927746 1E-16 84668.004 NM_032581.2 AL597549.1
EST 1 169 3872.007.1-F_at -0.71916 0.71915759 9.927246 1E-16
3872.007. NM_000422.1 BU155457.1 EST 1 170 57447.031.1-E_at -0.7189
0.71889801 9.919829 2E-16 57447.031 NM_201535.1 AI272253.1 EST 1
171 3084.012.3-T_at -0.71856 0.71855665 9.910088 2E-16 3084.012.
NM_013957.1 U02325.1 mRNA 1 172 3852.005.1-T_at -0.71827 0.71827136
9.901958 2E-16 3852.005. NM_000424.2 R47851.1 EST 1 173
84417.001.2-T_at -0.71816 0.71816117 9.898821 2E-16 84417.001
NM_032411.1 BI561114.1 EST 1 174 3866.003.2-T_at -0.71746
0.71745931 9.878874 2E-16 3866.003. NM_002275.2 AK090604.1 mRNA 22
175 3866.008.1-C_at -0.71716 0.71715783 9.870325 2E-16 3866.008.
NM_002275.2 BI771363.1 EST 1 176 3852.009.1-F_at -0.71671
0.71671024 9.857654 2E-16 3852.009. NM_000424.2 BQ378037.1 EST 1
177 59.015.1-B_at -0.71663 0.7166277 9.85532 2E-16 59.015.1
NM_001613.1 BP372009.1 EST 1 178 79937.002.1-F_at -0.71652
0.71651832 9.852229 2E-16 79937.002 NM_033655.2 AB051501.2 mRNA 9
179 7153.002.6-F_at 0.716462 0.71646227 9.850645 2E-16 7153.002.
NM_001067.2 CQ735949.1 GENBANK_PATENT 114 180 4281.010.1-B_at
-0.71619 0.71619361 9.84306 2E-16 4281.010. NM_033290.1 AY540016.1
mRNA 1 181 59.008.1-B_at -0.71578 0.7157817 9.831448 2E-16 59.008.1
NM_001613.1 BP373197.1 EST 1 182 1264.007.1-T_at -0.71577
0.71576716 9.831038 2E-16 1264.007. NM_001299.4 CX761868.1 EST 1
183 3868.004.1-T_at -0.7156 0.71560057 9.826348 2E-16 3868.004.
NM_005557.2 BM045170.1 EST 1 184 3084.002.1-F_at -0.71513
0.71512815 9.813066 3E-16 3084.002. NM_013957.1 CN603657.1 EST 1
185 5137.004.2-T_at -0.71508 0.71508204 9.811771 3E-16 5137.004.
NM_005020.1 BP222698.1 EST 1 186 4629.022.1-T_at -0.71428
0.71427853 9.789249 3E-16 4629.022. NM_022844.1 AX898971.1
GENBANK_PATENT 1 187 4915.011.1-T_at -0.71337 0.71336654 9.763782
3E-16 4915.011. NM_006180.3 CQ723929.1 GENBANK_PATENT 1 188
3852.013.1-E_at -0.71333 0.71332619 9.762657 3E-16 3852.013.
NM_000424.2 BG682634.1 EST 1 189 59.012.2-T_at -0.71189 0.71189085
9.722787 4E-16 59.012.2 NM_001613.1 AL546033.3 EST 1 190
59.015.1-F_at -0.71184 0.71184354 9.721477 4E-16 59.015.1
NM_001613.1 BP372009.1 EST 1 191 4638.006.2-T_at -0.7112 0.71119714
9.703606 4E-16 4638.006. NM_053025.2 DR005817.1 EST 2 192
23336.002.1-B_at -0.7108 0.71079772 9.692588 6E-16 23336.002
NM_145728.1 NM_015286.4 REFSEQ 6 193 3868.005.1-C_at -0.70987
0.7098711 9.6671 6E-16 3868.005. NM_005557.2 BG682632.1 EST 1 194
3866.011.2-D_at -0.7087 0.70870117 9.635065 7E-16 3866.011.
NM_002275.2 BQ218433.1 EST 1 195 56477.001.1-T_at -0.70868
0.70868235 9.634551 7E-16 56477.001 NM_148672.1 NM_019846.3 REFSEQ
13 196 3815.001.1-T_at -0.70825 0.70824726 9.622678 7E-16 3815.001.
NM_000222.1 CS237377.1 GENBANK_PATENT 1 197 4311.001.1-T_at
-0.70821 0.70820529 9.621535 7E-16 4311.001. NM_000902.2 CB988534.1
EST 1 198 1264.003.1-D_at -0.70785 0.70785219 9.611918 8E-16
1264.003. NM_001299.4 CV811526.1 EST 1 199 59.031.1-T_at -0.70756
0.70755684 9.603885 8E-16 59.031.1 NM_001613.1 BG197213.1 EST 19
200 57447.030.1-B_at -0.70751 0.70750665 9.60252 8E-16 57447.030
NM_201535.1 BM783465.1 EST 5 201 1410.003.2-B_at -0.70746
0.70745636 9.601154 8E-16 1410.003. NM_001885.1 AX899079.1
GENBANK_PATENT 1 202 3866.009.2-D_at -0.70722 0.70721526 9.594607
8E-16 3866.009. NM_002275.2 BI457146.1 EST 1 203 59.026.1-T_at
-0.70717 0.70717265 9.59345 8E-16 59.026.1 -- -- -- -- 204
440421.001.1-T -0.70711 0.70711453 9.591873 8E-16 440421.00
XM_496202.2 XM_934894.1 REFSEQ 2 205 1756.022.4-D_at -0.70675
0.70675086 9.582014 9E-16 1756.022. NM_000109.2 CQ714747.1
GENBANK_PATENT 1 206 65983.009.1-D_at -0.7066 0.70660056 9.577944
9E-16 65983.009 NM_023927.1 CQ413222.1 GENBANK_PATENT 2 207
57447.041.1-T_at -0.70624 0.70624401 9.5683 9E-16 57447.041
NM_201535.1 DA295124.1 EST 1 208 3872.010.2-D_at -0.70603 0.7060339
9.562622 1E-15 3872.010. NM_000422.1 BM008795.1 EST 1 209
4629.006.2-T_at -0.70601 0.70600879 9.561944 1E-15 4629.006.
NM_022844.1 DB079784.1 EST 1 210 3861.018.1-F_at -0.70592
0.70592127 9.559582 1E-15 3861.018. NM_000526.3 BM019687.1 EST 1
211 3815.002.2-T_at -0.70576 0.70576231 9.555292 1E-15 3815.002.
NM_000222.1 CQ719901.1 GENBANK_PATENT 1 212 3866.012.2-D_at
-0.70556 0.70555782 9.549778 1E-15 3866.012. NM_002275.2 BI772438.1
EST 1 213 57447.021.1-D_at -0.70548 0.70548085 9.547704 1E-15
57447.021 NM_201535.1 BQ954948.1 EST 28 214 59.015.1-T_at -0.70494
0.7049442 9.533261 1E-15 59.015.1 NM_001613.1 BP372009.1 EST 1 215
8626.007.1-F_at -0.70484 0.70483534 9.530336 1E-15 8626.007.
NM_003722.3 BG698723.1 EST 1 216 5288.001.1-B_at -0.70452
0.70452172 9.521914 1E-15 5288.001. NM_004570.2 CQ720591.1
GENBANK_PATENT 1 217 72.001.1-B_at -0.70441 0.70440953 9.518904
1E-15 72.001.1 NM_001615.3 BP330025.1 EST 1 218 3866.006.2-D_at
-0.70383 0.70382789 9.503322 1E-15 3866.006. NM_002275.2 BQ641523.1
EST 1 219 3852.004.1-T_at -0.70371 0.70371224 9.500228 1E-15
3852.004. NM_000424.2 BE715131.1 EST 1 220 4629.016.1-F_at -0.70364
0.70363752 9.49823 1E-15 4629.016. NM_022844.1 DB289769.1 EST 1 221
4629.007.1-T_at -0.70359 0.70358925 9.49694 1E-15 4629.007.
NM_022844.1 AY520817.1 mRNA 16 222 65983.008.1-T_at -0.70354
0.70353523 9.495496 1E-15 65983.008 NM_023927.1 BI547735.1 EST 2
223 65983.013.1-F_at -0.70278 0.7027824 9.475409 1E-15 65983.013
NM_023927.1 AA610396.1 EST 1 224 3084.004.1-F_at -0.70205
0.70204717 9.455852 2E-15 3084.004. NM_013957.1 NM_013964.1 REFSEQ
5 225 27122.007.1-F_at -0.70181 0.70180898 9.449529 2E-15 27122.007
NM_013253.4 DA177251.1 EST 1 226 3866.008.1-D_at -0.70143
0.70142639 9.439386 2E-15 3866.008. NM_002275.2 BI771363.1 EST 1
227 26289.009.1-T_at -0.70109 0.70108634 9.430384 2E-15 26289.009
NM_174858.1 AA393277.1 EST 1 228 59.009.1-B_at -0.70065 0.7006532
9.418936 2E-15 59.009.1 NM_001613.1 CD299238.1 EST 1 229
4629.010.1-D_at -0.70044 0.70044198 9.413361 2E-15 4629.010.
NM_022844.1 AI285326.1 EST 1 230 59.023.1-B_at -0.70011 0.70010609
9.404505 2E-15 59.023.1 NM_001613.1 DB248573.1 EST 1 231
26289.002.1-F_at -0.69973 0.6997339 9.394706 2E-15 26289.002
NM_174858.1 BF966377.1 EST 1 232 1908.001.1-T_at -0.69949
0.69948609 9.388191 2E-15 1908.001. NM_207032.1 BC008876.2 mRNA 3
233 4915.008.1-F_at -0.69917 0.69916784 9.379833 2E-15 4915.008.
NM_006180.3 NM_001007097 REFSEQ 4 234 23336.002.1-T_at -0.69904
0.69903724 9.376406 2E-15 23336.002 NM_145728.1 NM_015286.4 REFSEQ
6 235 3861.008.1-C_at -0.69903 0.69902539 9.376095 2E-15 3861.008.
NM_000526.3 BE184532.1 EST 1 236 3861.008.1-D_at -0.69889
0.69889457 9.372664 2E-15 3861.008. NM_000526.3 BE184532.1 EST 1
237 57447.035.1-E_at -0.69855 0.69855253 9.363704 2E-15 57447.035
NM_201535.1 BQ636638.1 EST 1 238 3861.018.1-C_at -0.69848
0.69848178 9.361852 3E-15 3861.018. NM_000526.3 BM019687.1 EST 1
239 1308.003.1-B_at -0.69839 0.69838688 9.359369 3E-15 1308.003.
NM_130778.1 NM_000494.2 REFSEQ 19 240 667.022.1-B_at -0.69713
0.69712975 9.326564 3E-15 667.022.1 NM_183380.1 AX683196.1
GENBANK_PATENT 1 241 3866.011.2-T_at -0.69701 0.69700959 9.323438
3E-15 3866.011. NM_002275.2 BQ218433.1 EST 1 242 2115.001.2-F_at
-0.69674 0.69674446 9.316544 3E-15 2115.001. NM_004956.3 X87175.1
mRNA 1 243 3866.011.2-B_at -0.69651 0.69651246 9.310518 3E-15
3866.011. NM_002275.2 BQ218433.1 EST 1 244 26289.010.1-T_at
-0.69627 0.69627463 9.304346 3E-15 26289.010 NM_174858.1 AX988359.1
GENBANK_PATENT 1 245 27303.004.1-E_at -0.69571 0.69571431 9.28983
4E-15 27303.004 NM_001003793. BQ876639.1 EST 1 246 59.003.1-B_at
-0.69503 0.69503447 9.27226 4E-15 59.003.1 NM_001613.1 DD218797.1
GENBANK_PATENT 1 247 4311.009.1-C_at -0.69487 0.69486903 9.267992
4E-15 4311.009. NM_000902.2 A30431.1 GENBANK_PATENT 1
248 7373.003.6-B_at -0.69405 0.69404745 9.246838 4E-15 7373.003.
NM_021110.1 CQ716670.1 GENBANK_PATENT 1 249 65983.004.1-T_at
-0.69339 0.69339166 9.230003 5E-15 65983.004 NM_023927.1 BP262020.1
EST 1 250 26289.013.1-D_at -0.69304 0.69304425 9.221102 5E-15
26289.013 NM_174858.1 CK024190.1 EST 1 251 3866.004.1-F_at -0.69262
0.6926248 9.210372 5E-15 3866.004. NM_002275.2 BC110649.1 mRNA 1
252 56477.001.1-F_at -0.69247 0.69247193 9.206466 5E-15 56477.001
NM_148672.1 NM_019846.3 REFSEQ 13 253 57447.037.1-F_at -0.69228
0.6922756 9.201453 5E-15 57447.037 NM_201535.1 BF793156.1 EST 1 254
59.022.2-T_at -0.69208 0.69207912 9.19644 6E-15 59.022.2 -- -- --
-- 255 147495.008.1-F -0.69208 0.69207819 9.196417 6E-15 147495.00
NM_153000.3 BU541433.1 EST 1 256 2.018.1-T_at -0.69207 0.69207481
9.196331 6E-15 2.018.1 NM_000014.4 DB090657.1 EST 1 257
140807.003.1-E -0.69207 0.69207171 9.196251 6E-15 140807.00
NM_080747.1 DB022590.1 EST 1 258 65983.009.1-T_at -0.69206
0.69205534 9.195834 6E-15 65983.009 NM_023927.1 CQ413222.1
GENBANK_PATENT 2 259 84668.002.1-F_at -0.69156 0.69155609 9.183115
6E-15 84668.002 NM_032581.2 AL833296.1 mRNA 20 260 3872.007.1-C_at
-0.69153 0.69153411 9.182556 6E-15 3872.007. NM_000422.1 BU155457.1
EST 1 261 2115.008.1-T_at -0.69097 0.6909716 9.168257 6E-15
2115.008. NM_004956.3 BC045776.1 mRNA 3 262 65983.004.2-T_at
-0.69096 0.69095787 9.167908 6E-15 65983.004 NM_023927.1 BP262020.1
EST 1 263 57447.034.1-D_at -0.69053 0.69052533 9.156935 7E-15
57447.034 NM_201535.1 BC011240.1 mRNA 1 264 3866.001.1-F_at
-0.69016 0.69016212 9.147735 7E-15 3866.001. NM_002275.2 CQ733235.1
GENBANK_PATENT 23 265 3866.008.1-T_at -0.69014 0.69014281 9.147247
7E-15 3866.008. NM_002275.2 BI771363.1 EST 1 266 1959.003.1-C_at
-0.68985 0.68984796 9.139789 7E-15 1959.003. NM_000399.2 BX414563.2
EST 3 267 389432.002.1-T -0.68963 0.6896308 9.134301 8E-15
389432.00 NM_001030060. CQ751492.1 GENBANK_PATENT 1 268
389734.001.1-T -0.68953 0.68953203 9.131807 8E-15 389734.00
XM_928572.1 NM_033655.2 REFSEQ 1 269 3855.001.2-D_at -0.68928
0.68928425 9.125555 8E-15 3855.001. NM_005556.3 BM754696.1 EST 1
270 3866.003.1-T_at -0.68911 0.68910803 9.121111 8E-15 3866.003.
NM_002275.2 AK090604.1 mRNA 22 271 3084.006.1-F_at -0.689
0.68900076 9.118408 8E-15 3084.006. NM_013957.1 NM_013956.1 REFSEQ
3 272 4915.008.1-B_at -0.68884 0.68884477 9.114479 8E-15 4915.008.
NM_006180.3 NM_001007097 REFSEQ 4 273 2115.011.1-T_at -0.68881
0.68880926 9.113585 8E-15 2115.011. NM_004956.3 DB093597.1 EST 1
274 65983.005.1-T_at -0.68876 0.68875602 9.112245 8E-15 65983.005
NM_023927.1 CQ471280.1 GENBANK_PATENT 6 275 84668.004.1-T_at
-0.68808 0.68807773 9.095195 9E-15 84668.004 NM_032581.2 AL597549.1
EST 1 276 59.015.2-T_at -0.68802 0.68801589 9.093643 9E-15 59.015.2
NM_001613.1 BP372009.1 EST 1 277 2119.006.1-B_at -0.6878 0.687801
9.088252 9E-15 2119.006. NM_004454.1 DB094869.1 EST 1 278
4638.006.2-F_at -0.68764 0.6876412 9.084246 1E-14 4638.006.
NM_053025.2 DR005817.1 EST 2 279 3866.007.2-D_at -0.687 0.68699646
9.068108 1E-14 3866.007. NM_002275.2 BM548942.1 EST 1 280
59.014.1-T_at -0.68691 0.68691236 9.066007 1E-14 59.014.1
NM_001613.1 CB962422.1 EST 1 281 3866.001.2-F_at -0.68681
0.68680934 9.063433 1E-14 3866.001. NM_002275.2 CQ733235.1
GENBANK_PATENT 23 282 1308.008.1-B_at -0.68652 0.68652289 9.056281
1E-14 1308.008. NM_130778.1 BE148646.1 EST 1 283 59.026.1-F_at
-0.68647 0.68647292 9.055034 1E-14 59.026.1 -- -- -- -- 284
3866.013.1-T_at -0.68626 0.68625953 9.049713 1E-14 3866.013.
NM_002275.2 BI769443.1 EST 1 285 1264.007.1-F_at -0.68577
0.68577484 9.037643 1E-14 1264.007. NM_001299.4 CX761868.1 EST 1
286 3866.007.2-T_at -0.68566 0.68566296 9.034861 1E-14 3866.007.
NM_002275.2 BM548942.1 EST 1 287 27122.013.1-T_at -0.68541
0.68541178 9.028617 1E-14 27122.013 NM_013253.4 DR155720.1 EST 1
288 27122.006.2-T_at -0.68531 0.68531032 9.026097 1E-14 27122.006
NM_013253.4 DA171350.1 EST 1 289 3866.006.2-T_at -0.68509
0.68508881 9.020598 1E-14 3866.006. NM_002275.2 BQ641523.1 EST 1
290 3866.009.2-T_at -0.68506 0.68506091 9.019906 1E-14 3866.009.
NM_002275.2 BI457146.1 EST 1 291 4240.004.1-D_at -0.68504
0.68503667 9.019305 1E-14 4240.004. NM_005928.1 BC003610.2 mRNA 448
292 3866.010.1-C_at -0.68501 0.68500991 9.018641 1E-14 3866.010.
NM_002275.2 BM045201.1 EST 1 293 3866.009.2-B_at -0.68464
0.68464309 9.009548 1E-14 3866.009. NM_002275.2 BI457146.1 EST 1
294 3866.009.1-T_at -0.68457 0.68456652 9.007652 1E-14 3866.009.
NM_002275.2 BI457146.1 EST 1 295 4629.006.1-T_at -0.68451
0.68450911 9.00623 1E-14 4629.006. NM_022844.1 DB079784.1 EST 1 296
7018.029.1-B_at -0.68388 0.68388329 8.990755 2E-14 7018.029.
NM_001063.2 AV656085.1 EST 1 297 1410.002.2-B_at -0.68375 0.6837454
8.987351 2E-14 1410.002. NM_001885.1 AX899073.1 GENBANK_PATENT 4
298 3866.012.1-T_at -0.68307 0.68306583 8.970598 2E-14 3866.012.
NM_002275.2 BI772438.1 EST 1 299 59.034.2-D_at -0.68305 0.68305272
8.970275 2E-14 59.034.2 -- -- -- -- 300 27122.019.1-F_at -0.68293
0.68293177 8.967298 2E-14 27122.019 NM_013253.4 CX758435.1 EST 1
301 5156.001.1-T_at -0.68292 0.6829222 8.967063 2E-14 5156.001.
NM_006206.3 BC015186.1 mRNA 1 302 389734.001.2-T -0.68274
0.68273641 8.962493 2E-14 389734.00 XM_928572.1 NM_033655.2 REFSEQ
1 303 27122.014.1-T_at -0.68257 0.68256552 8.958292 2E-14 27122.014
NM_013253.4 DA180412.1 EST 1 304 57447.010.3-T_at -0.68236
0.68236044 8.953255 2E-14 57447.010 NM_201535.1 BP349691.1 EST 1
305 358.018.1-F_at -0.68232 0.68232244 8.952322 2E-14 358.018.1
NM_198098.1 BI765065.1 EST 1 306 3866.006.1-T_at -0.68218 0.6821773
8.948759 2E-14 3866.006. NM_002275.2 BQ641523.1 EST 1 307
7373.001.1-T_at -0.68199 0.68198548 8.944055 2E-14 7373.001.
NM_021110.1 DB089175.1 EST 1 308 26289.012.1-B_at -0.68184
0.68184048 8.940501 2E-14 26289.012 NM_174858.1 BG189938.1 EST 1
309 57447.029.1-T_at -0.68178 0.68178369 8.939109 2E-14 57447.029
NM_201535.1 BX354120.2 EST 6 310 358.018.1-B_at -0.68156 0.68155712
8.933561 2E-14 358.018.1 NM_198098.1 BI765065.1 EST 1 311
79068.010.1-B_at -0.68149 0.68149173 8.93196 2E-14 79068.010
XM_051200.8 DA647247.1 EST 1 312 59.024.1-B_at -0.68126 0.68126043
8.926302 2E-14 59.024.1 -- -- -- -- 313 59.004.1-B_at -0.68117
0.68116935 8.924076 2E-14 59.004.1 NM_001613.1 CQ696293.1
GENBANK_PATENT 1 314 3866.011.1-T_at -0.68101 0.68100958 8.920172
2E-14 3866.011. NM_002275.2 BQ218433.1 EST 1 315 3866.013.1-E_at
-0.68096 0.68096121 8.91899 2E-14 3866.013. NM_002275.2 BI769443.1
EST 1 316 3866.010.1-D_at -0.68032 0.68032145 8.903385 2E-14
3866.010. NM_002275.2 BM045201.1 EST 1 317 59.004.1-T_at -0.68016
0.68016229 8.899508 2E-14 59.004.1 NM_001613.1 CQ696293.1
GENBANK_PATENT 1 318 2115.012.1-T_at -0.68003 0.68003217 8.896341
2E-14 2115.012. NM_004956.3 DA407403.1 EST 1 319 2.018.1-D_at
-0.68003 0.68003048 8.8963 2E-14 2.018.1 NM_000014.4 DB090657.1 EST
1 320 2115.007.1-T_at -0.67992 0.67991611 8.893517 2E-14 2115.007.
NM_004956.3 DA189670.1 EST 1 321 59.040.1-T_at -0.67978 0.67977663
8.890125 2E-14 59.040.1 NM_001613.1 EH_001613.6 PREDICTED 1 322
130497.001.2-T -0.67974 0.67974133 8.889267 2E-14 130497.00
NM_145260.2 BP316395.1 EST 1 323 140885.014.1-T -0.67971 0.67971161
8.888544 2E-14 140885.01 NM_080792.2 DR423079.1 EST 1 324
3866.005.1-F_at -0.6797 0.67970122 8.888292 2E-14 3866.005.
NM_002275.2 AL832226.1 mRNA 37 325 7373.003.3-F_at -0.67961
0.67961087 8.886096 3E-14 7373.003. NM_021110.1 CQ716670.1
GENBANK_PATENT 1 326 8404.028.1-F_at -0.67957 0.67957039 8.885112
3E-14 8404.028. NM_004684.2 CQ727530.1 GENBANK_PATENT 1 327
3860.007.1-D_at -0.67955 0.67954786 8.884565 3E-14 3860.007.
NM_153490.1 DB256579.1 EST 1 328 4638.003.1-C_at -0.67882 0.678822
8.866957 3E-14 4638.003. NM_053025.2 BP289609.1 EST 2 329
3872.009.1-E_at -0.67861 0.67861088 8.861844 3E-14 3872.009.
NM_000422.1 BX647923.1 mRNA 91 330 59.004.2-T_at -0.67859
0.67859272 8.861405 3E-14 59.004.2 NM_001613.1 CQ696293.1
GENBANK_PATENT 1 331 3872.006.1-C_at -0.67843 0.67842819 8.857424
3E-14 3872.006. NM_000422.1 BM017443.1 EST 1 332 3866.005.1-C_at
-0.67822 0.67822035 8.852398 3E-14 3866.005. NM_002275.2 AL832226.1
mRNA 37 333 25925.008.1-T_at -0.67797 0.6779714 8.846384 3E-14
25925.008 NM_015461.1 DA093254.1 EST 1 334 23650.011.2-T_at
-0.67792 0.67792361 8.84523 3E-14 23650.011 NM_058193.1 NM_012101.2
REFSEQ 11 335 3866.012.2-T_at -0.67755 0.67754608 8.836122 3E-14
3866.012. NM_002275.2 BI772438.1 EST 1 336 3852.017.1-D_at -0.6775
0.67750467 8.835124 3E-14 3852.017. NM_000424.2 CV575305.1 EST 1
337 4915.005.1-T_at -0.67735 0.67734733 8.831332 3E-14 4915.005.
NM_006180.3 BP348402.1 EST 1 338 4638.003.1-B_at -0.67707
0.67706981 8.82465 3E-14 4638.003. NM_053025.2 BP289609.1 EST 2 339
1756.003.1-B_at -0.67674 0.67673545 8.816608 4E-14 1756.003.
NM_000109.2 AB208836.1 mRNA 1 340 4638.006.1-F_at -0.67651
0.6765092 8.811172 4E-14 4638.006. NM_053025.2 DR005817.1 EST 2 341
57447.035.1-F_at -0.67604 0.67604162 8.799953 4E-14 57447.035
NM_201535.1 BQ636638.1 EST 1 342 4638.014.1-T_at -0.67585
0.67584646 8.795276 4E-14 4638.014. NM_053025.2 NM_053027.2 REFSEQ
2 343 7373.003.4-T_at -0.67582 0.67582231 8.794697 4E-14 7373.003.
NM_021110.1 CQ716670.1 GENBANK_PATENT 1 344 27122.014.2-D_at
-0.67579 0.67578648 8.793839 4E-14 27122.014 NM_013253.4 DA180412.1
EST 1 345 3866.007.1-T_at -0.67504 0.67503748 8.775925 4E-14
3866.007. NM_002275.2 BM548942.1 EST 1 346 2707.002.1-E_at -0.67499
0.67498884 8.774763 4E-14 2707.002. NM_024009.2 DA669405.1 EST 4
347 59.024.1-T_at -0.67481 0.67480778 8.770441 4E-14 59.024.1 -- --
-- -- 348 23650.011.1-T_at -0.6747 0.67469739 8.767807 4E-14
23650.011 NM_058193.1 NM_012101.2 REFSEQ 11 349 4638.011.1-F_at
-0.67462 0.67462378 8.766052 4E-14 4638.011. NM_053025.2 DB267860.1
EST 1 350 7373.002.1-F_at -0.67455 0.67455304 8.764365 5E-14
7373.002. NM_021110.1 BC036192.1 mRNA 2 351 3866.013.1-F_at -0.6745
0.6744968 8.763024 5E-14 3866.013. NM_002275.2 BI769443.1 EST 1 352
5608.002.1-T_at -0.67444 0.67443693 8.761597 5E-14 5608.002.
NM_002758.2 DA427998.1 EST 1 353 3866.001.1-C_at -0.67411
0.67411218 8.753863 5E-14 3866.001. NM_002275.2 CQ733235.1
GENBANK_PATENT 23 354 1756.013.1-B_at -0.67402 0.67402382 8.75176
5E-14 1756.013. NM_000109.2 NM_004019.1 REFSEQ 2 355
2115.006.1-E_at -0.67381 0.67381491 8.746791 5E-14 2115.006.
NM_004956.3 DA210177.1 EST 1 356 6376.001.2-F_at -0.67341 0.6734055
8.737064 5E-14 6376.001. NM_002996.3 AK223351.1 mRNA 48 357
3084.004.1-B_at -0.67338 0.67337698 8.736388 5E-14 3084.004.
NM_013957.1 NM_013964.1 REFSEQ 5 358 3815.002.4-F_at -0.67334
0.67333838 8.735471 5E-14 3815.002. NM_000222.1 CQ719901.1
GENBANK_PATENT 1 359 8404.002.1-D_at -0.6733 0.6733018 8.734603
5E-14 8404.002. NM_004684.2 BP383384.1 EST 1 360 1264.006.1-T_at
-0.67319 0.67318534 8.73184 5E-14 1264.006. NM_001299.4 CN366945.1
EST 1 361 59.022.2-D_at -0.67316 0.67315986 8.731236 5E-14 59.022.2
-- -- -- -- 362 25925.001.1-T_at -0.67306 0.67306029 8.728874 5E-14
25925.001 NM_015461.1 BC032869.2 mRNA 19 363 4638.006.2-B_at
-0.67278 0.67278344 8.722314 6E-14 4638.006. NM_053025.2 DR005817.1
EST 2 364 7373.003.5-B_at -0.67271 0.67270981 8.72057 6E-14
7373.003. NM_021110.1 CQ716670.1 GENBANK_PATENT 1 365
8404.035.1-B_at -0.6727 0.67269572 8.720236 6E-14 8404.035.
NM_004684.2 BG716198.1 EST 1 366 59.012.1-T_at -0.67254 0.67254112
8.716577 6E-14 59.012.1 NM_001613.1 AL546033.3 EST 1 367
3852.017.1-T_at -0.67188 0.67188165 8.70099 6E-14 3852.017.
NM_000424.2 CV575305.1 EST 1 368 3866.012.2-B_at -0.67185
0.67184565 8.70014 6E-14 3866.012. NM_002275.2 BI772438.1 EST 1 369
2.022.1-B_at -0.67169 0.67168628 8.69638 6E-14 2.022.1 NM_000014.4
BP343424.1 EST 1 370 27122.016.1-F_at -0.67125 0.67124955 8.686085
7E-14 27122.016 NM_013253.4 BQ962557.1 EST 1 371 4311.009.1-B_at
-0.67109 0.67108684 8.682254 7E-14 4311.009. NM_000902.2 A30431.1
GENBANK_PATENT 1 372 59.031.2-T_at -0.67084 0.67084085 8.676467
7E-14 59.031.2 NM_001613.1 BG197213.1 EST 19 373 4311.009.1-T_at
-0.67054 0.67053973 8.669389 7E-14 4311.009. NM_000902.2 A30431.1
GENBANK_PATENT 1 374 3866.006.2-B_at -0.67045 0.67044748 8.667223
7E-14 3866.006. NM_002275.2 BQ641523.1 EST 1 375 57447.025.2-T_at
-0.67023 0.67022566 8.662016 7E-14 57447.025 NM_201535.1 DA646455.1
EST 2 376 1717.007.1-F_at -0.67014 0.67013656 8.659925 8E-14
1717.007.
NM_001360.1 BX438503.2 EST 1 377 59.004.2-D_at -0.67008 0.67008376
8.658687 8E-14 59.004.2 NM_001613.1 CQ696293.1 GENBANK_PATENT 1 378
3866.007.2-B_at -0.66995 0.66994537 8.655442 8E-14 3866.007.
NM_002275.2 BM548942.1 EST 1 379 3866.010.1-F_at -0.66945
0.66944797 8.643794 8E-14 3866.010. NM_002275.2 BM045201.1 EST 1
380 9768.004.1-D_at 0.669331 0.66933125 8.641063 8E-14 9768.004.
NM_014736.4 BG506365.1 EST 2 381 3084.012.2-T_at -0.66928
0.66928297 8.639934 8E-14 3084.012. NM_013957.1 U02325.1 mRNA 1 382
1410.004.2-B_at -0.66925 0.66925228 8.639216 8E-14 1410.004.
NM_001885.1 AX888027.1 GENBANK_PATENT 1 383 59.008.1-D_at -0.66919
0.66919054 8.637773 8E-14 59.008.1 NM_001613.1 BP373197.1 EST 1 384
57447.030.1-C_at -0.66908 0.66908366 8.635275 8E-14 57447.030
NM_201535.1 BM783465.1 EST 5 385 2327.002.1-D_at -0.66908
0.66907887 8.635163 8E-14 2327.002. NM_001460.2 CD684429.1 EST 1
386 1308.004.1-B_at -0.66865 0.66864754 8.625092 9E-14 1308.004.
NM_130778.1 BE615666.1 EST 1 387 2568.005.2-B_at -0.66838
0.66838113 8.61888 9E-14 2568.005. NM_014211.1 AK055205.1 mRNA 11
388 2568.001.1-T_at -0.66811 0.66811257 8.612624 9E-14 2568.001.
NM_014211.1 BX509618.1 EST 1 389 3084.004.2-T_at -0.66789
0.66788994 8.607442 1E-13 3084.004. NM_013957.1 NM_013964.1 REFSEQ
5 390 7373.003.4-B_at -0.66777 0.66776994 8.604651 1E-13 7373.003.
NM_021110.1 CQ716670.1 GENBANK_PATENT 1 391 7153.002.2-D_at
0.667642 0.66764203 8.601677 1E-13 7153.002. NM_001067.2 CQ735949.1
GENBANK_PATENT 114 392 2893.006.2-T_at -0.66761 0.66760773 8.600879
1E-13 2893.006. NM_000829.1 BF669210.1 EST 1 393 3872.016.1-D_at
-0.66759 0.66758641 8.600384 1E-13 3872.016. NM_000422.1 CB127430.1
EST 1 394 9413.006.1-F_at -0.6674 0.6674036 8.596137 1E-13
9413.006. NM_004816.2 BC021685.1 mRNA 2 395 59.023.2-B_at -0.66731
0.6673108 8.593982 1E-13 59.023.2 NM_001613.1 DB248573.1 EST 1 396
72.005.1-B_at -0.66711 0.66711142 8.589354 1E-13 72.005.1
NM_001615.3 CF130984.1 EST 20 397 4915.011.1-C_at -0.66689
0.66688915 8.5842 1E-13 4915.011. NM_006180.3 CQ723929.1
GENBANK_PATENT 1 398 27122.018.1-F_at -0.66662 0.6666247 8.578072
1E-13 27122.018 NM_013253.4 BG715341.1 EST 1 399 3852.006.1-B_at
-0.66652 0.66652184 8.57569 1E-13 3852.006. NM_000424.2 BG679014.1
EST 1 400 4638.006.2-D_at -0.66649 0.66648584 8.574857 1E-13
4638.006. NM_053025.2 DR005817.1 EST 2 401 7153.005.1-E_at 0.666056
0.66605623 8.56492 1E-13 7153.005. NM_001067.2 DB061604.1 EST 1 402
7373.001.2-T_at -0.66587 0.66587031 8.560624 1E-13 7373.001.
NM_021110.1 DB089175.1 EST 1 403 7018.026.1-B_at -0.66537
0.66537209 8.549127 1E-13 7018.026. NM_001063.2 BM690655.1 EST 1
404 7402.014.1-B_at -0.66525 0.66524627 8.546227 1E-13 7402.014.
NM_007124.1 AL703969.1 EST 1 405 57447.010.3-D_at -0.66513
0.66513034 8.543556 1E-13 57447.010 NM_201535.1 BP349691.1 EST 1
406 140446.004.1-T -0.66502 0.66501858 8.540982 1E-13 140446.00
NM_058242.1 DB016079.1 EST 1 407 59.026.2-T_at -0.66495 0.66494798
8.539356 1E-13 59.026.2 -- -- -- -- 408 59.038.1-B_at -0.66494
0.66493959 8.539163 1E-13 59.038.1 NM_001613.1 EH_001613.2
PREDICTED 1 409 4240.009.1-C_at -0.66471 0.66470997 8.533879 1E-13
4240.009. NM_005928.1 BG829936.1 EST 2 410 57447.030.1-F_at
-0.66468 0.66468295 8.533258 1E-13 57447.030 NM_201535.1 BM783465.1
EST 5 411 9768.004.1-B_at 0.664563 0.66456315 8.530503 1E-13
9768.004. NM_014736.4 BG506365.1 EST 2 412 57447.008.1-T_at
-0.66453 0.66453368 8.529826 1E-13 57447.008 NM_201535.1 DB195772.1
EST 1 413 59.014.2-T_at -0.66423 0.66423397 8.52294 1E-13 59.014.2
NM_001613.1 CB962422.1 EST 1 414 4915.012.1-T_at -0.66407 0.6640741
8.51927 1E-13 4915.012. NM_006180.3 CD103051.1 EST 1 415
3866.004.1-T_at -0.66398 0.66397879 8.517083 1E-13 3866.004.
NM_002275.2 BC110649.1 mRNA 1 416 2582.007.2-C_at -0.66357
0.66357028 8.507718 2E-13 2582.007. NM_001008216. AK057302.1 mRNA
32 417 7153.002.5-T_at 0.663259 0.66325931 8.500598 2E-13 7153.002.
NM_001067.2 CQ735949.1 GENBANK_PATENT 114 418 4638.009.1-T_at
-0.66296 0.66295877 8.493725 2E-13 4638.009. NM_053025.2 AX885051.1
GENBANK_PATENT 39 419 3861.023.1-T_at -0.66279 0.66279224 8.489919
2E-13 3861.023. NM_000526.3 BG676679.1 EST 1 420 5858.003.3-C_at
-0.66243 0.66242627 8.481564 2E-13 5858.003. NM_002864.1 AX512279.1
GENBANK_PATENT 2 421 3861.020.1-F_at -0.66242 0.66241661 8.481344
2E-13 3861.020. NM_000526.3 BM018298.1 EST 1 422 147495.005.1-T
-0.66232 0.66231598 8.479048 2E-13 147495.00 NM_153000.3 BI822892.1
EST 1 423 4638.006.2-C_at -0.66228 0.66227571 8.47813 2E-13
4638.006. NM_053025.2 DR005817.1 EST 2 424 1308.004.1-F_at -0.66213
0.66212634 8.474725 2E-13 1308.004. NM_130778.1 BE615666.1 EST 1
425 4915.004.1-F_at -0.66185 0.66184583 8.468335 2E-13 4915.004.
NM_006180.3 NM_001018066 REFSEQ 28 426 3866.008.1-B_at -0.66173
0.66172906 8.465676 2E-13 3866.008. NM_002275.2 BI771363.1 EST 1
427 8626.002.1-E_at -0.66173 0.66172521 8.465589 2E-13 8626.002.
NM_003722.3 AB016072.1 mRNA 16 428 1264.003.1-T_at -0.66156
0.66156109 8.461855 2E-13 1264.003. NM_001299.4 CV811526.1 EST 1
429 59.042.1-F_at -0.66151 0.66151227 8.460744 2E-13 59.042.1
NM_001613.1 EH_001613.8 PREDICTED 1 430 4833.004.1-C_at 0.661269
0.66126853 8.455204 2E-13 4833.004. NM_005009.2 BG478602.1 EST 8
431 2568.006.1-B_at -0.66106 0.661057 8.450399 2E-13 2568.006.
NM_014211.1 CD385249.1 EST 1 432 57447.004.2-T_at -0.66103
0.66102604 8.449696 2E-13 57447.004 NM_201535.1 CD515320.1 EST 2
433 59.014.2-B_at -0.66085 0.66084763 8.445647 2E-13 59.014.2
NM_001613.1 CB962422.1 EST 1 434 3084.012.1-T_at -0.66068
0.66068046 8.441855 2E-13 3084.012. NM_013957.1 U02325.1 mRNA 1 435
27122.017.1-T_at -0.6605 0.66049978 8.43776 2E-13 27122.017
NM_013253.4 CB155251.1 EST 1 436 3852.012.2-T_at -0.66039
0.66039403 8.435364 2E-13 3852.012. NM_000424.2 CQ733668.1
GENBANK_PATENT 1 437 59.033.1-T_at -0.66029 0.66028879 8.43298
2E-13 59.033.1 -- -- -- -- 438 27122.002.1-C_at -0.66018 0.66018203
8.430563 2E-13 27122.002 NM_013253.4 AK098756.1 mRNA 1 439
3880.011.1-B_at -0.65981 0.65981353 8.422227 2E-13 3880.011.
NM_002276.3 BP330400.1 EST 1 440 65983.013.1-T_at -0.65959
0.65958733 8.417116 2E-13 65983.013 NM_023927.1 AA610396.1 EST 1
441 3872.014.1-T_at -0.65949 0.65948987 8.414915 2E-13 3872.014.
NM_000422.1 BG678436.1 EST 1 442 162605.001.4-C -0.65946 0.65945748
8.414184 2E-13 162605.00 NM_181535.2 CQ735954.1 GENBANK_PATENT 1
443 59.031.2-B_at -0.65937 0.65937317 8.41228 2E-13 59.031.2
NM_001613.1 BG197213.1 EST 19 444 3084.012.2-B_at -0.65926
0.65925637 8.409644 3E-13 3084.012. NM_013957.1 U02325.1 mRNA 1 445
5858.001.2-C_at -0.65925 0.65925226 8.409552 3E-13 5858.001.
NM_002864.1 BC111756.1 mRNA 2 446 65983.010.1-T_at -0.65919
0.65918848 8.408113 3E-13 65983.010 NM_023927.1 DB261377.1 EST 1
447 7373.003.5-F_at -0.65893 0.65892789 8.402237 3E-13 7373.003.
NM_021110.1 CQ716670.1 GENBANK_PATENT 1 448 3866.010.1-T_at
-0.65871 0.65871193 8.397372 3E-13 3866.010. NM_002275.2 BM045201.1
EST 1 449 8404.005.1-B_at -0.65871 0.65870759 8.397274 3E-13
8404.005. NM_004684.2 DA763956.1 EST 1 450 3866.005.1-T_at -0.65866
0.65866359 8.396284 3E-13 3866.005. NM_002275.2 AL832226.1 mRNA 37
451 59.003.1-F_at -0.65865 0.65864902 8.395956 3E-13 59.003.1
NM_001613.1 DD218797.1 GENBANK_PATENT 1 452 7153.002.5-F_at
0.658561 0.65856119 8.393979 3E-13 7153.002. NM_001067.2 CQ735949.1
GENBANK_PATENT 114 453 2487.001.1-T_at -0.65846 0.65846487 8.391811
3E-13 2487.001. NM_001463.2 CS141780.1 GENBANK_PATENT 7 454
3866.010.1-B_at -0.6577 0.65770261 8.374683 3E-13 3866.010.
NM_002275.2 BM045201.1 EST 1 455 147495.009.1-T -0.65745 0.65745477
8.369124 3E-13 147495.00 NM_153000.3 CX164031.1 EST 1 456
65983.003.2-T_at -0.65736 0.65735504 8.366888 3E-13 65983.003
NM_023927.1 BP292708.1 EST 1 457 59.040.1-D_at -0.65731 0.65731134
8.365909 3E-13 59.040.1 NM_001613.1 EH_001613.6 PREDICTED 1 458
59.024.2-T_at -0.6568 0.65679913 8.35444 3E-13 59.024.2 -- -- -- --
459 1717.009.2-B_at -0.65673 0.65673229 8.352945 3E-13 1717.009.
NM_001360.1 DB170498.1 EST 1 460 1756.027.1-F_at -0.65672 0.6567193
8.352655 3E-13 1756.027. NM_000109.2 S60971.1 mRNA 1 461
59.042.1-B_at -0.65672 0.65671619 8.352585 3E-13 59.042.1
NM_001613.1 EH_001613.8 PREDICTED 1 462 7153.002.5-D_at 0.656687
0.65668727 8.351939 3E-13 7153.002. NM_001067.2 CQ735949.1
GENBANK_PATENT 114 463 57447.031.1-F_at -0.6565 0.65650401 8.347842
3E-13 57447.031 NM_201535.1 AI272253.1 EST 1 464 140885.011.1-C
-0.65642 0.6564245 8.346065 3E-13 140885.01 NM_080792.2 BM041242.1
EST 1 465 59.003.1-T_at -0.65633 0.65632979 8.34395 3E-13 59.003.1
NM_001613.1 DD218797.1 GENBANK_PATENT 1 466 3832.002.1-D_at
0.655783 0.65578291 8.331747 4E-13 3832.002. NM_004523.2 BQ959682.1
EST 1 467 3880.005.1-D_at -0.65576 0.65576275 8.331298 4E-13
3880.005. NM_002276.3 BE732853.1 EST 1 468 3084.012.1-F_at -0.65533
0.65532867 8.32163 4E-13 3084.012. NM_013957.1 U02325.1 mRNA 1 469
6595.012.1-B_at -0.65524 0.65523847 8.319622 4E-13 6595.012.
NM_003070.3 DA368288.1 EST 1 470 59.012.2-D_at -0.65512 0.65511987
8.316984 4E-13 59.012.2 NM_001613.1 AL546033.3 EST 1 471
57447.034.1-C_at -0.655 0.65500441 8.314417 4E-13 57447.034
NM_201535.1 BC011240.1 mRNA 1 472 56477.001.1-B_at -0.65493
0.65492856 8.312731 4E-13 56477.001 NM_148672.1 NM_019846.3 REFSEQ
13 473 57447.041.1-D_at -0.65415 0.6541546 8.295552 4E-13 57447.041
NM_201535.1 DA295124.1 EST 1 474 9768.005.1-B_at 0.653838
0.65383824 8.288543 5E-13 9768.005. NM_014736.4 BG529193.1 EST 13
475 285203.001.2-C -0.65337 0.653374 8.278271 5E-13 285203.00
NM_173654.1 AK126187.1 mRNA 3 476 147495.006.1-B -0.65324 0.6532398
8.275305 5E-13 147495.00 NM_153000.3 CN421888.1 EST 1 477
7018.029.1-D_at -0.65323 0.65323377 8.275172 5E-13 7018.029.
NM_001063.2 AV656085.1 EST 1 478 3852.009.1-T_at -0.65315
0.65314811 8.273279 5E-13 3852.009. NM_000424.2 BQ378037.1 EST 1
479 59.023.2-D_at -0.65311 0.65311489 8.272545 5E-13 59.023.2
NM_001613.1 DB248573.1 EST 1 480 1959.002.1-D_at -0.65279
0.65278556 8.265275 5E-13 1959.002. NM_000399.2 DB264199.1 EST 5
481 7018.014.1-D_at -0.65274 0.65273731 8.264211 5E-13 7018.014.
NM_001063.2 AX147483.1 GENBANK_PATENT 1 482 5858.004.1-F_at
-0.65256 0.65255793 8.260255 5E-13 5858.004. NM_002864.1 DB033417.1
EST 1 483 79192.002.2-D_at -0.65251 0.65251201 8.259242 5E-13
79192.002 NM_024337.3 CQ731489.1 GENBANK_PATENT 1 484 59.008.2-B_at
-0.65248 0.65247737 8.258479 5E-13 59.008.2 NM_001613.1 BP373197.1
EST 1 485 8404.008.1-E_at -0.65196 0.65195548 8.246986 6E-13
8404.008. NM_004684.2 DA342341.1 EST 1 486 59.008.1-F_at -0.65193
0.65192656 8.24635 6E-13 59.008.1 NM_001613.1 BP373197.1 EST 1 487
4240.011.1-B_at -0.65168 0.65168158 8.240963 6E-13 4240.011.
NM_005928.1 DA921691.1 EST 1 488 94274.002.1-C_at -0.65161
0.65161159 8.239425 6E-13 94274.002 NM_033256.1 CQ730829.1
GENBANK_PATENT 1 489 4638.015.1-T_at -0.65116 0.65115703 8.229444
6E-13 4638.015. NM_053025.2 NM_053029.2 REFSEQ 2 490
6376.001.1-T_at -0.65101 0.6510092 8.226201 6E-13 6376.001.
NM_002996.3 AK223351.1 mRNA 48 491 57447.043.1-F_at -0.65059
0.65059178 8.217053 6E-13 57447.043 NM_201535.1 DA829299.1 EST 1
492 59.039.1-T_at -0.65045 0.65045393 8.214035 6E-13 59.039.1
NM_001613.1 EH_001613.4 PREDICTED 1 493 4638.006.1-B_at -0.65024
0.65023997 8.209353 7E-13 4638.006. NM_053025.2 DR005817.1 EST 2
494 25802.003.1-F_at -0.65011 0.65011381 8.206594 7E-13 25802.003
NM_012134.1 BC001755.1 mRNA 1 495 57447.025.1-T_at -0.65004
0.65003729 8.204921 7E-13 57447.025 NM_201535.1 DA646455.1 EST 2
496 57447.017.1-T_at -0.64984 0.64984134 8.20064 7E-13 57447.017
NM_201535.1 DA130260.1 EST 1 497 7018.026.1-C_at -0.64969
0.64969118 8.19736 7E-13 7018.026. NM_001063.2 BM690655.1 EST 1 498
7018.028.1-E_at -0.64913 0.64913076 8.185136 7E-13 7018.028.
NM_001063.2 BX537660.1 mRNA 1 499 4915.008.1-C_at -0.64904
0.64904081 8.183176 7E-13 4915.008. NM_006180.3 NM_001007097 REFSEQ
4 500 358.018.1-C_at -0.64903 0.64902608 8.182855 7E-13 358.018.1
NM_198098.1 BI765065.1 EST 1 501 7153.002.6-B_at 0.648669
0.64866924 8.175087 8E-13 7153.002. NM_001067.2 CQ735949.1
GENBANK_PATENT 114 502 57447.012.1-T_at -0.6478 0.64780212 8.156247
9E-13 57447.012 NM_201535.1 DB294263.1 EST 1 503 59.040.1-B_at
-0.6477 0.64769503 8.153924 9E-13 59.040.1 NM_001613.1
EH_001613.6 PREDICTED 1 504 57447.006.1-T_at -0.64719 0.64718891
8.142957 9E-13 57447.006 NM_201535.1 DA283861.1 EST 4 505
9493.006.1-F_at 0.646558 0.64655811 8.129315 1E-12 9493.006.
NM_138555.1 BF240578.1 EST 1 506 57447.004.1-T_at -0.64628
0.64628054 8.123321 1E-12 57447.004 NM_201535.1 CD515320.1 EST 2
507 57447.004.2-B_at -0.64619 0.64619175 8.121404 1E-12 57447.004
NM_201535.1 CD515320.1 EST 2 508 7373.001.2-D_at -0.64567
0.64566532 8.110055 1E-12 7373.001. NM_021110.1 DB089175.1 EST 1
509 9493.004.1-B_at 0.64562 0.64562012 8.109081 1E-12 9493.004.
NM_138555.1 BM792243.1 EST 1 510 2568.005.2-C_at -0.64555
0.64555051 8.107582 1E-12 2568.005. NM_014211.1 AK055205.1 mRNA 11
511 7018.029.1-F_at -0.64542 0.64541955 8.104763 1E-12 7018.029.
NM_001063.2 AV656085.1 EST 1 512 26289.013.1-B_at -0.64525
0.64525015 8.101118 1E-12 26289.013 NM_174858.1 CK024190.1 EST 1
513 7169.015.1-B_at -0.64523 0.64522581 8.100594 1E-12 7169.015.
NM_213674.1 DB291177.1 EST 1 514 57451.001.3-F_at -0.64518
0.64517957 8.0996 1E-12 57451.001 XM_931456.1 CS188752.1
GENBANK_PATENT 1 515 2568.005.2-F_at -0.64485 0.64485248 8.092569
1E-12 2568.005. NM_014211.1 AK055205.1 mRNA 11 516 57447.004.2-F_at
-0.6444 0.6444048 8.082959 1E-12 57447.004 NM_201535.1 CD515320.1
EST 2 517 8404.004.1-D_at -0.64434 0.6443376 8.081518 1E-12
8404.004. NM_004684.2 DA589023.1 EST 1 518 3855.004.2-D_at -0.64418
0.6441826 8.078194 1E-12 3855.004. NM_005556.3 BU164293.1 EST 1 519
3872.014.1-F_at -0.64417 0.64416831 8.077888 1E-12 3872.014.
NM_000422.1 BG678436.1 EST 1 520 57447.033.1-F_at -0.64416
0.64415874 8.077683 1E-12 57447.033 NM_201535.1 DA135222.1 EST 1
521 9452.001.1-T_at -0.64405 0.64405491 8.075458 1E-12 9452.001.
NM_004867.3 BG713980.1 EST 4 522 59.033.2-T_at -0.64401 0.6440144
8.07459 1E-12 59.033.2 NM_001613.1 BQ881176.1 EST 6 523
3084.009.1-T_at -0.64398 0.64398407 8.07394 1E-12 3084.009.
NM_013957.1 U02327.1 mRNA 2 524 57447.040.1-T_at -0.64395 0.6439477
8.073161 1E-12 57447.040 NM_201535.1 DA207862.1 EST 1 525
4833.004.1-T_at 0.643936 0.64393608 8.072912 1E-12 4833.004.
NM_005009.2 BG478602.1 EST 8 526 3426.001.1-F_at -0.64388
0.64388211 8.071756 1E-12 3426.001. NM_000204.1 BC020718.1 mRNA 165
527 59.034.1-B_at -0.64382 0.64381551 8.07033 1E-12 59.034.1 -- --
-- -- 528 10253.001.1-E_at -0.64381 0.64381114 8.070237 1E-12
10253.001 NM_005842.2 BE297407.1 EST 1 529 9073.001.1-C_at -0.64379
0.64379361 8.069862 1E-12 9073.001. NM_199328.1 BC020866.1 mRNA 1
530 51201.005.1-T_at -0.64366 0.64366016 8.067005 1E-12 51201.005
NM_016353.2 DA655803.1 EST 1 531 9477.006.1-C_at -0.64347
0.64347364 8.063015 1E-12 9477.006. NM_004275.3 DA588860.1 EST 1
532 57447.028.1-T_at -0.64334 0.64334257 8.060213 1E-12 57447.028
NM_201535.1 DA205446.1 EST 1 533 25925.007.1-T_at -0.64319
0.64319062 8.056966 1E-12 25925.007 NM_015461.1 DA235718.1 EST 1
534 59.024.2-B_at -0.64296 0.64295617 8.051959 1E-12 59.024.2 -- --
-- -- 535 2.022.1-T_at -0.64285 0.64285401 8.049778 1E-12 2.022.1
NM_000014.4 BP343424.1 EST 1 536 4281.008.2-B_at -0.64283
0.64282648 8.04919 1E-12 4281.008. NM_033290.1 AY539984.1 mRNA 1
537 90231.001.1-C_at -0.64281 0.64281469 8.048939 1E-12 90231.001
NM_138346.1 BQ673619.1 EST 1 538 358.012.1-D_at -0.64281 0.64280918
8.048821 1E-12 358.012.1 NM_198098.1 AX597685.1 GENBANK_PATENT 1
539 3852.021.1-T_at -0.64278 0.64278273 8.048257 1E-12 3852.021.
NM_000424.2 DA764437.1 EST 1 540 7373.003.4-D_at -0.64275
0.64274774 8.04751 1E-12 7373.003. NM_021110.1 CQ716670.1
GENBANK_PATENT 1 541 57447.048.1-T_at -0.64264 0.64264124 8.045239
1E-12 57447.048 NM_201535.1 BX480398.1 EST 1 542 358.012.1-B_at
-0.6417 0.6417015 8.025228 2E-12 358.012.1 NM_198098.1 AX597685.1
GENBANK_PATENT 1 543 7018.025.1-C_at -0.64167 0.64166912 8.024539
2E-12 7018.025. NM_001063.2 BE971065.1 EST 1 544 5608.004.1-T_at
-0.64157 0.64157449 8.022528 2E-12 5608.004. NM_002758.2 AL709891.1
EST 1 545 3084.012.2-F_at -0.64148 0.64148473 8.020621 2E-12
3084.012. NM_013957.1 U02325.1 mRNA 1 546 4306.002.1-C_at -0.64137
0.64137229 8.018232 2E-12 4306.002. NM_000901.1 AJ315515.1 mRNA 1
547 4288.004.1-D_at 0.641215 0.64121481 8.014889 2E-12 4288.004.
NM_002417.2 BP232141.1 EST 1 548 57447.002.1-F_at -0.6411
0.64110459 8.012549 2E-12 57447.002 NM_201535.1 BF526188.1 EST 1
549 4281.018.1-T_at -0.64087 0.64086989 8.007571 2E-12 4281.018.
NM_033290.1 AY539998.1 mRNA 1 550 10144.020.2-B_at -0.64053
0.64053304 8.000433 2E-12 10144.020 NM_014883.2 DA864231.1 EST 1
551 6876.016.1-E_at -0.64047 0.64046896 7.999075 2E-12 6876.016.
NM_001001522. AB209555.1 mRNA 2 552 57447.008.2-T_at -0.64046
0.64045856 7.998855 2E-12 57447.008 NM_201535.1 DB195772.1 EST 1
553 51203.004.1-T_at 0.640272 0.64027205 7.994907 2E-12 51203.004
NM_016359.2 DB126040.1 EST 1 554 2335.028.1-B_at 0.639825
0.63982479 7.985449 2E-12 2335.028. NM_212482.1 AJ320525.1 mRNA 1
555 7018.028.1-F_at -0.63974 0.63973608 7.983575 2E-12 7018.028.
NM_001063.2 BX537660.1 mRNA 1 556 7373.003.5-T_at -0.63956
0.63955526 7.979756 2E-12 7373.003. NM_021110.1 CQ716670.1
GENBANK_PATENT 1 557 81557.006.1-C_at -0.63955 0.63955366 7.979722
2E-12 81557.006 NM_030801.2 AK094541.1 mRNA 9 558 3866.002.1-D_at
-0.63923 0.63923163 7.972927 2E-12 3866.002. NM_002275.2 BG990007.1
EST 1 559 3866.001.1-B_at -0.63865 0.63865251 7.960724 2E-12
3866.001. NM_002275.2 CQ733235.1 GENBANK_PATENT 23 560
55107.006.2-T_at -0.63865 0.63864972 7.960666 2E-12 55107.006
NM_018043.4 CQ722042.1 GENBANK_PATENT 1 561 79068.010.1-D_at
-0.63836 0.63836198 7.954611 2E-12 79068.010 XM_051200.8 DA647247.1
EST 1 562 57447.009.1-T_at -0.63836 0.63835821 7.954532 2E-12
57447.009 NM_201535.1 BI550962.1 EST 1 563 2115.015.1-T_at -0.638
0.63799997 7.947002 2E-12 2115.015. NM_004956.3 DA220931.1 EST 1
564 1756.013.1-C_at -0.638 0.63799967 7.946996 2E-12 1756.013.
NM_000109.2 NM_004019.1 REFSEQ 2 565 7169.015.1-F_at -0.63796
0.63796151 7.946194 2E-12 7169.015. NM_213674.1 DB291177.1 EST 1
566 65983.013.2-F_at -0.63792 0.63792448 7.945416 2E-12 65983.013
NM_023927.1 AA610396.1 EST 1 567 8404.001.1-B_at -0.63758
0.63757819 7.938148 2E-12 8404.001. NM_004684.2 DA132781.1 EST 1
568 4240.004.1-B_at -0.63705 0.6370484 7.927043 3E-12 4240.004.
NM_005928.1 BC003610.2 mRNA 448 569 57447.012.2-T_at -0.63699
0.63699351 7.925894 3E-12 57447.012 NM_201535.1 DB294263.1 EST 1
570 57447.024.1-F_at -0.63699 0.63698737 7.925765 3E-12 57447.024
NM_201535.1 DA566498.1 EST 1 571 358.018.1-T_at -0.63696 0.63695985
7.925189 3E-12 358.018.1 NM_198098.1 BI765065.1 EST 1 572
57447.048.2-T_at -0.63688 0.6368768 7.92345 3E-12 57447.048
NM_201535.1 BX480398.1 EST 1 573 59.031.1-C_at -0.63685 0.63684644
7.922815 3E-12 59.031.1 NM_001613.1 BG197213.1 EST 19 574
3860.007.1-F_at -0.63682 0.63682338 7.922332 3E-12 3860.007.
NM_153490.1 DB256579.1 EST 1 575 8404.028.1-C_at -0.63664
0.63664266 7.918551 3E-12 8404.028. NM_004684.2 CQ727530.1
GENBANK_PATENT 1 576 4240.011.3-E_at -0.63664 0.63664099 7.918517
3E-12 4240.011. NM_005928.1 DA921691.1 EST 1 577 59.022.2-B_at
-0.63634 0.63633565 7.912134 3E-12 59.022.2 -- -- -- -- 578
3866.002.1-F_at -0.63598 0.63598268 7.904763 3E-12 3866.002.
NM_002275.2 BG990007.1 EST 1 579 3866.002.1-T_at -0.63597
0.63596762 7.904448 3E-12 3866.002. NM_002275.2 BG990007.1 EST 1
580 4915.005.1-B_at -0.63568 0.63568404 7.898533 3E-12 4915.005.
NM_006180.3 BP348402.1 EST 1 581 8404.008.1-F_at -0.63556
0.63555525 7.895848 3E-12 8404.008. NM_004684.2 DA342341.1 EST 1
582 79608.002.1-F_at -0.63554 0.63553682 7.895464 3E-12 79608.002
NM_024557.2 AK021670.1 mRNA 3 583 8404.023.1-D_at -0.63553
0.6355289 7.895299 3E-12 8404.023. NM_004684.2 BX463355.2 EST 1 584
3426.002.1-D_at -0.63533 0.63533255 7.891208 3E-12 3426.002.
NM_000204.1 CQ718881.1 GENBANK_PATENT 1 585 2335.027.1-T_at
0.635297 0.63529691 7.890465 3E-12 2335.027. NM_212482.1 AJ320527.1
mRNA 1 586 11065.009.1-T_at 0.635032 0.63503202 7.884951 3E-12
11065.009 NM_181802.1 CN354813.1 EST 1 587 140885.013.1-F -0.63461
0.63461049 7.876186 3E-12 140885.01 NM_080792.2 BU180215.1 EST 1
588 57447.021.1-B_at -0.6346 0.63459853 7.875938 3E-12 57447.021
NM_201535.1 BQ954948.1 EST 28 589 25802.004.1-C_at -0.63457
0.63457163 7.875379 3E-12 25802.004 NM_012134.1 DA924386.1 EST 1
590 4638.014.1-F_at -0.63442 0.63441678 7.872162 3E-12 4638.014.
NM_053025.2 NM_053027.2 REFSEQ 2 591 9493.004.1-F_at 0.634402
0.63440178 7.871851 3E-12 9493.004. NM_138555.1 BM792243.1 EST 1
592 8404.004.1-B_at -0.63427 0.63426893 7.869093 3E-12 8404.004.
NM_004684.2 DA589023.1 EST 1 593 8404.004.2-T_at -0.63407
0.63407245 7.865016 3E-12 8404.004. NM_004684.2 DA589023.1 EST 1
594 57447.010.2-T_at -0.63407 0.63406601 7.864882 3E-12 57447.010
NM_201535.1 BP349691.1 EST 1 595 57447.010.3-B_at -0.634 0.6340009
7.863532 3E-12 57447.010 NM_201535.1 BP349691.1 EST 1 596
27122.006.1-T_at -0.63398 0.63398053 7.863109 3E-12 27122.006
NM_013253.4 DA171350.1 EST 1 597 5156.005.1-T_at -0.63358
0.63357822 7.854771 4E-12 5156.005. NM_006206.3 BP336054.1 EST 1
598 5858.004.1-E_at -0.63354 0.63353969 7.853973 4E-12 5858.004.
NM_002864.1 DB033417.1 EST 1 599 25802.008.1-D_at -0.63342
0.63342256 7.851548 4E-12 25802.008 NM_012134.1 DA767597.1 EST 1
600 2327.002.2-T_at -0.63326 0.63326081 7.848201 4E-12 2327.002.
NM_001460.2 CD684429.1 EST 1 601 3852.004.1-C_at -0.63298
0.63298294 7.842454 4E-12 3852.004. NM_000424.2 BE715131.1 EST 1
602 59.026.2-F_at -0.63296 0.63295912 7.841961 4E-12 59.026.2 -- --
-- -- 603 57447.029.1-C_at -0.63295 0.63295354 7.841846 4E-12
57447.029 NM_201535.1 BX354120.2 EST 6 604 7169.022.1-D_at -0.63293
0.63293098 7.84138 4E-12 7169.022. NM_213674.1 BG385598.1 EST 1 605
23266.001.3-B_at -0.63277 0.63276519 7.837954 4E-12 23266.001
NM_012302.2 AK123422.1 mRNA 2 606 3084.012.1-B_at -0.63235
0.63235255 7.829435 4E-12 3084.012. NM_013957.1 U02325.1 mRNA 1 607
29127.019.2-T_at 0.632352 0.63235178 7.829419 4E-12 29127.019
NM_013277.2 DA779708.1 EST 1 608 10253.004.1-T_at -0.63208
0.63208261 7.823868 4E-12 10253.004 NM_005842.2 BQ889545.1 EST 2
609 10124.002.1-D_at -0.63205 0.63205489 7.823297 4E-12 10124.002
NM_001037164. BG178114.1 EST 6 610 3861.013.1-D_at -0.63198
0.63198062 7.821766 4E-12 3861.013. NM_000526.3 BM563823.1 EST 1
611 8404.032.1-T_at -0.63197 0.63197222 7.821593 4E-12 8404.032.
NM_004684.2 CQ498058.1 GENBANK_PATENT 1 612 84441.002.1-E_at
-0.63188 0.63188122 7.819718 4E-12 84441.002 NM_032427.1 CQ739825.1
GENBANK_PATENT 1 613 2.013.1-E_at -0.63181 0.63181031 7.818258
4E-12 2.013.1 NM_000014.4 DA467444.1 EST 1 614 3084.004.1-T_at
-0.63137 0.63136737 7.809141 4E-12 3084.004. NM_013957.1
NM_013964.1 REFSEQ 5 615 5288.001.2-F_at -0.63124 0.63123725
7.806466 5E-12 5288.001. NM_004570.2 CQ720591.1 GENBANK_PATENT 1
616 57447.017.1-F_at -0.63113 0.63113433 7.80435 5E-12 57447.017
NM_201535.1 DA130260.1 EST 1 617 3084.006.1-T_at -0.63106
0.63105508 7.802721 5E-12 3084.006. NM_013957.1 NM_013956.1 REFSEQ
3 618 59.039.1-F_at -0.63095 0.63094608 7.800482 5E-12 59.039.1
NM_001613.1 EH_001613.4 PREDICTED 1 619 2.024.1-T_at -0.63086
0.63085582 7.798628 5E-12 2.024.1 NM_000014.4 DB286897.1 EST 1 620
3815.002.2-E_at -0.63085 0.63085365 7.798584 5E-12 3815.002.
NM_000222.1 CQ719901.1 GENBANK_PATENT 1 621 1756.009.1-D_at
-0.63082 0.63082241 7.797942 5E-12 1756.009. NM_000109.2
NM_004023.1 REFSEQ 1 622 7091.014.1-B_at -0.63047 0.63046815
7.790673 5E-12 7091.014. NM_007005.3 BM480087.1 EST 1 623
4629.015.1-F_at -0.6304 0.63039903 7.789255 5E-12 4629.015.
NM_022844.1 DB284318.1 EST 1 624 59.008.2-F_at -0.63016 0.63015808
7.784317 5E-12 59.008.2 NM_001613.1 BP373197.1 EST 1 625
2568.005.2-T_at -0.63012 0.6301238 7.783614 5E-12 2568.005.
NM_014211.1 AK055205.1 mRNA 11 626 115207.002.1-T -0.62994
0.62993556 7.779759 5E-12 115207.00 NM_138444.2 CQ851144.1
GENBANK_PATENT 1 627 4281.001.1-T_at -0.62982 0.62981987 7.777391
5E-12 4281.001. NM_033290.1 AY539999.1 mRNA 1 628 84668.002.2-T_at
-0.62976 0.62975676 7.776099 5E-12 84668.002 NM_032581.2 AL833296.1
mRNA 20 629 4240.004.1-F_at -0.6295 0.62950111 7.77087 5E-12
4240.004. NM_005928.1 BC003610.2 mRNA 448 630 8404.005.1-D_at
-0.62918 0.62917718 7.76425 6E-12 8404.005. NM_004684.2 DA763956.1
EST 1
631 8404.032.1-B_at -0.62902 0.62902338 7.761109 6E-12 8404.032.
NM_004684.2 CQ498058.1 GENBANK_PATENT 1 632 57447.044.1-E_at
-0.6289 0.62890008 7.758592 6E-12 57447.044 NM_201535.1 DB232855.1
EST 1 633 8626.006.2-F_at -0.62867 0.6286676 7.753849 6E-12
8626.006. NM_003722.3 CB049427.1 EST 1 634 57447.051.2-B_at
-0.62855 0.62855194 7.751491 6E-12 57447.051 NM_201535.1 BX460053.2
EST 1 635 1063.001.1-T_at 0.628003 0.62800305 7.74031 6E-12
1063.001. NM_016343.3 BG941308.1 EST 1 636 3426.002.1-T_at -0.62796
0.62796276 7.73949 6E-12 3426.002. NM_000204.1 CQ718881.1
GENBANK_PATENT 1 637 1308.001.1-T_at -0.62793 0.62793498 7.738925
6E-12 1308.001. NM_130778.1 BM773425.1 EST 1 638 389432.002.1-F
-0.62759 0.62758948 7.731899 6E-12 389432.00 NM_001030060.
CQ751492.1 GENBANK_PATENT 1 639 57447.017.1-B_at -0.62755
0.62754878 7.731072 7E-12 57447.017 NM_201535.1 DA130260.1 EST 1
640 2115.014.1-F_at -0.62729 0.62729339 7.725883 7E-12 2115.014.
NM_004956.3 CN396909.1 EST 1 641 5284.004.1-T_at -0.62724 0.6272429
7.724858 7E-12 5284.004. NM_002644.2 DB225999.1 EST 1 642
57447.029.1-F_at -0.62716 0.6271633 7.723242 7E-12 57447.029
NM_201535.1 BX354120.2 EST 6 643 8626.006.1-F_at -0.62697
0.62697054 7.71933 7E-12 8626.006. NM_003722.3 CB049427.1 EST 1 644
2982.002.1-C_at -0.62686 0.62686245 7.717138 7E-12 2982.002.
NM_000856.2 BP199345.1 EST 1 645 57447.047.1-T_at -0.62685
0.62685067 7.716899 7E-12 57447.047 NM_201535.1 DA353543.1 EST 1
646 5803.006.1-E_at -0.62682 0.62681659 7.716208 7E-12 5803.006.
NM_002851.1 BM473091.1 EST 1 647 57447.021.1-F_at -0.62659
0.62658775 7.71157 7E-12 57447.021 NM_201535.1 BQ954948.1 EST 28
648 57447.039.1-F_at -0.62651 0.62651329 7.710061 7E-12 57447.039
NM_201535.1 DA356658.1 EST 1 649 4281.008.2-F_at -0.62638
0.62637927 7.707347 7E-12 4281.008. NM_033290.1 AY539984.1 mRNA 1
650 57447.029.1-D_at -0.62629 0.62629118 7.705563 7E-12 57447.029
NM_201535.1 BX354120.2 EST 6 651 65983.013.1-B_at -0.62562
0.6256189 7.691968 8E-12 65983.013 NM_023927.1 AA610396.1 EST 1 652
5284.004.1-E_at -0.62553 0.6255276 7.690123 8E-12 5284.004.
NM_002644.2 DB225999.1 EST 1 653 4240.011.1-D_at -0.62513
0.62512689 7.682036 8E-12 4240.011. NM_005928.1 DA921691.1 EST 1
654 57447.024.1-T_at -0.62502 0.62502436 7.679968 8E-12 57447.024
NM_201535.1 DA566498.1 EST 1 655 6876.011.1-B_at -0.625 0.62499658
7.679408 8E-12 6876.011. NM_001001522. AW956430.1 EST 1 656
7373.003.2-T_at -0.62485 0.62484538 7.676359 8E-12 7373.003.
NM_021110.1 CQ716670.1 GENBANK_PATENT 1 657 3852.014.1-D_at
-0.62476 0.62476477 7.674735 9E-12 3852.014. NM_000424.2 BF826002.1
EST 1 658 4915.005.1-D_at -0.62473 0.62473239 7.674083 9E-12
4915.005. NM_006180.3 BP348402.1 EST 1 659 9768.002.2-B_at 0.624527
0.62452688 7.669944 9E-12 9768.002. NM_014736.4 BM908225.1 EST 1
660 140885.010.1-D -0.62442 0.62441747 7.667741 9E-12 140885.01
NM_080792.2 CQ728313.1 GENBANK_PATENT 1 661 4638.020.1-E_at
-0.62432 0.62431859 7.665751 9E-12 4638.020. NM_053025.2 DA694890.1
EST 1 662 57447.017.1-C_at -0.62424 0.62423695 7.664109 9E-12
57447.017 NM_201535.1 DA130260.1 EST 1 663 7373.004.1-T_at -0.62423
0.6242336 7.664041 9E-12 7373.004. NM_021110.1 M64109.1 mRNA 1 664
3852.008.2-E_at -0.62396 0.62396244 7.658589 9E-12 3852.008.
NM_000424.2 BG675837.1 EST 1 665 4281.015.1-E_at -0.62376
0.62376072 7.654536 9E-12 4281.015. NM_033290.1 AY540009.1 mRNA 1
666 8404.013.1-C_at -0.62375 0.62374788 7.654278 9E-12 8404.013.
NM_004684.2 BP376616.1 EST 9 667 90293.001.3-T_at -0.62357
0.62357218 7.65075 1E-11 90293.001 NM_033495.2 CQ714141.1
GENBANK_PATENT 1 668 57447.044.1-T_at -0.62348 0.6234819 7.648937
1E-11 57447.044 NM_201535.1 DB232855.1 EST 1 669 23650.011.2-D_at
-0.62318 0.62317705 7.642822 1E-11 23650.011 NM_058193.1
NM_012101.2 REFSEQ 11 670 2335.006.1-D_at 0.623003 0.62300327
7.639338 1E-11 2335.006. NM_212482.1 CX785805.1 EST 1 671
57447.022.1-T_at -0.6229 0.62290388 7.637347 1E-11 57447.022
NM_201535.1 DA079074.1 EST 2 672 8404.032.1-D_at -0.62271
0.62271252 7.633514 1E-11 8404.032. NM_004684.2 CQ498058.1
GENBANK_PATENT 1 673 8404.030.1-F_at -0.62267 0.62267432 7.632749
1E-11 8404.030. NM_004684.2 CD357736.1 EST 1 674 5803.002.2-T_at
-0.6225 0.62250014 7.629263 1E-11 5803.002. NM_002851.1 CQ725791.1
GENBANK_PATENT 24 675 8404.004.2-C_at -0.62246 0.62245993 7.628459
1E-11 8404.004. NM_004684.2 DA589023.1 EST 1 676 84441.005.1-C_at
-0.62236 0.62236291 7.626518 1E-11 84441.005 NM_032427.1 CQ739827.1
GENBANK_PATENT 1 677 7091.015.1-F_at -0.62201 0.62201208 7.619505
1E-11 7091.015. NM_007005.3 CQ724084.1 GENBANK_PATENT 1 678
2119.005.1-D_at -0.62174 0.6217418 7.614107 1E-11 2119.005.
NM_004454.1 BU197295.1 EST 1 679 7373.003.6-F_at -0.6217 0.62170218
7.613316 1E-11 7373.003. NM_021110.1 CQ716670.1 GENBANK_PATENT 1
680 79608.008.1-T_at -0.6214 0.62140438 7.607374 1E-11 79608.008
NM_024557.2 DA748988.1 EST 2 681 3852.008.1-T_at -0.62129
0.62128908 7.605075 1E-11 3852.008. NM_000424.2 BG675837.1 EST 1
682 8626.007.1-T_at -0.62113 0.62113254 7.601955 1E-11 8626.007.
NM_003722.3 BG698723.1 EST 1 683 8404.022.1-T_at -0.62104
0.62103797 7.60007 1E-11 8404.022. NM_004684.2 BP311988.1 EST 1 684
8404.034.1-T_at -0.62101 0.62101196 7.599552 1E-11 8404.034.
NM_004684.2 DA148306.1 EST 1 685 57447.049.1-T_at -0.62097
0.62096556 7.598628 1E-11 57447.049 NM_201535.1 DB180733.1 EST 1
686 5311.002.1-B_at -0.62092 0.62092128 7.597746 1E-11 5311.002.
NM_000297.2 CQ727531.1 GENBANK_PATENT 1 687 2335.025.3-T_at
0.620916 0.62091648 7.597651 1E-11 2335.025. NM_212482.1 CQ715726.1
GENBANK_PATENT 3 688 4147.012.1-T_at -0.62076 0.62075962 7.594528
1E-11 4147.012. NM_002380.3 BX397573.2 EST 1 689 301.015.1-T_at
-0.62074 0.62074218 7.594181 1E-11 301.015.1 NM_000700.1 BM477702.1
EST 1 690 301.004.1-T_at -0.62073 0.62073001 7.593939 1E-11
301.004.1 NM_000700.1 DB194639.1 EST 1 691 3426.002.2-F_at -0.62048
0.62047946 7.588954 1E-11 3426.002. NM_000204.1 CQ718881.1
GENBANK_PATENT 1 692 7091.001.1-C_at -0.62037 0.62037055 7.586788
1E-11 7091.001. NM_007005.3 BC045650.1 mRNA 17 693 8404.021.1-D_at
-0.62032 0.6203222 7.585827 1E-11 8404.021. NM_004684.2 DA291834.1
EST 1 694 7153.002.3-B_at 0.620304 0.62030417 7.585469 1E-11
7153.002. NM_001067.2 CQ735949.1 GENBANK_PATENT 114 695
53335.002.1-E_at -0.62026 0.62026302 7.584651 1E-11 53335.002
NM_018014.2 BU159551.1 EST 1 696 5284.003.2-T_at -0.62002
0.62001653 7.579754 1E-11 5284.003. NM_002644.2 BP220016.1 EST 1
697 4306.002.1-F_at -0.61996 0.61995574 7.578547 1E-11 4306.002.
NM_000901.1 AJ315515.1 mRNA 1 698 5284.003.2-D_at -0.61991
0.61991035 7.577646 1E-11 5284.003. NM_002644.2 BP220016.1 EST 1
699 5803.002.1-T_at -0.61977 0.61977142 7.574888 1E-11 5803.002.
NM_002851.1 CQ725791.1 GENBANK_PATENT 24 700 10253.004.1-E_at
-0.61973 0.61973277 7.574121 1E-11 10253.004 NM_005842.2 BQ889545.1
EST 2 701 23650.020.1-T_at -0.61972 0.61971511 7.573771 1E-11
23650.020 NM_058193.1 DB266728.1 EST 1 702 57447.042.1-T_at
-0.61964 0.6196367 7.572215 1E-11 57447.042 NM_201535.1 DA937014.1
EST 1 703 6876.023.1-F_at -0.6196 0.61960408 7.571568 1E-11
6876.023. NM_001001522. CN482091.1 EST 1 704 7169.015.1-C_at
-0.61949 0.61948888 7.569283 1E-11 7169.015. NM_213674.1 DB291177.1
EST 1 705 7153.002.4-F_at 0.619203 0.61920323 7.563622 1E-11
7153.002. NM_001067.2 CQ735949.1 GENBANK_PATENT 114 706
4629.016.1-B_at -0.61918 0.61917512 7.563065 1E-11 4629.016.
NM_022844.1 DB289769.1 EST 1 707 6876.002.1-C_at -0.61913
0.61912596 7.562091 1E-11 6876.002. NM_001001522. DB262921.1 EST 1
708 65983.007.1-T_at -0.61906 0.61905788 7.560743 1E-11 65983.007
NM_023927.1 DA388235.1 EST 1 709 7373.003.2-F_at -0.61891
0.61891452 7.557905 1E-11 7373.003. NM_021110.1 CQ716670.1
GENBANK_PATENT 1 710 152015.004.1-T -0.61872 0.61872078 7.554071
2E-11 152015.00 NM_001012337. BC015413.1 mRNA 2 711 8404.004.2-B_at
-0.61824 0.61823995 7.544566 2E-11 8404.004. NM_004684.2 DA589023.1
EST 1 712 6285.001.1-B_at -0.61815 0.61815486 7.542886 2E-11
6285.001. NM_006272.1 BP349776.1 EST 1 713 2115.007.1-E_at -0.61784
0.61784158 7.536702 2E-11 2115.007. NM_004956.3 DA189670.1 EST 1
714 2.013.1-T_at -0.61782 0.61782175 7.536311 2E-11 2.013.1
NM_000014.4 DA467444.1 EST 1 715 6289.005.1-T_at -0.61778 0.6177768
7.535424 2E-11 6289.005. NM_030754.2 BG618888.1 EST 39 716
9232.002.1-T_at 0.617748 0.61774763 7.534848 2E-11 9232.002.
NM_004219.2 BM459529.1 EST 2 717 59.014.1-B_at -0.61765 0.61765007
7.532925 2E-11 59.014.1 NM_001613.1 CB962422.1 EST 1 718
59.031.1-F_at -0.61751 0.61750627 7.53009 2E-11 59.031.1
NM_001613.1 BG197213.1 EST 19 719 3084.011.1-T_at -0.61746
0.61746489 7.529274 2E-11 3084.011. NM_013957.1 CN603661.1 EST 1
720 3872.005.1-F_at -0.61737 0.61737414 7.527486 2E-11 3872.005.
NM_000422.1 BG682094.1 EST 1 721 3084.012.3-F_at -0.6173 0.61730492
7.526122 2E-11 3084.012. NM_013957.1 U02325.1 mRNA 1 722
81704.008.1-F_at -0.61719 0.61719009 7.523861 2E-11 81704.008
NM_203447.1 BC045629.1 mRNA 1 723 140885.010.2-C -0.617 0.61700383
7.520194 2E-11 140885.01 NM_080792.2 CQ728313.1 GENBANK_PATENT 1
724 338707.006.1-E -0.61688 0.61687839 7.517726 2E-11 338707.00
NM_178537.3 BX115728.1 EST 1 725 23266.008.2-T_at -0.61684
0.61683767 7.516924 2E-11 23266.008 NM_012302.2 CQ799210.1
GENBANK_PATENT 1 726 120.005.2-E_at -0.61665 0.61664987 7.513231
2E-11 120.005.2 NM_019903.3 AK223270.1 mRNA 78 727 4281.009.1-E_at
-0.61647 0.61647345 7.509764 2E-11 4281.009. NM_033290.1 AY540014.1
mRNA 1 728 4094.001.1-T_at -0.61638 0.61638223 7.507972 2E-11
4094.001. NM_001031804. NM_005360.3 REFSEQ 17 729 2995.001.1-T_at
-0.61614 0.6161404 7.503223 2E-11 2995.001. NM_002101.3 CQ729268.1
GENBANK_PATENT 1 730 4638.011.1-T_at -0.61607 0.61606684 7.501779
2E-11 4638.011. NM_053025.2 DB267860.1 EST 1 731 2335.017.1-T_at
0.615955 0.61595485 7.499582 2E-11 2335.017. NM_212482.1 CQ896577.1
GENBANK_PATENT 4 732 5284.001.1-F_at -0.61592 0.61592058 7.498909
2E-11 5284.001. NM_002644.2 AX012182.1 GENBANK_PATENT 1 733
8404.026.1-D_at -0.61589 0.61588535 7.498218 2E-11 8404.026.
NM_004684.2 BX647713.1 mRNA 141 734 2335.009.1-D_at 0.615806
0.61580556 7.496653 2E-11 2335.009. NM_212482.1 BG927121.1 EST 51
735 10461.002.2-F_at -0.61571 0.61570541 7.49469 2E-11 10461.002
NM_006343.2 CQ725500.1 GENBANK_PATENT 1 736 84441.002.1-T_at
-0.6157 0.61570234 7.494629 2E-11 84441.002 NM_032427.1 CQ739825.1
GENBANK_PATENT 1 737 147495.006.1-T -0.61568 0.61567688 7.49413
2E-11 147495.00 NM_153000.3 CN421888.1 EST 1 738 7091.010.1-B_at
-0.61565 0.61564596 7.493524 2E-11 7091.010. NM_007005.3 AL551038.3
EST 1 739 8404.008.1-C_at -0.61554 0.61554203 7.491488 2E-11
8404.008. NM_004684.2 DA342341.1 EST 1 740 6376.001.2-C_at -0.61538
0.61538183 7.488349 2E-11 6376.001. NM_002996.3 AK223351.1 mRNA 48
741 3832.002.1-B_at 0.615014 0.61501375 7.481144 2E-11 3832.002.
NM_004523.2 BQ959682.1 EST 1 742 59.034.2-T_at -0.61499 0.61498701
7.480621 2E-11 59.034.2 -- -- -- -- 743 147495.005.1-B -0.61488
0.61488109 7.478549 2E-11 147495.00 NM_153000.3 BI822892.1 EST 1
744 3872.005.1-T_at -0.61477 0.61477315 7.476439 2E-11 3872.005.
NM_000422.1 BG682094.1 EST 1 745 79895.001.1-D_at -0.61472
0.61471741 7.475349 2E-11 79895.001 NM_024837.2 AX575481.1
GENBANK_PATENT 5 746 57447.038.1-T_at -0.61465 0.61464905 7.474013
2E-11 57447.038 NM_201535.1 DB238920.1 EST 1 747 7373.008.1-T_at
-0.61439 0.61438569 7.468868 2E-11 7373.008. NM_021110.1 CQ656872.1
GENBANK_PATENT 1 748 4744.004.1-C_at -0.61432 0.61431915 7.467569
2E-11 4744.004. NM_021076.2 BQ636126.1 EST 1 749 140885.010.1-T
-0.61432 0.61431838 7.467554 2E-11 140885.01 NM_080792.2 CQ728313.1
GENBANK_PATENT 1 750 6876.016.2-E_at -0.61423 0.61422523 7.465735
2E-11 6876.016. NM_001001522. AB209555.1 mRNA 2 751 8404.015.1-T_at
-0.61419 0.61419393 7.465124 2E-11 8404.015. NM_004684.2 BP194755.1
EST 4 752 4281.014.1-T_at -0.61417 0.61416566 7.464573 2E-11
4281.014. NM_033290.1 AY539986.1 mRNA 1 753 4288.006.1-F_at
0.614163 0.61416265 7.464514 2E-11 4288.006. NM_002417.2 BP363635.1
EST 1 754 25925.009.1-E_at -0.61404 0.61403923 7.462106 2E-11
25925.009 NM_015461.1 DB064380.1 EST 1 755 4240.009.1-B_at -0.61385
0.61385445 7.458502 2E-11 4240.009. NM_005928.1 BG829936.1 EST 2
756 667.010.1-E_at -0.61376 0.61376087 7.456678 2E-11 667.010.1
NM_183380.1 DA361412.1 EST 1
757 3866.005.1-B_at -0.61345 0.61345384 7.450696 2E-11 3866.005.
NM_002275.2 AL832226.1 mRNA 37 758 57447.011.1-T_at -0.61343
0.61343087 7.450249 2E-11 57447.011 NM_201535.1 BP199520.1 EST 1
759 57447.034.1-B_at -0.61342 0.61342094 7.450055 2E-11 57447.034
NM_201535.1 BC011240.1 mRNA 1 760 25802.004.1-B_at -0.61332
0.61331747 7.448041 2E-11 25802.004 NM_012134.1 DA924386.1 EST 1
761 8404.024.1-T_at -0.61318 0.61317717 7.44531 3E-11 8404.024.
NM_004684.2 DB260047.1 EST 1 762 57447.032.1-T_at -0.61307
0.61306529 7.443134 3E-11 57447.032 NM_201535.1 BI771628.1 EST 3
763 667.021.1-F_at -0.61305 0.61304874 7.442812 3E-11 667.021.1
NM_183380.1 DB134537.1 EST 1 764 5858.001.2-F_at -0.61258 0.6125845
7.433788 3E-11 5858.001. NM_002864.1 BC111756.1 mRNA 2 765
51062.008.1-T_at -0.61217 0.61217313 7.425802 3E-11 51062.008
NM_015915.3 CQ719775.1 GENBANK_PATENT 1 766 2335.013.1-F_at
0.612162 0.61216233 7.425593 3E-11 2335.013. NM_212482.1 AL551632.3
EST 2 767 2568.001.2-T_at -0.61211 0.61210705 7.424521 3E-11
2568.001. NM_014211.1 BX509618.1 EST 1 768 7170.005.2-D_at 0.611952
0.61195174 7.421509 3E-11 7170.005. NM_153649.2 DA762962.1 EST 1
769 57447.034.1-F_at -0.61184 0.61184024 7.419347 3E-11 57447.034
NM_201535.1 BC011240.1 mRNA 1 770 7153.002.6-C_at 0.611814
0.61181444 7.418847 3E-11 7153.002. NM_001067.2 CQ735949.1
GENBANK_PATENT 114 771 2568.003.1-T_at -0.61165 0.61164713 7.415606
3E-11 2568.003. NM_014211.1 CD696885.1 EST 1 772 59.008.2-T_at
-0.61162 0.61161827 7.415046 3E-11 59.008.2 NM_001613.1 BP373197.1
EST 1 773 9898.015.2-B_at 0.611466 0.61146611 7.4121 3E-11
9898.015. NM_014847.2 AJ243670.2 mRNA 1 774 7018.013.1-T_at
-0.61122 0.6112152 7.407244 3E-11 7018.013. NM_001063.2 AX147484.1
GENBANK_PATENT 1 775 7170.034.2-D_at 0.611012 0.61101246 7.403323
3E-11 7170.034. NM_153649.2 DA894441.1 EST 1 776 3866.004.1-E_at
-0.61074 0.61073542 7.397968 3E-11 3866.004. NM_002275.2 BC110649.1
mRNA 1 777 5284.001.1-T_at -0.61068 0.61067717 7.396843 3E-11
5284.001. NM_002644.2 AX012182.1 GENBANK_PATENT 1 778 2.002.1-C_at
-0.61064 0.61064092 7.396143 3E-11 2.002.1 NM_000014.4 CQ672194.1
GENBANK_PATENT 1 779 57447.050.1-T_at -0.61051 0.61050599 7.393537
3E-11 57447.050 NM_201535.1 DA257961.1 EST 1 780 7018.014.1-F_at
-0.61047 0.61046981 7.392839 3E-11 7018.014. NM_001063.2 AX147483.1
GENBANK_PATENT 1 781 2335.032.1-D_at 0.610251 0.61025134 7.388623
3E-11 2335.032. NM_212482.1 DA647475.1 EST 1 782 3866.002.1-C_at
-0.61025 0.61024968 7.388591 3E-11 3866.002. NM_002275.2 BG990007.1
EST 1 783 57447.043.1-T_at -0.61025 0.61024544 7.388509 3E-11
57447.043 NM_201535.1 DA829299.1 EST 1 784 51201.005.1-D_at
-0.61021 0.61021006 7.387827 3E-11 51201.005 NM_016353.2 DA655803.1
EST 1 785 51203.003.1-T_at 0.610008 0.61000819 7.383934 3E-11
51203.003 NM_016359.2 BP283628.1 EST 1 786 9493.001.1-F_at 0.609767
0.60976675 7.379281 3E-11 9493.001. NM_138555.1 BC051826.1 mRNA 17
787 57447.024.1-B_at -0.60944 0.60943797 7.37295 4E-11 57447.024
NM_201535.1 DA566498.1 EST 1 788 80034.003.4-B_at -0.60942
0.6094211 7.372625 4E-11 80034.003 NM_024969.2 CQ733306.1
GENBANK_PATENT 1 789 7170.016.3-C_at 0.609237 0.60923665 7.369076
4E-11 7170.016. NM_153649.2 BF575596.1 EST 1 790 65983.003.1-T_at
-0.60914 0.60913896 7.367198 4E-11 65983.003 NM_023927.1 BP292708.1
EST 1 791 57447.026.1-T_at -0.60891 0.60891356 7.362865 4E-11
57447.026 NM_201535.1 BP196338.1 EST 4 792 440421.001.1-F -0.60867
0.6086702 7.35819 4E-11 440421.00 XM_496202.2 XM_934894.1 REFSEQ 2
793 301.008.1-D_at -0.60853 0.60852747 7.355449 4E-11 301.008.1
NM_000700.1 CD688703.1 EST 1 794 80034.002.2-T_at -0.60832
0.60831755 7.351421 4E-11 80034.002 NM_024969.2 DA769284.1 EST 1
795 7153.002.5-B_at 0.608304 0.60830361 7.351154 4E-11 7153.002.
NM_001067.2 CQ735949.1 GENBANK_PATENT 114 796 3852.023.1-T_at
-0.60821 0.60820967 7.349352 4E-11 3852.023. NM_000424.2 BG681715.1
EST 1 797 8404.013.1-F_at -0.60812 0.60812437 7.347716 4E-11
8404.013. NM_004684.2 BP376616.1 EST 9 798 2.018.1-C_at -0.60779
0.60778896 7.341289 4E-11 2.018.1 NM_000014.4 DB090657.1 EST 1 799
10124.003.1-B_at -0.60773 0.60772913 7.340143 4E-11 10124.003
NM_001037164. BU664973.1 EST 1 800 3852.008.2-F_at -0.60757
0.60757027 7.337101 4E-11 3852.008. NM_000424.2 BG675837.1 EST 1
801 4288.006.2-T_at 0.607439 0.60743897 7.334588 4E-11 4288.006.
NM_002417.2 BP363635.1 EST 1 802 8404.026.1-C_at -0.60743
0.60742535 7.334327 4E-11 8404.026. NM_004684.2 BX647713.1 mRNA 141
803 23650.019.1-C_at -0.6074 0.6073959 7.333764 4E-11 23650.019
NM_058193.1 BI224541.1 EST 1 804 7170.027.1-T_at 0.607197
0.60719709 7.329961 4E-11 7170.027. NM_153649.2 BQ959117.1 EST 1
805 54928.003.1-E_at -0.60719 0.60719005 7.329827 4E-11 54928.003
NM_017813.2 DB283344.1 EST 1 806 2335.025.1-B_at 0.607111
0.60711088 7.328313 4E-11 2335.025. NM_212482.1 CQ715726.1
GENBANK_PATENT 3 807 3084.010.1-T_at -0.60698 0.60697967 7.325805
4E-11 3084.010. NM_013957.1 BC007675.2 mRNA 7 808 57447.051.1-T_at
-0.60697 0.60697421 7.325701 4E-11 57447.051 NM_201535.1 BX460053.2
EST 1 809 80034.003.4-T_at -0.60692 0.6069173 7.324613 4E-11
80034.003 NM_024969.2 CQ733306.1 GENBANK_PATENT 1 810
2568.005.1-D_at -0.60678 0.6067777 7.321947 5E-11 2568.005.
NM_014211.1 AK055205.1 mRNA 11 811 8404.032.1-F_at -0.60677
0.60676941 7.321788 5E-11 8404.032. NM_004684.2 CQ498058.1
GENBANK_PATENT 1 812 2115.003.1-E_at -0.60663 0.60662753 7.319079
5E-11 2115.003. NM_004956.3 DA128833.1 EST 1 813 57447.035.1-T_at
-0.60656 0.60656033 7.317796 5E-11 57447.035 NM_201535.1 BQ636638.1
EST 1 814 8404.009.1-T_at -0.60613 0.60612981 7.309584 5E-11
8404.009. NM_004684.2 BP258993.1 EST 1 815 8404.028.3-B_at -0.60565
0.60564939 7.300432 5E-11 8404.028. NM_004684.2 CQ727530.1
GENBANK_PATENT 1 816 6289.003.1-B_at -0.60525 0.60524909 7.292816
5E-11 6289.003. NM_030754.2 R83510.1 EST 1 817 7170.025.1-F_at
0.604985 0.6049846 7.287789 5E-11 7170.025. NM_153649.2 BE208737.1
EST 1 818 8404.030.1-D_at -0.60498 0.60498368 7.287771 5E-11
8404.030. NM_004684.2 CD357736.1 EST 1 819 8404.009.1-F_at -0.60494
0.6049439 7.287016 5E-11 8404.009. NM_004684.2 BP258993.1 EST 1 820
2335.009.1-T_at 0.604716 0.60471597 7.282687 5E-11 2335.009.
NM_212482.1 BG927121.1 EST 51 821 22974.007.1-F_at 0.604647
0.60464714 7.28138 5E-11 22974.007 NM_012112.4 AF287265.1 mRNA 213
822 3426.002.1-B_at -0.6044 0.60439543 7.276604 6E-11 3426.002.
NM_000204.1 CQ718881.1 GENBANK_PATENT 1 823 4638.003.1-D_at
-0.60438 0.60437577 7.276231 6E-11 4638.003. NM_053025.2 BP289609.1
EST 2 824 4147.011.1-T_at -0.6043 0.60430187 7.274829 6E-11
4147.011. NM_002380.3 BI559593.1 EST 1 825 6876.016.2-T_at -0.60425
0.60425392 7.27392 6E-11 6876.016. NM_001001522. AB209555.1 mRNA 2
826 23650.003.1-F_at -0.60408 0.60408338 7.270687 6E-11 23650.003
NM_058193.1 BI333387.1 EST 1 827 4744.004.1-E_at -0.60408 0.6040798
7.270619 6E-11 4744.004. NM_021076.2 BQ636126.1 EST 1 828
64168.010.1-F_at -0.60405 0.60404978 7.270051 6E-11 64168.010
NM_022351.2 BM985162.1 EST 1 829 9073.001.1-F_at -0.60404
0.60404345 7.269931 6E-11 9073.001. NM_199328.1 BC020866.1 mRNA 1
830 5288.001.3-B_at -0.60399 0.60398504 7.268824 6E-11 5288.001.
NM_004570.2 CQ720591.1 GENBANK_PATENT 1 831 3866.005.1-D_at
-0.60384 0.60383806 7.26604 6E-11 3866.005. NM_002275.2 AL832226.1
mRNA 37 832 8404.021.1-T_at -0.6038 0.60380179 7.265353 6E-11
8404.021. NM_004684.2 DA291834.1 EST 1 833 25925.011.1-E_at
-0.60378 0.6037774 7.264891 6E-11 25925.011 NM_015461.1 DA105762.1
EST 1 834 23266.001.3-F_at -0.60352 0.60352263 7.260069 6E-11
23266.001 NM_012302.2 AK123422.1 mRNA 2 835 9232.004.1-F_at
0.603479 0.60347894 7.259242 6E-11 9232.004. NM_004219.2 BF983295.1
EST 1 836 4147.005.2-F_at -0.60347 0.60346555 7.258989 6E-11
4147.005. NM_002380.3 CQ716197.1 GENBANK_PATENT 1 837
2335.025.3-B_at 0.603394 0.60339429 7.257641 6E-11 2335.025.
NM_212482.1 CQ715726.1 GENBANK_PATENT 3 838 4638.006.1-C_at
-0.60335 0.60335253 7.256851 6E-11 4638.006. NM_053025.2 DR005817.1
EST 2 839 147804.004.1-T 0.603318 0.60331792 7.256196 6E-11
147804.00 NM_001010856. DA204897.1 EST 1 840 81704.013.1-D_at
-0.60318 0.60318333 7.253652 6E-11 81704.013 NM_203447.1 CQ723361.1
GENBANK_PATENT 1 841 54443.013.1-B_at 0.603178 0.60317758 7.253543
6E-11 54443.013 NM_018685.2 BX410228.2 EST 1 842 1410.005.1-T_at
-0.60301 0.60300785 7.250335 6E-11 1410.005. NM_001885.1 BM702557.1
EST 1 843 25925.009.1-T_at -0.60288 0.60287704 7.247864 6E-11
25925.009 NM_015461.1 DB064380.1 EST 1 844 3204.001.1-T_at -0.60272
0.60272058 7.24491 6E-11 3204.001. NM_006896.3 BX104300.1 EST 1 845
29997.012.1-F_at -0.60268 0.60268472 7.244233 7E-11 29997.012
NM_015710.3 BG746448.1 EST 1 846 2.005.1-C_at -0.60255 0.60254732
7.24164 7E-11 2.005.1 NM_000014.4 BI493707.1 EST 1 847
140885.011.1-F -0.60254 0.60254281 7.241555 7E-11 140885.01
NM_080792.2 BM041242.1 EST 1 848 7153.002.3-F_at 0.602528
0.60252816 7.241278 7E-11 7153.002. NM_001067.2 CQ735949.1
GENBANK_PATENT 114 849 1063.002.1-F_at 0.602485 0.60248476 7.24046
7E-11 1063.002. NM_016343.3 CQ728087.1 GENBANK_PATENT 1 850
10144.021.1-F_at -0.60221 0.60221389 7.235351 7E-11 10144.021
NM_014883.2 BG434219.1 EST 1 851 8404.025.1-E_at -0.60217
0.60217399 7.234599 7E-11 8404.025. NM_004684.2 DB086831.1 EST 1
852 6876.020.1-B_at -0.60216 0.60215903 7.234317 7E-11 6876.020.
NM_001001522. BM921237.1 EST 1 853 7170.006.1-C_at 0.601994
0.6019941 7.231209 7E-11 7170.006. NM_153649.2 DB003864.1 EST 1 854
10051.016.1-T_at 0.601783 0.60178293 7.227232 7E-11 10051.016
NM_001002799. DB062440.1 EST 1 855 5288.001.2-D_at -0.60173
0.6017334 7.2263 7E-11 5288.001. NM_004570.2 CQ720591.1
GENBANK_PATENT 1 856 7018.029.1-T_at -0.60153 0.60152604 7.222397
7E-11 7018.029. NM_001063.2 AV656085.1 EST 1 857 5627.002.1-B_at
-0.60134 0.6013408 7.218913 7E-11 5627.002. NM_000313.1 CQ731592.1
GENBANK_PATENT 1 858 57447.037.1-T_at -0.60118 0.60117663 7.215826
7E-11 57447.037 NM_201535.1 BF793156.1 EST 1 859 4147.005.2-D_at
-0.60084 0.60084391 7.209576 8E-11 4147.005. NM_002380.3 CQ716197.1
GENBANK_PATENT 1 860 8404.023.1-T_at -0.60074 0.6007351 7.207533
8E-11 8404.023. NM_004684.2 BX463355.2 EST 1 861 3872.006.1-D_at
-0.60063 0.60063372 7.20563 8E-11 3872.006. NM_000422.1 BM017443.1
EST 1 862 399687.001.1-C -0.60061 0.60060752 7.205138 8E-11
399687.00 NM_078471.3 BM922301.1 EST 2 863 3815.002.4-D_at -0.60047
0.60047483 7.202648 8E-11 3815.002. NM_000222.1 CQ719901.1
GENBANK_PATENT 1 864 59.034.2-B_at -0.60033 0.60033475 7.200021
8E-11 59.034.2 -- -- -- -- 865 8404.035.1-T_at -0.60027 0.60026583
7.198729 8E-11 8404.035. NM_004684.2 BG716198.1 EST 1 866
8404.030.1-T_at -0.60022 0.60021743 7.197822 8E-11 8404.030.
NM_004684.2 CD357736.1 EST 1 867 54997.002.2-T_at -0.60016
0.60015635 7.196677 8E-11 54997.002 NM_017899.1 CQ729176.1
GENBANK_PATENT 1 868 57561.001.1-F_at -0.6001 0.60010368 7.19569
8E-11 57561.001 NM_020801.1 BQ428339.1 EST 1 869 8404.031.1-T_at
-0.6 0.59999606 7.193674 8E-11 8404.031. NM_004684.2 BP327616.1 EST
1 870 2.025.1-E_at -0.59999 0.59998752 7.193514 8E-11 2.025.1
NM_000014.4 DB288732.1 EST 1 871 699.002.1-F_at 0.599982 0.59998236
7.193417 8E-11 699.002.1 NM_004336.2 CQ715813.1 GENBANK_PATENT 1
872 57447.041.1-F_at -0.59992 0.5999151 7.192157 8E-11 57447.041
NM_201535.1 DA295124.1 EST 1 873 9055.013.1-D_at 0.59986 0.59986038
7.191132 8E-11 9055.013. NM_003981.2 CN348395.1 EST 1 874
8404.008.1-D_at -0.59979 0.5997907 7.189828 8E-11 8404.008.
NM_004684.2 DA342341.1 EST 1 875 7018.028.1-T_at -0.59975
0.59975341 7.189129 8E-11 7018.028. NM_001063.2 BX537660.1 mRNA 1
876 2568.005.1-T_at -0.59968 0.59967705 7.1877 8E-11 2568.005.
NM_014211.1 AK055205.1 mRNA 11 877 10051.005.3-T_at 0.599532
0.59953164 7.184979 9E-11 10051.005 NM_001002799. BU183025.1 EST 1
878 2568.002.2-T_at -0.59944 0.59943802 7.183228 9E-11 2568.002.
NM_014211.1 DB235581.1 EST 1 879 4147.004.1-F_at -0.59921
0.59921316 7.179023 9E-11 4147.004. NM_002380.3 AX675291.1
GENBANK_PATENT 1 880 2938.001.1-T_at -0.59919 0.59919321 7.17865
9E-11 2938.001. NM_145740.2 AV683456.1 EST 1 881 1308.007.1-E_at
-0.59902 0.59902115 7.175435 9E-11 1308.007. NM_130778.1 BF916393.1
EST 1 882 2982.012.1-T_at -0.59882 0.59881603 7.171604 9E-11
2982.012. NM_000856.2 BC012627.1 mRNA 2
883 8404.028.1-D_at -0.59877 0.5987733 7.170806 9E-11 8404.028.
NM_004684.2 CQ727530.1 GENBANK_PATENT 1 884 7373.001.2-B_at -0.5986
0.598602 7.167609 9E-11 7373.001. NM_021110.1 DB089175.1 EST 1 885
2893.002.2-B_at -0.59834 0.59834456 7.162807 1E-10 2893.002.
NM_000829.1 DA365406.1 EST 1 886 116369.006.4-C -0.59832 0.59831944
7.162338 1E-10 116369.00 NM_052961.2 AX480884.1 GENBANK_PATENT 1
887 6304.007.1-T_at -0.59819 0.59819347 7.15999 1E-10 6304.007.
NM_002971.2 DB141052.1 EST 1 888 2335.035.1-T_at 0.597963 0.5979628
7.155692 1E-10 2335.035. NM_212482.1 CX755647.1 EST 1 889
4751.002.1-T_at 0.597837 0.59783662 7.153342 1E-10 4751.002.
NM_002497.2 BI464450.1 EST 1 890 64151.001.2-T_at 0.597704
0.59770416 7.150876 1E-10 64151.001 NM_022346.3 CQ729716.1
GENBANK_PATENT 2 891 29089.003.1-T_at 0.597695 0.59769515 7.150708
1E-10 29089.003 NM_014176.1 AV740591.1 EST 1 892 59.031.1-B_at
-0.59762 0.59761835 7.149279 1E-10 59.031.1 NM_001613.1 BG197213.1
EST 19 893 7018.025.1-T_at -0.59758 0.59757801 7.148528 1E-10
7018.025. NM_001063.2 BE971065.1 EST 1 894 3860.008.1-T_at -0.59747
0.5974712 7.146541 1E-10 3860.008. NM_153490.1 DA668693.1 EST 1 895
5858.003.3-F_at -0.59734 0.5973382 7.144067 1E-10 5858.003.
NM_002864.1 AX512279.1 GENBANK_PATENT 2 896 8404.009.1-C_at
-0.59725 0.59725088 7.142444 1E-10 8404.009. NM_004684.2 BP258993.1
EST 1 897 7169.022.1-T_at -0.59719 0.59718906 7.141295 1E-10
7169.022. NM_213674.1 BG385598.1 EST 1 898 25925.006.1-T_at
-0.59714 0.59714283 7.140436 1E-10 25925.006 NM_015461.1 DB276803.1
EST 1 899 59.049.1-F_at -0.59713 0.59712525 7.140109 1E-10 59.049.1
-- -- -- -- 900 5284.003.1-T_at -0.59709 0.59708796 7.139416 1E-10
5284.003. NM_002644.2 BP220016.1 EST 1 901 2982.002.1-F_at -0.59705
0.59705092 7.138728 1E-10 2982.002. NM_000856.2 BP199345.1 EST 1
902 2568.002.1-T_at -0.59693 0.59693461 7.136567 1E-10 2568.002.
NM_014211.1 DB235581.1 EST 1 903 301.004.1-B_at -0.59688 0.59688305
7.135609 1E-10 301.004.1 NM_000700.1 DB194639.1 EST 1 904
25925.011.1-F_at -0.59665 0.59664856 7.131256 1E-10 25925.011
NM_015461.1 DA105762.1 EST 1 905 59.004.1-F_at -0.59647 0.59647098
7.127961 1E-10 59.004.1 NM_001613.1 CQ696293.1 GENBANK_PATENT 1 906
6289.002.1-B_at -0.59635 0.59634661 7.125655 1E-10 6289.002.
NM_030754.2 AA345111.1 EST 1 907 244.003.1-C_at -0.59612 0.59612161
7.121484 1E-10 244.003.1 NM_001630.1 BM809869.1 EST 1 908
11065.008.1-C_at 0.595877 0.59587676 7.116948 1E-10 11065.008
NM_181802.1 NM_181800.1 REFSEQ 5 909 7091.006.1-T_at -0.59586
0.59586302 7.116693 1E-10 7091.006. NM_007005.3 AK057236.1 mRNA 1
910 79608.009.1-F_at -0.59581 0.59580998 7.115711 1E-10 79608.009
NM_024557.2 CA406619.1 EST 1 911 9413.002.1-T_at -0.5958 0.59580106
7.115546 1E-10 9413.002. NM_004816.2 AW779892.1 EST 1 912
7431.064.1-C_at -0.59575 0.59575257 7.114648 1E-10 7431.064.
NM_003380.2 BE728213.1 EST 1 913 8404.029.1-E_at -0.5957 0.59569505
7.113583 1E-10 8404.029. NM_004684.2 AA384658.1 EST 1 914
6876.020.1-T_at -0.59541 0.59541268 7.108359 1E-10 6876.020.
NM_001001522. BM921237.1 EST 1 915 301.005.1-T_at -0.59539
0.59538592 7.107864 1E-10 301.005.1 NM_000700.1 AU139656.1 EST 7
916 9055.014.1-T_at 0.59529 0.5952897 7.106085 1E-10 9055.014.
NM_003981.2 BE300335.1 EST 1 917 4281.023.1-T_at -0.5952 0.59520125
7.104449 1E-10 4281.023. NM_033290.1 AY539976.1 mRNA 1 918
3868.005.1-D_at -0.59519 0.59519189 7.104276 1E-10 3868.005.
NM_005557.2 BG682632.1 EST 1 919 1062.001.6-B_at 0.595002
0.59500239 7.100775 1E-10 1062.001. NM_001813.2 CQ715352.1
GENBANK_PATENT 1 920 5858.005.1-T_at -0.59493 0.5949259 7.099362
1E-10 5858.005. NM_002864.1 DB040351.1 EST 1 921 51201.007.1-F_at
-0.59491 0.59490972 7.099063 1E-10 51201.007 NM_016353.2 BF541714.1
EST 1 922 4240.001.1-B_at -0.59478 0.59477936 7.096655 1E-10
4240.001. NM_005928.1 BF525404.1 EST 1 923 8404.029.1-T_at -0.59477
0.59477341 7.096546 1E-10 8404.029. NM_004684.2 AA384658.1 EST 1
924 9413.001.1-T_at -0.59469 0.59468964 7.094999 1E-10 9413.001.
NM_004816.2 DA824091.1 EST 1 925 9768.005.1-T_at 0.59458 0.59458041
7.092983 1E-10 9768.005. NM_014736.4 BG529193.1 EST 13 926
11197.001.1-T_at -0.59454 0.59454222 7.092279 1E-10 11197.001
NM_007191.2 W37154.1 EST 1 927 6285.002.1-T_at -0.59451 0.59450684
7.091626 1E-10 6285.002. NM_006272.1 BQ435930.1 EST 1 928
2335.006.2-F_at 0.594359 0.59435947 7.088907 1E-10 2335.006.
NM_212482.1 CX785805.1 EST 1 929 7169.001.1-C_at -0.59424
0.59424202 7.086742 1E-10 7169.001. NM_213674.1 BM809268.1 EST 4
930 9493.004.1-T_at 0.594108 0.59410838 7.084278 1E-10 9493.004.
NM_138555.1 BM792243.1 EST 1 931 4601.014.1-T_at -0.59408
0.59408377 7.083825 1E-10 4601.014. NM_130439.3 AX885544.1
GENBANK_PATENT 1 932 51203.002.2-F_at 0.593876 0.59387576 7.079993
1E-10 51203.002 NM_016359.2 AL561514.3 EST 1 933 7018.022.1-F_at
-0.59374 0.593741 7.077512 1E-10 7018.022. NM_001063.2 T74625.1 EST
1 934 4288.009.1-F_at 0.593675 0.59367472 7.076291 1E-10 4288.009.
NM_002417.2 BG106198.1 EST 1 935 8321.004.1-D_at -0.59365
0.59365154 7.075865 1E-10 8321.004. NM_003505.1 AA249884.1 EST 1
936 8564.004.1-E_at -0.59345 0.59344954 7.072148 1E-10 8564.004.
NM_003679.2 AV646525.1 EST 3 937 7169.022.1-C_at -0.59343
0.59343079 7.071803 1E-10 7169.022. NM_213674.1 BG385598.1 EST 1
938 29127.013.1-T_at 0.593386 0.59338577 7.070975 1E-10 29127.013
NM_013277.2 DA812983.1 EST 1 939 2.018.1-B_at -0.59317 0.59316746
7.066961 1E-10 2.018.1 NM_000014.4 DB090657.1 EST 1 940
2.005.1-D_at -0.59314 0.59313787 7.066417 1E-10 2.005.1 NM_000014.4
BI493707.1 EST 1 941 1058.004.2-T_at 0.5931 0.59310026 7.065726
2E-10 1058.004. NM_001809.2 AL555851.3 EST 1 942 2232.014.1-C_at
-0.59284 0.59284081 7.060959 2E-10 2232.014. NM_004110.2 DB052280.1
EST 1 943 23650.005.1-E_at -0.59283 0.59282614 7.06069 2E-10
23650.005 NM_058193.1 DB116882.1 EST 1 944 5621.002.2-T_at -0.59271
0.59270593 7.058482 2E-10 5621.002. NM_000311.2 DA151722.1 EST 1
945 51201.005.1-B_at -0.5927 0.59270147 7.058401 2E-10 51201.005
NM_016353.2 DA655803.1 EST 1 946 667.022.1-F_at -0.59265 0.59265274
7.057506 2E-10 667.022.1 NM_183380.1 AX683196.1 GENBANK_PATENT 1
947 54443.012.1-C_at 0.592546 0.59254619 7.055551 2E-10 54443.012
NM_018685.2 BG167656.1 EST 1 948 25802.003.1-C_at -0.59251
0.59250565 7.054807 2E-10 25802.003 NM_012134.1 BC001755.1 mRNA 1
949 3479.003.1-T_at -0.59248 0.59247776 7.054295 2E-10 3479.003.
NM_000618.2 U40870.1 mRNA 4 950 94274.003.1-D_at -0.59243
0.59242603 7.053346 2E-10 94274.003 NM_033256.1 AB056509.1 mRNA 1
951 84668.003.1-T_at -0.59229 0.5922945 7.050934 2E-10 84668.003
NM_032581.2 CQ727246.1 GENBANK_PATENT 1 952 22974.008.1-E_at
0.592131 0.59213066 7.04793 2E-10 22974.008 NM_012112.4 CQ727779.1
GENBANK_PATENT 1 953 55656.007.3-B_at 0.592104 0.59210361 7.047434
2E-10 55656.007 NM_017864.2 CQ715091.1 GENBANK_PATENT 1 954
29127.002.1-T_at 0.591958 0.59195836 7.044773 2E-10 29127.002
NM_013277.2 AB030251.1 mRNA 44 955 4281.012.2-T_at -0.59195
0.59194704 7.044565 2E-10 4281.012. NM_033290.1 CN298826.1 EST 1
956 2335.013.1-B_at 0.591874 0.59187364 7.043221 2E-10 2335.013.
NM_212482.1 AL551632.3 EST 2 957 79627.003.1-B_at -0.59185
0.59184571 7.042709 2E-10 79627.003 NM_024576.3 CQ725357.1
GENBANK_PATENT 1 958 2982.014.1-T_at -0.5918 0.5918033 7.041932
2E-10 2982.014. NM_000856.2 BM469193.1 EST 1 959 2335.053.1-T_at
0.591795 0.59179543 7.041788 2E-10 2335.053. NM_212482.1 BX380854.2
EST 1 960 667.001.1-F_at -0.59167 0.5916653 7.039406 2E-10
667.001.1 NM_183380.1 BG387402.1 EST 2 961 8404.030.1-B_at -0.59165
0.59165467 7.039211 2E-10 8404.030. NM_004684.2 CD357736.1 EST 1
962 2335.025.1-C_at 0.591645 0.59164549 7.039043 2E-10 2335.025.
NM_212482.1 CQ715726.1 GENBANK_PATENT 3 963 140885.010.3-D -0.59164
0.59164248 7.038988 2E-10 140885.01 NM_080792.2 CQ728313.1
GENBANK_PATENT 1 964 55366.001.2-F_at -0.59159 0.59158568 7.037948
2E-10 55366.001 NM_018490.1 CQ722924.1 GENBANK_PATENT 1 965
7169.015.1-D_at -0.59148 0.59147642 7.035949 2E-10 7169.015.
NM_213674.1 DB291177.1 EST 1 966 57447.002.1-B_at -0.59141
0.59140949 7.034725 2E-10 57447.002 NM_201535.1 BF526188.1 EST 1
967 22974.008.1-T_at 0.591372 0.59137204 7.034039 2E-10 22974.008
NM_012112.4 CQ727779.1 GENBANK_PATENT 1 968 6876.011.1-C_at
-0.59135 0.59135455 7.033719 2E-10 6876.011. NM_001001522.
AW956430.1 EST 1 969 4281.008.2-D_at -0.59123 0.591231 7.03146
2E-10 4281.008. NM_033290.1 AY539984.1 mRNA 1 970 59.008.1-T_at
-0.59118 0.59117565 7.030448 2E-10 59.008.1 NM_001613.1 BP373197.1
EST 1 971 23266.008.1-F_at -0.59109 0.59109236 7.028926 2E-10
23266.008 NM_012302.2 CQ799210.1 GENBANK_PATENT 1 972
2568.003.2-T_at -0.59089 0.59089352 7.025292 2E-10 2568.003.
NM_014211.1 CD696885.1 EST 1 973 5311.003.1-T_at -0.59073
0.59073163 7.022336 2E-10 5311.003. NM_000297.2 DA153606.1 EST 1
974 6304.011.1-T_at -0.59052 0.59052216 7.018512 2E-10 6304.011.
NM_002971.2 BP359118.1 EST 1 975 3861.008.1-B_at -0.59048
0.59048159 7.017772 2E-10 3861.008. NM_000526.3 BE184532.1 EST 1
976 7018.013.1-B_at -0.59035 0.59035214 7.01541 2E-10 7018.013.
NM_001063.2 AX147484.1 GENBANK_PATENT 1 977 8404.005.1-F_at
-0.59023 0.59022734 7.013134 2E-10 8404.005. NM_004684.2 DA763956.1
EST 1 978 7170.027.1-C_at 0.590216 0.59021624 7.012932 2E-10
7170.027. NM_153649.2 BQ959117.1 EST 1 979 8404.023.1-C_at -0.59009
0.59009089 7.010646 2E-10 8404.023. NM_004684.2 BX463355.2 EST 1
980 7373.007.1-C_at -0.59009 0.59009037 7.010637 2E-10 7373.007.
NM_021110.1 Y11710.1 mRNA 1 981 1410.009.1-T_at -0.5899 0.5898986
7.007142 2E-10 1410.009. NM_001885.1 BQ437433.1 EST 2 982
79745.004.3-D_at -0.58947 0.58947272 6.999388 2E-10 79745.004
NM_024692.3 AK057267.1 mRNA 3 983 24137.004.1-T_at 0.589449
0.5894492 6.99896 2E-10 24137.004 NM_012310.2 BQ055679.1 EST 1 984
6241.013.1-B_at 0.589418 0.58941768 6.998387 2E-10 6241.013.
NM_001034.1 BG261296.1 EST 1 985 1410.001.1-T_at -0.5894 0.58939515
6.997977 2E-10 1410.001. NM_001885.1 W40377.1 EST 1 986
4781.015.2-B_at -0.58938 0.5893752 6.997614 2E-10 4781.015.
NM_005596.1 DN995118.1 EST 1 987 72.002.1-T_at -0.58937 0.58936787
6.99748 2E-10 72.002.1 NM_001615.3 BP372072.1 EST 2 988
4833.004.1-D_at 0.589279 0.58927851 6.995855 2E-10 4833.004.
NM_005009.2 BG478602.1 EST 8 989 57447.024.1-D_at -0.58924
0.58924443 6.995235 2E-10 57447.024 NM_201535.1 DA566498.1 EST 1
990 2982.013.2-T_at -0.5892 0.58920321 6.994486 2E-10 2982.013.
NM_000856.2 CF594362.1 EST 1 991 79971.012.1-T_at -0.58907
0.5890694 6.992053 2E-10 79971.012 NM_001002292. BG702604.1 EST 1
992 8404.028.3-C_at -0.589 0.58899948 6.990782 2E-10 8404.028.
NM_004684.2 CQ727530.1 GENBANK_PATENT 1 993 4638.011.1-E_at
-0.58897 0.58897325 6.990305 2E-10 4638.011. NM_053025.2 DB267860.1
EST 1 994 7169.004.1-C_at -0.58895 0.58894617 6.989813 2E-10
7169.004. NM_213674.1 BG027526.1 EST 1 995 4288.004.1-F_at 0.588788
0.58878813 6.986942 2E-10 4288.004. NM_002417.2 BP232141.1 EST 1
996 59.012.2-C_at -0.58875 0.58875113 6.98627 2E-10 59.012.2
NM_001613.1 AL546033.3 EST 1 997 301.008.1-B_at -0.5887 0.58869814
6.985308 2E-10 301.008.1 NM_000700.1 CD688703.1 EST 1 998
4281.012.1-T_at -0.58864 0.58863805 6.984217 2E-10 4281.012.
NM_033290.1 CN298826.1 EST 1 999 2335.016.1-F_at 0.58863 0.58863031
6.984076 2E-10 2335.016. NM_212482.1 CQ875357.1 GENBANK_PATENT 281
1000 259266.003.1-C 0.588552 0.58855227 6.98266 2E-10 259266.00
NM_018136.2 CB217235.1 EST 1 1001 9055.020.1-T_at 0.588545
0.58854487 6.982525 2E-10 9055.020. NM_003981.2 BP363287.1 EST 1
1002 7091.016.1-T_at -0.58837 0.58836788 6.979313 2E-10 7091.016.
NM_007005.3 DA323941.1 EST 1 1003 59.023.1-T_at -0.5882 0.58819673
6.976209 2E-10 59.023.1 NM_001613.1 DB248573.1 EST 1 1004
57162.010.1-B_at -0.58814 0.58813698 6.975125 2E-10 57162.010
NM_020651.2 DB241492.1 EST 1 1005 4781.002.2-D_at -0.58809
0.58808634 6.974207 2E-10 4781.002. NM_005596.1 BF688131.1 EST 2
1006 6122.037.1-T_at -0.58806 0.58805933 6.973718 2E-10 6122.037.
NM_000967.3 BP417473.1 EST 1 1007 4240.015.1-B_at -0.58803
0.58803047 6.973195 2E-10 4240.015. NM_005928.1 AA021047.1 EST 1
1008 59.034.1-T_at -0.58783 0.58782732 6.969513 2E-10 59.034.1 --
-- -- --
1009 8404.004.2-D_at -0.58782 0.58782345 6.969443 2E-10 8404.004.
NM_004684.2 DA589023.1 EST 1 1010 9413.001.2-T_at -0.58777
0.5877726 6.968522 2E-10 9413.001. NM_004816.2 DA824091.1 EST 1
1011 2.005.1-F_at -0.58772 0.58771984 6.967566 2E-10 2.005.1
NM_000014.4 BI493707.1 EST 1 1012 6304.002.1-T_at -0.58771
0.58770553 6.967307 2E-10 6304.002. NM_002971.2 BC001744.1 mRNA 33
1013 3852.005.1-C_at -0.58768 0.58768033 6.966851 2E-10 3852.005.
NM_000424.2 R47851.1 EST 1 1014 7170.027.1-B_at 0.587642 0.58764175
6.966152 2E-10 7170.027. NM_153649.2 BQ959117.1 EST 1 1015
301.013.1-T_at -0.5873 0.58729565 6.959888 2E-10 301.013.1
NM_000700.1 BF130804.1 EST 1 1016 6304.012.1-F_at -0.58724
0.58724193 6.958916 2E-10 6304.012. NM_002971.2 BP359502.1 EST 1
1017 57447.051.2-T_at -0.58722 0.58721828 6.958489 2E-10 57447.051
NM_201535.1 BX460053.2 EST 1 1018 11065.005.1-C_at 0.587192
0.58719194 6.958012 2E-10 11065.005 NM_181802.1 CS138820.1
GENBANK_PATENT 2 1019 6422.002.1-F_at -0.58719 0.58719017 6.95798
2E-10 6422.002. NM_003012.3 AX565729.1 GENBANK_PATENT 3 1020
6241.013.1-F_at 0.587043 0.58704329 6.955324 3E-10 6241.013.
NM_001034.1 BG261296.1 EST 1 1021 2335.032.1-T_at 0.58699
0.58699048 6.95437 3E-10 2335.032. NM_212482.1 DA647475.1 EST 1
1022 11065.005.2-T_at 0.586925 0.5869248 6.953183 3E-10 11065.005
NM_181802.1 CS138820.1 GENBANK_PATENT 2 1023 2335.028.1-D_at
0.586789 0.58678853 6.95072 3E-10 2335.028. NM_212482.1 AJ320525.1
mRNA 1 1024 29997.016.1-F_at -0.58672 0.58671564 6.949404 3E-10
29997.016 NM_015710.3 BF686243.1 EST 1 1025 7018.014.1-T_at
-0.58659 0.58658835 6.947105 3E-10 7018.014. NM_001063.2 AX147483.1
GENBANK_PATENT 1 1026 1410.011.1-E_at -0.58657 0.58657023 6.946778
3E-10 1410.011. NM_001885.1 BI561839.1 EST 1 1027 7170.040.1-E_at
0.586568 0.58656826 6.946742 3E-10 7170.040. NM_153649.2 BG283654.1
EST 1 1028 6289.002.2-F_at -0.5864 0.58639668 6.943645 3E-10
6289.002. NM_030754.2 AA345111.1 EST 1 1029 7373.003.4-C_at
-0.58637 0.58636622 6.943095 3E-10 7373.003. NM_021110.1 CQ716670.1
GENBANK_PATENT 1 1030 7170.041.1-E_at 0.58605 0.58604991 6.93739
3E-10 7170.041. NM_153649.2 BF967161.1 EST 4 1031 128553.003.1-B
-0.586 0.58599544 6.936408 3E-10 128553.00 NM_173485.2 BP394387.1
EST 1 1032 4094.002.1-D_at -0.58596 0.58595549 6.935688 3E-10
4094.002. NM_001031804. BI458211.1 EST 1 1033 7113.011.1-T_at
-0.5859 0.58589757 6.934644 3E-10 7113.011. NM_005656.2 DA868984.1
EST 1 1034 7170.002.1-C_at 0.585876 0.58587638 6.934262 3E-10
7170.002. NM_153649.2 AL547448.3 EST 1 1035 8404.017.2-T_at
-0.58585 0.58584564 6.933708 3E-10 8404.017. NM_004684.2 CD001002.1
EST 1 1036 59.029.1-T_at -0.58564 0.58563959 6.929996 3E-10
59.029.1 NM_001613.1 AL540709.3 EST 1 1037 29089.001.1-T_at
0.585601 0.58560082 6.929298 3E-10 29089.001 NM_014176.1 CA495294.1
EST 2 1038 358.012.1-T_at -0.5856 0.58559702 6.929229 3E-10
358.012.1 NM_198098.1 AX597685.1 GENBANK_PATENT 1 1039
9134.001.1-B_at 0.585561 0.58556099 6.92858 3E-10 9134.001.
NM_057749.1 BC007015.1 mRNA 1 1040 2335.013.1-C_at 0.585476
0.58547585 6.927047 3E-10 2335.013. NM_212482.1 AL551632.3 EST 2
1041 1410.010.1-T_at -0.58543 0.58542981 6.926219 3E-10 1410.010.
NM_001885.1 AJ710474.1 EST 2 1042 2327.003.4-F_at -0.58542
0.58541593 6.925969 3E-10 2327.003. NM_001460.2 AI223310.1 EST 1
1043 59.042.1-T_at -0.58536 0.58536256 6.925008 3E-10 59.042.1
NM_001613.1 EH_001613.8 PREDICTED 1 1044 6304.007.2-T_at -0.58518
0.58517695 6.921669 3E-10 6304.007. NM_002971.2 DB141052.1 EST 1
1045 8404.031.1-B_at -0.58502 0.5850183 6.918815 3E-10 8404.031.
NM_004684.2 BP327616.1 EST 1 1046 6289.001.1-F_at -0.58499
0.58499281 6.918357 3E-10 6289.001. NM_030754.2 CR744712.1 EST 1
1047 1410.006.1-T_at -0.58487 0.58487369 6.916216 3E-10 1410.006.
NM_001885.1 BF670917.1 EST 1 1048 80034.004.1-T_at -0.58483
0.58482793 6.915393 3E-10 80034.004 NM_024969.2 DA786544.1 EST 1
1049 1410.008.1-T_at -0.58477 0.58476949 6.914343 3E-10 1410.008.
NM_001885.1 R68496.1 EST 1 1050 57447.051.2-D_at -0.5847 0.58469568
6.913017 3E-10 57447.051 NM_201535.1 BX460053.2 EST 1 1051
7170.016.3-B_at 0.58466 0.58466041 6.912384 3E-10 7170.016.
NM_153649.2 BF575596.1 EST 1 1052 4240.001.1-C_at -0.58464
0.58463983 6.912014 3E-10 4240.001. NM_005928.1 BF525404.1 EST 1
1053 6288.001.1-T_at -0.58463 0.58462773 6.911797 3E-10 6288.001.
NM_199161.1 AX899121.1 GENBANK_PATENT 2 1054 7018.014.1-C_at
-0.58462 0.58461793 6.911621 3E-10 7018.014. NM_001063.2 AX147483.1
GENBANK_PATENT 1 1055 8404.020.1-T_at -0.58456 0.58455592 6.910507
3E-10 8404.020. NM_004684.2 DA298626.1 EST 1 1056 6289.001.2-F_at
-0.58442 0.58441549 6.907986 3E-10 6289.001. NM_030754.2 CR744712.1
EST 1 1057 6876.011.1-F_at -0.58434 0.58433766 6.906588 3E-10
6876.011. NM_001001522. AW956430.1 EST 1 1058 8404.031.1-C_at
-0.5841 0.58410499 6.902414 3E-10 8404.031. NM_004684.2 BP327616.1
EST 1 1059 57447.010.1-T_at -0.58408 0.5840791 6.90195 3E-10
57447.010 NM_201535.1 BP349691.1 EST 1 1060 1410.007.2-C_at
-0.58404 0.58404076 6.901262 3E-10 1410.007. NM_001885.1 BI548180.1
EST 1 1061 59.012.2-B_at -0.58397 0.58396561 6.899914 3E-10
59.012.2 NM_001613.1 AL546033.3 EST 1 1062 3459.005.1-T_at -0.58389
0.58388527 6.898474 3E-10 3459.005. NM_000416.1 BP259682.1 EST 1
1063 301.013.1-C_at -0.58378 0.58377547 6.896506 3E-10 301.013.1
NM_000700.1 BF130804.1 EST 1 1064 83539.001.1-D_at -0.58353
0.58353306 6.892163 3E-10 83539.001 NM_031422.1 BM919514.1 EST 1
1065 6288.004.1-F_at -0.58351 0.58351232 6.891792 3E-10 6288.004.
NM_199161.1 BG567754.1 EST 3 1066 4781.016.1-E_at -0.58347
0.58347336 6.891094 3E-10 4781.016. NM_005596.1 DA518562.1 EST 1
1067 29997.012.1-E_at -0.58343 0.58343189 6.890351 3E-10 29997.012
NM_015710.3 BG746448.1 EST 1 1068 57447.021.1-T_at -0.5834
0.58339709 6.889728 3E-10 57447.021 NM_201535.1 BQ954948.1 EST 28
1069 3426.002.1-C_at -0.58304 0.58304119 6.88336 4E-10 3426.002.
NM_000204.1 CQ718881.1 GENBANK_PATENT 1 1070 53829.001.2-T_at
-0.58296 0.58295977 6.881904 4E-10 53829.001 NM_023914.2
NM_176894.1 REFSEQ 12 1071 2115.001.2-B_at -0.58274 0.58274226
6.878015 4E-10 2115.001. NM_004956.3 X87175.1 mRNA 1 1072
10051.008.1-T_at 0.58274 0.58274024 6.877979 4E-10 10051.008
NM_001002799. DA436898.1 EST 1 1073 1033.002.1-T_at 0.582723
0.58272336 6.877677 4E-10 1033.002. NM_005192.2 BG771524.1 EST 1
1074 2335.005.1-D_at 0.582597 0.58259651 6.875411 4E-10 2335.005.
NM_212482.1 BX417388.2 EST 1 1075 7113.009.1-T_at -0.58253
0.58252547 6.874142 4E-10 7113.009. NM_005656.2 DA873416.1 EST 1
1076 3866.002.1-B_at -0.58251 0.58251356 6.873929 4E-10 3866.002.
NM_002275.2 BG990007.1 EST 1 1077 140885.014.1-D -0.58226
0.58225938 6.869391 4E-10 140885.01 NM_080792.2 DR423079.1 EST 1
1078 7168.003.1-T_at -0.58216 0.58215776 6.867577 4E-10 7168.003.
NM_001018020. AK092051.1 mRNA 25 1079 79608.001.1-T_at -0.58215
0.58214776 6.867399 4E-10 79608.001 NM_024557.2 CQ739424.1
GENBANK_PATENT 1 1080 79608.008.2-F_at -0.58205 0.58205249 6.865699
4E-10 79608.008 NM_024557.2 DA748988.1 EST 2 1081 1410.001.1-B_at
-0.58186 0.58185842 6.862238 4E-10 1410.001. NM_001885.1 W40377.1
EST 1 1082 7113.010.1-T_at -0.5816 0.5816021 6.857669 4E-10
7113.010. NM_005656.2 DA460061.1 EST 1 1083 4781.014.2-B_at -0.5816
0.58160201 6.857667 4E-10 4781.014. NM_005596.1 DN918235.1 EST 1
1084 2335.016.1-E_at 0.581544 0.58154398 6.856633 4E-10 2335.016.
NM_212482.1 CQ875357.1 GENBANK_PATENT 281 1085 11065.003.1-T_at
0.581391 0.58139079 6.853905 4E-10 11065.003 NM_181802.1 CS138819.1
GENBANK_PATENT 5 1086 3872.006.1-T_at -0.58132 0.58131729 6.852596
4E-10 3872.006. NM_000422.1 BM017443.1 EST 1 1087 3084.005.1-F_at
-0.58129 0.58128817 6.852078 4E-10 3084.005. NM_013957.1
NM_013960.1 REFSEQ 2 1088 6285.003.1-T_at -0.5812 0.58120469
6.850591 4E-10 6285.003. NM_006272.1 BG765453.1 EST 2 1089
6876.016.2-F_at -0.58101 0.58100573 6.847051 4E-10 6876.016.
NM_001001522. AB209555.1 mRNA 2 1090 8404.004.1-T_at -0.58099
0.58098676 6.846714 4E-10 8404.004. NM_004684.2 DA589023.1 EST 1
1091 54829.001.1-F_at 0.580792 0.58079186 6.843247 4E-10 54829.001
NM_017680.3 AK027359.1 mRNA 4 1092 8404.001.1-T_at -0.58046
0.58046456 6.83743 4E-10 8404.001. NM_004684.2 DA132781.1 EST 1
1093 9055.011.1-E_at 0.580443 0.58044278 6.837043 4E-10 9055.011.
NM_003981.2 CX868839.1 EST 1 1094 6289.003.2-F_at -0.58043
0.58043238 6.836859 4E-10 6289.003. NM_030754.2 R83510.1 EST 1 1095
22974.007.1-T_at 0.580276 0.5802757 6.834076 4E-10 22974.007
NM_012112.4 AF287265.1 mRNA 213 1096 59.023.2-T_at -0.58018
0.58017715 6.832326 4E-10 59.023.2 NM_001613.1 DB248573.1 EST 1
1097 7169.015.1-T_at -0.58013 0.58013361 6.831554 4E-10 7169.015.
NM_213674.1 DB291177.1 EST 1 1098 6289.002.1-F_at -0.58009
0.58008892 6.83076 4E-10 6289.002. NM_030754.2 AA345111.1 EST 1
1099 4288.008.1-B_at 0.580029 0.58002917 6.8297 4E-10 4288.008.
NM_002417.2 BP235232.1 EST 1 1100 4781.007.1-B_at -0.5799
0.57989557 6.82733 5E-10 4781.007. NM_005596.1 BP350370.1 EST 1
1101 6876.023.1-T_at -0.57988 0.57988374 6.82712 5E-10 6876.023.
NM_001001522. CN482091.1 EST 1 1102 9055.017.1-F_at 0.579678
0.57967782 6.823468 5E-10 9055.017. NM_003981.2 DB031145.1 EST 1
1103 7170.018.2-D_at 0.579645 0.5796446 6.822879 5E-10 7170.018.
NM_153649.2 DB037267.1 EST 1 1104 4781.014.2-D_at -0.57948
0.57948256 6.820008 5E-10 4781.014. NM_005596.1 DN918235.1 EST 1
1105 7170.025.1-T_at 0.579385 0.5793851 6.818281 5E-10 7170.025.
NM_153649.2 BE208737.1 EST 1 1106 7018.025.1-B_at -0.57934
0.57934031 6.817488 5E-10 7018.025. NM_001063.2 BE971065.1 EST 1
1107 10253.003.1-T_at -0.57928 0.5792786 6.816395 5E-10 10253.003
NM_005842.2 DA345721.1 EST 1 1108 57447.039.1-D_at -0.57924
0.57923531 6.815628 5E-10 57447.039 NM_201535.1 DA356658.1 EST 1
1109 59.022.1-T_at -0.5792 0.57920027 6.815007 5E-10 59.022.1
NM_001613.1 BQ881176.1 EST 6 1110 2982.015.1-F_at -0.57917
0.57917337 6.814531 5E-10 2982.015. NM_000856.2 CB049566.1 EST 1
1111 10124.004.2-F_at -0.57893 0.57892871 6.810201 5E-10 10124.004
NM_001037164. BU661374.1 EST 12 1112 6289.001.1-B_at -0.57871
0.57871022 6.806336 5E-10 6289.001. NM_030754.2 CR744712.1 EST 1
1113 7091.005.1-F_at -0.57865 0.57864807 6.805237 5E-10 7091.005.
NM_007005.3 BC059405.1 mRNA 1 1114 501.006.1-B_at -0.57847
0.57847445 6.802168 5E-10 501.006.1 NM_001182.2 AI142140.1 EST 1
1115 1410.001.1-C_at -0.57836 0.57835697 6.800092 5E-10 1410.001.
NM_001885.1 W40377.1 EST 1 1116 57447.021.1-C_at -0.57826
0.57825824 6.798348 5E-10 57447.021 NM_201535.1 BQ954948.1 EST 28
1117 244.012.1-B_at -0.57821 0.57821349 6.797558 5E-10 244.012.1
NM_001630.1 DA445163.1 EST 1 1118 7018.026.1-F_at -0.57794
0.57793533 6.792647 5E-10 7018.026. NM_001063.2 BM690655.1 EST 1
1119 3872.018.1-T_at -0.57791 0.57790767 6.792159 5E-10 3872.018.
NM_000422.1 BP226405.1 EST 1 1120 10144.017.3-T_at -0.57781
0.57781025 6.79044 5E-10 10144.017 NM_014883.2 AX747234.1
GENBANK_PATENT 1 1121 11197.001.1-F_at -0.57764 0.57763981 6.787434
5E-10 11197.001 NM_007191.2 W37154.1 EST 1 1122 29127.007.1-B_at
0.577519 0.57751875 6.785299 6E-10 29127.007 NM_013277.2 DA362566.1
EST 1 1123 10010.004.1-F_at -0.57745 0.57744716 6.784037 6E-10
10010.004 NM_004180.2 BM750784.1 EST 1 1124 81704.013.1-C_at
-0.57744 0.57744059 6.783922 6E-10 81704.013 NM_203447.1 CQ723361.1
GENBANK_PATENT 1 1125 4781.006.2-B_at -0.57742 0.57742143 6.783584
6E-10 4781.006. NM_005596.1 AK131233.1 mRNA 2 1126 7373.003.1-F_at
-0.57736 0.57736415 6.782575 6E-10 7373.003. NM_021110.1 CQ716670.1
GENBANK_PATENT 1 1127 8404.009.1-D_at -0.57736 0.57735822 6.78247
6E-10 8404.009. NM_004684.2 BP258993.1 EST 1 1128 23092.004.1-T_at
-0.57727 0.5772653 6.780833 6E-10 23092.004 NM_015071.2 DA211853.1
EST 1 1129 2335.002.1-F_at 0.577229 0.57722889 6.780192 6E-10
2335.002. NM_212482.1 AU118498.1 EST 26 1130 8404.031.1-F_at
-0.5772 0.57720205 6.779719 6E-10 8404.031. NM_004684.2 BP327616.1
EST 1 1131 6304.006.2-T_at -0.57715 0.57714631 6.778737 6E-10
6304.006. NM_002971.2 BI462843.1 EST 1 1132 1410.008.1-E_at
-0.57711 0.57710598 6.778027 6E-10 1410.008. NM_001885.1 R68496.1
EST 1 1133 9055.019.1-F_at 0.577072 0.57707199 6.777428 6E-10
9055.019. NM_003981.2 AL079833.1 EST 1 1134 1398.001.1-D_at
-0.57704 0.577042 6.7769 6E-10 1398.001. NM_016823.2
BE898353.1 EST 1 1135 57447.051.1-E_at -0.57704 0.57703991 6.776863
6E-10 57447.051 NM_201535.1 BX460053.2 EST 1 1136 339965.001.2-B
-0.57702 0.57701808 6.776479 6E-10 339965.00 NM_178555.2 BC086869.1
mRNA 5 1137 7113.001.1-C_at -0.57697 0.57697321 6.775689 6E-10
7113.001. NM_005656.2 CQ976407.1 GENBANK_PATENT 1 1138
4240.009.1-D_at -0.57692 0.57692271 6.7748 6E-10 4240.009.
NM_005928.1 BG829936.1 EST 2 1139 7153.002.4-B_at 0.576735
0.57673523 6.771501 6E-10 7153.002. NM_001067.2 CQ735949.1
GENBANK_PATENT 114 1140 7169.004.1-D_at -0.57658 0.57658017
6.768774 6E-10 7169.004. NM_213674.1 BG027526.1 EST 1 1141
1410.001.1-D_at -0.57648 0.57647869 6.766989 6E-10 1410.001.
NM_001885.1 W40377.1 EST 1 1142 59.015.2-B_at -0.57634 0.57634377
6.764618 6E-10 59.015.2 NM_001613.1 BP372009.1 EST 1 1143
4833.010.1-T_at 0.576197 0.57619729 6.762044 6E-10 4833.010.
NM_005009.2 BU532120.1 EST 1 1144 7169.022.1-B_at -0.57611
0.57611084 6.760525 6E-10 7169.022. NM_213674.1 BG385598.1 EST 1
1145 11065.005.1-T_at 0.576067 0.57606684 6.759752 6E-10 11065.005
NM_181802.1 CS138820.1 GENBANK_PATENT 2 1146 7170.018.2-T_at
0.575994 0.57599361 6.758466 6E-10 7170.018. NM_153649.2 DB037267.1
EST 1 1147 79971.013.2-F_at -0.57599 0.57598932 6.758391 6E-10
79971.013 NM_001002292. DA878291.1 EST 1 1148 152015.005.2-F
-0.5759 0.57589713 6.756772 6E-10 152015.00 NM_001012337.
CQ732372.1 GENBANK_PATENT 1 1149 4288.005.1-D_at 0.575849
0.57584855 6.75592 6E-10 4288.005. NM_002417.2 BM455229.1 EST 1
1150 8404.002.1-T_at -0.57584 0.57584028 6.755774 6E-10 8404.002.
NM_004684.2 BP383384.1 EST 1 1151 6441.004.1-E_at -0.57578
0.5757767 6.754659 6E-10 6441.004. NM_003019.4 BG542824.1 EST 1
1152 6122.046.1-B_at -0.57577 0.57577128 6.754563 6E-10 6122.046.
NM_000967.3 BM019962.1 EST 1 1153 115908.002.1-T 0.575641
0.57564097 6.752277 6E-10 115908.00 NM_138455.2 AF395488.1 mRNA 1
1154 9481.001.1-F_at -0.57564 0.5756408 6.752274 6E-10 9481.001.
NM_004277.2 BC033091.1 mRNA 2 1155 8404.008.1-T_at -0.57561
0.57561259 6.751779 6E-10 8404.008. NM_004684.2 DA342341.1 EST 1
1156 1410.007.1-D_at -0.57559 0.57559279 6.751432 6E-10 1410.007.
NM_001885.1 BI548180.1 EST 1 1157 8404.030.1-C_at -0.57555
0.57554678 6.750625 6E-10 8404.030. NM_004684.2 CD357736.1 EST 1
1158 57447.039.1-T_at -0.57552 0.57551972 6.75015 6E-10 57447.039
NM_201535.1 DA356658.1 EST 1 1159 4147.004.1-E_at -0.57546
0.57545554 6.749025 7E-10 4147.004. NM_002380.3 AX675291.1
GENBANK_PATENT 1 1160 2335.024.2-F_at 0.575372 0.57537228 6.747565
7E-10 2335.024. NM_212482.1 CQ731573.1 GENBANK_PATENT 1 1161
891.007.1-T_at 0.575369 0.57536931 6.747513 7E-10 891.007.1
NM_031966.2 BT020128.1 mRNA 1 1162 2335.002.1-T_at 0.575308
0.57530785 6.746436 7E-10 2335.002. NM_212482.1 AU118498.1 EST 26
1163 8404.017.1-T_at -0.57528 0.5752762 6.745881 7E-10 8404.017.
NM_004684.2 CD001002.1 EST 1 1164 57451.004.1-B_at -0.57522
0.57521923 6.744883 7E-10 57451.004 XM_931456.1 AK056053.1 mRNA 5
1165 8404.001.1-F_at -0.57518 0.57517525 6.744112 7E-10 8404.001.
NM_004684.2 DA132781.1 EST 1 1166 8626.006.2-B_at -0.57508
0.57507892 6.742424 7E-10 8626.006. NM_003722.3 CB049427.1 EST 1
1167 2335.025.1-T_at 0.575019 0.5750189 6.741373 7E-10 2335.025.
NM_212482.1 CQ715726.1 GENBANK_PATENT 3 1168 6286.001.1-T_at
0.574986 0.57498586 6.740794 7E-10 6286.001. NM_005980.2 BM850288.1
EST 1 1169 10580.012.1-C_at -0.57498 0.57497814 6.740659 7E-10
10580.012 NM_015385.2 AX879149.1 GENBANK_PATENT 1 1170
23321.014.1-T_at -0.57485 0.57484627 6.73835 7E-10 23321.014
NM_015271.2 CQ723480.1 GENBANK_PATENT 1 1171 2824.001.2-B_at
-0.57481 0.57480725 6.737667 7E-10 2824.001. NM_001001994.
CQ717842.1 GENBANK_PATENT 1 1172 29127.022.1-T_at 0.574796
0.57479644 6.737478 7E-10 29127.022 NM_013277.2 DB065206.1 EST 1
1173 6289.003.1-F_at -0.57455 0.57455392 6.733234 7E-10 6289.003.
NM_030754.2 R83510.1 EST 1 1174 7170.005.2-B_at 0.574471 0.57447114
6.731785 7E-10 7170.005. NM_153649.2 DA762962.1 EST 1 1175
54443.011.1-F_at 0.574461 0.57446085 6.731605 7E-10 54443.011
NM_018685.2 DA244113.1 EST 1 1176 29127.019.1-T_at 0.574322
0.57432168 6.729172 7E-10 29127.019 NM_013277.2 DA779708.1 EST 1
1177 6288.004.1-T_at -0.57432 0.57432014 6.729145 7E-10 6288.004.
NM_199161.1 BG567754.1 EST 3 1178 29997.008.1-C_at -0.57411
0.57411065 6.725483 7E-10 29997.008 NM_015710.3 BI871613.1 EST 1
1179 57447.039.1-B_at -0.57407 0.57406597 6.724703 7E-10 57447.039
NM_201535.1 DA356658.1 EST 1 1180 3872.007.1-B_at -0.57388 0.573875
6.721367 7E-10 3872.007. NM_000422.1 BU155457.1 EST 1 1181
57561.002.1-T_at -0.57383 0.57383005 6.720582 7E-10 57561.002
NM_020801.1 DB094913.1 EST 1 1182 57451.002.3-B_at -0.57383
0.57382775 6.720542 7E-10 57451.002 XM_931456.1 AX133821.1
GENBANK_PATENT 1 1183 5213.024.1-B_at -0.57376 0.57376229 6.719399
7E-10 5213.024. NM_000289.3 CQ723196.1 GENBANK_PATENT 1 1184
2.005.1-T_at -0.57371 0.57370601 6.718416 8E-10 2.005.1 NM_000014.4
BI493707.1 EST 1 1185 11065.004.1-C_at 0.573605 0.57360463 6.716647
8E-10 11065.004 NM_181802.1 NM_181803.1 REFSEQ 3 1186
1410.006.1-C_at -0.57357 0.57356845 6.716015 8E-10 1410.006.
NM_001885.1 BF670917.1 EST 1 1187 6289.006.1-T_at -0.57356
0.5735557 6.715793 8E-10 6289.006. NM_030754.2 BG618255.1 EST 3
1188 55366.001.1-T_at -0.57354 0.57353923 6.715506 8E-10 55366.001
NM_018490.1 CQ722924.1 GENBANK_PATENT 1 1189 23284.007.1-F_at
-0.57343 0.57342883 6.71358 8E-10 23284.007 NM_015236.3 CX868514.1
EST 1 1190 79971.009.1-T_at -0.57327 0.573273 6.710862 8E-10
79971.009 NM_001002292. DA264864.1 EST 1 1191 6288.004.1-E_at
-0.57316 0.57316396 6.708961 8E-10 6288.004. NM_199161.1 BG567754.1
EST 3 1192 11065.004.1-T_at 0.573162 0.57316172 6.708922 8E-10
11065.004 NM_181802.1 NM_181803.1 REFSEQ 3 1193 51203.009.1-T_at
0.572864 0.57286422 6.703738 8E-10 51203.009 NM_016359.2 AV714397.1
EST 1 1194 1410.010.1-E_at -0.57282 0.57282236 6.703009 8E-10
1410.010. NM_001885.1 AJ710474.1 EST 2 1195 57447.030.1-D_at
-0.57277 0.57277435 6.702173 8E-10 57447.030 NM_201535.1 BM783465.1
EST 5 1196 1308.002.1-T_at -0.57253 0.57252742 6.697874 8E-10
1308.002. NM_130778.1 BX117940.1 EST 2 1197 4288.007.1-C_at
0.572423 0.57242333 6.696062 8E-10 4288.007. NM_002417.2 BE840921.1
EST 1 1198 244.011.1-T_at -0.5724 0.57240479 6.69574 8E-10
244.011.1 NM_001630.1 BX399166.2 EST 1 1199 94274.003.1-B_at
-0.57238 0.57238283 6.695358 8E-10 94274.003 NM_033256.1 AB056509.1
mRNA 1 1200 3178.003.1-E_at -0.57235 0.5723545 6.694865 8E-10
3178.003. NM_031157.2 DA761057.1 EST 1 1201 7153.002.4-T_at
0.572294 0.57229362 6.693806 8E-10 7153.002. NM_001067.2 CQ735949.1
GENBANK_PATENT 114 1202 9055.012.1-D_at 0.57223 0.57222967 6.692694
8E-10 9055.012. NM_003981.2 BE298728.1 EST 1 1203 9232.001.1-E_at
0.572158 0.57215824 6.691452 8E-10 9232.001. NM_004219.2 CN285866.1
EST 1 1204 79068.011.2-B_at -0.57201 0.57200741 6.68883 9E-10
79068.011 XM_051200.8 CQ733443.1 GENBANK_PATENT 1 1205
120.005.2-F_at -0.57195 0.57194991 6.687831 9E-10 120.005.2
NM_019903.3 AK223270.1 mRNA 78 1206 7534.001.1-C_at 0.571947
0.57194717 6.687783 9E-10 7534.001. NM_003406.2 CB051503.1 EST 1
1207 120.005.2-T_at -0.57189 0.57188711 6.686739 9E-10 120.005.2
NM_019903.3 AK223270.1 mRNA 78 1208 7373.003.3-C_at -0.57177
0.57177348 6.684765 9E-10 7373.003. NM_021110.1 CQ716670.1
GENBANK_PATENT 1 1209 57447.004.2-D_at -0.57171 0.57171371 6.683727
9E-10 57447.004 NM_201535.1 CD515320.1 EST 2 1210 2568.005.1-F_at
-0.57162 0.57161693 6.682047 9E-10 2568.005. NM_014211.1 AK055205.1
mRNA 11 1211 1308.001.1-E_at -0.57152 0.5715167 6.680307 9E-10
1308.001. NM_130778.1 BM773425.1 EST 1 1212 6876.020.1-F_at
-0.57133 0.5713288 6.677046 9E-10 6876.020. NM_001001522.
BM921237.1 EST 1 1213 79971.014.1-D_at -0.57124 0.57124451 6.675583
9E-10 79971.014 NM_001002292. DA776805.1 EST 1 1214 5621.008.1-D_at
-0.57121 0.57120843 6.674957 9E-10 5621.008. NM_000311.2 DA648110.1
EST 1 1215 55732.003.2-T_at 0.571055 0.57105463 6.67229 9E-10
55732.003 NM_018186.2 DA733233.1 EST 2 1216 221120.006.1-D -0.57094
0.57093826 6.670273 9E-10 221120.00 NM_139178.1 BE892721.1 EST 1
1217 23266.008.1-T_at -0.57077 0.57076776 6.667318 9E-10 23266.008
NM_012302.2 CQ799210.1 GENBANK_PATENT 1 1218 2335.045.1-F_at
0.570754 0.57075398 6.66708 1E-09 2335.045. NM_212482.1 DA989523.1
EST 1 1219 7170.007.1-F_at 0.570733 0.57073264 6.66671 1E-09
7170.007. NM_153649.2 DA684242.1 EST 1 1220 10461.002.1-B_at
-0.57071 0.57071065 6.666329 1E-09 10461.002 NM_006343.2 CQ725500.1
GENBANK_PATENT 1 1221 59.031.2-F_at -0.57071 0.57070847 6.666291
1E-09 59.031.2 NM_001613.1 BG197213.1 EST 19 1222 9055.010.1-T_at
0.570674 0.5706743 6.665699 1E-09 9055.010. NM_003981.2 BU164001.1
EST 1 1223 58499.005.2-F_at -0.5706 0.5706034 6.664471 1E-09
58499.005 NM_021224.3 BI461756.1 EST 1 1224 54443.006.2-F_at
0.570459 0.57045888 6.661969 1E-09 54443.006 NM_018685.2 CQ716589.1
GENBANK_PATENT 1 1225 59.016.1-B_at -0.57036 0.57035643 6.660196
1E-09 59.016.1 -- -- -- -- 1226 4288.004.1-C_at 0.570301 0.5703013
6.659241 1E-09 4288.004. NM_002417.2 BP232141.1 EST 1 1227
7170.014.1-C_at 0.570269 0.57026859 6.658675 1E-09 7170.014.
NM_153649.2 DA690776.1 EST 1 1228 7170.007.1-D_at 0.570241
0.57024107 6.658199 1E-09 7170.007. NM_153649.2 DA684242.1 EST 1
1229 244.004.2-B_at -0.56972 0.56971798 6.649154 1E-09 244.004.2
NM_001630.1 CB115047.1 EST 1 1230 59.015.2-D_at -0.56961 0.56961045
6.647297 1E-09 59.015.2 NM_001613.1 BP372009.1 EST 1 1231
2327.002.1-B_at -0.56956 0.56955941 6.646415 1E-09 2327.002.
NM_001460.2 CD684429.1 EST 1 1232 79068.011.2-C_at -0.56954
0.5695389 6.646061 1E-09 79068.011 XM_051200.8 CQ733443.1
GENBANK_PATENT 1 1233 23266.006.1-T_at -0.56936 0.56936191 6.643005
1E-09 23266.006 NM_012302.2 DR005890.1 EST 1 1234 4288.007.1-B_at
0.56932 0.56931985 6.642278 1E-09 4288.007. NM_002417.2 BE840921.1
EST 1 1235 301.008.1-T_at -0.5693 0.56929536 6.641856 1E-09
301.008.1 NM_000700.1 CD688703.1 EST 1 1236 5156.003.1-T_at
-0.56918 0.56918229 6.639904 1E-09 5156.003. NM_006206.3 BP321319.1
EST 1 1237 4781.001.1-F_at -0.56917 0.56917015 6.639695 1E-09
4781.001. NM_005596.1 BF541662.1 EST 1 1238 4281.016.1-E_at
-0.56916 0.56915511 6.639435 1E-09 4281.016. NM_033290.1 AY540010.1
mRNA 1 1239 72.004.1-T_at -0.5691 0.56910279 6.638533 1E-09
72.004.1 NM_001615.3 BF680547.1 EST 1 1240 57447.029.1-B_at
-0.56896 0.56895732 6.636023 1E-09 57447.029 NM_201535.1 BX354120.2
EST 6 1241 79971.006.2-T_at -0.56871 0.56870809 6.631726 1E-09
79971.006 NM_001002292. DA048370.1 EST 1 1242 2327.003.2-F_at
-0.56867 0.56866928 6.631058 1E-09 2327.003. NM_001460.2 AI223310.1
EST 1 1243 166824.001.2-F -0.56859 0.56858745 6.629647 1E-09
166824.00 NM_201431.1 CQ492114.1 GENBANK_PATENT 4 1244
29997.010.1-F_at -0.56857 0.56856635 6.629284 1E-09 29997.010
NM_015710.3 BG120545.1 EST 1 1245 57447.024.1-C_at -0.56853
0.56852805 6.628624 1E-09 57447.024 NM_201535.1 DA566498.1 EST 1
1246 4781.007.1-F_at -0.56839 0.56838621 6.626181 1E-09 4781.007.
NM_005596.1 BP350370.1 EST 1 1247 4306.001.1-C_at -0.5682
0.56819649 6.622914 1E-09 4306.001. NM_000901.1 AJ315514.1 mRNA 5
1248 137682.002.2-T 0.568182 0.56818211 6.622667 1E-09 137682.00
NM_152416.1 BX375940.2 EST 1 1249 24137.002.1-F_at 0.568153
0.56815265 6.62216 1E-09 24137.002 NM_012310.2 BC050548.1 mRNA 1
1250 79971.006.1-T_at -0.56815 0.5681458 6.622042 1E-09 79971.006
NM_001002292. DA048370.1 EST 1 1251 7168.004.1-F_at -0.56797
0.56796804 6.618983 1E-09 7168.004. NM_001018020. BX438993.2 EST 3
1252 79068.011.1-T_at -0.56789 0.56788757 6.617599 1E-09 79068.011
XM_051200.8 CQ733443.1 GENBANK_PATENT 1 1253 4781.009.1-T_at
-0.56772 0.56772333 6.614775 1E-09 4781.009. NM_005596.1 CQ732556.1
GENBANK_PATENT 1 1254 5608.003.1-T_at -0.56753 0.56752894 6.611433
1E-09 5608.003. NM_002758.2 BP220368.1 EST 1 1255 9055.014.1-D_at
0.56752 0.56752001 6.61128 1E-09 9055.014. NM_003981.2 BE300335.1
EST 1 1256 5156.009.1-F_at -0.56751 0.56750707 6.611058 1E-09
5156.009. NM_006206.3 L25829.1 mRNA 3 1257 9055.018.2-F_at 0.567502
0.56750204 6.610971 1E-09 9055.018. NM_003981.2 DA033856.1 EST 1
1258 92241.002.1-D_at -0.5675 0.56749779 6.610898 1E-09 92241.002
NM_052862.2 CQ730679.1 GENBANK_PATENT 5 1259 5010.007.1-B_at
-0.56735 0.56734864 6.608336 1E-09 5010.007. NM_005602.4 BQ067107.1
EST 1
1260 2335.028.1-T_at 0.567345 0.56734544 6.608281 1E-09 2335.028.
NM_212482.1 AJ320525.1 mRNA 1 1261 7113.006.1-E_at -0.56728
0.56728076 6.60717 1E-09 7113.006. NM_005656.2 DA874671.1 EST 1
1262 1756.024.1-B_at -0.56726 0.5672562 6.606748 1E-09 1756.024.
NM_000109.2 CD299688.1 EST 1 1263 79971.008.2-T_at -0.56716
0.56716259 6.605141 1E-09 79971.008 NM_001002292. DA711278.1 EST 1
1264 7169.001.1-F_at -0.56705 0.56704888 6.603189 1E-09 7169.001.
NM_213674.1 BM809268.1 EST 4 1265 2.022.1-D_at -0.56703 0.56702777
6.602826 1E-09 2.022.1 NM_000014.4 BP343424.1 EST 1 1266
6876.020.1-D_at -0.56697 0.56697169 6.601864 1E-09 6876.020.
NM_001001522. BM921237.1 EST 1 1267 301.011.1-C_at -0.56692
0.56691975 6.600973 1E-09 301.011.1 NM_000700.1 BG435248.1 EST 1
1268 25862.005.1-E_at -0.56682 0.5668213 6.599284 1E-09 25862.005
NM_018561.3 DR003626.1 EST 1 1269 7170.047.2-D_at 0.566775
0.56677489 6.598488 1E-09 7170.047. NM_153649.2 BF693459.1 EST 1
1270 4281.010.1-T_at -0.56677 0.56677057 6.598413 1E-09 4281.010.
NM_033290.1 AY540016.1 mRNA 1 1271 57447.020.1-T_at -0.56666
0.56665556 6.596441 1E-09 57447.020 NM_201535.1 BX461883.2 EST 5
1272 7170.035.2-D_at 0.566638 0.56663777 6.596136 1E-09 7170.035.
NM_153649.2 BF575164.1 EST 1 1273 10124.005.1-T_at -0.56646
0.56645955 6.593081 1E-09 10124.005 NM_001037164. BU661565.1 EST 1
1274 9055.018.1-C_at 0.566425 0.56642488 6.592487 1E-09 9055.018.
NM_003981.2 DA033856.1 EST 1 1275 59.038.1-T_at -0.56631 0.56630982
6.590515 1E-09 59.038.1 NM_001613.1 EH_001613.2 PREDICTED 1 1276
4288.009.1-B_at 0.566296 0.56629606 6.59028 1E-09 4288.009.
NM_002417.2 BG106198.1 EST 1 1277 57561.004.1-E_at -0.5662
0.56620405 6.588704 1E-09 57561.004 NM_020801.1 DB046772.1 EST 1
1278 2568.003.2-B_at -0.56616 0.56615719 6.587901 1E-09 2568.003.
NM_014211.1 CD696885.1 EST 1 1279 55713.004.1-T_at -0.56607
0.56607498 6.586493 1E-09 55713.004 NM_018102.3 AL833936.1 mRNA 1
1280 2335.026.3-F_at 0.565913 0.56591326 6.583725 1E-09 2335.026.
NM_212482.1 BX641150.1 mRNA 43 1281 7168.010.1-C_at -0.56585
0.56585375 6.582706 1E-09 7168.010. NM_001018020. CD556048.1 EST 1
1282 1959.002.1-T_at -0.56583 0.56583226 6.582339 1E-09 1959.002.
NM_000399.2 DB264199.1 EST 5 1283 259266.002.2-F 0.565786
0.56578622 6.581551 1E-09 259266.00 NM_018136.2 CQ729660.1
GENBANK_PATENT 1 1284 57447.010.3-C_at -0.56578 0.56578285 6.581493
1E-09 57447.010 NM_201535.1 BP349691.1 EST 1 1285 59.026.2-D_at
-0.56573 0.56573398 6.580657 1E-09 59.026.2 -- -- -- -- 1286
5156.002.1-B_at -0.56572 0.56571946 6.580409 1E-09 5156.002.
NM_006206.3 DB259428.1 EST 1 1287 10124.003.1-F_at -0.56572
0.56571682 6.580364 1E-09 10124.003 NM_001037164. BU664973.1 EST 1
1288 4240.007.1-T_at -0.56557 0.56556799 6.577818 1E-09 4240.007.
NM_005928.1 CN485231.1 EST 1 1289 4931.007.1-F_at 0.565418
0.56541793 6.575252 1E-09 4931.007. NM_002533.2 CQ731324.1
GENBANK_PATENT 1 1290 57447.039.1-C_at -0.5653 0.56530385 6.573303
1E-09 57447.039 NM_201535.1 DA356658.1 EST 1 1291 57561.001.1-T_at
-0.56529 0.56529076 6.573079 1E-09 57561.001 NM_020801.1 BQ428339.1
EST 1 1292 57447.002.1-D_at -0.56527 0.56526525 6.572643 1E-09
57447.002 NM_201535.1 BF526188.1 EST 1 1293 4094.001.1-B_at
-0.56526 0.56525669 6.572497 1E-09 4094.001. NM_001031804.
NM_005360.3 REFSEQ 17 1294 59.041.2-T_at -0.56524 0.56524383
6.572277 1E-09 59.041.2 NM_001613.1 AL540709.3 EST 1 1295
137682.004.2-T 0.565172 0.56517245 6.571058 1E-09 137682.00
NM_152416.1 BI670491.1 EST 1 1296 4931.011.2-T_at 0.565117
0.56511747 6.570118 1E-09 4931.011. NM_002533.2 BU170621.1 EST 1
1297 79971.010.2-T_at -0.56505 0.56505357 6.569027 1E-09 79971.010
NM_001002292. CB268343.1 EST 1 1298 29127.009.1-T_at 0.564971
0.56497093 6.567616 1E-09 29127.009 NM_013277.2 BX421176.2 EST 1
1299 2770.004.1-T_at -0.56473 0.56473004 6.563504 2E-09 2770.004.
NM_002069.4 DA801873.1 EST 1 1300 59.015.2-F_at -0.56468 0.56468244
6.562692 2E-09 59.015.2 NM_001613.1 BP372009.1 EST 1 1301
2335.032.1-B_at 0.564674 0.56467386 6.562545 2E-09 2335.032.
NM_212482.1 DA647475.1 EST 1 1302 1410.006.1-B_at -0.56446
0.56446046 6.558905 2E-09 1410.006. NM_001885.1 BF670917.1 EST 1
1303 79971.004.1-B_at -0.56442 0.56442019 6.558218 2E-09 79971.004
NM_001002292. BX648748.1 mRNA 2 1304 94274.003.1-T_at -0.56432
0.56432491 6.556594 2E-09 94274.003 NM_033256.1 AB056509.1 mRNA 1
1305 2335.005.1-T_at 0.564117 0.5641167 6.553045 2E-09 2335.005.
NM_212482.1 BX417388.2 EST 1 1306 966.004.2-B_at -0.56412
0.56411646 6.553041 2E-09 966.004.2 NM_203330.1 AU117114.1 EST 3
1307 79780.006.1-B_at -0.56406 0.5640582 6.552049 2E-09 79780.006
NM_024725.2 BG570666.1 EST 1 1308 57561.003.1-T_at -0.56392
0.56392094 6.549711 2E-09 57561.003 NM_020801.1 DA797962.1 EST 1
1309 9073.002.1-B_at -0.56389 0.56389001 6.549184 2E-09 9073.002.
NM_199328.1 BP277133.1 EST 1 1310 55656.014.2-F_at 0.56379
0.56378984 6.547479 2E-09 55656.014 NM_017864.2 BF770934.1 EST 1
1311 2335.035.1-B_at 0.563724 0.56372399 6.546357 2E-09 2335.035.
NM_212482.1 CX755647.1 EST 1 1312 3161.005.1-T_at 0.563648
0.56364847 6.545072 2E-09 3161.005. NM_012484.1 AX675838.1
GENBANK_PATENT 1 1313 57451.006.1-B_at -0.56362 0.56362219 6.544625
2E-09 57451.006 XM_931456.1 AL598057.1 EST 1 1314 2568.004.1-T_at
-0.56349 0.56348518 6.542294 2E-09 2568.004. NM_014211.1 BP342098.1
EST 1 1315 440073.003.1-E -0.56329 0.56329195 6.539007 2E-09
440073.00 NM_015232.1 BX110676.1 EST 1 1316 2335.006.1-T_at
0.563204 0.56320431 6.537517 2E-09 2335.006. NM_212482.1 CX785805.1
EST 1 1317 10051.011.2-T_at 0.563182 0.56318212 6.53714 2E-09
10051.011 NM_001002799. BG776861.1 EST 4 1318 55784.003.1-T_at
-0.56304 0.56303549 6.534648 2E-09 55784.003 NM_018349.2 BC025708.1
mRNA 2 1319 3860.010.1-T_at -0.56302 0.56302355 6.534445 2E-09
3860.010. NM_153490.1 DA441591.1 EST 1 1320 5284.001.1-D_at
-0.56297 0.56297106 6.533553 2E-09 5284.001. NM_002644.2 AX012182.1
GENBANK_PATENT 1 1321 301.003.1-T_at -0.56291 0.56291408 6.532585
2E-09 301.003.1 NM_000700.1 CB124198.1 EST 1 1322 4240.007.1-F_at
-0.5629 0.56290348 6.532405 2E-09 4240.007. NM_005928.1 CN485231.1
EST 1 1323 4240.007.1-B_at -0.56283 0.56283211 6.531193 2E-09
4240.007. NM_005928.1 CN485231.1 EST 1 1324 4781.015.2-D_at
-0.56272 0.56272205 6.529324 2E-09 4781.015. NM_005596.1 DN995118.1
EST 1 1325 10124.001.1-T_at -0.56261 0.56260672 6.527366 2E-09
10124.001 NM_001037164. BX354322.2 EST 87 1326 57561.004.1-T_at
-0.56258 0.56258399 6.52698 2E-09 57561.004 NM_020801.1 DB046772.1
EST 1 1327 29127.022.2-T_at 0.562515 0.56251532 6.525814 2E-09
29127.022 NM_013277.2 DB065206.1 EST 1 1328 10461.002.2-T_at
-0.56243 0.56242806 6.524333 2E-09 10461.002 NM_006343.2 CQ725500.1
GENBANK_PATENT 1 1329 7168.039.1-B_at -0.56237 0.56236838 6.523321
2E-09 7168.039. NM_001018020. AA096317.1 EST 1 1330
90293.004.2-T_at -0.56231 0.56231454 6.522407 2E-09 90293.004
NM_033495.2 AL591986.1 mRNA 38 1331 1410.006.1-D_at -0.56207
0.56206646 6.518201 2E-09 1410.006. NM_001885.1 BF670917.1 EST 1
1332 7113.010.1-E_at -0.56205 0.56205065 6.517933 2E-09 7113.010.
NM_005656.2 DA460061.1 EST 1 1333 8404.025.1-T_at -0.562 0.56200329
6.51713 2E-09 8404.025. NM_004684.2 DB086831.1 EST 1 1334
79971.008.1-T_at -0.56198 0.56198359 6.516796 2E-09 79971.008
NM_001002292. DA711278.1 EST 1 1335 4240.005.1-T_at -0.56194
0.5619438 6.516122 2E-09 4240.005. NM_005928.1 BX341151.2 EST 1
1336 10051.007.1-T_at 0.561888 0.56188758 6.515169 2E-09 10051.007
NM_001002799. CS161896.1 GENBANK_PATENT 13 1337 2.002.1-F_at
-0.56186 0.56185527 6.514621 2E-09 2.002.1 NM_000014.4 CQ672194.1
GENBANK_PATENT 1 1338 29997.021.1-E_at -0.56185 0.56185259 6.514576
2E-09 29997.021 NM_015710.3 CN353870.1 EST 1 1339 1410.011.1-T_at
-0.56169 0.56168682 6.511768 2E-09 1410.011. NM_001885.1 BI561839.1
EST 1 1340 4601.009.2-F_at -0.56154 0.5615434 6.509339 2E-09
4601.009. NM_130439.3 BE789186.1 EST 1 1341 1959.001.1-T_at
-0.56154 0.56153623 6.509218 2E-09 1959.001. NM_000399.2 DB086600.1
EST 1 1342 2335.026.3-T_at 0.561472 0.56147179 6.508127 2E-09
2335.026. NM_212482.1 BX641150.1 mRNA 43 1343 55107.001.1-F_at
-0.56145 0.56144879 6.507738 2E-09 55107.001 NM_018043.4 AY728143.1
mRNA 30 1344 1062.001.1-D_at 0.561342 0.56134161 6.505924 2E-09
1062.001. NM_001813.2 CQ715352.1 GENBANK_PATENT 1 1345
6876.002.1-B_at -0.56132 0.56132281 6.505606 2E-09 6876.002.
NM_001001522. DB262921.1 EST 1 1346 358.018.1-D_at -0.56116
0.56116002 6.502851 2E-09 358.018.1 NM_198098.1 BI765065.1 EST 1
1347 4781.004.1-F_at -0.5611 0.56110421 6.501907 2E-09 4781.004.
NM_005596.1 BG742798.1 EST 4 1348 8404.028.3-F_at -0.56107
0.56107051 6.501338 2E-09 8404.028. NM_004684.2 CQ727530.1
GENBANK_PATENT 1 1349 11130.004.1-T_at 0.561027 0.56102703 6.500602
2E-09 11130.004 NM_001005414. BQ065119.1 EST 1 1350 2568.002.2-B_at
-0.56101 0.56100825 6.500285 2E-09 2568.002. NM_014211.1 DB235581.1
EST 1 1351 29089.004.1-T_at 0.560878 0.56087834 6.498089 2E-09
29089.004 NM_014176.1 AV727151.1 EST 1 1352 57685.005.1-B_at
-0.5608 0.56079992 6.496763 2E-09 57685.005 NM_020925.1 CQ721664.1
GENBANK_PATENT 1 1353 7170.016.3-T_at 0.560753 0.56075324 6.495974
2E-09 7170.016. NM_153649.2 BF575596.1 EST 1 1354 10440.003.1-T_at
0.560736 0.56073635 6.495689 2E-09 10440.003 NM_006335.1 BG492850.1
EST 1 1355 2335.017.1-F_at 0.560696 0.56069643 6.495015 2E-09
2335.017. NM_212482.1 CQ896577.1 GENBANK_PATENT 4 1356 2.002.1-D_at
-0.56056 0.56056211 6.492745 2E-09 2.002.1 NM_000014.4 CQ672194.1
GENBANK_PATENT 1 1357 9055.018.1-D_at 0.56056 0.56056001 6.49271
2E-09 9055.018. NM_003981.2 DA033856.1 EST 1 1358 64151.003.1-T_at
0.56055 0.56055011 6.492543 2E-09 64151.003 NM_022346.3 BG202075.1
EST 1 1359 59342.002.1-B_at -0.5605 0.56049557 6.491622 2E-09
59342.002 NM_021626.1 BP338281.1 EST 1 1360 7169.007.1-F_at
-0.56034 0.56033824 6.488965 2E-09 7169.007. NM_213674.1 BQ923578.1
EST 67 1361 7170.026.1-C_at 0.560224 0.5602241 6.487039 2E-09
7170.026. NM_153649.2 BQ933569.1 EST 1 1362 667.010.1-B_at -0.56012
0.56011837 6.485255 2E-09 667.010.1 NM_183380.1 DA361412.1 EST 1
1363 4781.010.1-F_at -0.56006 0.56006097 6.484286 2E-09 4781.010.
NM_005596.1 BX648845.1 mRNA 3 1364 10051.001.1-T_at 0.560051
0.56005099 6.484118 2E-09 10051.001 NM_001002799. BC106033.1 mRNA
52 1365 7113.004.1-C_at -0.56001 0.56001252 6.483469 2E-09
7113.004. NM_005656.2 CQ976405.1 GENBANK_PATENT 2 1366
140885.010.2-F -0.55988 0.55988455 6.481311 2E-09 140885.01
NM_080792.2 CQ728313.1 GENBANK_PATENT 1 1367 29997.019.1-F_at
-0.55983 0.55982573 6.480319 2E-09 29997.019 NM_015710.3 BF771953.1
EST 1 1368 2335.013.1-T_at 0.559752 0.55975189 6.479074 2E-09
2335.013. NM_212482.1 AL551632.3 EST 2 1369 7170.017.1-D_at 0.55967
0.55967009 6.477696 2E-09 7170.017. NM_153649.2 BF574676.1 EST 1
1370 219972.004.1-F -0.55958 0.55957847 6.476152 2E-09 219972.00
XM_166227.6 DA946058.1 EST 1 1371 22974.010.1-E_at 0.559421
0.55942061 6.473493 2E-09 22974.010 NM_012112.4 DB096591.1 EST 1
1372 2982.011.1-T_at -0.55932 0.55932229 6.471837 2E-09 2982.011.
NM_000856.2 BX649180.1 mRNA 10 1373 152015.005.1-F -0.55929
0.55929021 6.471297 2E-09 152015.00 NM_001012337. CQ732372.1
GENBANK_PATENT 1 1374 3914.001.1-C_at -0.5592 0.55919902 6.469761
2E-09 3914.001. NM_000228.2 CQ921791.1 GENBANK_PATENT 2 1375
7168.012.2-B_at -0.55912 0.55911961 6.468425 2E-09 7168.012.
NM_001018020. AK129882.1 mRNA 2 1376 1938.024.1-C_at -0.55904
0.55903817 6.467054 2E-09 1938.024. NM_001961.3 BE747136.1 EST 1
1377 10051.004.1-T_at 0.559001 0.55900072 6.466424 2E-09 10051.004
NM_001002799. DB144219.1 EST 1 1378 2335.006.1-B_at 0.55897
0.55897034 6.465913 2E-09 2335.006. NM_212482.1 CX785805.1 EST 1
1379 57447.028.1-E_at -0.55892 0.55891938 6.465056 2E-09 57447.028
NM_201535.1 DA205446.1 EST 1 1380 2893.001.1-T_at -0.5589
0.55890095 6.464746 2E-09 2893.001. NM_000829.1 DA258118.1 EST 1
1381 4288.005.1-F_at 0.558883 0.55888308 6.464445 2E-09 4288.005.
NM_002417.2 BM455229.1 EST 1 1382 2938.007.1-T_at -0.55888
0.55887858 6.464369 2E-09 2938.007. NM_145740.2 AX477713.1
GENBANK_PATENT 1 1383 29127.020.1-T_at 0.558848 0.55884819 6.463858
2E-09 29127.020 NM_013277.2 DB089267.1 EST 1 1384 154810.002.1-T
-0.55861 0.55861375 6.459916 2E-09 154810.00 NM_130847.1 AX886249.1
GENBANK_PATENT 1 1385 9232.001.1-T_at 0.558605 0.55860527 6.459774
2E-09 9232.001.
NM_004219.2 CN285866.1 EST 1 1386 55214.004.1-T_at -0.55803
0.55802814 6.450079 3E-09 55214.004 NM_018192.2 DA953365.1 EST 1
1387 79971.002.1-B_at -0.55798 0.5579779 6.449236 3E-09 79971.002
NM_001002292. CQ720425.1 GENBANK_PATENT 1 1388 3977.002.1-T_at
-0.55793 0.55793279 6.448479 3E-09 3977.002. NM_002310.3 DR005799.1
EST 1 1389 7170.028.1-F_at 0.557857 0.5578569 6.447206 3E-09
7170.028. NM_153649.2 BQ220396.1 EST 2 1390 1410.009.1-E_at
-0.55785 0.55784993 6.447089 3E-09 1410.009. NM_001885.1 BQ437433.1
EST 2 1391 4781.004.1-T_at -0.55762 0.55762387 6.443297 3E-09
4781.004. NM_005596.1 BG742798.1 EST 4 1392 9413.002.2-T_at
-0.55755 0.5575481 6.442026 3E-09 9413.002. NM_004816.2 AW779892.1
EST 1 1393 25925.005.1-T_at -0.55744 0.55744483 6.440295 3E-09
25925.005 NM_015461.1 DB285938.1 EST 1 1394 55366.002.1-T_at
-0.55743 0.55743398 6.440113 3E-09 55366.002 NM_018490.1 BC033039.2
mRNA 3 1395 6288.001.1-E_at -0.55742 0.55742086 6.439893 3E-09
6288.001. NM_199161.1 AX899121.1 GENBANK_PATENT 2 1396
2335.025.2-C_at 0.557411 0.55741092 6.439727 3E-09 2335.025.
NM_212482.1 CQ715726.1 GENBANK_PATENT 3 1397 2335.004.1-F_at
0.557345 0.55734468 6.438616 3E-09 2335.004. NM_212482.1 AU139388.1
EST 1 1398 7170.038.1-F_at 0.557344 0.55734423 6.438609 3E-09
7170.038. NM_153649.2 BG425254.1 EST 2 1399 7373.003.3-B_at
-0.55728 0.55728249 6.437574 3E-09 7373.003. NM_021110.1 CQ716670.1
GENBANK_PATENT 1 1400 5744.003.2-B_at -0.55713 0.55713472 6.435099
3E-09 5744.003. NM_198965.1 BG680355.1 EST 1 1401 1164.001.1-F_at
0.556978 0.5569777 6.432469 3E-09 1164.001. NM_001827.1 AX971617.1
GENBANK_PATENT 1 1402 23266.005.1-T_at -0.55685 0.55685184 6.430362
3E-09 23266.005 NM_012302.2 DA764511.1 EST 1 1403 4601.015.2-F_at
-0.55673 0.55673111 6.428342 3E-09 4601.015. NM_130439.3 DA279837.1
EST 1 1404 23092.009.1-D_at -0.55669 0.55668653 6.427596 3E-09
23092.009 NM_015071.2 BM045740.1 EST 1 1405 83699.004.1-T_at
-0.55668 0.55667613 6.427422 3E-09 83699.004 NM_031469.1 AX980231.1
GENBANK_PATENT 1 1406 2982.013.1-T_at -0.55666 0.55665713 6.427104
3E-09 2982.013. NM_000856.2 CF594362.1 EST 1 1407 26289.013.1-F_at
-0.55662 0.55662356 6.426543 3E-09 26289.013 NM_174858.1 CK024190.1
EST 1 1408 7113.003.1-F_at -0.55657 0.5565676 6.425607 3E-09
7113.003. NM_005656.2 CQ976404.1 GENBANK_PATENT 2 1409
390.003.1-T_at -0.55648 0.55648155 6.424167 3E-09 390.003.1
NM_005168.3 DA532407.1 EST 1 1410 6304.002.2-T_at -0.55641
0.55641323 6.423025 3E-09 6304.002. NM_002971.2 BC001744.1 mRNA 33
1411 6304.009.2-T_at -0.55633 0.55633335 6.42169 3E-09 6304.009.
NM_002971.2 DA497369.1 EST 1 1412 3872.017.1-T_at -0.55631
0.55631309 6.421351 3E-09 3872.017. NM_000422.1 BX378477.2 EST 1
1413 2335.013.1-D_at 0.556298 0.55629818 6.421102 3E-09 2335.013.
NM_212482.1 AL551632.3 EST 2 1414 6790.001.1-T_at 0.556293
0.55629311 6.421017 3E-09 6790.001. NM_198436.1 D84212.1 mRNA 8
1415 51201.007.1-B_at -0.55615 0.55614867 6.418603 3E-09 51201.007
NM_016353.2 BF541714.1 EST 1 1416 54443.009.1-T_at 0.55614
0.5561397 6.418453 3E-09 54443.009 NM_018685.2 DA242046.1 EST 1
1417 54443.012.1-F_at 0.556003 0.55600288 6.416167 3E-09 54443.012
NM_018685.2 BG167656.1 EST 1 1418 5608.003.1-D_at -0.55592
0.55592463 6.41486 3E-09 5608.003. NM_002758.2 BP220368.1 EST 1
1419 2.005.1-B_at -0.55591 0.55590928 6.414604 3E-09 2.005.1
NM_000014.4 BI493707.1 EST 1 1420 23015.010.2-F_at -0.55591
0.55590628 6.414554 3E-09 23015.010 NM_181076.2 XM_497449.1 REFSEQ
1 1421 25925.010.1-T_at -0.55586 0.55585644 6.413722 3E-09
25925.010 NM_015461.1 DA215395.1 EST 1 1422 79745.002.2-T_at
-0.55584 0.55584433 6.413519 3E-09 79745.002 NM_024692.3 DB034631.1
EST 2 1423 23650.007.1-E_at -0.55581 0.55580568 6.412874 3E-09
23650.007 NM_058193.1 BX395679.2 EST 1 1424 953.013.1-B_at -0.55579
0.55578981 6.412609 3E-09 953.013.1 NM_001776.3 CQ721824.1
GENBANK_PATENT 1 1425 7153.002.5-C_at 0.555743 0.55574323 6.411832
3E-09 7153.002. NM_001067.2 CQ735949.1 GENBANK_PATENT 114 1426
4240.001.1-T_at -0.55574 0.55573744 6.411735 3E-09 4240.001.
NM_005928.1 BF525404.1 EST 1 1427 58499.005.1-T_at -0.55571
0.55571242 6.411317 3E-09 58499.005 NM_021224.3 BI461756.1 EST 1
1428 7168.026.1-C_at -0.55559 0.55558982 6.409271 3E-09 7168.026.
NM_001018020. CV810859.1 EST 1 1429 8404.026.1-T_at -0.55558
0.55558292 6.409156 3E-09 8404.026. NM_004684.2 BX647713.1 mRNA 141
1430 94274.002.1-D_at -0.55557 0.55557226 6.408978 3E-09 94274.002
NM_033256.1 CQ730829.1 GENBANK_PATENT 1 1431 301.008.1-C_at
-0.55554 0.55553521 6.40836 3E-09 301.008.1 NM_000700.1 CD688703.1
EST 1 1432 3426.001.1-C_at -0.55549 0.55548513 6.407525 3E-09
3426.001. NM_000204.1 BC020718.1 mRNA 165 1433 2938.007.2-B_at
-0.55543 0.55543318 6.406658 3E-09 2938.007. NM_145740.2 AX477713.1
GENBANK_PATENT 1 1434 7373.003.5-C_at -0.55538 0.55537917 6.405757
3E-09 7373.003. NM_021110.1 CQ716670.1 GENBANK_PATENT 1 1435
7169.001.2-F_at -0.55536 0.55535866 6.405415 3E-09 7169.001.
NM_213674.1 BM809268.1 EST 4 1436 2119.007.1-F_at -0.55522
0.5552225 6.403145 3E-09 2119.007. NM_004454.1 BE408130.1 EST 1
1437 1959.001.2-T_at -0.55498 0.55498357 6.399162 3E-09 1959.001.
NM_000399.2 DB086600.1 EST 1 1438 9824.006.1-T_at 0.55476
0.55475962 6.395432 3E-09 9824.006. NM_014783.2 CK903028.1 EST 2
1439 301.013.1-B_at -0.55475 0.55475105 6.395289 3E-09 301.013.1
NM_000700.1 BF130804.1 EST 1 1440 10124.004.1-B_at -0.55458
0.55458304 6.392491 3E-09 10124.004 NM_001037164. BU661374.1 EST 12
1441 140885.010.3-F -0.55438 0.55438483 6.389193 3E-09 140885.01
NM_080792.2 CQ728313.1 GENBANK_PATENT 1 1442 54443.012.1-B_at
0.554381 0.5543815 6.389137 3E-09 54443.012 NM_018685.2 BG167656.1
EST 1 1443 29997.008.1-F_at -0.55437 0.554365 6.388863 3E-09
29997.008 NM_015710.3 BI871613.1 EST 1 1444 23092.002.1-T_at
-0.55436 0.55435963 6.388774 3E-09 23092.002 NM_015071.2 CQ732129.1
GENBANK_PATENT 1 1445 1308.009.1-E_at -0.55427 0.55427197 6.387315
3E-09 1308.009. NM_130778.1 DA425187.1 EST 1 1446 1308.004.1-C_at
-0.55418 0.55418499 6.385868 3E-09 1308.004. NM_130778.1 BE615666.1
EST 1 1447 59342.003.1-B_at -0.55416 0.55416164 6.38548 3E-09
59342.003 NM_021626.1 DA821057.1 EST 1 1448 2119.006.1-F_at
-0.55414 0.55413804 6.385088 3E-09 2119.006. NM_004454.1 DB094869.1
EST 1 1449 6304.011.2-T_at -0.55412 0.55411832 6.38476 3E-09
6304.011. NM_002971.2 BP359118.1 EST 1 1450 4288.006.2-D_at
0.553943 0.5539433 6.38185 3E-09 4288.006. NM_002417.2 BP363635.1
EST 1 1451 358.017.1-D_at -0.55393 0.5539341 6.381697 3E-09
358.017.1 NM_198098.1 AY312580.1 mRNA 1 1452 29994.009.1-D_at
-0.55389 0.55388615 6.380901 4E-09 29994.009 NM_013450.1 DA218896.1
EST 1 1453 23650.006.1-T_at -0.55388 0.55387924 6.380786 4E-09
23650.006 NM_058193.1 BE304682.1 EST 1 1454 3945.024.1-T_at -0.5538
0.55379733 6.379425 4E-09 3945.024. NM_002300.3 BF127786.1 EST 1
1455 9073.003.1-T_at -0.55367 0.55367412 6.377378 4E-09 9073.003.
NM_199328.1 BP276390.1 EST 1 1456 55165.004.1-B_at 0.553669
0.55366932 6.377298 4E-09 55165.004 NM_018131.3 BX416068.2 EST 1
1457 54928.003.1-C_at -0.55352 0.55352466 6.374896 4E-09 54928.003
NM_017813.2 DB283344.1 EST 1 1458 489.006.1-C_at -0.55341
0.55340971 6.372987 4E-09 489.006.1 NM_174958.1 CV379840.1 EST 1
1459 6122.030.1-T_at -0.55337 0.55337311 6.37238 4E-09 6122.030.
NM_000967.3 BF315041.1 EST 1 1460 4781.014.2-T_at -0.55315
0.55315167 6.368705 4E-09 4781.014. NM_005596.1 DN918235.1 EST 1
1461 7168.014.3-B_at -0.55307 0.55307042 6.367357 4E-09 7168.014.
NM_001018020. BP257563.1 EST 1 1462 4147.003.1-F_at -0.55281
0.55280885 6.36302 4E-09 4147.003. NM_002380.3 AY358895.1 mRNA 81
1463 57451.001.3-B_at -0.55273 0.55273245 6.361754 4E-09 57451.001
XM_931456.1 CS188752.1 GENBANK_PATENT 1 1464 9055.018.1-T_at
0.552521 0.55252074 6.358246 4E-09 9055.018. NM_003981.2 DA033856.1
EST 1 1465 4931.013.1-T_at 0.552443 0.552443 6.356958 4E-09
4931.013. NM_002533.2 BG771162.1 EST 1 1466 7169.001.1-T_at
-0.55242 0.55241607 6.356513 4E-09 7169.001. NM_213674.1 BM809268.1
EST 4 1467 2568.005.1-B_at -0.55241 0.55241426 6.356483 4E-09
2568.005. NM_014211.1 AK055205.1 mRNA 11 1468 4435.001.1-T_at
-0.5524 0.55240125 6.356267 4E-09 4435.001. NM_004143.2 AA317379.1
EST 1 1469 2335.006.1-F_at 0.552355 0.55235498 6.355501 4E-09
2335.006. NM_212482.1 CX785805.1 EST 1 1470 55294.007.1-T_at
-0.55234 0.55234085 6.355267 4E-09 55294.007 NM_033632.2 BF380630.1
EST 1 1471 4288.006.2-B_at 0.55233 0.55233026 6.355092 4E-09
4288.006. NM_002417.2 BP363635.1 EST 1 1472 29089.003.1-F_at
0.552316 0.55231581 6.354852 4E-09 29089.003 NM_014176.1 AV740591.1
EST 1 1473 2335.032.1-F_at 0.55229 0.55228962 6.354419 4E-09
2335.032. NM_212482.1 DA647475.1 EST 1 1474 57162.003.1-T_at
-0.55221 0.55220544 6.353025 4E-09 57162.003 NM_020651.2 BX380539.2
EST 3 1475 4288.005.1-B_at 0.552168 0.5521684 6.352412 4E-09
4288.005. NM_002417.2 BM455229.1 EST 1 1476 3860.004.1-T_at
-0.55215 0.5521477 6.35207 4E-09 3860.004. NM_153490.1 DA763721.1
EST 1 1477 2.018.1-F_at -0.55206 0.55205696 6.350568 4E-09 2.018.1
NM_000014.4 DB090657.1 EST 1 1478 23015.010.2-C_at -0.55198
0.55198079 6.349308 4E-09 23015.010 NM_181076.2 XM_497449.1 REFSEQ
1 1479 6122.029.1-F_at -0.55188 0.55188275 6.347686 4E-09 6122.029.
NM_000967.3 BG547902.1 EST 1 1480 7113.007.1-E_at -0.55181
0.55181118 6.346503 4E-09 7113.007. NM_005656.2 DR005196.1 EST 1
1481 2982.001.1-T_at -0.55178 0.55177855 6.345963 4E-09 2982.001.
NM_000856.2 DA793192.1 EST 1 1482 56999.003.1-C_at -0.55176
0.55175685 6.345604 4E-09 56999.003 NM_182920.1 CQ721254.1
GENBANK_PATENT 1 1483 152015.005.1-B -0.55166 0.55165647 6.343945
4E-09 152015.00 NM_001012337. CQ732372.1 GENBANK_PATENT 1 1484
1410.002.1-T_at -0.55165 0.55165464 6.343914 4E-09 1410.002.
NM_001885.1 AX899073.1 GENBANK_PATENT 4 1485 7373.004.1-B_at
-0.55161 0.55160828 6.343148 4E-09 7373.004. NM_021110.1 M64109.1
mRNA 1 1486 492304.010.1-T -0.5516 0.55160004 6.343012 4E-09
492304.01 -- -- -- -- 1487 80034.003.2-T_at -0.55149 0.55148932
6.341182 4E-09 80034.003 NM_024969.2 CQ733306.1 GENBANK_PATENT 1
1488 4281.009.1-F_at -0.55134 0.55133895 6.338698 4E-09 4281.009.
NM_033290.1 AY540014.1 mRNA 1 1489 301.011.1-B_at -0.5513
0.55130021 6.338058 4E-09 301.011.1 NM_000700.1 BG435248.1 EST 1
1490 90293.002.2-T_at -0.55112 0.55112335 6.335138 4E-09 90293.002
NM_033495.2 BP360232.1 EST 1 1491 800.013.1-C_at -0.55112
0.55112102 6.335099 4E-09 800.013.1 NM_033138.2 NM_033157.2 REFSEQ
151 1492 142.011.1-T_at 0.550921 0.55092062 6.331791 4E-09
142.011.1 NM_001618.2 DA757025.1 EST 1 1493 6876.017.1-T_at
-0.55079 0.55078992 6.329635 4E-09 6876.017. NM_001001522.
BX428130.2 EST 1 1494 825.021.1-D_at -0.55076 0.55076446 6.329215
4E-09 825.021.1 NM_212464.1 AV645796.1 EST 1 1495 714.002.1-F_at
-0.5507 0.55069829 6.328124 4E-09 714.002.1 NM_172369.2 AX894785.1
GENBANK_PATENT 1 1496 2335.039.1-C_at 0.550688 0.55068782 6.327951
4E-09 2335.039. NM_212482.1 BP288118.1 EST 1 1497 2.024.2-D_at
-0.55068 0.55068374 6.327884 4E-09 2.024.2 NM_000014.4 DB286897.1
EST 1 1498 9037.004.2-T_at -0.55067 0.55066904 6.327641 4E-09
9037.004. NM_003966.1 BF923022.1 EST 1 1499 4781.006.2-D_at
-0.55052 0.55051889 6.325165 5E-09 4781.006. NM_005596.1 AK131233.1
mRNA 2 1500 4601.012.1-T_at -0.55051 0.55051321 6.325072 5E-09
4601.012. NM_130439.3 DA746301.1 EST 1 1501 4781.009.2-B_at
-0.55048 0.55048372 6.324586 5E-09 4781.009. NM_005596.1 CQ732556.1
GENBANK_PATENT 1 1502 7169.004.1-F_at -0.55041 0.55041381 6.323433
5E-09 7169.004. NM_213674.1 BG027526.1 EST 1 1503 54443.010.1-C_at
0.550402 0.55040232 6.323244 5E-09 54443.010 NM_018685.2 DA196444.1
EST 1 1504 7818.023.1-F_at 0.550382 0.55038162 6.322903 5E-09
7818.023. NM_004632.2 BQ424083.1 EST 1 1505 79971.009.2-T_at
-0.55036 0.5503562 6.322484 5E-09 79971.009 NM_001002292.
DA264864.1 EST 1 1506 4601.007.1-T_at -0.55036 0.5503552 6.322467
5E-09 4601.007. NM_130439.3 DA009519.1 EST 1 1507 7113.011.2-D_at
-0.55032 0.55031657 6.321831 5E-09 7113.011. NM_005656.2 DA868984.1
EST 1 1508 54443.008.1-B_at 0.550158 0.5501582 6.319222 5E-09
54443.008 NM_018685.2 DB172145.1 EST 1 1509 23092.009.2-D_at
-0.55009 0.5500931 6.318149 5E-09 23092.009 NM_015071.2 BM045740.1
EST 1 1510 57447.006.1-E_at -0.55005 0.55004557 6.317367 5E-09
57447.006 NM_201535.1 DA283861.1 EST 4
1511 7170.035.2-B_at 0.549889 0.54988872 6.314784 5E-09 7170.035.
NM_153649.2 BF575164.1 EST 1 1512 79971.010.1-T_at -0.54986
0.54986373 6.314373 5E-09 79971.010 NM_001002292. CB268343.1 EST 1
1513 4288.004.1-T_at 0.549863 0.54986337 6.314367 5E-09 4288.004.
NM_002417.2 BP232141.1 EST 1 1514 59342.006.1-T_at -0.54953
0.54953056 6.308891 5E-09 59342.006 NM_021626.1 BP196952.1 EST 1
1515 4781.017.1-T_at -0.54938 0.54938028 6.30642 5E-09 4781.017.
NM_005596.1 DR002043.1 EST 1 1516 4781.013.2-B_at -0.54937
0.54936792 6.306216 5E-09 4781.013. NM_005596.1 DA750893.1 EST 1
1517 23015.010.3-E_at -0.54933 0.54932704 6.305544 5E-09 23015.010
NM_181076.2 XM_497449.1 REFSEQ 1 1518 9055.013.1-B_at 0.548993
0.54899327 6.30006 5E-09 9055.013. NM_003981.2 CN348395.1 EST 1
1519 5621.003.1-T_at -0.54894 0.54894022 6.299188 5E-09 5621.003.
NM_000311.2 BP218622.1 EST 1 1520 2893.006.1-T_at -0.5488
0.54880253 6.296927 5E-09 2893.006. NM_000829.1 BF669210.1 EST 1
1521 3161.007.1-F_at 0.548622 0.54862189 6.293962 5E-09 3161.007.
NM_012484.1 BG198860.1 EST 1 1522 55107.001.1-T_at -0.54841
0.548412 6.290518 5E-09 55107.001 NM_018043.4 AY728143.1 mRNA 30
1523 2327.002.1-C_at -0.54819 0.54819208 6.286911 5E-09 2327.002.
NM_001460.2 CD684429.1 EST 1 1524 3945.014.1-B_at -0.54812
0.54812393 6.285794 5E-09 3945.014. NM_002300.3 BG402389.1 EST 1
1525 151438.003.1-C -0.54801 0.54801484 6.284006 5E-09 151438.00
AK055877.1 DB124570.1 EST 2 1526 7113.013.1-E_at -0.54795
0.54795303 6.282993 5E-09 7113.013. NM_005656.2 DA627080.1 EST 1
1527 441417.001.1-B -0.54784 0.54783722 6.281095 5E-09 441417.00
XM_497039.2 XM_933326.1 REFSEQ 3 1528 2982.012.1-F_at -0.54781
0.54781217 6.280685 6E-09 2982.012. NM_000856.2 BC012627.1 mRNA 2
1529 7168.005.3-E_at -0.54767 0.54766942 6.278347 6E-09 7168.005.
NM_001018020. BP373012.1 EST 1 1530 27338.001.1-B_at 0.547668
0.54766773 6.27832 6E-09 27338.001 NM_014501.1 BI198504.1 EST 3
1531 8404.028.1-B_at -0.54766 0.54766289 6.27824 6E-09 8404.028.
NM_004684.2 CQ727530.1 GENBANK_PATENT 1 1532 4601.019.1-F_at
-0.54764 0.54764478 6.277944 6E-09 4601.019. NM_130439.3 BQ425277.1
EST 1 1533 8404.008.1-B_at -0.54752 0.54751598 6.275835 6E-09
8404.008. NM_004684.2 DA342341.1 EST 1 1534 23266.008.3-F_at
-0.54739 0.54739477 6.273851 6E-09 23266.008 NM_012302.2 CQ799210.1
GENBANK_PATENT 1 1535 4931.012.1-F_at 0.547302 0.54730211 6.272335
6E-09 4931.012. NM_002533.2 BQ930348.1 EST 1 1536 10010.007.1-E_at
-0.54712 0.54711818 6.269326 6E-09 10010.007 NM_004180.2 AI525053.1
EST 1 1537 11065.003.1-B_at 0.54698 0.54697977 6.267063 6E-09
11065.003 NM_181802.1 CS138819.1 GENBANK_PATENT 5 1538
3925.016.1-C_at 0.546859 0.5468594 6.265095 6E-09 3925.016.
NM_203399.1 BE888426.1 EST 1 1539 7170.017.1-C_at 0.546805
0.54680477 6.264203 6E-09 7170.017. NM_153649.2 BF574676.1 EST 1
1540 301.011.1-F_at -0.54668 0.54668114 6.262183 6E-09 301.011.1
NM_000700.1 BG435248.1 EST 1 1541 57685.005.2-T_at -0.54663
0.54663145 6.261371 6E-09 57685.005 NM_020925.1 CQ721664.1
GENBANK_PATENT 1 1542 23015.014.1-T_at -0.54659 0.54658979 6.26069
6E-09 23015.014 NM_181076.2 DA928720.1 EST 1 1543 7153.002.3-T_at
0.546559 0.54655896 6.260187 6E-09 7153.002. NM_001067.2 CQ735949.1
GENBANK_PATENT 114 1544 2568.005.2-D_at -0.5465 0.5464996 6.259217
6E-09 2568.005. NM_014211.1 AK055205.1 mRNA 11 1545 2335.039.1-F_at
0.546413 0.5464132 6.257806 6E-09 2335.039. NM_212482.1 BP288118.1
EST 1 1546 10124.002.1-F_at -0.5464 0.54640453 6.257665 6E-09
10124.002 NM_001037164. BG178114.1 EST 6 1547 283299.003.1-D
-0.5461 0.54610398 6.252759 6E-09 283299.00 XM_498506.1 XM_932188.1
REFSEQ 1 1548 4781.013.1-T_at -0.54585 0.54585341 6.248672 6E-09
4781.013. NM_005596.1 DA750893.1 EST 1 1549 7170.012.2-D_at
0.545774 0.545774 6.247378 6E-09 7170.012. NM_153649.2 DA893534.1
EST 1 1550 667.014.1-T_at -0.54573 0.54572906 6.246645 6E-09
667.014.1 NM_183380.1 CQ851391.1 GENBANK_PATENT 1 1551
4781.009.2-D_at -0.54569 0.54568951 6.246 6E-09 4781.009.
NM_005596.1 CQ732556.1 GENBANK_PATENT 1 1552 7169.001.1-D_at
-0.54565 0.54565203 6.24539 6E-09 7169.001. NM_213674.1 BM809268.1
EST 4 1553 2161.001.1-T_at 0.545644 0.54564352 6.245251 6E-09
2161.001. NM_000505.2 AX147449.1 GENBANK_PATENT 30 1554
1308.001.1-F_at -0.5456 0.54560226 6.244578 6E-09 1308.001.
NM_130778.1 BM773425.1 EST 1 1555 7168.012.2-D_at -0.54541
0.54540889 6.241428 7E-09 7168.012. NM_001018020. AK129882.1 mRNA 2
1556 10010.004.1-E_at -0.54541 0.54540884 6.241427 7E-09 10010.004
NM_004180.2 BM750784.1 EST 1 1557 54443.009.1-D_at 0.545394
0.54539371 6.241181 7E-09 54443.009 NM_018685.2 DA242046.1 EST 1
1558 7039.002.1-D_at -0.54538 0.54537813 6.240927 7E-09 7039.002.
NM_003236.1 AF149096.1 mRNA 2 1559 57447.041.1-B_at -0.54524
0.54523712 6.23863 7E-09 57447.041 NM_201535.1 DA295124.1 EST 1
1560 4281.007.1-B_at -0.54521 0.54521491 6.238269 7E-09 4281.007.
NM_033290.1 AY540023.1 mRNA 2 1561 301.009.1-T_at -0.54517
0.54516544 6.237463 7E-09 301.009.1 NM_000700.1 CD357777.1 EST 2
1562 9055.014.1-F_at 0.545101 0.54510063 6.236408 7E-09 9055.014.
NM_003981.2 BE300335.1 EST 1 1563 79971.013.1-T_at -0.54495
0.54494911 6.233942 7E-09 79971.013 NM_001002292. DA878291.1 EST 1
1564 11065.003.2-T_at 0.544945 0.5449453 6.23388 7E-09 11065.003
NM_181802.1 CS138819.1 GENBANK_PATENT 5 1565 7113.009.1-E_at
-0.54493 0.54493426 6.233701 7E-09 7113.009. NM_005656.2 DA873416.1
EST 1 1566 51203.002.2-T_at 0.544867 0.54486653 6.232599 7E-09
51203.002 NM_016359.2 AL561514.3 EST 1 1567 7170.006.1-B_at 0.54486
0.54486029 6.232497 7E-09 7170.006. NM_153649.2 DB003864.1 EST 1
1568 80034.002.1-T_at -0.54484 0.54484345 6.232223 7E-09 80034.002
NM_024969.2 DA769284.1 EST 1 1569 1345.012.1-D_at 0.544806
0.54480624 6.231618 7E-09 1345.012. NM_004374.2 DB564533.1 EST 1
1570 8321.004.1-T_at -0.54478 0.54477916 6.231178 7E-09 8321.004.
NM_003505.1 AA249884.1 EST 1 1571 10461.001.1-T_at -0.54469
0.54468608 6.229664 7E-09 10461.001 NM_006343.2 CQ760423.1
GENBANK_PATENT 4 1572 4601.010.1-T_at -0.54466 0.54466418 6.229308
7E-09 4601.010. NM_130439.3 CS031066.1 GENBANK_PATENT 3 1573
3709.004.1-E_at -0.54444 0.54444277 6.225708 7E-09 3709.004.
NM_002223.1 BP364657.1 EST 1 1574 4781.017.2-T_at -0.5444
0.54440035 6.225019 7E-09 4781.017. NM_005596.1 DR002043.1 EST 1
1575 5621.010.1-B_at -0.54431 0.54431029 6.223555 7E-09 5621.010.
NM_000311.2 DA174560.1 EST 1 1576 54763.001.1-T_at -0.54431
0.54430594 6.223485 7E-09 54763.001 NM_017578.2 BI465233.1 EST 4
1577 306.003.1-B_at -0.54429 0.54428587 6.223159 7E-09 306.003.1
NM_005139.1 CQ721707.1 GENBANK_PATENT 1 1578 2335.035.1-C_at
0.544238 0.54423813 6.222383 7E-09 2335.035. NM_212482.1 CX755647.1
EST 1 1579 4601.015.1-T_at -0.54414 0.54413917 6.220776 7E-09
4601.015. NM_130439.3 DA279837.1 EST 1 1580 7168.038.1-D_at
-0.54409 0.54408836 6.219951 7E-09 7168.038. NM_001018020.
AK092573.1 mRNA 5 1581 55732.003.1-T_at 0.543852 0.54385205
6.216114 7E-09 55732.003 NM_018186.2 DA733233.1 EST 2 1582
23266.001.1-T_at -0.54381 0.54380864 6.21541 7E-09 23266.001
NM_012302.2 AK123422.1 mRNA 2 1583 4288.006.2-E_at 0.543777
0.54377742 6.214903 7E-09 4288.006. NM_002417.2 BP363635.1 EST 1
1584 4781.013.2-D_at -0.54375 0.54374747 6.214417 7E-09 4781.013.
NM_005596.1 DA750893.1 EST 1 1585 259266.001.1-B 0.543672
0.54367202 6.213193 7E-09 259266.00 NM_018136.2 BC034607.1 mRNA 7
1586 7170.029.1-F_at 0.543574 0.54357435 6.211608 8E-09 7170.029.
NM_153649.2 BM011010.1 EST 1 1587 51201.007.1-T_at -0.54346
0.5434567 6.2097 8E-09 51201.007 NM_016353.2 BF541714.1 EST 1 1588
7169.002.1-F_at -0.54328 0.54327991 6.206834 8E-09 7169.002.
NM_213674.1 AL555921.3 EST 1 1589 8404.028.1-T_at -0.54323
0.5432313 6.206046 8E-09 8404.028. NM_004684.2 CQ727530.1
GENBANK_PATENT 1 1590 4781.015.1-T_at -0.54315 0.54314788 6.204695
8E-09 4781.015. NM_005596.1 DN995118.1 EST 1 1591 9055.012.1-T_at
0.543077 0.54307679 6.203543 8E-09 9055.012. NM_003981.2 BE298728.1
EST 1 1592 2893.004.1-T_at -0.5429 0.54289557 6.200607 8E-09
2893.004. NM_000829.1 DA066848.1 EST 1 1593 91653.015.1-T_at
-0.54284 0.54283984 6.199705 8E-09 91653.015 NM_033254.2 R75666.1
EST 1 1594 10010.001.1-T_at -0.54281 0.54280637 6.199163 8E-09
10010.001 NM_004180.2 DA670701.1 EST 6 1595 1410.003.2-T_at
-0.54281 0.54280581 6.199154 8E-09 1410.003. NM_001885.1 AX899079.1
GENBANK_PATENT 1 1596 6595.013.1-B_at -0.54268 0.54268082 6.19713
8E-09 6595.013. NM_003070.3 DA825858.1 EST 1 1597 4601.009.1-T_at
-0.54264 0.54264498 6.19655 8E-09 4601.009. NM_130439.3 BE789186.1
EST 1 1598 23015.009.1-E_at -0.54245 0.5424498 6.193392 8E-09
23015.009 NM_181076.2 CA943083.1 EST 1 1599 2335.024.1-T_at
0.542425 0.54242468 6.192986 8E-09 2335.024. NM_212482.1 CQ731573.1
GENBANK_PATENT 1 1600 23650.009.1-F_at -0.54242 0.54242338 6.192965
8E-09 23650.009 NM_058193.1 BF836741.1 EST 1 1601 11254.001.1-F_at
-0.54238 0.54237719 6.192217 8E-09 11254.001 NM_007231.1 BE819593.1
EST 1 1602 7286.002.1-T_at 0.542342 0.5423416 6.191642 8E-09
7286.002. NM_020127.1 BP315579.1 EST 1 1603 4931.004.1-T_at 0.54224
0.54223963 6.189993 8E-09 4931.004. NM_002533.2 BM693264.1 EST 1
1604 7113.005.1-E_at -0.54224 0.5422385 6.189974 8E-09 7113.005.
NM_005656.2 DA865300.1 EST 1 1605 150572.004.1-F -0.54223
0.54222998 6.189837 8E-09 150572.00 NM_198274.2 BF790590.1 EST 1
1606 57447.002.1-C_at -0.54216 0.54215776 6.188669 8E-09 57447.002
NM_201535.1 BF526188.1 EST 1 1607 1410.002.2-T_at -0.54199
0.54198899 6.185941 8E-09 1410.002. NM_001885.1 AX899073.1
GENBANK_PATENT 4 1608 4316.001.1-F_at -0.54197 0.54197342 6.185689
8E-09 4316.001. NM_002423.3 CQ733055.1 GENBANK_PATENT 1 1609
254042.002.1-E -0.54193 0.54192668 6.184934 8E-09 254042.00
NM_199227.1 AX188221.1 GENBANK_PATENT 7 1610 79971.006.2-B_at
-0.54193 0.54192511 6.184909 8E-09 79971.006 NM_001002292.
DA048370.1 EST 1 1611 1396.001.1-T_at 0.54189 0.54189009 6.184343
8E-09 1396.001. NM_001311.3 N46592.1 EST 2 1612 7153.002.3-D_at
0.541626 0.54162631 6.180082 9E-09 7153.002. NM_001067.2 CQ735949.1
GENBANK_PATENT 114 1613 54443.001.1-F_at 0.541435 0.54143463
6.176988 9E-09 54443.001 NM_018685.2 BC070066.1 mRNA 10 1614
142.012.1-F_at 0.541335 0.54133459 6.175374 9E-09 142.012.1
NM_001618.2 BG900662.1 EST 1 1615 301.013.1-F_at -0.54115
0.54115484 6.172474 9E-09 301.013.1 NM_000700.1 BF130804.1 EST 1
1616 152015.004.1-E -0.54097 0.54096565 6.169423 9E-09 152015.00
NM_001012337. BC015413.1 mRNA 2 1617 8857.001.1-F_at -0.54089
0.54089094 6.168218 9E-09 8857.001. NM_003890.1 CQ730859.1
GENBANK_PATENT 1 1618 6203.002.1-B_at -0.54088 0.54087544 6.167968
9E-09 6203.002. NM_001013.3 AX969894.1 GENBANK_PATENT 1 1619
7168.010.1-D_at -0.54079 0.54078858 6.166568 9E-09 7168.010.
NM_001018020. CD556048.1 EST 1 1620 57447.051.2-C_at -0.54076
0.54076391 6.166171 9E-09 57447.051 NM_201535.1 BX460053.2 EST 1
1621 4288.006.1-T_at 0.540756 0.54075554 6.166036 9E-09 4288.006.
NM_002417.2 BP363635.1 EST 1 1622 54443.013.1-T_at 0.54066
0.54065959 6.16449 9E-09 54443.013 NM_018685.2 BX410228.2 EST 1
1623 9055.017.1-E_at 0.540557 0.54055744 6.162844 9E-09 9055.017.
NM_003981.2 DB031145.1 EST 1 1624 55732.004.1-T_at 0.540487
0.54048721 6.161713 9E-09 55732.004 NM_018186.2 BF216714.1 EST 1
1625 9413.003.2-F_at -0.54047 0.5404689 6.161418 9E-09 9413.003.
NM_004816.2 BX641153.1 mRNA 10 1626 4629.015.1-B_at -0.54046
0.5404569 6.161225 9E-09 4629.015. NM_022844.1 DB284318.1 EST 1
1627 84766.002.2-C_at -0.54045 0.54045424 6.161182 9E-09 84766.002
NM_032680.2 XM_498532.1 REFSEQ 1 1628 11065.008.1-T_at 0.540347
0.5403468 6.159452 9E-09 11065.008 NM_181802.1 NM_181800.1 REFSEQ 5
1629 81704.013.8-F_at -0.54034 0.5403434 6.159398 9E-09 81704.013
NM_203447.1 CQ723361.1 GENBANK_PATENT 1 1630 667.016.1-T_at
-0.54033 0.54032607 6.159119 9E-09 667.016.1 NM_183380.1 DB013737.1
EST 1 1631 29997.004.1-F_at -0.5403 0.54030048 6.158707 1E-08
29997.004 NM_015710.3 BU154441.1 EST 1 1632 2824.001.3-B_at -0.5403
0.54029788 6.158665 1E-08 2824.001. NM_001001994. CQ717842.1
GENBANK_PATENT 1 1633 57447.004.1-B_at -0.54026 0.54025744 6.158014
1E-08 57447.004 NM_201535.1 CD515320.1 EST 2 1634 2982.003.1-T_at
-0.54014 0.54014125 6.156144 1E-08 2982.003. NM_000856.2 DB179470.1
EST 1 1635 4288.005.1-T_at 0.539862 0.53986198 6.151651 1E-08
4288.005. NM_002417.2 BM455229.1 EST 1 1636 10957.018.1-F_at
-0.53982 0.53982225 6.151012 1E-08 10957.018
NM_006813.1 AI547283.1 EST 1 1637 2568.006.2-B_at -0.53981
0.53980996 6.150815 1E-08 2568.006. NM_014211.1 CD385249.1 EST 1
1638 10051.015.2-F_at 0.539796 0.53979645 6.150597 1E-08 10051.015
NM_001002799. BM010546.1 EST 1 1639 2.007.1-F_at -0.53972
0.53972151 6.149392 1E-08 2.007.1 NM_000014.4 BG547500.1 EST 1 1640
5803.003.1-T_at -0.53965 0.53964973 6.148239 1E-08 5803.003.
NM_002851.1 CD672822.1 EST 1 Table 3. Polynucleotides probe sets
that harbor different values between malignant and benign
tumors.
[0531] In order to find subsets of smaller amounts of
polynucleotide probe sets to be used for classifying the benign or
malignant status of tissues, prediction rules were constructed
using the top 50, top 100, top 150 and top 200 polynucleotide probe
sets of Table 4 (with identifiers no 1 to no 50, no 1 to no 100, no
1 to no 150 and no 1 to no 200). The estimated prediction
accuracies by leave-one-out crossvalidation were as follows: [0532]
using the top 50 polynucleotide probe sets: 1 out of 24 patients
with benign status were misclassified and 7 out of 70 patients with
malignant status. [0533] using the top 100 polynucleotide probe
sets: 1 out of 24 patients with benign status were misclassified
and 5 out of 70 patients with malignant status. [0534] using the
top 150 polynucleotide probe sets: 0 out of 24 patients with benign
status were misclassified and 6 out of 70 patients with malignant
status. [0535] using the top 200 polynucleotide probe sets: 0 out
of 24 patients with benign status were misclassified and 4 out of
70 patients with malignant status.
[0536] Table 5 contains the average profiles of the preferred 1,228
signature polynucleotide probe sets with p<10e-9 measured on the
24 benign and 70 malignant tissues of the training set. Thus, the
preferred set of probes to be used for predicting the malignant
status of a tissue of a future patient is reported here.
[0537] An additional 100 patients referred at the Institut Gustave
Roussy for a clinical or radiological breast lesion in 2006-2007
for which a FNA was performed to assess the diagnosis of the breast
lesion has been analyzed by exon profiling. The prediction rule
using the preferred 1228 signature polynucleotide probe sets has
been applied to this independent validation set.
The inventors have developed an optimal prediction rule based on
the methodology reported previously. The preferred p-value
threshold for defining signature genes was p<10e-9. When using
leave-one-out cross-validation to estimate the prediction accuracy
of the prediction rule with this particular threshold, the
inventors accurately classified all the samples as shown in FIG. 4.
This corresponds to a sensitivity of 100% and a specificity of
100%. Table 5 contains the average profiles of the preferred 1228
signature probe sets with p<10e-9 measured on the 20 benign and
74 malignant tissues of the training set. The probes with positive
correlation are those which have increased expression in malignant
tissues, those with negative correlation have increased expression
in the benign tissues.
TABLE-US-00008 TABLE 4 Table 4. Probe sets used to construct
molecular predictor (n = 1228). NO Probeset_Id Symbol RefSeq
Location Transcrit Transcrit Transcrit2 Transcrit2 1
1756.022.2-C_at DMD NM_000109 Xp21.2 1756.022.2 10010.002.1 1756.22
1756.22 2 1756.029.1-D_at DMD NM_000110 Xp21.2 1756.029.1
10010.004.1 1756.29 1756.29 3 1756.026.1-C_at DMD NM_000111 Xp21.2
1756.026.1 10051.005.3 1756.26 1756.26 4 1756.022.4-T_at DMD
NM_000112 Xp21.2 1756.022.4 10051.008.1 1756.22 1756.22 5
1756.011.1-B_at DMD NM_000113 Xp21.2 1756.011.1 10051.016.1 1756.11
1756.11 6 1308.008.1-C_at COL17A1 NM_000494 10q24.3 1308.008.1
10124.002.1 1308.8 1308.8 7 1756.022.3-F_at DMD NM_000114 Xp21.2
1756.022.3 10124.003.1 1756.22 3861.20 8 3861.020.1-D_at KRT14
NM_000526 17q12-q21 3861.020.1 10124.004.2 3861.20 4629.7 9
1756.011.1-F_at DMD NM_000115 Xp21.2 1756.011.1 10144.017.3 1756.11
1756.24 10 4629.007.1-F_at MYH11 NM_001040113 16p13.11 4629.007.1
10144.020.2 4629.7 3861.19 11 1756.022.4-B_at DMD NM_000116 Xp21.2
1756.022.4 10144.021.1 1756.22 3861.1 12 1756.024.1-F_at DMD
NM_000117 Xp21.2 1756.024.1 10253.001.1 1756.24 4629.20 13
3861.019.1-T_at KRT14 NM_000526 17q12-q21 3861.019.1 10253.003.1
3861.19 1756.27 14 1756.026.1-T_at DMD NM_000118 Xp21.2 1756.026.1
10253.004.1 1756.26 3861.13 15 1756.022.1-B_at DMD NM_000119 Xp21.2
1756.022.1 1033.002.1 1756.22 3861.22 16 3861.001.1-T_at KRT14
NM_000526 17q12-q21 3861.001.1 10461.002.1 3861.1 3868.4 17
1308.008.1-T_at COL17A1 NM_000495 10q24.3 1308.008.1 10461.002.2
1308.8 4629.15 18 4629.020.1-C_at MYH11 NM_001040114 16p13.11
4629.020.1 1058.004.2 4629.20 6422.2 19 1756.027.1-T_at DMD
NM_000120 Xp21.2 1756.027.1 10580.012.1 1756.27 1308.3 20
3861.013.1-T_at KRT14 NM_000526 17q12-q21 3861.013.1 1062.001.6
3861.13 3868.5 21 4629.020.1-F_at MYH11 NM_001040115 16p13.11
4629.020.1 1063.001.1 4629.20 1308.7 22 3861.001.1-B_at KRT14
NM_000526 17q12-q21 3861.001.1 1063.002.1 3861.1 1308.9 23
1756.022.4-F_at DMD NM_000121 Xp21.2 1756.022.4 11065.003.1 1756.22
3861.7 24 1756.026.1-F_at DMD NM_000122 Xp21.2 1756.026.1
11065.004.1 1756.26 4629.16 25 1756.022.2-T_at DMD NM_000123 Xp21.2
1756.022.2 11065.005.1 1756.22 3084.7 26 1756.022.2-F_at DMD
NM_000124 Xp21.2 1756.022.2 11065.005.2 1756.22 26289.3 27
3861.022.1-B_at KRT14 NM_000526 17q12-q21 3861.022.1 11065.008.1
3861.22 1756.28 28 3868.004.1-D_at KRT16 NM_005557 17q12-q21
3868.004.1 11065.009.1 3868.4 4629.21 29 4629.015.1-C_at MYH11
NM_001040116 16p13.11 4629.015.1 11197.001.1 4629.15 5764.1 30
6422.002.1-E_at SFRP1 NM_003012 8p12-p11.1 6422.002.1 115207.002.1
6422.2 3815.2 31 3861.001.1-D_at KRT14 NM_000526 17q12-q21
3861.001.1 115908.002.1 3861.1 3852.20 32 1756.022.1-F_at DMD
NM_000125 Xp21.2 1756.022.1 116369.006.4 1756.22 128553.3 33
1308.003.1-T_at COL17A1 NM_000496 10q24.3 1308.003.1 120.005.2
1308.3 4629.5 34 3868.005.1-B_at KRT16 NM_005557 17q12-q21
3868.005.1 1264.003.1 3868.5 4629.10 35 1308.007.1-F_at COL17A1
NM_000497 10q24.3 1308.007.1 1264.006.1 1308.7 6422.1 36
1308.009.1-F_at COL17A1 NM_000498 10q24.3 1308.009.1 1264.007.1
1308.9 3861.8 37 3861.007.1-E_at KRT14 NM_000526 17q12-q21
3861.007.1 128553.003.1 3861.7 1756.30 38 4629.016.1-D_at MYH11
NM_001040117 16p13.11 4629.016.1 130497.001.2 4629.16 3084.9 39
3084.007.1-F_at NRG1 NM_004495 8p12 3084.007.1 1308.001.1 3084.7
26289.2 40 3861.007.1-F_at KRT14 NM_000526 17q12-q21 3861.007.1
1308.002.1 3861.7 23336.1 41 26289.003.1- AK5 NM_012093 1p31
26289.003.1 1308.003.1 26289.3 3852.12 E_at 42 1756.028.1-T_at DMD
NM_000126 Xp21.2 1756.028.1 1308.004.1 1756.28 26289.12 43
4629.021.1-E_at MYH11 NM_001040118 16p13.11 4629.021.1 1308.007.1
4629.21 23336.3 44 4629.020.1-D_at MYH11 NM_001040119 16p13.11
4629.020.1 1308.008.1 4629.20 26289.7 45 5764.001.1-F_at PTN
NM_002825 7q33-q34 5764.001.1 1308.009.1 5764.1 84417.1 46
3815.002.3-F_at KIT NM_000222 4q11-q12 3815.002.3 1398.001.1 3815.2
3861.18 47 3852.020.1-T_at KRT5 NM_000424 12q12-q13 3852.020.1
140446.004.1 3852.20 3852.4 48 4629.007.1-E_at MYH11 NM_001040120
16p13.11 4629.007.1 140807.003.1 4629.7 90865.6 49 128553.003.1-F
TSHZ2 NM_173485 20q13.2 128553.003.1 140885.010.1 128553.3 1264.3
50 26289.003.1- AK5 NM_012094 1p31 26289.003.1 140885.010.2 26289.3
26289.10 F_at 51 3815.002.2-F_at KIT NM_000223 4q11-q12 3815.002.2
140885.010.3 3815.2 1908.2 52 1756.029.1-B_at DMD NM_000127 Xp21.2
1756.029.1 140885.011.1 1756.29 3852.8 53 4629.005.1-E_at MYH11
NM_001040121 16p13.11 4629.005.1 140885.013.1 4629.5 4915.11 54
4629.010.1-B_at MYH11 NM_001040122 16p13.11 4629.010.1 140885.014.1
4629.10 5288.1 55 6422.001.1-T_at SFRP1 NM_003012 8p12-p11.1
6422.001.1 1410.001.1 6422.1 3852.6 56 5764.001.1-E_at PTN
NM_002825 7q33-q34 5764.001.1 1410.002.2 5764.1 9413.3 57
3861.008.1-F_at KRT14 NM_000526 17q12-q21 3861.008.1 1410.003.2
3861.8 3815.1 58 1756.030.2-T_at DMD NM_000128 Xp21.2 1756.030.2
1410.004.2 1756.30 79937.1 59 3084.009.1-B_at NRG1 NM_004496 8p12
3084.009.1 1410.005.1 3084.9 4915.12 60 26289.002.1- AK5 NM_012095
1p31 26289.002.1 1410.006.1 26289.2 26289.5 T_at 61 1756.022.5-B_at
DMD NM_000129 Xp21.2 1756.022.5 1410.007.1 1756.22 4311.9 62
4629.007.1-D_at MYH11 NM_001040123 16p13.11 4629.007.1 1410.007.2
4629.7 26289.6 63 23336.001.1- DMN NM_015286 15q26.3 23336.001.1
1410.008.1 23336.1 5288.3 C_at 64 1308.003.1-D_at COL17A1 NM_000499
10q24.3 1308.003.1 1410.009.1 1308.3 26289.4 65 1756.022.3-T_at DMD
NM_000130 Xp21.2 1756.022.3 1410.010.1 1756.22 79192.2 66
3861.020.1-T_at KRT14 NM_000526 17q12-q21 3861.020.1 1410.011.1
3861.20 4638.6 67 3861.022.1-C_at KRT14 NM_000526 17q12-q21
3861.022.1 147495.005.1 3861.22 3084.8 68 3852.012.2-B_at KRT5
NM_000424 12q12-q13 3852.012.2 147495.006.1 3852.12 4311.1 69
26289.012.1- AK5 NM_012096 1p31 26289.012.1 147495.008.1 26289.12
3852.22 E_at 70 23336.003.1- DMN NM_015287 15q26.3 23336.003.1
147495.009.1 23336.3 23194.3 T_at 71 26289.007.1- AK5 NM_012097
1p31 26289.007.1 147804.004.1 26289.7 65983.9 B_at 72 84417.001.1-
C2orf40 NM_032411 2q12.2 84417.001.1 152015.004.1 84417.1 1410.7
T_at 73 3861.018.1-D_at KRT14 NM_000526 17q12-q21 3861.018.1
152015.005.2 3861.18 7373.3 74 3852.004.1-B_at KRT5 NM_000424
12q12-q13 3852.004.1 162605.001.4 3852.4 10010.2 75 90865.006.1-
IL33 NM_033439 9p24.1 90865.006.1 1717.007.1 90865.6 59.26 B_at 76
4629.021.1-F_at MYH11 NM_001040124 16p13.11 4629.021.1 1717.009.2
4629.21 3872.7 77 3861.018.1-T_at KRT14 NM_000526 17q12-q21
3861.018.1 1756.002.2 3861.18 84668.2 78 1756.022.1-T_at DMD
NM_000131 Xp21.2 1756.022.1 1756.003.1 1756.22 1756.2 79
1264.003.1-B_at CNN1 NM_001299 19p13.2-p13.1 1264.003.1 1756.009.1
1264.3 57447.33 80 26289.010.1- AK5 NM_012098 1p31 26289.010.1
1756.011.1 26289.10 26289.9 E_at 81 3861.001.1-F_at KRT14 NM_000526
17q12-q21 3861.001.1 1756.013.1 3861.1 3872.6 82 1908.002.1-T_at
EDN3 NM_001729 20q13.2-q13.3 1908.002.1 1756.022.1 1908.2 667.21 83
4629.007.1-C_at MYH11 NM_001040125 16p13.11 4629.007.1 1756.022.2
4629.7 57447.27 84 1756.022.5-T_at DMD NM_000132 Xp21.2 1756.022.5
1756.022.3 1756.22 56477.1 85 3815.002.4-B_at KIT NM_000224
4q11-q12 3815.002.4 1756.022.4 3815.2 26289.8 86 1756.022.2-B_at
DMD NM_000133 Xp21.2 1756.022.2 1756.022.5 1756.22 59.24 87
1756.027.1-B_at DMD NM_000134 Xp21.2 1756.027.1 1756.024.1 1756.27
3084.4 88 3852.008.2-T_at KRT5 NM_000424 12q12-q13 3852.008.2
1756.026.1 3852.8 27122.14 89 6422.001.1-E_at SFRP1 NM_003012
8p12-p11.1 6422.001.1 1756.027.1 6422.1 286887.3 90 3861.022.1-F_at
KRT14 NM_000526 17q12-q21 3861.022.1 1756.028.1 3861.22 3872.9 91
4915.011.1-D_at NTRK2 NM_001007097 9q22.1 4915.011.1 1756.029.1
4915.11 59.14 92 5288.001.1-F_at PIK3C2G NM_004570 12p12 5288.001.1
1756.030.2 5288.1 403340.1 93 3861.007.1-T_at KRT14 NM_000526
17q12-q21 3861.007.1 1908.001.1 3861.7 3852.14 94 3852.006.1-C_at
KRT5 NM_000424 12q12-q13 3852.006.1 1908.002.1 3852.6 27122.1 95
9413.003.1-T_at C9orf61 NM_004816 9q13-q21 9413.003.1 1959.002.1
9413.3 8626.5 96 3861.020.1-C_at KRT14 NM_000526 17q12-q21
3861.020.1 1959.003.1 3861.20 84668.4 97 1308.008.1-D_at COL17A1
NM_000500 10q24.3 1308.008.1 2.002.1 1308.8 57447.31 98
23336.001.1- DMN NM_015288 15q26.3 23336.001.1 2.005.1 23336.1
3084.12 T_at 99 3815.001.1-F_at KIT NM_000225 4q11-q12 3815.001.1
2.013.1 3815.1 3852.5 100 1756.022.5-F_at DMD NM_000135 Xp21.2
1756.022.5 2.018.1 1756.22 3866.3 101 79937.001.1- CNTNAP3
NM_033655 9p13.1 79937.001.1 2.022.1 79937.1 3866.8 T_at 102
4915.012.1-E_at NTRK2 NM_001007098 9q22.1 4915.012.1 2.024.1
4915.12 3852.9 103 3861.022.1-T_at KRT14 NM_000526 17q12-q21
3861.022.1 2.025.1 3861.22 59.15 104 26289.005.1- AK5 NM_012099
1p31 26289.005.1 2115.001.2 26289.5 79937.2 T_at 105
3815.002.3-B_at KIT NM_000226 4q11-q12 3815.002.3 2115.003.1 3815.2
7153.2 106 4311.009.1-F_at MME NM_000902 3q25.1-q25.2 4311.009.1
2115.006.1 4311.9 4281.10 107 26289.006.1- AK5 NM_012100 1p31
26289.006.1 2115.007.1 26289.6 59.8 T_at 108 5288.003.1-F_at
PIK3C2G NM_004570 12p12 5288.003.1 2115.008.1 5288.3 1264.7 109
4629.020.1-B_at MYH11 NM_001040126 16p13.11 4629.020.1 2115.011.1
4629.20 3084.2 110 26289.007.1- AK5 NM_012101 1p31 26289.007.1
2115.012.1 26289.7 5137.4 D_at 111 3815.002.1-B_at KIT NM_000227
4q11-q12 3815.002.1 2115.014.1 3815.2 4629.22 112 26289.004.1- AK5
NM_012102 1p31 26289.004.1 2115.015.1 26289.4 3852.13 T_at 113
79192.002.2- IRX1 NM_024337 5p15.3 79192.002.2 2119.005.1 79192.2
59.12 T_at 114 4638.006.1-D_at MYLK NM_005965 3q21 4638.006.1
2119.006.1 4638.6 23336.2 115 3084.008.1-F_at NRG1 NM_004497 8p12
3084.008.1 221120.006.1 3084.8 3866.11 116 4311.001.2-T_at MME
NM_000903 3q25.1-q25.2 4311.001.2 2232.014.1 4311.1 59.31
117 3815.002.1-D_at KIT NM_000228 4q11-q12 3815.002.1 22974.007.1
3815.2 57447.30 118 4629.020.1-T_at MYH11 NM_001040127 16p13.11
4629.020.1 22974.008.1 4629.20 1410.3 119 1756.026.1-B_at DMD
NM_000136 Xp21.2 1756.026.1 23092.004.1 1756.26 3866.9 120
3852.022.1-T_at KRT5 NM_000424 12q12-q13 3852.022.1 23194.003.1
3852.22 440421.1 121 4629.015.1-D_at MYH11 NM_001040128 16p13.11
4629.015.1 23266.001.3 4629.15 57447.41 122 26289.007.1- AK5
NM_012103 1p31 26289.007.1 23266.008.1 26289.7 3872.10 C_at 123
23194.003.1- FBXL7 NM_012304 5p15.1 23194.003.1 23266.008.2 23194.3
4629.6 C_at 124 3815.002.1-F_at KIT NM_000229 4q11-q12 3815.002.1
2327.002.1 3815.2 3866.12 125 26289.007.1- AK5 NM_012104 1p31
26289.007.1 2327.002.2 26289.7 57447.21 T_at 126 65983.009.1-
GRAMD3 NM_023927 5q23.2 65983.009.1 2327.003.4 65983.9 8626.7 B_at
127 23336.001.1- DMN NM_015289 15q26.3 23336.001.1 23284.007.1
23336.1 72.1 F_at 128 1410.007.2-B_at CRYAB NM_001885 11q22.3-q23.1
1410.007.2 23321.014.1 1410.7 3866.6 129 1756.029.1-F_at DMD
NM_000137 Xp21.2 1756.029.1 23336.001.1 1756.29 65983.8 130
7373.003.6-C_at COL14A1 NM_021110 8q23 7373.003.6 23336.002.1
7373.3 65983.13 131 10010.002.1- TANK NM_004180 2q24-q31
10010.002.1 23336.003.1 10010.2 27122.7 E_at 132 59.026.1-B_at
ACTA2 NM_001613 10q23.3 59.026.1 2335.002.1 59.26 59.9 133
4915.011.1-F_at NTRK2 NM_001007099 9q22.1 4915.011.1 2335.005.1
4915.11 59.23 134 3872.007.1-D_at KRT17 NM_000422 17q12-q21
3872.007.1 2335.006.1 3872.7 1908.1 135 26289.002.1- AK5 NM_012105
1p31 26289.002.1 2335.006.2 26289.2 4915.8 D_at 136 84668.002.1-
FAM126A NM_032581 7p15.3 84668.002.1 2335.009.1 84668.2 57447.35
C_at 137 1756.002.2-T_at DMD NM_000138 Xp21.2 1756.002.2 2335.013.1
1756.2 667.22 138 57447.033.1- NDRG2 NM_016250 14q11.2 57447.033.1
2335.016.1 57447.33 2115.1 C_at 139 26289.009.1- AK5 NM_012106 1p31
26289.009.1 2335.017.1 26289.9 27303.4 E_at 140 3872.006.1-F_at
KRT17 NM_000422 17q12-q21 3872.006.1 2335.024.2 3872.6 59.3 141
3861.022.1-D_at KRT14 NM_000526 17q12-q21 3861.022.1 2335.025.1
3861.22 65983.4 142 3861.020.1-B_at KRT14 NM_000526 17q12-q21
3861.020.1 2335.025.3 3861.20 26289.13 143 667.021.1-B_at DST
NM_001723 6p12.1 667.021.1 2335.027.1 667.21 3866.4 144
57447.027.1- NDRG2 NM_016251 14q11.2 57447.027.1 2335.028.1
57447.27 57447.37 F_at 145 56477.001.1- CCL28 NM_148672 5p12
56477.001.1 2335.032.1 56477.1 59.22 D_at 146 26289.008.1- AK5
NM_012107 1p31 26289.008.1 2335.035.1 26289.8 147495.8 F_at 147
59.024.2-D_at ACTA2 NM_001613 10q23.3 59.024.2 2335.045.1 59.24
2.18 148 4629.005.1-T_at MYH11 NM_001040129 16p13.11 4629.005.1
2335.053.1 4629.5 140807.3 149 3815.002.1-T_at KIT NM_000230
4q11-q12 3815.002.1 23650.003.1 3815.2 2115.8 150 23336.001.1- DMN
NM_015290 15q26.3 23336.001.1 23650.005.1 23336.1 57447.34 B_at 151
3084.004.2-F_at NRG1 NM_004498 8p12 3084.004.2 23650.011.1 3084.4
3866.1 152 27122.014.2- DKK3 NM_001018057 11p15.2 27122.014.2
23650.011.2 27122.14 1959.3 T_at 153 26289.008.1- AK5 NM_012108
1p31 26289.008.1 23650.019.1 26289.8 389432.2 C_at 154
286887.003.2-B KRT6C NM_173086 12q13.13 286887.003.2 23650.020.1
286887.3 389734.1 155 4629.005.1-F_at MYH11 NM_001040130 16p13.11
4629.005.1 24137.004.1 4629.5 3855.1 156 3872.009.1-T_at KRT17
NM_000422 17q12-q21 3872.009.1 244.003.1 3872.9 3084.6 157
59.014.2-D_at ACTA2 NM_001613 10q23.3 59.014.2 244.011.1 59.14
2115.11 158 403340.001.2-B MGC70870 NM_203481 -- 403340.001.2
244.012.1 403340.1 65983.5 159 3852.014.1-F_at KRT5 NM_000424
12q12-q13 3852.014.1 2487.001.1 3852.14 2119.6 160 27122.001.1-
DKK3 NM_001018058 11p15.2 27122.001.1 2568.001.1 27122.1 3866.7
T_at 161 3815.002.3-T_at KIT NM_000231 4q11-q12 3815.002.3
2568.001.2 3815.2 3866.13 162 3852.008.1-E_at KRT5 NM_000424
12q12-q13 3852.008.1 2568.002.1 3852.8 27122.13 163 26289.012.1-
AK5 NM_012109 1p31 26289.012.1 2568.002.2 26289.12 27122.6 T_at 164
26289.007.1- AK5 NM_012110 1p31 26289.007.1 2568.003.1 26289.7
4240.4 F_at 165 4638.006.1-T_at MYLK NM_005966 3q21 4638.006.1
2568.003.2 4638.6 3866.10 166 8626.005.1-B_at TP63 NM_003722 3q28
8626.005.1 2568.005.1 8626.5 7018.29 167 3815.002.4-T_at KIT
NM_000232 4q11-q12 3815.002.4 2568.005.2 3815.2 1410.2 168
84668.004.1- FAM126A NM_032581 7p15.3 84668.004.1 2568.006.1
84668.4 59.34 F_at 169 3872.007.1-F_at KRT17 NM_000422 17q12-q21
3872.007.1 25802.003.1 3872.7 27122.19 170 57447.031.1- NDRG2
NM_016252 14q11.2 57447.031.1 25802.004.1 57447.31 5156.1 E_at 171
3084.012.3-T_at NRG1 NM_004499 8p12 3084.012.3 25802.008.1 3084.12
57447.10 172 3852.005.1-T_at KRT5 NM_000424 12q12-q13 3852.005.1
2582.007.2 3852.5 358.18 173 84417.001.2- C2orf40 NM_032411 2q12.2
84417.001.2 25925.001.1 84417.1 7373.1 T_at 174 3866.003.2-T_at
KRT15 NM_002275 17q21.2 3866.003.2 25925.006.1 3866.3 57447.29 175
3866.008.1-C_at KRT15 NM_002275 17q21.2 3866.008.1 25925.007.1
3866.8 79068.10 176 3852.009.1-F_at KRT5 NM_000424 12q12-q13
3852.009.1 25925.008.1 3852.9 59.4 177 59.015.1-B_at ACTA2
NM_001613 10q23.3 59.015.1 25925.009.1 59.15 2115.12 178
79937.002.1- CNTNAP3 NM_033655 9p13.1 79937.002.1 25925.011.1
79937.2 2115.7 F_at 179 7153.002.6-F_at TOP2A NM_001067 17q21-q22
7153.002.6 259266.003.1 7153.2 59.40 180 4281.010.1-B_at MID1
NM_000381 Xp22 4281.010.1 26289.002.1 4281.10 130497.1 181
59.008.1-B_at ACTA2 NM_001613 10q23.3 59.008.1 26289.003.1 59.8
140885.14 182 1264.007.1-T_at CNN1 NM_001299 19p13.2-p13.1
1264.007.1 26289.004.1 1264.7 3866.5 183 3868.004.1-T_at KRT16
NM_005557 17q12-q21 3868.004.1 26289.005.1 3868.4 8404.28 184
3084.002.1-F_at NRG1 NM_004500 8p12 3084.002.1 26289.006.1 3084.2
3860.7 185 5137.004.2-T_at PDE1C NM_005020 7p15.1-p14.3 5137.004.2
26289.007.1 5137.4 4638.3 186 4629.022.1-T_at MYH11 NM_001040131
16p13.11 4629.022.1 26289.008.1 4629.22 25925.8 187 4915.011.1-T_at
NTRK2 NM_001007100 9q22.1 4915.011.1 26289.009.1 4915.11 23650.11
188 3852.013.1-E_at KRT5 NM_000424 12q12-q13 3852.013.1 26289.010.1
3852.13 3852.17 189 59.012.2-T_at ACTA2 NM_001613 10q23.3 59.012.2
26289.012.1 59.12 4915.5 190 59.015.1-F_at ACTA2 NM_001613 10q23.3
59.015.1 26289.013.1 59.15 1756.3 191 4638.006.2-T_at MYLK
NM_005967 3q21 4638.006.2 2707.002.1 4638.6 4638.14 192
23336.002.1- DMN NM_015291 15q26.3 23336.002.1 27122.001.1 23336.2
2707.2 B_at 193 3868.005.1-C_at KRT16 NM_005557 17q12-q21
3868.005.1 27122.002.1 3868.5 4638.11 194 3866.011.2-D_at KRT15
NM_002275 17q21.2 3866.011.2 27122.006.1 3866.11 7373.2 195
56477.001.1- CCL28 NM_148672 5p12 56477.001.1 27122.006.2 56477.1
5608.2 T_at 196 3815.001.1-T_at KIT NM_000233 4q11-q12 3815.001.1
27122.007.1 3815.1 1756.13 197 4311.001.1-T_at MME NM_000904
3q25.1-q25.2 4311.001.1 27122.013.1 4311.1 2115.6 198
1264.003.1-D_at CNN1 NM_001299 19p13.2-p13.1 1264.003.1 27122.014.1
1264.3 6376.1 199 59.031.1-T_at ACTA2 NM_001613 10q23.3 59.031.1
27122.014.2 59.31 8404.2 200 57447.030.1- NDRG2 NM_016253 14q11.2
57447.030.1 27122.016.1 57447.30 1264.6 B_at 201 1410.003.2-B_at
CRYAB NM_001885 11q22.3-q23.1 1410.003.2 27122.017.1 1410.3 25925.1
202 3866.009.2-D_at KRT15 NM_002275 17q21.2 3866.009.2 27122.018.1
3866.9 8404.35 203 59.026.1-T_at ACTA2 NM_001613 10q23.3 59.026.1
27122.019.1 59.26 2.22 204 440421.001.1-T 440421.001.1 27303.004.1
440421.1 27122.16 205 1756.022.4-D_at DMD NM_000139 Xp21.2
1756.022.4 2824.001.2 1756.22 57447.25 206 65983.009.1- GRAMD3
NM_023927 5q23.2 65983.009.1 285203.001.2 65983.9 1717.7 D_at 207
57447.041.1- NDRG2 NM_016254 14q11.2 57447.041.1 286887.003.2
57447.41 9768.4 T_at 208 3872.010.2-D_at KRT17 NM_000422 17q12-q21
3872.010.2 2893.002.2 3872.10 1410.4 209 4629.006.2-T_at MYH11
NM_001040132 16p13.11 4629.006.2 2893.006.2 4629.6 2327.2 210
3861.018.1-F_at KRT14 NM_000526 17q12-q21 3861.018.1 29089.001.1
3861.18 1308.4 211 3815.002.2-T_at KIT NM_000234 4q11-q12
3815.002.2 29089.003.1 3815.2 2568.5 212 3866.012.2-D_at KRT15
NM_002275 17q21.2 3866.012.2 29127.002.1 3866.12 2568.1 213
57447.021.1- NDRG2 NM_016255 14q11.2 57447.021.1 29127.007.1
57447.21 2893.6 D_at 214 59.015.1-T_at ACTA2 NM_001613 10q23.3
59.015.1 29127.013.1 59.15 3872.16 215 8626.007.1-F_at TP63
NM_003722 3q28 8626.007.1 29127.019.1 8626.7 9413.6 216
5288.001.1-B_at PIK3C2G NM_004570 12p12 5288.001.1 29127.019.2
5288.1 72.5 217 72.001.1-B_at ACTG2 NM_001615 2p13.1 72.001.1
29127.022.1 72.1 27122.18 218 3866.006.2-D_at KRT15 NM_002275
17q21.2 3866.006.2 2938.001.1 3866.6 7153.5 219 3852.004.1-T_at
KRT5 NM_000424 12q12-q13 3852.004.1 2982.002.1 3852.4 7018.26 220
4629.016.1-F_at MYH11 NM_001040133 16p13.11 4629.016.1 2982.012.1
4629.16 7402.14 221 4629.007.1-T_at MYH11 NM_001040134 16p13.11
4629.007.1 2982.013.2 4629.7 140446.4 222 65983.008.1- GRAMD3
NM_023927 5q23.2 65983.008.1 2982.014.1 65983.8 59.38 T_at 223
65983.013.1- GRAMD3 NM_023927 5q23.2 65983.013.1 2982.015.1
65983.13 4240.9 F_at 224 3084.004.1-F_at NRG1 NM_004501 8p12
3084.004.1 2995.001.1 3084.4 57447.8 225 27122.007.1- DKK3
NM_001018059 11p15.2 27122.007.1 29997.008.1 27122.7 2582.7 F_at
226 3866.008.1-D_at KRT15 NM_002275 17q21.2 3866.008.1 29997.012.1
3866.8 4638.9 227 26289.009.1- AK5 NM_012111 1p31 26289.009.1
29997.016.1 26289.9 3861.23 T_at 228 59.009.1-B_at ACTA2 NM_001613
10q23.3 59.009.1 301.004.1 59.9 5858.3 229 4629.010.1-D_at MYH11
NM_001040135 16p13.11 4629.010.1 301.005.1
4629.10 147495.5 230 59.023.1-B_at ACTA2 NM_001613 10q23.3 59.023.1
301.008.1 59.23 4915.4 231 26289.002.1- AK5 NM_012112 1p31
26289.002.1 301.013.1 26289.2 8626.2 F_at 232 1908.001.1-T_at EDN3
NM_001730 20q13.2-q13.3 1908.001.1 301.015.1 1908.1 59.42 233
4915.008.1-F_at NTRK2 NM_001007101 9q22.1 4915.008.1 3084.002.1
4915.8 4833.4 234 23336.002.1- DMN NM_015292 15q26.3 23336.002.1
3084.004.1 23336.2 2568.6 T_at 235 3861.008.1-C_at KRT14 NM_000526
17q12-q21 3861.008.1 3084.004.2 3861.8 57447.4 236 3861.008.1-D_at
KRT14 NM_000526 17q12-q21 3861.008.1 3084.005.1 3861.8 27122.17 237
57447.035.1- NDRG2 NM_016256 14q11.2 57447.035.1 3084.006.1
57447.35 59.33 E_at 238 3861.018.1-C_at KRT14 NM_000526 17q12-q21
3861.018.1 3084.007.1 3861.18 27122.2 239 1308.003.1-B_at COL17A1
NM_000501 10q24.3 1308.003.1 3084.008.1 1308.3 3880.11 240
667.022.1-B_at DST NM_001724 6p12.1 667.022.1 3084.009.1 667.22
3872.14 241 3866.011.2-T_at KRT15 NM_002275 17q21.2 3866.011.2
3084.010.1 3866.11 162605.1 242 2115.001.2-F_at ETV1 NM_004956
7p21.3 2115.001.2 3084.011.1 2115.1 5858.1 243 3866.011.2-B_at
KRT15 NM_002275 17q21.2 3866.011.2 3084.012.1 3866.11 65983.10 244
26289.010.1- AK5 NM_012113 1p31 26289.010.1 3084.012.2 26289.10
8404.5 T_at 245 27303.004.1- RBMS3 NM_001003792 3p24-p23
27303.004.1 3084.012.3 27303.4 2487.1 E_at 246 59.003.1-B_at ACTA2
NM_001613 10q23.3 59.003.1 3178.003.1 59.3 147495.9 247
4311.009.1-C_at MME NM_000905 3q25.1-q25.2 4311.009.1 3204.001.1
4311.9 65983.3 248 7373.003.6-B_at COL14A1 NM_021110 8q23
7373.003.6 338707.006.1 7373.3 1717.9 249 65983.004.1- GRAMD3
NM_023927 5q23.2 65983.004.1 339965.001.2 65983.4 140885.11 T_at
250 26289.013.1- AK5 NM_012114 1p31 26289.013.1 3426.001.1 26289.13
3832.2 D_at 251 3866.004.1-F_at KRT15 NM_002275 17q21.2 3866.004.1
3426.002.1 3866.4 3880.5 252 56477.001.1- CCL28 NM_148672 5p12
56477.001.1 3426.002.2 56477.1 6595.12 F_at 253 57447.037.1- NDRG2
NM_016257 14q11.2 57447.037.1 3459.005.1 57447.37 9768.5 F_at 254
59.022.2-T_at ACTA2 NM_001613 10q23.3 59.022.2 3479.003.1 59.22
285203.1 255 147495.008.1-F APCDD1 NM_153000 18p11.22 147495.008.1
358.012.1 147495.8 147495.6 256 2.018.1-T_at A2M NM_000014
12p13.3-p12.3 2.018.1 358.018.1 2.18 1959.2 257 140807.003.1-E
KRT72 NM_080747 12q13.13 140807.003.1 3815.001.1 140807.3 7018.14
258 65983.009.1- GRAMD3 NM_023927 5q23.2 65983.009.1 3815.002.1
65983.9 5858.4 T_at 259 84668.002.1- FAM126A NM_032581 7p15.3
84668.002.1 3815.002.2 84668.2 8404.8 F_at 260 3872.007.1-C_at
KRT17 NM_000422 17q12-q21 3872.007.1 3815.002.3 3872.7 4240.11 261
2115.008.1-T_at ETV1 NM_004956 7p21.3 2115.008.1 3815.002.4 2115.8
94274.2 262 65983.004.2- GRAMD3 NM_023927 5q23.2 65983.004.2
3832.002.1 65983.4 4638.15 T_at 263 57447.034.1- NDRG2 NM_016258
14q11.2 57447.034.1 3852.004.1 57447.34 57447.43 D_at 264
3866.001.1-F_at KRT15 NM_002275 17q21.2 3866.001.1 3852.005.1
3866.1 59.39 265 3866.008.1-T_at KRT15 NM_002275 17q21.2 3866.008.1
3852.006.1 3866.8 25802.3 266 1959.003.1-C_at EGR2 NM_000399
10q21.1 1959.003.1 3852.008.1 1959.3 57447.17 267 389432.002.1-T
SAMD5 NM_001030060 6q24.3 389432.002.1 3852.008.2 389432.2 7018.28
268 389734.001.1-T 389734.001.1 3852.009.1 389734.1 57447.12 269
3855.001.2-D_at KRT7 NM_005556 12q12-q13 3855.001.2 3852.012.2
3855.1 57447.6 270 3866.003.1-T_at KRT15 NM_002275 17q21.2
3866.003.1 3852.013.1 3866.3 9493.6 271 3084.006.1-F_at NRG1
NM_004502 8p12 3084.006.1 3852.014.1 3084.6 9493.4 272
4915.008.1-B_at NTRK2 NM_001007102 9q22.1 4915.008.1 3852.017.1
4915.8 7169.15 273 2115.011.1-T_at ETV1 NM_004956 7p21.3 2115.011.1
3852.020.1 2115.11 57451.1 274 65983.005.1- GRAMD3 NM_023927 5q23.2
65983.005.1 3852.021.1 65983.5 8404.4 T_at 275 84668.004.1- FAM126A
NM_032581 7p15.3 84668.004.1 3852.022.1 84668.4 3855.4 T_at 276
59.015.2-T_at ACTA2 NM_001613 10q23.3 59.015.2 3852.023.1 59.15
9452.1 277 2119.006.1-B_at ETV5 NM_004454 3q28 2119.006.1
3855.001.2 2119.6 57447.40 278 4638.006.2-F_at MYLK NM_005968 3q21
4638.006.2 3855.004.2 4638.6 3426.1 279 3866.007.2-D_at KRT15
NM_002275 17q21.2 3866.007.2 3860.007.1 3866.7 10253.1 280
59.014.1-T_at ACTA2 NM_001613 10q23.3 59.014.1 3860.008.1 59.14
9073.1 281 3866.001.2-F_at KRT15 NM_002275 17q21.2 3866.001.2
3861.001.1 3866.1 51201.5 282 1308.008.1-B_at COL17A1 NM_000502
10q24.3 1308.008.1 3861.007.1 1308.8 9477.6 283 59.026.1-F_at ACTA2
NM_001613 10q23.3 59.026.1 3861.008.1 59.26 57447.28 284
3866.013.1-T_at KRT15 NM_002275 17q21.2 3866.013.1 3861.013.1
3866.13 25925.7 285 1264.007.1-F_at CNN1 NM_001299 19p13.2-p13.1
1264.007.1 3861.018.1 1264.7 4281.8 286 3866.007.2-T_at KRT15
NM_002275 17q21.2 3866.007.2 3861.019.1 3866.7 90231.1 287
27122.013.1- DKK3 NM_001018060 11p15.2 27122.013.1 3861.020.1
27122.13 358.12 T_at 288 27122.006.2- DKK3 NM_001018061 11p15.2
27122.006.2 3861.022.1 27122.6 3852.21 T_at 289 3866.006.2-T_at
KRT15 NM_002275 17q21.2 3866.006.2 3861.023.1 3866.6 57447.48 290
3866.009.2-T_at KRT15 NM_002275 17q21.2 3866.009.2 3866.001.1
3866.9 7018.25 291 4240.004.1-D_at MFGE8 NM_005928 15q25 4240.004.1
3866.001.2 4240.4 5608.4 292 3866.010.1-C_at KRT15 NM_002275
17q21.2 3866.010.1 3866.002.1 3866.10 4306.2 293 3866.009.2-B_at
KRT15 NM_002275 17q21.2 3866.009.2 3866.003.1 3866.9 4288.4 294
3866.009.1-T_at KRT15 NM_002275 17q21.2 3866.009.1 3866.003.2
3866.9 57447.2 295 4629.006.1-T_at MYH11 NM_001040136 16p13.11
4629.006.1 3866.004.1 4629.6 4281.18 296 7018.029.1-B_at TF
NM_001063 3q22.1 7018.029.1 3866.005.1 7018.29 10144.20 297
1410.002.2-B_at CRYAB NM_001885 11q22.3-q23.1 1410.002.2 3866.006.1
1410.2 6876.16 298 3866.012.1-T_at KRT15 NM_002275 17q21.2
3866.012.1 3866.006.2 3866.12 51203.4 299 59.034.2-D_at ACTA2
NM_001613 10q23.3 59.034.2 3866.007.1 59.34 2335.28 300
27122.019.1- DKK3 NM_001018062 11p15.2 27122.019.1 3866.007.2
27122.19 81557.6 F_at 301 5156.001.1-T_at PDGFRA NM_006206 4q11-q13
5156.001.1 3866.008.1 5156.1 3866.2 302 389734.001.2-T 389734.001.2
3866.009.1 389734.1 55107.6 303 27122.014.1- DKK3 NM_001018063
11p15.2 27122.014.1 3866.009.2 27122.14 57447.9 T_at 304
57447.010.3- NDRG2 NM_016259 14q11.2 57447.010.3 3866.010.1
57447.10 2115.15 T_at 305 358.018.1-F_at AQP1 NM_198098 7p14
358.018.1 3866.011.1 358.18 8404.1 306 3866.006.1-T_at KRT15
NM_002275 17q21.2 3866.006.1 3866.011.2 3866.6 57447.24 307
7373.001.1-T_at COL14A1 NM_021110 8q23 7373.001.1 3866.012.1 7373.1
79608.2 308 26289.012.1- AK5 NM_012115 1p31 26289.012.1 3866.012.2
26289.12 8404.23 B_at 309 57447.029.1- NDRG2 NM_016260 14q11.2
57447.029.1 3866.013.1 57447.29 3426.2 T_at 310 358.018.1-B_at AQP1
NM_198098 7p14 358.018.1 3868.004.1 358.18 2335.27 311 79068.010.1-
FTO NM_001080432 16q12.2 79068.010.1 3868.005.1 79068.10 11065.9
B_at 312 59.024.1-B_at ACTA2 NM_001613 10q23.3 59.024.1 3872.005.1
59.24 140885.13 313 59.004.1-B_at ACTA2 NM_001613 10q23.3 59.004.1
3872.006.1 59.4 25802.4 314 3866.011.1-T_at KRT15 NM_002275 17q21.2
3866.011.1 3872.007.1 3866.11 5156.5 315 3866.013.1-E_at KRT15
NM_002275 17q21.2 3866.013.1 3872.009.1 3866.13 25802.8 316
3866.010.1-D_at KRT15 NM_002275 17q21.2 3866.010.1 3872.010.2
3866.10 7169.22 317 59.004.1-T_at ACTA2 NM_001613 10q23.3 59.004.1
3872.014.1 59.4 23266.1 318 2115.012.1-T_at ETV1 NM_004956 7p21.3
2115.012.1 3872.016.1 2115.12 29127.19 319 2.018.1-D_at A2M
NM_000014 12p13.3-p12.3 2.018.1 3872.018.1 2.18 10253.4 320
2115.007.1-T_at ETV1 NM_004956 7p21.3 2115.007.1 3880.005.1 2115.7
10124.2 321 59.040.1-T_at ACTA2 NM_001613 10q23.3 59.040.1
3880.011.1 59.40 8404.32 322 130497.001.2-T OSR1 NM_145260 2p24.1
130497.001.2 389432.002.1 130497.1 84441.2 323 140885.014.1-T SIRPA
NM_001040022 20p13 140885.014.1 389734.001.1 140885.14 2.13 324
3866.005.1-F_at KRT15 NM_002275 17q21.2 3866.005.1 389734.001.2
3866.5 2.24 325 7373.003.3-F_at COL14A1 NM_021110 8q23 7373.003.3
399687.001.1 7373.3 1756.9 326 8404.028.1-F_at SPARCL1 NM_004684
4q22.1 8404.028.1 403340.001.2 8404.28 7091.14 327 3860.007.1-D_at
KRT13 NM_002274 17q12-q21.2 3860.007.1 4094.001.1 3860.7 115207.2
328 4638.003.1-C_at MYLK NM_005969 3q21 4638.003.1 4094.002.1
4638.3 4281.1 329 3872.009.1-E_at KRT17 NM_000422 17q12-q21
3872.009.1 4147.004.1 3872.9 57447.44 330 59.004.2-T_at ACTA2
NM_001613 10q23.3 59.004.2 4147.005.2 59.4 8626.6 331
3872.006.1-C_at KRT17 NM_000422 17q12-q21 3872.006.1 4147.011.1
3872.6 57447.51 332 3866.005.1-C_at KRT15 NM_002275 17q21.2
3866.005.1 4147.012.1 3866.5 1063.1 333 25925.008.1- ZNF521
NM_015461 18q11.2 25925.008.1 4240.001.1 25925.8 1308.1 T_at 334
23650.011.2- TRIM29 NM_012101 11q22-q23 23650.011.2 4240.004.1
23650.11 2115.14 T_at 335 3866.012.2-T_at KRT15 NM_002275 17q21.2
3866.012.2 4240.009.1 3866.12 5284.4 336 3852.017.1-D_at KRT5
NM_000424 12q12-q13 3852.017.1 4240.011.1 3852.17 2982.2 337
4915.005.1-T_at NTRK2 NM_001007103 9q22.1 4915.005.1 4240.011.3
4915.5 57447.47 338 4638.003.1-B_at MYLK NM_005970 3q21 4638.003.1
4240.015.1 4638.3 5803.6 339 1756.003.1-B_at DMD NM_000140 Xp21.2
1756.003.1 4281.001.1 1756.3 57447.39 340 4638.006.1-F_at MYLK
NM_005971 3q21 4638.006.1 4281.008.2 4638.6 6876.11 341
57447.035.1- NDRG2 NM_016261 14q11.2 57447.035.1 4281.009.1
57447.35 9768.2 F_at 342 4638.014.1-T_at MYLK NM_005972 3q21
4638.014.1 4281.010.1 4638.14 140885.10 343 7373.003.4-T_at COL14A1
NM_021110 8q23 7373.003.4 4281.012.1 7373.3 4638.20 344
27122.014.2- DKK3 NM_001018064 11p15.2 27122.014.2 4281.012.2
27122.14 7373.4
D_at 345 3866.007.1-T_at KRT15 NM_002275 17q21.2 3866.007.1
4281.014.1 3866.7 4281.15 346 2707.002.1-E_at GJB3 NM_001005752
1p34 2707.002.1 4281.015.1 2707.2 8404.13 347 59.024.1-T_at ACTA2
NM_001613 10q23.3 59.024.1 4281.018.1 59.24 90293.1 348
23650.011.1- TRIM29 NM_012101 11q22-q23 23650.011.1 4281.023.1
23650.11 2335.6 T_at 349 4638.011.1-F_at MYLK NM_005973 3q21
4638.011.1 4288.004.1 4638.11 57447.22 350 7373.002.1-F_at COL14A1
NM_021110 8q23 7373.002.1 4288.005.1 7373.2 8404.30 351
3866.013.1-F_at KRT15 NM_002275 17q21.2 3866.013.1 4288.006.1
3866.13 5803.2 352 5608.002.1-T_at MAP2K6 NM_002758 17q24.3
5608.002.1 4288.006.2 5608.2 84441.5 353 3866.001.1-C_at KRT15
NM_002275 17q21.2 3866.001.1 4288.007.1 3866.1 7091.15 354
1756.013.1-B_at DMD NM_000141 Xp21.2 1756.013.1 4288.008.1 1756.13
2119.5 355 2115.006.1-E_at ETV1 NM_004956 7p21.3 2115.006.1
4288.009.1 2115.6 79608.8 356 6376.001.2-F_at CX3CL1 NM_002996
16q13 6376.001.2 4306.002.1 6376.1 8404.22 357 3084.004.1-B_at NRG1
NM_004503 8p12 3084.004.1 4311.001.1 3084.4 8404.34 358
3815.002.4-F_at KIT NM_000235 4q11-q12 3815.002.4 4311.001.2 3815.2
57447.49 359 8404.002.1-D_at SPARCL1 NM_004684 4q22.1 8404.002.1
4311.009.1 8404.2 5311.2 360 1264.006.1-T_at CNN1 NM_001299
19p13.2-p13.1 1264.006.1 440421.001.1 1264.6 2335.25 361
59.022.2-D_at ACTA2 NM_001613 10q23.3 59.022.2 4601.014.1 59.22
4147.12 362 25925.001.1- ZNF521 NM_015461 18q11.2 25925.001.1
4629.005.1 25925.1 301.15 T_at 363 4638.006.2-B_at MYLK NM_005974
3q21 4638.006.2 4629.006.1 4638.6 301.4 364 7373.003.5-B_at COL14A1
NM_021110 8q23 7373.003.5 4629.006.2 7373.3 7091.1 365
8404.035.1-B_at SPARCL1 NM_004684 4q22.1 8404.035.1 4629.007.1
8404.35 8404.21 366 59.012.1-T_at ACTA2 NM_001613 10q23.3 59.012.1
4629.010.1 59.12 53335.2 367 3852.017.1-T_at KRT5 NM_000424
12q12-q13 3852.017.1 4629.015.1 3852.17 5284.3 368 3866.012.2-B_at
KRT15 NM_002275 17q21.2 3866.012.2 4629.016.1 3866.12 23650.20 369
2.022.1-B_at A2M NM_000014 12p13.3-p12.3 2.022.1 4629.020.1 2.22
57447.42 370 27122.016.1- DKK3 NM_001018065 11p15.2 27122.016.1
4629.021.1 27122.16 6876.23 F_at 371 4311.009.1-B_at MME NM_000906
3q25.1-q25.2 4311.009.1 4629.022.1 4311.9 6876.2 372 59.031.2-T_at
ACTA2 NM_001613 10q23.3 59.031.2 4638.003.1 59.31 65983.7 373
4311.009.1-T_at MME NM_000907 3q25.1-q25.2 4311.009.1 4638.006.1
4311.9 152015.4 374 3866.006.2-B_at KRT15 NM_002275 17q21.2
3866.006.2 4638.006.2 3866.6 6285.1 375 57447.025.2- NDRG2
NM_016262 14q11.2 57447.025.2 4638.009.1 57447.25 6289.5 T_at 376
1717.007.1-F_at DHCR7 NM_001360 11q13.2-q13.5 1717.007.1 4638.011.1
1717.7 9232.2 377 59.004.2-D_at ACTA2 NM_001613 10q23.3 59.004.2
4638.014.1 59.4 3084.11 378 3866.007.2-B_at KRT15 NM_002275 17q21.2
3866.007.2 4638.015.1 3866.7 3872.5 379 3866.010.1-F_at KRT15
NM_002275 17q21.2 3866.010.1 4638.020.1 3866.10 81704.8 380
9768.004.1-D_at KIAA0101 NM_001029989 15q22.31 9768.004.1
4744.004.1 9768.4 338707.6 381 3084.012.2-T_at NRG1 NM_004504 8p12
3084.012.2 4751.002.1 3084.12 23266.8 382 1410.004.2-B_at CRYAB
NM_001885 11q22.3-q23.1 1410.004.2 4781.002.2 1410.4 120.5 383
59.008.1-D_at ACTA2 NM_001613 10q23.3 59.008.1 4781.006.2 59.8
4281.9 384 57447.030.1- NDRG2 NM_016263 14q11.2 57447.030.1
4781.007.1 57447.30 4094.1 C_at 385 2327.002.1-D_at FMO2 NM_001460
1q23-q25 2327.002.1 4781.014.2 2327.2 2995.1 386 1308.004.1-B_at
COL17A1 NM_000503 10q24.3 1308.004.1 4781.015.2 1308.4 2335.17 387
2568.005.2-B_at GABRP NM_014211 5q33-q34 2568.005.2 4781.016.1
2568.5 5284.1 388 2568.001.1-T_at GABRP NM_014211 5q33-q34
2568.001.1 4833.004.1 2568.1 8404.26 389 3084.004.2-T_at NRG1
NM_004505 8p12 3084.004.2 4833.010.1 3084.4 2335.9 390
7373.003.4-B_at COL14A1 NM_021110 8q23 7373.003.4 4915.004.1 7373.3
10461.2 391 7153.002.2-D_at TOP2A NM_001067 17q21-q22 7153.002.2
4915.005.1 7153.2 7091.10 392 2893.006.2-T_at GRIA4 NM_000829 11q22
2893.006.2 4915.008.1 2893.6 79895.1 393 3872.016.1-D_at KRT17
NM_000422 17q12-q21 3872.016.1 4915.011.1 3872.16 57447.38 394
9413.006.1-F_at C9orf61 NM_004816 9q13-q21 9413.006.1 4915.012.1
9413.6 7373.8 395 59.023.2-B_at ACTA2 NM_001613 10q23.3 59.023.2
501.006.1 59.23 4744.4 396 72.005.1-B_at ACTG2 NM_001615 2p13.1
72.005.1 51062.008.1 72.5 8404.15 397 4915.011.1-C_at NTRK2
NM_001007104 9q22.1 4915.011.1 51201.005.1 4915.11 4281.14 398
27122.018.1- DKK3 NM_001018066 11p15.2 27122.018.1 51201.007.1
27122.18 4288.6 F_at 399 3852.006.1-B_at KRT5 NM_000424 12q12-q13
3852.006.1 51203.002.2 3852.6 25925.9 400 4638.006.2-D_at MYLK
NM_005975 3q21 4638.006.2 51203.003.1 4638.6 667.10 401
7153.005.1-E_at TOP2A NM_001067 17q21-q22 7153.005.1 51203.004.1
7153.5 57447.11 402 7373.001.2-T_at COL14A1 NM_021110 8q23
7373.001.2 51203.009.1 7373.1 8404.24 403 7018.026.1-B_at TF
NM_001063 3q22.1 7018.026.1 5137.004.2 7018.26 57447.32 404
7402.014.1-B_at UTRN NM_007124 6q24 7402.014.1 5156.001.1 7402.14
51062.8 405 57447.010.3- NDRG2 NM_016264 14q11.2 57447.010.3
5156.005.1 57447.10 2335.13 D_at 406 140446.004.1-T 140446.004.1
5213.024.1 140446.4 7170.5 407 59.026.2-T_at ACTA2 NM_001613
10q23.3 59.026.2 5284.001.1 59.26 2568.3 408 59.038.1-B_at ACTA2
NM_001613 10q23.3 59.038.1 5284.003.1 59.38 9898.15 409
4240.009.1-C_at MFGE8 NM_005928 15q25 4240.009.1 5284.003.2 4240.9
7018.13 410 57447.030.1- NDRG2 NM_016265 14q11.2 57447.030.1
5284.004.1 57447.30 7170.34 F_at 411 9768.004.1-B_at KIAA0101
NM_001029990 15q22.31 9768.004.1 5288.001.1 9768.4 2.2 412
57447.008.1- NDRG2 NM_016266 14q11.2 57447.008.1 5288.001.2 57447.8
57447.50 T_at 413 59.014.2-T_at ACTA2 NM_001613 10q23.3 59.014.2
5288.001.3 59.14 2335.32 414 4915.012.1-T_at NTRK2 NM_001007105
9q22.1 4915.012.1 5288.003.1 4915.12 51203.3 415 3866.004.1-T_at
KRT15 NM_002275 17q21.2 3866.004.1 5311.002.1 3866.4 9493.1 416
2582.007.2-C_at GALE NM_000403 1p36-p35 2582.007.2 5311.003.1
2582.7 80034.3 417 7153.002.5-T_at TOP2A NM_001067 17q21-q22
7153.002.5 53335.002.1 7153.2 7170.16 418 4638.009.1-T_at MYLK
NM_005976 3q21 4638.009.1 53829.001.2 4638.9 57447.26 419
3861.023.1-T_at KRT14 NM_000526 17q12-q21 3861.023.1 54443.006.2
3861.23 301.8 420 5858.003.3-C_at PZP NM_002864 12p13-p12.2
5858.003.3 54443.011.1 5858.3 80034.2 421 3861.020.1-F_at KRT14
NM_000526 17q12-q21 3861.020.1 54443.012.1 3861.20 3852.23 422
147495.005.1-T APCDD1 NM_153000 18p11.22 147495.005.1 54443.013.1
147495.5 10124.3 423 4638.006.2-C_at MYLK NM_005977 3q21 4638.006.2
54829.001.1 4638.6 23650.19 424 1308.004.1-F_at COL17A1 NM_000504
10q24.3 1308.004.1 54928.003.1 1308.4 7170.27 425 4915.004.1-F_at
NTRK2 NM_001007106 9q22.1 4915.004.1 54997.002.2 4915.4 54928.3 426
3866.008.1-B_at KRT15 NM_002275 17q21.2 3866.008.1 55107.006.2
3866.8 3084.10 427 8626.002.1-E_at TP63 NM_003722 3q28 8626.002.1
55366.001.1 8626.2 2115.3 428 1264.003.1-T_at CNN1 NM_001299
19p13.2-p13.1 1264.003.1 55366.001.2 1264.3 8404.9 429
59.042.1-F_at ACTA2 NM_001613 10q23.3 59.042.1 55656.007.3 59.42
6289.3 430 4833.004.1-C_at NME4 NM_005009 16p13.3 4833.004.1
55732.003.2 4833.4 7170.25 431 2568.006.1-B_at GABRP NM_014211
5q33-q34 2568.006.1 5608.002.1 2568.6 22974.7 432 57447.004.2-
NDRG2 NM_016267 14q11.2 57447.004.2 5608.004.1 57447.4 4147.11 T_at
433 59.014.2-B_at ACTA2 NM_001613 10q23.3 59.014.2 5621.002.2 59.14
23650.3 434 3084.012.1-T_at NRG1 NM_004506 8p12 3084.012.1
5621.008.1 3084.12 64168.10 435 27122.017.1- DKK3 NM_001018067
11p15.2 27122.017.1 5627.002.1 27122.17 25925.11 T_at 436
3852.012.2-T_at KRT5 NM_000424 12q12-q13 3852.012.2 56477.001.1
3852.12 9232.4 437 59.033.1-T_at ACTA2 NM_001613 10q23.3 59.033.1
57162.010.1 59.33 4147.5 438 27122.002.1- DKK3 NM_001018068 11p15.2
27122.002.1 57447.002.1 27122.2 147804.4 C_at 439 3880.011.1-B_at
KRT19 NM_002276 17q21.2 3880.011.1 57447.004.1 3880.11 81704.13 440
65983.013.1- GRAMD3 NM_023927 5q23.2 65983.013.1 57447.004.2
65983.13 54443.13 T_at 441 3872.014.1-T_at KRT17 NM_000422
17q12-q21 3872.014.1 57447.006.1 3872.14 1410.5 442 162605.001.4-C
KRT28 NM_181535 17q21.2 162605.001.4 57447.008.1 162605.1 3204.1
443 59.031.2-B_at ACTA2 NM_001613 10q23.3 59.031.2 57447.008.2
59.31 29997.12 444 3084.012.2-B_at NRG1 NM_004507 8p12 3084.012.2
57447.009.1 3084.12 2.5 445 5858.001.2-C_at PZP NM_002864
12p13-p12.2 5858.001.2 57447.010.1 5858.1 1063.2 446 65983.010.1-
GRAMD3 NM_023927 5q23.2 65983.010.1 57447.010.2 65983.10 10144.21
T_at 447 7373.003.5-F_at COL14A1 NM_021110 8q23 7373.003.5
57447.010.3 7373.3 8404.25 448 3866.010.1-T_at KRT15 NM_002275
17q21.2 3866.010.1 57447.011.1 3866.10 6876.20 449 8404.005.1-B_at
SPARCL1 NM_004684 4q22.1 8404.005.1 57447.012.1 8404.5 7170.6 450
3866.005.1-T_at KRT15 NM_002275 17q21.2 3866.005.1 57447.012.2
3866.5 10051.16 451 59.003.1-F_at ACTA2 NM_001613 10q23.3 59.003.1
57447.017.1 59.3 5627.2 452 7153.002.5-F_at TOP2A NM_001067
17q21-q22 7153.002.5 57447.021.1 7153.2 399687.1 453
2487.001.1-T_at FRZB NM_001463 2qter 2487.001.1 57447.022.1 2487.1
54997.2 454 3866.010.1-B_at KRT15 NM_002275 17q21.2 3866.010.1
57447.024.1 3866.10 57561.1 455 147495.009.1-T APCDD1 NM_153000
18p11.22 147495.009.1 57447.025.1 147495.9 8404.31 456 65983.003.2-
GRAMD3 NM_023927 5q23.2 65983.003.2 57447.025.2 65983.3 2.25 T_at
457 59.040.1-D_at ACTA2 NM_001613 10q23.3 59.040.1 57447.026.1
59.40 699.2 458 59.024.2-T_at ACTA2 NM_001613 10q23.3 59.024.2
57447.027.1 59.24 9055.13 459 1717.009.2-B_at DHCR7 NM_001360
11q13.2-q13.5 1717.009.2 57447.028.1 1717.9 10051.5 460
1756.027.1-F_at DMD NM_000142 Xp21.2 1756.027.1 57447.029.1 1756.27
2568.2 461 59.042.1-B_at ACTA2 NM_001613 10q23.3 59.042.1
57447.030.1 59.42 4147.4 462 7153.002.5-D_at TOP2A NM_001067
17q21-q22 7153.002.5 57447.031.1 7153.2 2938.1 463 57447.031.1-
NDRG2 NM_016268 14q11.2 57447.031.1 57447.032.1 57447.31
2982.12
F_at 464 140885.011.1-C SIRPA NM_001040023 20p13 140885.011.1
57447.033.1 140885.11 2893.2 465 59.003.1-T_at ACTA2 NM_001613
10q23.3 59.003.1 57447.034.1 59.3 116369.6 466 3832.002.1-D_at
KIF11 NM_004523 10q24.1 3832.002.1 57447.035.1 3832.2 6304.7 467
3880.005.1-D_at KRT19 NM_002276 17q21.2 3880.005.1 57447.037.1
3880.5 2335.35 468 3084.012.1-F_at NRG1 NM_004508 8p12 3084.012.1
57447.038.1 3084.12 4751.2 469 6595.012.1-B_at SMARCA2 NM_003070
9p22.3 6595.012.1 57447.039.1 6595.12 64151.1 470 59.012.2-D_at
ACTA2 NM_001613 10q23.3 59.012.2 57447.040.1 59.12 29089.3 471
57447.034.1- NDRG2 NM_016269 14q11.2 57447.034.1 57447.041.1
57447.34 3860.8 C_at 472 56477.001.1- CCL28 NM_148672 5p12
56477.001.1 57447.042.1 56477.1 25925.6 B_at 473 57447.041.1- NDRG2
NM_016270 14q11.2 57447.041.1 57447.043.1 57447.41 59.49 D_at 474
9768.005.1-B_at KIAA0101 NM_001029991 15q22.31 9768.005.1
57447.044.1 9768.5 6289.2 475 285203.001.2-C C3orf64 NM_173654
3p14.1 285203.001.2 57447.047.1 285203.1 244.3 476 147495.006.1-B
APCDD1 NM_153000 18p11.22 147495.006.1 57447.048.1 147495.6 11065.8
477 7018.029.1-D_at TF NM_001063 3q22.1 7018.029.1 57447.048.2
7018.29 7091.6 478 3852.009.1-T_at KRT5 NM_000424 12q12-q13
3852.009.1 57447.049.1 3852.9 79608.9 479 59.023.2-D_at ACTA2
NM_001613 10q23.3 59.023.2 57447.050.1 59.23 9413.2 480
1959.002.1-D_at EGR2 NM_000399 10q21.1 1959.002.1 57447.051.1
1959.2 7431.64 481 7018.014.1-D_at TF NM_001063 3q22.1 7018.014.1
57447.051.2 7018.14 8404.29 482 5858.004.1-F_at PZP NM_002864
12p13-p12.2 5858.004.1 57451.001.3 5858.4 301.5 483 79192.002.2-
IRX1 NM_024337 5p15.3 79192.002.2 57451.002.3 79192.2 9055.14 D_at
484 59.008.2-B_at ACTA2 NM_001613 10q23.3 59.008.2 57451.004.1 59.8
4281.23 485 8404.008.1-E_at SPARCL1 NM_004684 4q22.1 8404.008.1
57561.001.1 8404.8 1062.1 486 59.008.1-F_at ACTA2 NM_001613 10q23.3
59.008.1 57561.002.1 59.8 5858.5 487 4240.011.1-B_at MFGE8
NM_005928 15q25 4240.011.1 5764.001.1 4240.11 51201.7 488
94274.002.1- PPP1R14A NM_033256 19q13.1 94274.002.1 5803.002.1
94274.2 4240.1 C_at 489 4638.015.1-T_at MYLK NM_005978 3q21
4638.015.1 5803.002.2 4638.15 9413.1 490 6376.001.1-T_at CX3CL1
NM_002996 16q13 6376.001.1 5803.006.1 6376.1 11197.1 491
57447.043.1- NDRG2 NM_016271 14q11.2 57447.043.1 58499.005.2
57447.43 6285.2 F_at 492 59.039.1-T_at ACTA2 NM_001613 10q23.3
59.039.1 5858.001.2 59.39 7169.1 493 4638.006.1-B_at MYLK NM_005979
3q21 4638.006.1 5858.003.3 4638.6 4601.14 494 25802.003.1- LMOD1
NM_012134 1q32 25802.003.1 5858.004.1 25802.3 51203.2 F_at 495
57447.025.1- NDRG2 NM_016272 14q11.2 57447.025.1 5858.005.1
57447.25 7018.22 T_at 496 57447.017.1- NDRG2 NM_016273 14q11.2
57447.017.1 59.003.1 57447.17 4288.9 T_at 497 7018.026.1-C_at TF
NM_001063 3q22.1 7018.026.1 59.004.1 7018.26 8321.4 498
7018.028.1-E_at TF NM_001063 3q22.1 7018.028.1 59.004.2 7018.28
8564.4 499 4915.008.1-C_at NTRK2 NM_001007107 9q22.1 4915.008.1
59.008.1 4915.8 29127.13 500 358.018.1-C_at AQP1 NM_198098 7p14
358.018.1 59.008.2 358.18 1058.4 501 7153.002.6-B_at TOP2A
NM_001067 17q21-q22 7153.002.6 59.009.1 7153.2 2232.14 502
57447.012.1- NDRG2 NM_016274 14q11.2 57447.012.1 59.012.1 57447.12
23650.5 T_at 503 59.040.1-B_at ACTA2 NM_001613 10q23.3 59.040.1
59.012.2 59.40 5621.2 504 57447.006.1- NDRG2 NM_016275 14q11.2
57447.006.1 59.014.1 57447.6 54443.12 T_at 505 9493.006.1-F_at
KIF23 NM_004856 15q23 9493.006.1 59.014.2 9493.6 3479.3 506
57447.004.1- NDRG2 NM_016276 14q11.2 57447.004.1 59.015.1 57447.4
94274.3 T_at 507 57447.004.2- NDRG2 NM_016277 14q11.2 57447.004.2
59.015.2 57447.4 84668.3 B_at 508 7373.001.2-D_at COL14A1 NM_021110
8q23 7373.001.2 59.016.1 7373.1 22974.8 509 9493.004.1-B_at KIF23
NM_004856 15q23 9493.004.1 59.022.1 9493.4 55656.7 510
2568.005.2-C_at GABRP NM_014211 5q33-q34 2568.005.2 59.022.2 2568.5
29127.2 511 7018.029.1-F_at TF NM_001063 3q22.1 7018.029.1 59.023.1
7018.29 4281.12 512 26289.013.1- AK5 NM_012116 1p31 26289.013.1
59.023.2 26289.13 79627.3 B_at 513 7169.015.1-B_at TPM2 NM_003289
9p13.2-p13.1 7169.015.1 59.024.1 7169.15 2982.14 514 57451.001.3-
ODZ2 NM_001080428 5q34-q35.1 57451.001.3 59.024.2 57451.1 2335.53
F_at 515 2568.005.2-F_at GABRP NM_014211 5q33-q34 2568.005.2
59.026.1 2568.5 667.1 516 57447.004.2- NDRG2 NM_016278 14q11.2
57447.004.2 59.026.2 57447.4 55366.1 F_at 517 8404.004.1-D_at
SPARCL1 NM_004684 4q22.1 8404.004.1 59.029.1 8404.4 5311.3 518
3855.004.2-D_at KRT7 NM_005556 12q12-q13 3855.004.2 59.031.1 3855.4
6304.11 519 3872.014.1-F_at KRT17 NM_000422 17q12-q21 3872.014.1
59.031.2 3872.14 7373.7 520 57447.033.1- NDRG2 NM_016279 14q11.2
57447.033.1 59.033.1 57447.33 1410.9 F_at 521 9452.001.1-T_at ITM2A
NM_004867 Xq13.3-Xq21.2 9452.001.1 59.033.2 9452.1 79745.4 522
59.033.2-T_at ACTA2 NM_001613 10q23.3 59.033.2 59.034.1 59.33
24137.4 523 3084.009.1-T_at NRG1 NM_004509 8p12 3084.009.1 59.034.2
3084.9 6241.13 524 57447.040.1- NDRG2 NM_016280 14q11.2 57447.040.1
59.038.1 57447.40 1410.1 T_at 525 4833.004.1-T_at NME4 NM_005009
16p13.3 4833.004.1 59.039.1 4833.4 4781.15 526 3426.001.1-F_at CFI
NM_000204 4q25 3426.001.1 59.040.1 3426.1 72.2 527 59.034.1-B_at
ACTA2 NM_001613 10q23.3 59.034.1 59.042.1 59.34 2982.13 528
10253.001.1- SPRY2 NM_005842 13q31.1 10253.001.1 59.049.1 10253.1
79971.12 E_at 529 9073.001.1-C_at CLDN8 NM_199328 21q22.11
9073.001.1 6122.037.1 9073.1 7169.4 530 51201.005.1- ZDHHC2
NM_016353 8p21.3-p22 51201.005.1 6122.046.1 51201.5 2335.16 T_at
531 9477.006.1-C_at MED20 NM_004275 6p21.1 9477.006.1 6241.013.1
9477.6 259266.3 532 57447.028.1- NDRG2 NM_016281 14q11.2
57447.028.1 6285.001.1 57447.28 9055.20 T_at 533 25925.007.1-
ZNF521 NM_015461 18q11.2 25925.007.1 6285.002.1 25925.7 7091.16
T_at 534 59.024.2-B_at ACTA2 NM_001613 10q23.3 59.024.2 6285.003.1
59.24 57162.10 535 2.022.1-T_at A2M NM_000014 12p13.3-p12.3 2.022.1
6286.001.1 2.22 4781.2 536 4281.008.2-B_at MID1 NM_000382 Xp22
4281.008.2 6288.001.1 4281.8 6122.37 537 90231.001.1- KIAA2013
NM_138346 1p36.22 90231.001.1 6288.004.1 90231.1 4240.15 C_at 538
358.012.1-D_at AQP1 NM_198098 7p14 358.012.1 6289.001.1 358.12
6304.2 539 3852.021.1-T_at KRT5 NM_000424 12q12-q13 3852.021.1
6289.001.2 3852.21 301.13 540 7373.003.4-D_at COL14A1 NM_021110
8q23 7373.003.4 6289.002.1 7373.3 6304.12 541 57447.048.1- NDRG2
NM_016282 14q11.2 57447.048.1 6289.002.2 57447.48 11065.5 T_at 542
358.012.1-B_at AQP1 NM_198098 7p14 358.012.1 6289.003.1 358.12
29997.16 543 7018.025.1-C_at TF NM_001063 3q22.1 7018.025.1
6289.003.2 7018.25 1410.11 544 5608.004.1-T_at MAP2K6 NM_002758
17q24.3 5608.004.1 6289.005.1 5608.4 7170.40 545 3084.012.2-F_at
NRG1 NM_004510 8p12 3084.012.2 6289.006.1 3084.12 7170.41 546
4306.002.1-C_at NR3C2 NM_000901 4q31.1 4306.002.1 6304.002.1 4306.2
4094.2 547 4288.004.1-D_at MKI67 NM_002417 10q25-qter 4288.004.1
6304.006.2 4288.4 7113.11 548 57447.002.1- NDRG2 NM_016283 14q11.2
57447.002.1 6304.007.1 57447.2 7170.2 F_at 549 4281.018.1-T_at MID1
NM_000383 Xp22 4281.018.1 6304.007.2 4281.18 8404.17 550
10144.020.2- FAM13A1 NM_001015045 4q22.1 10144.020.2 6304.011.1
10144.20 59.29 B_at 551 6876.016.1-E_at TAGLN NM_001001522 11q23.2
6876.016.1 6304.012.1 6876.16 29089.1 552 57447.008.2- NDRG2
NM_016284 14q11.2 57447.008.2 6376.001.1 57447.8 9134.1 T_at 553
51203.004.1- NUSAP1 NM_016359 15q15.1 51203.004.1 6376.001.2
51203.4 1410.10 T_at 554 2335.028.1-B_at FN1 NM_002026 2q34
2335.028.1 64151.001.2 2335.28 2327.3 555 7018.028.1-F_at TF
NM_001063 3q22.1 7018.028.1 64168.010.1 7018.28 6289.1 556
7373.003.5-T_at COL14A1 NM_021110 8q23 7373.003.5 6422.001.1 7373.3
1410.6 557 81557.006.1- MAGED4B NM_030801 -- 81557.006.1 6422.002.1
81557.6 80034.4 C_at 558 3866.002.1-D_at KRT15 NM_002275 17q21.2
3866.002.1 6441.004.1 3866.2 1410.8 559 3866.001.1-B_at KRT15
NM_002275 17q21.2 3866.001.1 6595.012.1 3866.1 6288.1 560
55107.006.2- TMEM16A NM_018043 11q13.3 55107.006.2 65983.003.1
55107.6 8404.20 T_at 561 79068.010.1- FTO NM_001080432 16q12.2
79068.010.1 65983.003.2 79068.10 3459.5 D_at 562 57447.009.1- NDRG2
NM_016285 14q11.2 57447.009.1 65983.004.1 57447.9 83539.1 T_at 563
2115.015.1-T_at ETV1 NM_004956 7p21.3 2115.015.1 65983.004.2
2115.15 6288.4 564 1756.013.1-C_at DMD NM_000143 Xp21.2 1756.013.1
65983.005.1 1756.13 4781.16 565 7169.015.1-F_at TPM2 NM_003290
9p13.2-p13.1 7169.015.1 65983.007.1 7169.15 53829.1 566
65983.013.2- GRAMD3 NM_023927 5q23.2 65983.013.2 65983.008.1
65983.13 10051.8 F_at 567 8404.001.1-B_at SPARCL1 NM_004684 4q22.1
8404.001.1 65983.009.1 8404.1 1033.2 568 4240.004.1-B_at MFGE8
NM_005928 15q25 4240.004.1 65983.010.1 4240.4 2335.5 569
57447.012.2- NDRG2 NM_016286 14q11.2 57447.012.2 65983.013.1
57447.12 7113.9 T_at 570 57447.024.1- NDRG2 NM_016287 14q11.2
57447.024.1 65983.013.2 57447.24 7168.3 F_at 571 358.018.1-T_at
AQP1 NM_198098 7p14 358.018.1 667.001.1 358.18 79608.1 572
57447.048.2- NDRG2 NM_016288 14q11.2 57447.048.2 667.010.1 57447.48
7113.10 T_at 573 59.031.1-C_at ACTA2 NM_001613 10q23.3 59.031.1
667.021.1 59.31 4781.14 574 3860.007.1-F_at KRT13 NM_002275
17q12-q21.2 3860.007.1 667.022.1 3860.7 11065.3
575 8404.028.1-C_at SPARCL1 NM_004684 4q22.1 8404.028.1 6876.002.1
8404.28 3084.5 576 4240.011.3-E_at MFGE8 NM_005928 15q25 4240.011.3
6876.011.1 4240.11 6285.3 577 59.022.2-B_at ACTA2 NM_001613 10q23.3
59.022.2 6876.016.1 59.22 54829.1 578 3866.002.1-F_at KRT15
NM_002275 17q21.2 3866.002.1 6876.016.2 3866.2 9055.11 579
3866.002.1-T_at KRT15 NM_002275 17q21.2 3866.002.1 6876.020.1
3866.2 4288.8 580 4915.005.1-B_at NTRK2 NM_001007108 9q22.1
4915.005.1 6876.023.1 4915.5 4781.7 581 8404.008.1-F_at SPARCL1
NM_004684 4q22.1 8404.008.1 699.002.1 8404.8 9055.17 582
79608.002.1- RIC3 NM_024557 11p15.4 79608.002.1 7018.013.1 79608.2
7170.18 F_at 583 8404.023.1-D_at SPARCL1 NM_004684 4q22.1
8404.023.1 7018.014.1 8404.23 10253.3 584 3426.002.1-D_at CFI
NM_000204 4q25 3426.002.1 7018.022.1 3426.2 2982.15 585
2335.027.1-T_at FN1 NM_002027 2q34 2335.027.1 7018.025.1 2335.27
10124.4 586 11065.009.1- UBE2C NM_007019 20q13.12 11065.009.1
7018.026.1 11065.9 7091.5 T_at 587 140885.013.1-F SIRPA
NM_001040024 20p13 140885.013.1 7018.028.1 140885.13 501.6 588
57447.021.1- NDRG2 NM_016289 14q11.2 57447.021.1 7018.029.1
57447.21 244.12 B_at 589 25802.004.1- LMOD1 NM_012134 1q32
25802.004.1 7091.001.1 25802.4 3872.18 C_at 590 4638.014.1-F_at
MYLK NM_005980 3q21 4638.014.1 7091.005.1 4638.14 10144.17 591
9493.004.1-F_at KIF23 NM_004856 15q23 9493.004.1 7091.006.1 9493.4
29127.7 592 8404.004.1-B_at SPARCL1 NM_004684 4q22.1 8404.004.1
7091.010.1 8404.4 10010.4 593 8404.004.2-T_at SPARCL1 NM_004684
4q22.1 8404.004.2 7091.014.1 8404.4 4781.6 594 57447.010.2- NDRG2
NM_016290 14q11.2 57447.010.2 7091.015.1 57447.10 23092.4 T_at 595
57447.010.3- NDRG2 NM_016291 14q11.2 57447.010.3 7091.016.1
57447.10 2335.2 B_at 596 27122.006.1- DKK3 NM_001018069 11p15.2
27122.006.1 7113.001.1 27122.6 6304.6 T_at 597 5156.005.1-T_at
PDGFRA NM_006206 4q11-q13 5156.005.1 7113.009.1 5156.5 9055.19 598
5858.004.1-E_at PZP NM_002864 12p13-p12.2 5858.004.1 7113.010.1
5858.4 1398.1 599 25802.008.1- LMOD1 NM_012134 1q32 25802.008.1
7113.011.1 25802.8 339965.1 D_at 600 2327.002.2-T_at FMO2 NM_001460
1q23-q25 2327.002.2 7153.002.2 2327.2 7113.1 601 3852.004.1-C_at
KRT5 NM_000424 12q12-q13 3852.004.1 7153.002.3 3852.4 4833.10 602
59.026.2-F_at ACTA2 NM_001613 10q23.3 59.026.2 7153.002.4 59.26
79971.13 603 57447.029.1- NDRG2 NM_016292 14q11.2 57447.029.1
7153.002.5 57447.29 152015.5 C_at 604 7169.022.1-D_at TPM2
NM_003291 9p13.2-p13.1 7169.022.1 7153.002.6 7169.22 4288.5 605
23266.001.3- LPHN2 NM_012302 1p31.1 23266.001.3 7153.005.1 23266.1
6441.4 B_at 606 3084.012.1-B_at NRG1 NM_004511 8p12 3084.012.1
7168.003.1 3084.12 6122.46 607 29127.019.2- RACGAP1 NM_013277
12q13.13 29127.019.2 7169.001.1 29127.19 115908.2 T_at 608
10253.004.1- SPRY2 NM_005842 13q31.1 10253.004.1 7169.004.1 10253.4
9481.1 T_at 609 10124.002.1- ARL4A NM_001037164 7p21-p15.3
10124.002.1 7169.015.1 10124.2 2335.24 D_at 610 3861.013.1-D_at
KRT14 NM_000526 17q12-q21 3861.013.1 7169.022.1 3861.13 891.7 611
8404.032.1-T_at SPARCL1 NM_004684 4q22.1 8404.032.1 7170.002.1
8404.32 57451.4 612 84441.002.1- MAML2 NM_032427 11q21 84441.002.1
7170.005.2 84441.2 6286.1 E_at 613 2.013.1-E_at A2M NM_000014
12p13.3-p12.3 2.013.1 7170.006.1 2.13 10580.12 614 3084.004.1-T_at
NRG1 NM_004512 8p12 3084.004.1 7170.007.1 3084.4 23321.14 615
5288.001.2-F_at PIK3C2G NM_004570 12p12 5288.001.2 7170.014.1
5288.1 2824.1 616 57447.017.1- NDRG2 NM_016293 14q11.2 57447.017.1
7170.016.3 57447.17 29127.22 F_at 617 3084.006.1-T_at NRG1
NM_004513 8p12 3084.006.1 7170.018.2 3084.6 54443.11 618
59.039.1-F_at ACTA2 NM_001613 10q23.3 59.039.1 7170.025.1 59.39
29997.8 619 2.024.1-T_at A2M NM_000014 12p13.3-p12.3 2.024.1
7170.027.1 2.24 57561.2 620 3815.002.2-E_at KIT NM_000236 4q11-q12
3815.002.2 7170.034.2 3815.2 57451.2 621 1756.009.1-D_at DMD
NM_000144 Xp21.2 1756.009.1 7170.040.1 1756.9 5213.24 622
7091.014.1-B_at TLE4 NM_007005 9q21.31 7091.014.1 7170.041.1
7091.14 11065.4 623 4629.015.1-F_at MYH11 NM_001040137 16p13.11
4629.015.1 72.001.1 4629.15 6289.6 624 59.008.2-F_at ACTA2
NM_001613 10q23.3 59.008.2 72.002.1 59.8 23284.7 625
2568.005.2-T_at GABRP NM_014211 5q33-q34 2568.005.2 72.005.1 2568.5
79971.9 626 115207.002.1-T KCTD12 NM_138444 13q22.3 115207.002.1
7373.001.1 115207.2 51203.9 627 4281.001.1-T_at MID1 NM_000384 Xp22
4281.001.1 7373.001.2 4281.1 1308.2 628 84668.002.2- FAM126A
NM_032581 7p15.3 84668.002.2 7373.002.1 84668.2 4288.7 T_at 629
4240.004.1-F_at MFGE8 NM_005928 15q25 4240.004.1 7373.003.1 4240.4
244.11 630 8404.005.1-D_at SPARCL1 NM_004684 4q22.1 8404.005.1
7373.003.2 8404.5 3178.3 631 8404.032.1-B_at SPARCL1 NM_004684
4q22.1 8404.032.1 7373.003.3 8404.32 9055.12 632 57447.044.1- NDRG2
NM_016294 14q11.2 57447.044.1 7373.003.4 57447.44 9232.1 E_at 633
8626.006.2-F_at TP63 NM_003722 3q28 8626.006.2 7373.003.5 8626.6
79068.11 634 57447.051.2- NDRG2 NM_016295 14q11.2 57447.051.2
7373.003.6 57447.51 7534.1 B_at 635 1063.001.1-T_at CENPF NM_016343
1q32-q41 1063.001.1 7373.004.1 1063.1 79971.14 636 3426.002.1-T_at
CFI NM_000204 4q25 3426.002.1 7373.007.1 3426.2 5621.8 637
1308.001.1-T_at COL17A1 NM_000505 10q24.3 1308.001.1 7373.008.1
1308.1 55732.3 638 389432.002.1-F SAMD5 NM_001030060 6q24.3
389432.002.1 7402.014.1 389432.2 221120.6 639 57447.017.1- NDRG2
NM_016296 14q11.2 57447.017.1 7431.064.1 57447.17 2335.45 B_at 640
2115.014.1-F_at ETV1 NM_004956 7p21.3 2115.014.1 7534.001.1 2115.14
7170.7 641 5284.004.1-T_at PIGR NM_002644 1q31-q41 5284.004.1
79068.010.1 5284.4 9055.10 642 57447.029.1- NDRG2 NM_016297 14q11.2
57447.029.1 79068.011.2 57447.29 58499.5 F_at 643 8626.006.1-F_at
TP63 NM_003722 3q28 8626.006.1 79192.002.2 8626.6 54443.6 644
2982.002.1-C_at GUCY1A3 NM_000856 4q31.3-q33| 2982.002.1
79608.001.1 2982.2 59.16 4q31.1-q31.2 645 57447.047.1- NDRG2
NM_016298 14q11.2 57447.047.1 79608.002.1 57447.47 7170.14 T_at 646
5803.006.1-E_at PTPRZ1 NM_002851 7q31.3 5803.006.1 79608.008.1
5803.6 647 57447.021.1- NDRG2 NM_016299 14q11.2 57447.021.1
79608.008.2 57447.21 F_at 648 57447.039.1- NDRG2 NM_016300 14q11.2
57447.039.1 79608.009.1 57447.39 205 genes F_at 649 4281.008.2-F_at
MID1 NM_000385 Xp22 4281.008.2 79627.003.1 4281.8 645 transcrits
650 57447.029.1- NDRG2 NM_016301 14q11.2 57447.029.1 79745.004.3
57447.29 1228 D_at probesets 651 65983.013.1- GRAMD3 NM_023927
5q23.2 65983.013.1 79895.001.1 65983.13 B_at 652 5284.004.1-E_at
PIGR NM_002644 1q31-q41 5284.004.1 79937.001.1 5284.4 653
4240.011.1-D_at MFGE8 NM_005928 15q25 4240.011.1 79937.002.1
4240.11 654 57447.024.1- NDRG2 NM_016302 14q11.2 57447.024.1
79971.009.1 57447.24 T_at 655 6876.011.1-B_at TAGLN NM_001001523
11q23.2 6876.011.1 79971.012.1 6876.11 656 7373.003.2-T_at COL14A1
NM_021110 8q23 7373.003.2 79971.013.2 7373.3 657 3852.014.1-D_at
KRT5 NM_000424 12q12-q13 3852.014.1 79971.014.1 3852.14 658
4915.005.1-D_at NTRK2 NM_001007109 9q22.1 4915.005.1 80034.002.2
4915.5 659 9768.002.2-B_at KIAA0101 NM_001029992 15q22.31
9768.002.2 80034.003.4 9768.2 660 140885.010.1-D SIRPA NM_001040025
20p13 140885.010.1 80034.004.1 140885.10 661 4638.020.1-E_at MYLK
NM_005981 3q21 4638.020.1 81557.006.1 4638.20 662 57447.017.1-
NDRG2 NM_016303 14q11.2 57447.017.1 81704.008.1 57447.17 C_at 663
7373.004.1-T_at COL14A1 NM_021110 8q23 7373.004.1 81704.013.1
7373.4 664 3852.008.2-E_at KRT5 NM_000424 12q12-q13 3852.008.2
8321.004.1 3852.8 665 4281.015.1-E_at MID1 NM_000386 Xp22
4281.015.1 83539.001.1 4281.15 666 8404.013.1-C_at SPARCL1
NM_004684 4q22.1 8404.013.1 8404.001.1 8404.13 667 90293.001.3-
KLHL13 NM_033495 Xq23-q24 90293.001.3 8404.002.1 90293.1 T_at 668
57447.044.1- NDRG2 NM_016304 14q11.2 57447.044.1 8404.004.1
57447.44 T_at 669 23650.011.2- TRIM29 NM_012101 11q22-q23
23650.011.2 8404.004.2 23650.11 D_at 670 2335.006.1-D_at FN1
NM_002028 2q34 2335.006.1 8404.005.1 2335.6 671 57447.022.1- NDRG2
NM_016305 14q11.2 57447.022.1 8404.008.1 57447.22 T_at 672
8404.032.1-D_at SPARCL1 NM_004684 4q22.1 8404.032.1 8404.009.1
8404.32 673 8404.030.1-F_at SPARCL1 NM_004684 4q22.1 8404.030.1
8404.013.1 8404.30 674 5803.002.2-T_at PTPRZ1 NM_002851 7q31.3
5803.002.2 8404.015.1 5803.2 675 8404.004.2-C_at SPARCL1 NM_004684
4q22.1 8404.004.2 8404.017.1 8404.4 676 84441.005.1- MAML2
NM_032427 11q21 84441.005.1 8404.017.2 84441.5 C_at 677
7091.015.1-F_at TLE4 NM_007005 9q21.31 7091.015.1 8404.020.1
7091.15 678 2119.005.1-D_at ETV5 NM_004454 3q28 2119.005.1
8404.021.1 2119.5 679 7373.003.6-F_at COL14A1 NM_021110 8q23
7373.003.6 8404.022.1 7373.3 680 79608.008.1- RIC3 NM_024557
11p15.4 79608.008.1 8404.023.1 79608.8 T_at 681 3852.008.1-T_at
KRT5 NM_000424 12q12-q13 3852.008.1 8404.024.1 3852.8 682
8626.007.1-T_at TP63 NM_003722 3q28 8626.007.1 8404.025.1 8626.7
683 8404.022.1-T_at SPARCL1 NM_004684 4q22.1 8404.022.1 8404.026.1
8404.22 684 8404.034.1-T_at SPARCL1 NM_004684 4q22.1 8404.034.1
8404.028.1 8404.34 685 57447.049.1- NDRG2 NM_016306 14q11.2
57447.049.1 8404.028.3 57447.49 T_at 686 5311.002.1-B_at PKD2
NM_000297 4q21-q23 5311.002.1 8404.029.1 5311.2 687 2335.025.3-T_at
FN1 NM_002029 2q34 2335.025.3 8404.030.1 2335.25 688
4147.012.1-T_at MATN2 NM_002380 8q22 4147.012.1 8404.031.1 4147.12
689 301.015.1-T_at ANXA1 NM_000700 9q12-q21.2| 301.015.1 8404.032.1
301.15 9q12-q21.2 690 301.004.1-T_at ANXA1 NM_000700 9q12-q21.2|
301.004.1 8404.034.1 301.4 9q12-q21.2 691 3426.002.2-F_at CFI
NM_000204 4q25 3426.002.2 8404.035.1 3426.2 692 7091.001.1-C_at
TLE4 NM_007005 9q21.31 7091.001.1 84417.001.1 7091.1 693
8404.021.1-D_at SPARCL1 NM_004684 4q22.1 8404.021.1 84417.001.2
8404.21 694 7153.002.3-B_at TOP2A NM_001067 17q21-q22 7153.002.3
84441.002.1 7153.2 695 53335.002.1- BCL11A NM_018014 2p16.1
53335.002.1 84441.005.1 53335.2 E_at 696 5284.003.2-T_at PIGR
NM_002644 1q31-q41 5284.003.2 84668.002.1 5284.3 697
4306.002.1-F_at NR3C2 NM_000901 4q31.1 4306.002.1 84668.002.2
4306.2 698 5284.003.2-D_at PIGR NM_002644 1q31-q41 5284.003.2
84668.003.1 5284.3 699 5803.002.1-T_at PTPRZ1 NM_002851 7q31.3
5803.002.1 84668.004.1 5803.2 700 10253.004.1- SPRY2 NM_005842
13q31.1 10253.004.1 8564.004.1 10253.4
E_at 701 23650.020.1- TRIM29 NM_012101 11q22-q23 23650.020.1
8626.002.1 23650.20 T_at 702 57447.042.1- NDRG2 NM_016307 14q11.2
57447.042.1 8626.005.1 57447.42 T_at 703 6876.023.1-F_at TAGLN
NM_001001524 11q23.2 6876.023.1 8626.006.1 6876.23 704
7169.015.1-C_at TPM2 NM_003292 9p13.2-p13.1 7169.015.1 8626.006.2
7169.15 705 7153.002.4-F_at TOP2A NM_001067 17q21-q22 7153.002.4
8626.007.1 7153.2 706 4629.016.1-B_at MYH11 NM_001040138 16p13.11
4629.016.1 891.007.1 4629.16 707 6876.002.1-C_at TAGLN NM_001001525
11q23.2 6876.002.1 90231.001.1 6876.2 708 65983.007.1- GRAMD3
NM_023927 5q23.2 65983.007.1 90293.001.3 65983.7 T_at 709
7373.003.2-F_at COL14A1 NM_021110 8q23 7373.003.2 9055.010.1 7373.3
710 152015.004.1-T ROPN1B NM_001012337 3q21.2 152015.004.1
9055.011.1 152015.4 711 8404.004.2-B_at SPARCL1 NM_004684 4q22.1
8404.004.2 9055.012.1 8404.4 712 6285.001.1-B_at S100B NM_006272
21q22.3 6285.001.1 9055.013.1 6285.1 713 2115.007.1-E_at ETV1
NM_004956 7p21.3 2115.007.1 9055.014.1 2115.7 714 2.013.1-T_at A2M
NM_000014 12p13.3-p12.3 2.013.1 9055.017.1 2.13 715 6289.005.1-T_at
SAA2 NM_030754 11p15.1-p14 6289.005.1 9055.019.1 6289.5 716
9232.002.1-T_at PTTG1 NM_004219 5q35.1 9232.002.1 9055.020.1 9232.2
717 59.014.1-B_at ACTA2 NM_001613 10q23.3 59.014.1 9073.001.1 59.14
718 59.031.1-F_at ACTA2 NM_001613 10q23.3 59.031.1 90865.006.1
59.31 719 3084.011.1-T_at NRG1 NM_004514 8p12 3084.011.1 9134.001.1
3084.11 720 3872.005.1-F_at KRT17 NM_000422 17q12-q21 3872.005.1
9232.001.1 3872.5 721 3084.012.3-F_at NRG1 NM_004515 8p12
3084.012.3 9232.002.1 3084.12 722 81704.008.1- DOCK8 NM_203447
9p24.3 81704.008.1 9232.004.1 81704.8 F_at 723 140885.010.2-C SIRPA
NM_001040026 20p13 140885.010.2 9413.001.1 140885.10 724
338707.006.1-E B4GALNT4 NM_178537 11p15.5 338707.006.1 9413.001.2
338707.6 725 23266.008.2- LPHN2 NM_012302 1p31.1 23266.008.2
9413.002.1 23266.8 T_at 726 120.005.2-E_at ADD3 NM_001121
10q24.2-q24.3 120.005.2 9413.003.1 120.5 727 4281.009.1-E_at MID1
NM_000387 Xp22 4281.009.1 9413.006.1 4281.9 728 4094.001.1-T_at MAF
NM_001031804 16q22-q23 4094.001.1 94274.002.1 4094.1 729
2995.001.1-T_at GYPC NM_002101 2q14-q21 2995.001.1 94274.003.1
2995.1 730 4638.011.1-T_at MYLK NM_005982 3q21 4638.011.1
9452.001.1 4638.11 731 2335.017.1-T_at FN1 NM_002030 2q34
2335.017.1 9477.006.1 2335.17 732 5284.001.1-F_at PIGR NM_002644
1q31-q41 5284.001.1 9481.001.1 5284.1 733 8404.026.1-D_at SPARCL1
NM_004684 4q22.1 8404.026.1 9493.001.1 8404.26 734 2335.009.1-D_at
FN1 NM_002031 2q34 2335.009.1 9493.004.1 2335.9 735 10461.002.2-
MERTK NM_006343 2q14.1 10461.002.2 9493.006.1 10461.2 F_at 736
84441.002.1- MAML2 NM_032427 11q21 84441.002.1 9768.002.2 84441.2
T_at 737 147495.006.1-T APCDD1 NM_153000 18p11.22 147495.006.1
9768.004.1 147495.6 738 7091.010.1-B_at TLE4 NM_007005 9q21.31
7091.010.1 9768.005.1 7091.10 739 8404.008.1-C_at SPARCL1 NM_004684
4q22.1 8404.008.1 9898.015.2 8404.8 740 6376.001.2-C_at CX3CL1
NM_002996 16q13 6376.001.2 6376.1 741 3832.002.1-B_at KIF11
NM_004523 10q24.1 3832.002.1 3832.2 742 59.034.2-T_at ACTA2
NM_001613 10q23.3 59.034.2 59.34 743 147495.005.1-B APCDD1
NM_153000 18p11.22 147495.005.1 147495.5 744 3872.005.1-T_at KRT17
NM_000422 17q12-q21 3872.005.1 3872.5 745 79895.001.1- ATP8B4
NM_024837 15q21.2 79895.001.1 79895.1 D_at 746 57447.038.1- NDRG2
NM_016308 14q11.2 57447.038.1 57447.38 T_at 747 7373.008.1-T_at
COL14A1 NM_021110 8q23 7373.008.1 7373.8 748 4744.004.1-C_at NEFH
NM_021076 22q12.2 4744.004.1 4744.4 749 140885.010.1-T SIRPA
NM_001040027 20p13 140885.010.1 140885.10 750 6876.016.2-E_at TAGLN
NM_001001526 11q23.2 6876.016.2 6876.16 751 8404.015.1-T_at SPARCL1
NM_004684 4q22.1 8404.015.1 8404.15 752 4281.014.1-T_at MID1
NM_000388 Xp22 4281.014.1 4281.14 753 4288.006.1-F_at MKI67
NM_002417 10q25-qter 4288.006.1 4288.6 754 25925.009.1- ZNF521
NM_015461 18q11.2 25925.009.1 25925.9 E_at 755 4240.009.1-B_at
MFGE8 NM_005928 15q25 4240.009.1 4240.9 756 667.010.1-E_at DST
NM_001725 6p12.1 667.010.1 667.10 757 3866.005.1-B_at KRT15
NM_002275 17q21.2 3866.005.1 3866.5 758 57447.011.1- NDRG2
NM_016309 14q11.2 57447.011.1 57447.11 T_at 759 57447.034.1- NDRG2
NM_016310 14q11.2 57447.034.1 57447.34 B_at 760 25802.004.1- LMOD1
NM_012134 1q32 25802.004.1 25802.4 B_at 761 8404.024.1-T_at SPARCL1
NM_004684 4q22.1 8404.024.1 8404.24 762 57447.032.1- NDRG2
NM_016311 14q11.2 57447.032.1 57447.32 T_at 763 667.021.1-F_at DST
NM_001726 6p12.1 667.021.1 667.21 764 5858.001.2-F_at PZP NM_002864
12p13-p12.2 5858.001.2 5858.1 765 51062.008.1- SPG3A NM_015915
14q22.1 51062.008.1 51062.8 T_at 766 2335.013.1-F_at FN1 NM_002032
2q34 2335.013.1 2335.13 767 2568.001.2-T_at GABRP NM_014211
5q33-q34 2568.001.2 2568.1 768 7170.005.2-D_at TPM3 NM_001043351
1q21.2 7170.005.2 7170.5 769 57447.034.1- NDRG2 NM_016312 14q11.2
57447.034.1 57447.34 F_at 770 7153.002.6-C_at TOP2A NM_001067
17q21-q22 7153.002.6 7153.2 771 2568.003.1-T_at GABRP NM_014211
5q33-q34 2568.003.1 2568.3 772 59.008.2-T_at ACTA2 NM_001613
10q23.3 59.008.2 59.8 773 9898.015.2-B_at UBAP2L NM_014847 1q21.3
9898.015.2 9898.15 774 7018.013.1-T_at TF NM_001063 3q22.1
7018.013.1 7018.13 775 7170.034.2-D_at TPM3 NM_001043352 1q21.2
7170.034.2 7170.34 776 3866.004.1-E_at KRT15 NM_002275 17q21.2
3866.004.1 3866.4 777 5284.001.1-T_at PIGR NM_002644 1q31-q41
5284.001.1 5284.1 778 2.002.1-C_at A2M NM_000014 12p13.3-p12.3
2.002.1 2.2 779 57447.050.1- NDRG2 NM_016313 14q11.2 57447.050.1
57447.50 T_at 780 7018.014.1-F_at TF NM_001063 3q22.1 7018.014.1
7018.14 781 2335.032.1-D_at FN1 NM_002033 2q34 2335.032.1 2335.32
782 3866.002.1-C_at KRT15 NM_002275 17q21.2 3866.002.1 3866.2 783
57447.043.1- NDRG2 NM_016314 14q11.2 57447.043.1 57447.43 T_at 784
51201.005.1- ZDHHC2 NM_016353 8p21.3-p22 51201.005.1 51201.5 D_at
785 51203.003.1- NUSAP1 NM_016360 15q15.1 51203.003.1 51203.3 T_at
786 9493.001.1-F_at KIF23 NM_004856 15q23 9493.001.1 9493.1 787
57447.024.1- NDRG2 NM_016315 14q11.2 57447.024.1 57447.24 B_at 788
80034.003.4- FAM130A2 NM_024969 2q24.3 80034.003.4 80034.3 B_at 789
7170.016.3-C_at TPM3 NM_001043353 1q21.2 7170.016.3 7170.16 790
65983.003.1- GRAMD3 NM_023927 5q23.2 65983.003.1 65983.3 T_at 791
57447.026.1- NDRG2 NM_016316 14q11.2 57447.026.1 57447.26 T_at 792
440421.001.1-F 440421.001.1 440421.1 793 301.008.1-D_at ANXA1
NM_000700 9q12-q21.2| 301.008.1 301.8 9q12-q21.2 794 80034.002.2-
FAM130A2 NM_024969 2q24.3 80034.002.2 80034.2 T_at 795
7153.002.5-B_at TOP2A NM_001067 17q21-q22 7153.002.5 7153.2 796
3852.023.1-T_at KRT5 NM_000424 12q12-q13 3852.023.1 3852.23 797
8404.013.1-F_at SPARCL1 NM_004684 4q22.1 8404.013.1 8404.13 798
2.018.1-C_at A2M NM_000014 12p13.3-p12.3 2.018.1 2.18 799
10124.003.1- ARL4A NM_001037165 7p21-p15.3 10124.003.1 10124.3 B_at
800 3852.008.2-F_at KRT5 NM_000424 12q12-q13 3852.008.2 3852.8 801
4288.006.2-T_at MKI67 NM_002417 10q25-qter 4288.006.2 4288.6 802
8404.026.1-C_at SPARCL1 NM_004684 4q22.1 8404.026.1 8404.26 803
23650.019.1- TRIM29 NM_012101 11q22-q23 23650.019.1 23650.19 C_at
804 7170.027.1-T_at TPM3 NM_001043354 1q21.2 7170.027.1 7170.27 805
54928.003.1- IMPAD1 NM_017813 8q12.1 54928.003.1 54928.3 E_at 806
2335.025.1-B_at FN1 NM_002034 2q34 2335.025.1 2335.25 807
3084.010.1-T_at NRG1 NM_004516 8p12 3084.010.1 3084.10 808
57447.051.1- NDRG2 NM_016317 14q11.2 57447.051.1 57447.51 T_at 809
80034.003.4- FAM130A2 NM_024969 2q24.3 80034.003.4 80034.3 T_at 810
2568.005.1-D_at GABRP NM_014211 5q33-q34 2568.005.1 2568.5 811
8404.032.1-F_at SPARCL1 NM_004684 4q22.1 8404.032.1 8404.32 812
2115.003.1-E_at ETV1 NM_004956 7p21.3 2115.003.1 2115.3 813
57447.035.1- NDRG2 NM_016318 14q11.2 57447.035.1 57447.35 T_at 814
8404.009.1-T_at SPARCL1 NM_004684 4q22.1 8404.009.1 8404.9 815
8404.028.3-B_at SPARCL1 NM_004684 4q22.1 8404.028.3 8404.28 816
6289.003.1-B_at SAA2 NM_030754 11p15.1-p14 6289.003.1 6289.3 817
7170.025.1-F_at TPM3 NM_001043355 1q21.2 7170.025.1 7170.25 818
8404.030.1-D_at SPARCL1 NM_004684 4q22.1 8404.030.1 8404.30 819
8404.009.1-F_at SPARCL1 NM_004684 4q22.1 8404.009.1 8404.9 820
2335.009.1-T_at FN1 NM_002035 2q34 2335.009.1 2335.9 821
22974.007.1- TPX2 NM_012112 20q11.2 22974.007.1 22974.7 F_at 822
3426.002.1-B_at CFI NM_000204 4q25 3426.002.1 3426.2 823
4638.003.1-D_at MYLK NM_005983 3q21 4638.003.1 4638.3 824
4147.011.1-T_at MATN2 NM_002381 8q22 4147.011.1 4147.11 825
6876.016.2-T_at TAGLN NM_001001527 11q23.2 6876.016.2 6876.16 826
23650.003.1- TRIM29 NM_012101 11q22-q23 23650.003.1 23650.3 F_at
827 4744.004.1-E_at NEFH NM_021076 22q12.2 4744.004.1 4744.4 828
64168.010.1- EFCBP1 NM_022351 8q21.3 64168.010.1 64168.10 F_at 829
9073.001.1-F_at CLDN8 NM_199328 21q22.11 9073.001.1 9073.1 830
5288.001.3-B_at PIK3C2G NM_004570 12p12 5288.001.3 5288.1 831
3866.005.1-D_at KRT15 NM_002275 17q21.2 3866.005.1 3866.5 832
8404.021.1-T_at SPARCL1 NM_004684 4q22.1 8404.021.1 8404.21 833
25925.011.1- ZNF521 NM_015461 18q11.2 25925.011.1 25925.11 E_at 834
23266.001.3- LPHN2 NM_012302 1p31.1 23266.001.3 23266.1 F_at 835
9232.004.1-F_at PTTG1 NM_004219 5q35.1 9232.004.1 9232.4 836
4147.005.2-F_at MATN2 NM_002382 8q22 4147.005.2 4147.5 837
2335.025.3-B_at FN1 NM_002036 2q34 2335.025.3 2335.25 838
4638.006.1-C_at MYLK NM_005984 3q21 4638.006.1 4638.6 839
147804.004.1-T LOC147804 NM_001010856 19q13.41 147804.004.1
147804.4 840 81704.013.1- DOCK8 NM_203447 9p24.3 81704.013.1
81704.13 D_at 841 54443.013.1- ANLN NM_018685 7p15-p14 54443.013.1
54443.13 B_at 842 1410.005.1-T_at CRYAB NM_001885 11q22.3-q23.1
1410.005.1 1410.5 843 25925.009.1- ZNF521 NM_015461 18q11.2
25925.009.1 25925.9 T_at 844 3204.001.1-T_at HOXA7 NM_006896
7p15-p14 3204.001.1 3204.1 845 29997.012.1- GLTSCR2 NM_015710
19q13.3 29997.012.1 29997.12 F_at 846 2.005.1-C_at A2M NM_000014
12p13.3-p12.3 2.005.1 2.5 847 140885.011.1-F SIRPA NM_001040028
20p13 140885.011.1 140885.11 848 7153.002.3-F_at TOP2A NM_001067
17q21-q22 7153.002.3 7153.2 849 1063.002.1-F_at CENPF NM_016343
1q32-q41 1063.002.1 1063.2 850 10144.021.1- FAM13A1 NM_001015046
4q22.1 10144.021.1 10144.21 F_at 851 8404.025.1-E_at SPARCL1
NM_004684 4q22.1 8404.025.1 8404.25 852 6876.020.1-B_at TAGLN
NM_001001528 11q23.2 6876.020.1 6876.20 853 7170.006.1-C_at TPM3
NM_001043356 1q21.2 7170.006.1 7170.6 854 10051.016.1- SMC4
NM_001002799 3q26.1 10051.016.1 10051.16 T_at 855 5288.001.2-D_at
PIK3C2G NM_004570 12p12 5288.001.2 5288.1 856 7018.029.1-T_at TF
NM_001063 3q22.1 7018.029.1 7018.29 857 5627.002.1-B_at PROS1
NM_000313 3q11.2 5627.002.1 5627.2 858 57447.037.1- NDRG2 NM_016319
14q11.2 57447.037.1 57447.37 T_at 859 4147.005.2-D_at MATN2
NM_002383 8q22 4147.005.2 4147.5 860 8404.023.1-T_at SPARCL1
NM_004684 4q22.1 8404.023.1 8404.23 861 3872.006.1-D_at KRT17
NM_000422 17q12-q21 3872.006.1 3872.6 862 399687.001.1-C MYO18A
NM_078471 17q11.2 399687.001.1 399687.1 863 3815.002.4-D_at KIT
NM_000237 4q11-q12 3815.002.4 3815.2 864 59.034.2-B_at ACTA2
NM_001613 10q23.3 59.034.2 59.34 865 8404.035.1-T_at SPARCL1
NM_004684 4q22.1 8404.035.1 8404.35 866 8404.030.1-T_at SPARCL1
NM_004684 4q22.1 8404.030.1 8404.30 867 54997.002.2- TESC NM_017899
12q24.22 54997.002.2 54997.2 T_at 868 57561.001.1- ARRDC3 NM_020801
5q14.3 57561.001.1 57561.1 F_at 869 8404.031.1-T_at SPARCL1
NM_004684 4q22.1 8404.031.1 8404.31 870 2.025.1-E_at A2M NM_000014
12p13.3-p12.3 2.025.1 2.25 871 699.002.1-F_at BUB1 NM_004336 2q14
699.002.1 699.2 872 57447.041.1- NDRG2 NM_016320 14q11.2
57447.041.1 57447.41 F_at 873 9055.013.1-D_at PRC1 NM_003981
15q26.1 9055.013.1 9055.13 874 8404.008.1-D_at SPARCL1 NM_004684
4q22.1 8404.008.1 8404.8 875 7018.028.1-T_at TF NM_001063 3q22.1
7018.028.1 7018.28 876 2568.005.1-T_at GABRP NM_014211 5q33-q34
2568.005.1 2568.5 877 10051.005.3- SMC4 NM_001002800 3q26.1
10051.005.3 10051.5 T_at 878 2568.002.2-T_at GABRP NM_014211
5q33-q34 2568.002.2 2568.2 879 4147.004.1-F_at MATN2 NM_002384 8q22
4147.004.1 4147.4 880 2938.001.1-T_at GSTA1 NM_145740 6p12.1
2938.001.1 2938.1 881 1308.007.1-E_at COL17A1 NM_000506 10q24.3
1308.007.1 1308.7 882 2982.012.1-T_at GUCY1A3 NM_000856 4q31.3-q33|
2982.012.1 2982.12 4q31.1-q31.2 883 8404.028.1-D_at SPARCL1
NM_004684 4q22.1 8404.028.1 8404.28 884 7373.001.2-B_at COL14A1
NM_021110 8q23 7373.001.2 7373.1 885 2893.002.2-B_at GRIA4
NM_000829 11q22 2893.002.2 2893.2 886 116369.006.4-C SLC26A8
NM_052961 6p21 116369.006.4 116369.6
887 6304.007.1-T_at SATB1 NM_002971 3p23 6304.007.1 6304.7 888
2335.035.1-T_at FN1 NM_002037 2q34 2335.035.1 2335.35 889
4751.002.1-T_at NEK2 NM_002497 1q32.2-q41 4751.002.1 4751.2 890
64151.001.2- NCAPG NM_022346 4p15.33 64151.001.2 64151.1 T_at 891
29089.003.1- UBE2T NM_014176 1q32.1 29089.003.1 29089.3 T_at 892
59.031.1-B_at ACTA2 NM_001613 10q23.3 59.031.1 59.31 893
7018.025.1-T_at TF NM_001063 3q22.1 7018.025.1 7018.25 894
3860.008.1-T_at KRT13 NM_002276 17q12-q21.2 3860.008.1 3860.8 895
5858.003.3-F_at PZP NM_002864 12p13-p12.2 5858.003.3 5858.3 896
8404.009.1-C_at SPARCL1 NM_004684 4q22.1 8404.009.1 8404.9 897
7169.022.1-T_at TPM2 NM_003293 9p13.2-p13.1 7169.022.1 7169.22 898
25925.006.1- ZNF521 NM_015461 18q11.2 25925.006.1 25925.6 T_at 899
59.049.1-F_at ACTA2 NM_001613 10q23.3 59.049.1 59.49 900
5284.003.1-T_at PIGR NM_002644 1q31-q41 5284.003.1 5284.3 901
2982.002.1-F_at GUCY1A3 NM_000856 4q31.3-q33| 2982.002.1 2982.2
4q31.1-q31.2 902 2568.002.1-T_at GABRP NM_014211 5q33-q34
2568.002.1 2568.2 903 301.004.1-B_at ANXA1 NM_000700 9q12-q21.2|
301.004.1 301.4 9q12-q21.2 904 25925.011.1- ZNF521 NM_015461
18q11.2 25925.011.1 25925.11 F_at 905 59.004.1-F_at ACTA2 NM_001613
10q23.3 59.004.1 59.4 906 6289.002.1-B_at SAA2 NM_030754
11p15.1-p14 6289.002.1 6289.2 907 244.003.1-C_at ANXA8L2 NM_001630
10q11.22 244.003.1 244.3 908 11065.008.1- UBE2C NM_007020 20q13.12
11065.008.1 11065.8 C_at 909 7091.006.1-T_at TLE4 NM_007005 9q21.31
7091.006.1 7091.6 910 79608.009.1- RIC3 NM_024557 11p15.4
79608.009.1 79608.9 F_at 911 9413.002.1-T_at C9orf61 NM_004816
9q13-q21 9413.002.1 9413.2 912 7431.064.1-C_at VIM NM_003380 10p13
7431.064.1 7431.64 913 8404.029.1-E_at SPARCL1 NM_004684 4q22.1
8404.029.1 8404.29 914 6876.020.1-T_at TAGLN NM_001001529 11q23.2
6876.020.1 6876.20 915 301.005.1-T_at ANXA1 NM_000700 9q12-q21.2|
301.005.1 301.5 9q12-q21.2 916 9055.014.1-T_at PRC1 NM_003982
15q26.1 9055.014.1 9055.14 917 4281.023.1-T_at MID1 NM_000389 Xp22
4281.023.1 4281.23 918 3868.005.1-D_at KRT16 NM_005557 17q12-q21
3868.005.1 3868.5 919 1062.001.6-B_at CENPE NM_001813 4q24-q25
1062.001.6 1062.1 920 5858.005.1-T_at PZP NM_002864 12p13-p12.2
5858.005.1 5858.5 921 51201.007.1- ZDHHC2 NM_016353 8p21.3-p22
51201.007.1 51201.7 F_at 922 4240.001.1-B_at MFGE8 NM_005928 15q25
4240.001.1 4240.1 923 8404.029.1-T_at SPARCL1 NM_004684 4q22.1
8404.029.1 8404.29 924 9413.001.1-T_at C9orf61 NM_004816 9q13-q21
9413.001.1 9413.1 925 9768.005.1-T_at KIAA0101 NM_001029993
15q22.31 9768.005.1 9768.5 926 11197.001.1- WIF1 NM_007191 12q14.3
11197.001.1 11197.1 T_at 927 6285.002.1-T_at S100B NM_006272
21q22.3 6285.002.1 6285.2 928 2335.006.2-F_at FN1 NM_002038 2q34
2335.006.2 2335.6 929 7169.001.1-C_at TPM2 NM_003294 9p13.2-p13.1
7169.001.1 7169.1 930 9493.004.1-T_at KIF23 NM_004856 15q23
9493.004.1 9493.4 931 4601.014.1-T_at MXI1 NM_001008541 10q24-q25
4601.014.1 4601.14 932 51203.002.2- NUSAP1 NM_016361 15q15.1
51203.002.2 51203.2 F_at 933 7018.022.1-F_at TF NM_001063 3q22.1
7018.022.1 7018.22 934 4288.009.1-F_at MKI67 NM_002417 10q25-qter
4288.009.1 4288.9 935 8321.004.1-D_at FZD1 NM_003505 7q21
8321.004.1 8321.4 936 8564.004.1-E_at KMO NM_003679 1q42-q44
8564.004.1 8564.4 937 7169.022.1-C_at TPM2 NM_003295 9p13.2-p13.1
7169.022.1 7169.22 938 29127.013.1- RACGAP1 NM_013277 12q13.13
29127.013.1 29127.13 T_at 939 2.018.1-B_at A2M NM_000014
12p13.3-p12.3 2.018.1 2.18 940 2.005.1-D_at A2M NM_000014
12p13.3-p12.3 2.005.1 2.5 941 1058.004.2-T_at CENPA NM_001042426
2p24-p21 1058.004.2 1058.4 942 2232.014.1-C_at FDXR NM_004110
17q24-q25 2232.014.1 2232.14 943 23650.005.1- TRIM29 NM_012101
11q22-q23 23650.005.1 23650.5 E_at 944 5621.002.2-T_at PRNP
NM_000311 20p13 5621.002.2 5621.2 945 51201.005.1- ZDHHC2 NM_016353
8p21.3-p22 51201.005.1 51201.5 B_at 946 667.022.1-F_at DST
NM_001727 6p12.1 667.022.1 667.22 947 54443.012.1- ANLN NM_018685
7p15-p14 54443.012.1 54443.12 C_at 948 25802.003.1- LMOD1 NM_012134
1q32 25802.003.1 25802.3 C_at 949 3479.003.1-T_at IGF1 NM_000618
12q22-q23 3479.003.1 3479.3 950 94274.003.1- PPP1R14A NM_033256
19q13.1 94274.003.1 94274.3 D_at 951 84668.003.1- FAM126A NM_032581
7p15.3 84668.003.1 84668.3 T_at 952 22974.008.1- TPX2 NM_012112
20q11.2 22974.008.1 22974.8 E_at 953 55656.007.3- INTS8 NM_017864
8q22.1 55656.007.3 55656.7 B_at 954 29127.002.1- RACGAP1 NM_013277
12q13.13 29127.002.1 29127.2 T_at 955 4281.012.2-T_at MID1
NM_000390 Xp22 4281.012.2 4281.12 956 2335.013.1-B_at FN1 NM_002039
2q34 2335.013.1 2335.13 957 79627.003.1- OGFRL1 NM_024576 6q13
79627.003.1 79627.3 B_at 958 2982.014.1-T_at GUCY1A3 NM_000856
4q31.3-q33| 2982.014.1 2982.14 4q31.1-q31.2 959 2335.053.1-T_at FN1
NM_002040 2q34 2335.053.1 2335.53 960 667.001.1-F_at DST NM_001728
6p12.1 667.001.1 667.1 961 8404.030.1-B_at SPARCL1 NM_004684 4q22.1
8404.030.1 8404.30 962 2335.025.1-C_at FN1 NM_002041 2q34
2335.025.1 2335.25 963 140885.010.3-D SIRPA NM_001040029 20p13
140885.010.3 140885.10 964 55366.001.2- LGR4 NM_018490 11p14-p13
55366.001.2 55366.1 F_at 965 7169.015.1-D_at TPM2 NM_003296
9p13.2-p13.1 7169.015.1 7169.15 966 57447.002.1- NDRG2 NM_016321
14q11.2 57447.002.1 57447.2 B_at 967 22974.008.1- TPX2 NM_012112
20q11.2 22974.008.1 22974.8 T_at 968 6876.011.1-C_at TAGLN
NM_001001530 11q23.2 6876.011.1 6876.11 969 4281.008.2-D_at MID1
NM_000391 Xp22 4281.008.2 4281.8 970 59.008.1-T_at ACTA2 NM_001613
10q23.3 59.008.1 59.8 971 23266.008.1- LPHN2 NM_012302 1p31.1
23266.008.1 23266.8 F_at 972 2568.003.2-T_at GABRP NM_014211
5q33-q34 2568.003.2 2568.3 973 5311.003.1-T_at PKD2 NM_000297
4q21-q23 5311.003.1 5311.3 974 6304.011.1-T_at SATB1 NM_002971 3p23
6304.011.1 6304.11 975 3861.008.1-B_at KRT14 NM_000526 17q12-q21
3861.008.1 3861.8 976 7018.013.1-B_at TF NM_001063 3q22.1
7018.013.1 7018.13 977 8404.005.1-F_at SPARCL1 NM_004684 4q22.1
8404.005.1 8404.5 978 7170.027.1-C_at TPM3 NM_001043357 1q21.2
7170.027.1 7170.27 979 8404.023.1-C_at SPARCL1 NM_004684 4q22.1
8404.023.1 8404.23 980 7373.007.1-C_at COL14A1 NM_021110 8q23
7373.007.1 7373.7 981 1410.009.1-T_at CRYAB NM_001885 11q22.3-q23.1
1410.009.1 1410.9 982 79745.004.3- CLIP4 NM_024692 2p23.2
79745.004.3 79745.4 D_at 983 24137.004.1- KIF4A NM_012310 Xq13.1
24137.004.1 24137.4 T_at 984 6241.013.1-B_at RRM2 NM_001034
2p25-p24 6241.013.1 6241.13 985 1410.001.1-T_at CRYAB NM_001885
11q22.3-q23.1 1410.001.1 1410.1 986 4781.015.2-B_at NFIB NM_005596
9p24.1 4781.015.2 4781.15 987 72.002.1-T_at ACTG2 NM_001615 2p13.1
72.002.1 72.2 988 4833.004.1-D_at NME4 NM_005009 16p13.3 4833.004.1
4833.4 989 57447.024.1- NDRG2 NM_016322 14q11.2 57447.024.1
57447.24 D_at 990 2982.013.2-T_at GUCY1A3 NM_000856 4q31.3-q33|
2982.013.2 2982.13 4q31.1-q31.2 991 79971.012.1- GPR177
NM_001002292 1p31.3 79971.012.1 79971.12 T_at 992 8404.028.3-C_at
SPARCL1 NM_004684 4q22.1 8404.028.3 8404.28 993 4638.011.1-E_at
MYLK NM_005985 3q21 4638.011.1 4638.11 994 7169.004.1-C_at TPM2
NM_003297 9p13.2-p13.1 7169.004.1 7169.4 995 4288.004.1-F_at MKI67
NM_002417 10q25-qter 4288.004.1 4288.4 996 59.012.2-C_at ACTA2
NM_001613 10q23.3 59.012.2 59.12 997 301.008.1-B_at ANXA1 NM_000700
9q12-q21.2| 301.008.1 301.8 9q12-q21.2 998 4281.012.1-T_at MID1
NM_000381; Xp22 4281.012.1 4281.12 999 2335.016.1-F_at FN1
NM_002042 2q34 2335.016.1 2335.16 1000 259266.003.1-C ASPM
NM_018136 1q31 259266.003.1 259266.3 1001 9055.020.1-T_at PRC1
NM_003983 15q26.1 9055.020.1 9055.20 1002 7091.016.1-T_at TLE4
NM_007005 9q21.31 7091.016.1 7091.16 1003 59.023.1-T_at ACTA2
NM_001613 10q23.3 59.023.1 59.23 1004 57162.010.1- PELI1 NM_020651
2p13.3 57162.010.1 57162.10 B_at 1005 4781.002.2-D_at NFIB
NM_005596 9p24.1 4781.002.2 4781.2 1006 6122.037.1-T_at RPL3
NM_000967 22q13 6122.037.1 6122.37 1007 4240.015.1-B_at MFGE8
NM_005928 15q25 4240.015.1 4240.15 1008 59.034.1-T_at ACTA2
NM_001613 10q23.3 59.034.1 59.34 1009 8404.004.2-D_at SPARCL1
NM_004684 4q22.1 8404.004.2 8404.4 1010 9413.001.2-T_at C9orf61
NM_004816 9q13-q21 9413.001.2 9413.1 1011 2.005.1-F_at A2M
NM_000014 12p13.3-p12.3 2.005.1 2.5 1012 6304.002.1-T_at SATB1
NM_002971 3p23 6304.002.1 6304.2 1013 3852.005.1-C_at KRT5
NM_000424 12q12-q13 3852.005.1 3852.5 1014 7170.027.1-B_at TPM3
NM_001043358 1q21.2 7170.027.1 7170.27 1015 301.013.1-T_at ANXA1
NM_000700 9q12-q21.2| 301.013.1 301.13 9q12-q21.2 1016
6304.012.1-F_at SATB1 NM_002971 3p23 6304.012.1 6304.12 1017
57447.051.2- NDRG2 NM_016323 14q11.2 57447.051.2 57447.51 T_at 1018
11065.005.1- UBE2C NM_007021 20q13.12 11065.005.1 11065.5 C_at 1019
6422.002.1-F_at SFRP1 NM_003012 8p12-p11.1 6422.002.1 6422.2 1020
6241.013.1-F_at RRM2 NM_001034 2p25-p24 6241.013.1 6241.13 1021
2335.032.1-T_at FN1 NM_002043 2q34 2335.032.1 2335.32 1022
11065.005.2- UBE2C NM_007022 20q13.12 11065.005.2 11065.5 T_at 1023
2335.028.1-D_at FN1 NM_002044 2q34 2335.028.1 2335.28 1024
29997.016.1- GLTSCR2 NM_015710 19q13.3 29997.016.1 29997.16 F_at
1025 7018.014.1-T_at TF NM_001063 3q22.1 7018.014.1 7018.14 1026
1410.011.1-E_at CRYAB NM_001885 11q22.3-q23.1 1410.011.1 1410.11
1027 7170.040.1-E_at TPM3 NM_001043359 1q21.2 7170.040.1 7170.40
1028 6289.002.2-F_at SAA2 NM_030754 11p15.1-p14 6289.002.2 6289.2
1029 7373.003.4-C_at COL14A1 NM_021110 8q23 7373.003.4 7373.3 1030
7170.041.1-E_at TPM3 NM_001043360 1q21.2 7170.041.1 7170.41 1031
128553.003.1-B TSHZ2 NM_173485 20q13.2 128553.003.1 128553.3 1032
4094.002.1-D_at MAF NM_001031805 16q22-q23 4094.002.1 4094.2 1033
7113.011.1-T_at TMPRSS2 NM_005656 21q22.3 7113.011.1 7113.11 1034
7170.002.1-C_at TPM3 NM_001043361 1q21.2 7170.002.1 7170.2 1035
8404.017.2-T_at SPARCL1 NM_004684 4q22.1 8404.017.2 8404.17 1036
59.029.1-T_at ACTA2 NM_001613 10q23.3 59.029.1 59.29 1037
29089.001.1- UBE2T NM_014176 1q32.1 29089.001.1 29089.1 T_at 1038
358.012.1-T_at AQP1 NM_198098 7p14 358.012.1 358.12 1039
9134.001.1-B_at CCNE2 NM_057735 8q22.1 9134.001.1 9134.1 1040
2335.013.1-C_at FN1 NM_002045 2q34 2335.013.1 2335.13 1041
1410.010.1-T_at CRYAB NM_001885 11q22.3-q23.1 1410.010.1 1410.10
1042 2327.003.4-F_at FMO2 NM_001460 1q23-q25 2327.003.4 2327.3 1043
59.042.1-T_at ACTA2 NM_001613 10q23.3 59.042.1 59.42 1044
6304.007.2-T_at SATB1 NM_002971 3p23 6304.007.2 6304.7 1045
8404.031.1-B_at SPARCL1 NM_004684 4q22.1 8404.031.1 8404.31 1046
6289.001.1-F_at SAA2 NM_030754 11p15.1-p14 6289.001.1 6289.1 1047
1410.006.1-T_at CRYAB NM_001885 11q22.3-q23.1 1410.006.1 1410.6
1048 80034.004.1- FAM130A2 NM_024969 2q24.3 80034.004.1 80034.4
T_at 1049 1410.008.1-T_at CRYAB NM_001885 11q22.3-q23.1 1410.008.1
1410.8 1050 57447.051.2- NDRG2 NM_016324 14q11.2 57447.051.2
57447.51 D_at 1051 7170.016.3-B_at TPM3 NM_001043362 1q21.2
7170.016.3 7170.16 1052 4240.001.1-C_at MFGE8 NM_005928 15q25
4240.001.1 4240.1 1053 6288.001.1-T_at SAA1 NM_000331 11p15.1
6288.001.1 6288.1 1054 7018.014.1-C_at TF NM_001063 3q22.1
7018.014.1 7018.14 1055 8404.020.1-T_at SPARCL1 NM_004684 4q22.1
8404.020.1 8404.20 1056 6289.001.2-F_at SAA2 NM_030754 11p15.1-p14
6289.001.2 6289.1 1057 6876.011.1-F_at TAGLN NM_001001531 11q23.2
6876.011.1 6876.11 1058 8404.031.1-C_at SPARCL1 NM_004684 4q22.1
8404.031.1 8404.31 1059 57447.010.1- NDRG2 NM_016325 14q11.2
57447.010.1 57447.10 T_at 1060 1410.007.2-C_at CRYAB NM_001885
11q22.3-q23.1 1410.007.2 1410.7 1061 59.012.2-B_at ACTA2 NM_001613
10q23.3 59.012.2 59.12 1062 3459.005.1-T_at IFNGR1 NM_000416
6q23-q24 3459.005.1 3459.5 1063 301.013.1-C_at ANXA1 NM_000700
9q12-q21.2| 301.013.1 301.13 9q12-q21.2 1064 83539.001.1- CHST9
NM_031422 18q11.2 83539.001.1 83539.1 D_at 1065 6288.004.1-F_at
SAA1 NM_000332 11p15.1 6288.004.1 6288.4 1066 4781.016.1-E_at NFIB
NM_005596 9p24.1 4781.016.1 4781.16 1067 29997.012.1- GLTSCR2
NM_015710 19q13.3 29997.012.1 29997.12 E_at 1068 57447.021.1- NDRG2
NM_016326 14q11.2 57447.021.1 57447.21 T_at 1069 3426.002.1-C_at
CFI NM_000204 4q25 3426.002.1 3426.2 1070 53829.001.2- P2RY13
NM_023914 3q24 53829.001.2 53829.1 T_at 1071 2115.001.2-B_at ETV1
NM_004956 7p21.3 2115.001.2 2115.1 1072 10051.008.1- SMC4
NM_001002801 3q26.1 10051.008.1 10051.8 T_at 1073 1033.002.1-T_at
CDKN3 NM_005192 14q22 1033.002.1 1033.2 1074 2335.005.1-D_at FN1
NM_002046 2q34 2335.005.1 2335.5 1075 7113.009.1-T_at TMPRSS2
NM_005656 21q22.3 7113.009.1 7113.9 1076 3866.002.1-B_at KRT15
NM_002275 17q21.2 3866.002.1 3866.2 1077 140885.014.1-D SIRPA
NM_001040030 20p13 140885.014.1 140885.14 1078 7168.003.1-T_at TPM1
NM_000366 15q22.1 7168.003.1 7168.3 1079 79608.001.1- RIC3
NM_024557 11p15.4 79608.001.1 79608.1 T_at 1080 79608.008.2- RIC3
NM_024557 11p15.4 79608.008.2 79608.8 F_at 1081 1410.001.1-B_at
CRYAB NM_001885 11q22.3-q23.1 1410.001.1 1410.1 1082
7113.010.1-T_at TMPRSS2 NM_005656 21q22.3 7113.010.1 7113.10 1083
4781.014.2-B_at NFIB NM_005596 9p24.1 4781.014.2 4781.14 1084
2335.016.1-E_at FN1 NM_002047 2q34 2335.016.1 2335.16 1085
11065.003.1- UBE2C NM_007023 20q13.12 11065.003.1 11065.3
T_at 1086 3872.006.1-T_at KRT17 NM_000422 17q12-q21 3872.006.1
3872.6 1087 3084.005.1-F_at NRG1 NM_004517 8p12 3084.005.1 3084.5
1088 6285.003.1-T_at S100B NM_006272 21q22.3 6285.003.1 6285.3 1089
6876.016.2-F_at TAGLN NM_001001532 11q23.2 6876.016.2 6876.16 1090
8404.004.1-T_at SPARCL1 NM_004684 4q22.1 8404.004.1 8404.4 1091
54829.001.1- ASPN NM_017680 9q22 54829.001.1 54829.1 F_at 1092
8404.001.1-T_at SPARCL1 NM_004684 4q22.1 8404.001.1 8404.1 1093
9055.011.1-E_at PRC1 NM_003984 15q26.1 9055.011.1 9055.11 1094
6289.003.2-F_at SAA2 NM_030754 11p15.1-p14 6289.003.2 6289.3 1095
22974.007.1- TPX2 NM_012112 20q11.2 22974.007.1 22974.7 T_at 1096
59.023.2-T_at ACTA2 NM_001613 10q23.3 59.023.2 59.23 1097
7169.015.1-T_at TPM2 NM_003298 9p13.2-p13.1 7169.015.1 7169.15 1098
6289.002.1-F_at SAA2 NM_030754 11p15.1-p14 6289.002.1 6289.2 1099
4288.008.1-B_at MKI67 NM_002417 10q25-qter 4288.008.1 4288.8 1100
4781.007.1-B_at NFIB NM_005596 9p24.1 4781.007.1 4781.7 1101
6876.023.1-T_at TAGLN NM_001001533 11q23.2 6876.023.1 6876.23 1102
9055.017.1-F_at PRC1 NM_003985 15q26.1 9055.017.1 9055.17 1103
7170.018.2-D_at TPM3 NM_001043363 1q21.2 7170.018.2 7170.18 1104
4781.014.2-D_at NFIB NM_005596 9p24.1 4781.014.2 4781.14 1105
7170.025.1-T_at TPM3 NM_001043364 1q21.2 7170.025.1 7170.25 1106
7018.025.1-B_at TF NM_001063 3q22.1 7018.025.1 7018.25 1107
10253.003.1- SPRY2 NM_005842 13q31.1 10253.003.1 10253.3 T_at 1108
57447.039.1- NDRG2 NM_016327 14q11.2 57447.039.1 57447.39 D_at 1109
59.022.1-T_at ACTA2 NM_001613 10q23.3 59.022.1 59.22 1110
2982.015.1-F_at GUCY1A3 NM_000856 4q31.3-q33| 2982.015.1 2982.15
4q31.1-q31.2 1111 10124.004.2- ARL4A NM_001037166 7p21-p15.3
10124.004.2 10124.4 F_at 1112 6289.001.1-B_at SAA2 NM_030754
11p15.1-p14 6289.001.1 6289.1 1113 7091.005.1-F_at TLE4 NM_007005
9q21.31 7091.005.1 7091.5 1114 501.006.1-B_at ALDH7A1 NM_001182
5q31 501.006.1 501.6 1115 1410.001.1-C_at CRYAB NM_001885
11q22.3-q23.1 1410.001.1 1410.1 1116 57447.021.1- NDRG2 NM_016328
14q11.2 57447.021.1 57447.21 C_at 1117 244.012.1-B_at ANXA8L2
NM_001630 10q11.22 244.012.1 244.12 1118 7018.026.1-F_at TF
NM_001063 3q22.1 7018.026.1 7018.26 1119 3872.018.1-T_at KRT17
NM_000422 17q12-q21 3872.018.1 3872.18 1120 10144.017.3- FAM13A1
NM_001015047 4q22.1 10144.017.3 10144.17 T_at 1121 11197.001.1-
WIF1 NM_007191 12q14.3 11197.001.1 11197.1 F_at 1122 29127.007.1-
RACGAP1 NM_013277 12q13.13 29127.007.1 29127.7 B_at 1123
10010.004.1- TANK NM_004181 2q24-q31 10010.004.1 10010.4 F_at 1124
81704.013.1- DOCK8 NM_203447 9p24.3 81704.013.1 81704.13 C_at 1125
4781.006.2-B_at NFIB NM_005596 9p24.1 4781.006.2 4781.6 1126
7373.003.1-F_at COL14A1 NM_021110 8q23 7373.003.1 7373.3 1127
8404.009.1-D_at SPARCL1 NM_004684 4q22.1 8404.009.1 8404.9 1128
23092.004.1- ARHGAP26 NM_015071 5q31 23092.004.1 23092.4 T_at 1129
2335.002.1-F_at FN1 NM_002048 2q34 2335.002.1 2335.2 1130
8404.031.1-F_at SPARCL1 NM_004684 4q22.1 8404.031.1 8404.31 1131
6304.006.2-T_at SATB1 NM_002971 3p23 6304.006.2 6304.6 1132
1410.008.1-E_at CRYAB NM_001885 11q22.3-q23.1 1410.008.1 1410.8
1133 9055.019.1-F_at PRC1 NM_003986 15q26.1 9055.019.1 9055.19 1134
1398.001.1-D_at CRK NM_000509 17p13.3 1398.001.1 1398.1 1135
57447.051.1- NDRG2 NM_016329 14q11.2 57447.051.1 57447.51 E_at 1136
339965.001.2-B FLJ25770 NM_001042784 4q21.1 339965.001.2 339965.1
1137 7113.001.1-C_at TMPRSS2 NM_005656 21q22.3 7113.001.1 7113.1
1138 4240.009.1-D_at MFGE8 NM_005928 15q25 4240.009.1 4240.9 1139
7153.002.4-B_at TOP2A NM_001067 17q21-q22 7153.002.4 7153.2 1140
7169.004.1-D_at TPM2 NM_003299 9p13.2-p13.1 7169.004.1 7169.4 1141
1410.001.1-D_at CRYAB NM_001885 11q22.3-q23.1 1410.001.1 1410.1
1142 59.015.2-B_at ACTA2 NM_001613 10q23.3 59.015.2 59.15 1143
4833.010.1-T_at NME4 NM_005009 16p13.3 4833.010.1 4833.10 1144
7169.022.1-B_at TPM2 NM_003300 9p13.2-p13.1 7169.022.1 7169.22 1145
11065.005.1- UBE2C NM_007024 20q13.12 11065.005.1 11065.5 T_at 1146
7170.018.2-T_at TPM3 NM_001043365 1q21.2 7170.018.2 7170.18 1147
79971.013.2- GPR177 NM_001002293 1p31.3 79971.013.2 79971.13 F_at
1148 152015.005.2-F ROPN1B NM_001012337 3q21.2 152015.005.2
152015.5 1149 4288.005.1-D_at MKI67 NM_002417 10q25-qter 4288.005.1
4288.5 1150 8404.002.1-T_at SPARCL1 NM_004684 4q22.1 8404.002.1
8404.2 1151 6441.004.1-E_at SFTPD NM_003019 10q22.2-q23.1
6441.004.1 6441.4 1152 6122.046.1-B_at RPL3 NM_000967 22q13
6122.046.1 6122.46 1153 115908.002.1-T CTHRC1 NM_138455 8q22.3
115908.002.1 115908.2 1154 9481.001.1-F_at SLC25A27 NM_004277
6p11.2-q12 9481.001.1 9481.1 1155 8404.008.1-T_at SPARCL1 NM_004684
4q22.1 8404.008.1 8404.8 1156 1410.007.1-D_at CRYAB NM_001885
11q22.3-q23.1 1410.007.1 1410.7 1157 8404.030.1-C_at SPARCL1
NM_004684 4q22.1 8404.030.1 8404.30 1158 57447.039.1- NDRG2
NM_016330 14q11.2 57447.039.1 57447.39 T_at 1159 4147.004.1-E_at
MATN2 NM_002385 8q22 4147.004.1 4147.4 1160 2335.024.2-F_at FN1
NM_002049 2q34 2335.024.2 2335.24 1161 891.007.1-T_at CCNB1
NM_031966 5q12 891.007.1 891.7 1162 2335.002.1-T_at FN1 NM_002050
2q34 2335.002.1 2335.2 1163 8404.017.1-T_at SPARCL1 NM_004684
4q22.1 8404.017.1 8404.17 1164 57451.004.1- ODZ2 NM_001080428
5q34-q35.1 57451.004.1 57451.4 B_at 1165 8404.001.1-F_at SPARCL1
NM_004684 4q22.1 8404.001.1 8404.1 1166 8626.006.2-B_at TP63
NM_003722 3q28 8626.006.2 8626.6 1167 2335.025.1-T_at FN1 NM_002051
2q34 2335.025.1 2335.25 1168 6286.001.1-T_at S100P NM_005980 4p16
6286.001.1 6286.1 1169 10580.012.1- SORBS1 NM_001034954
10q23.3-q24.1 10580.012.1 10580.12 C_at 1170 23321.014.1- TRIM2
NM_015271 4q31.3 23321.014.1 23321.14 T_at 1171 2824.001.2-B_at
GPM6B NM_001001994 Xp22.2 2824.001.2 2824.1 1172 29127.022.1-
RACGAP1 NM_013277 12q13.13 29127.022.1 29127.22 T_at 1173
6289.003.1-F_at SAA2 NM_030754 11p15.1-p14 6289.003.1 6289.3 1174
7170.005.2-B_at TPM3 NM_001043366 1q21.2 7170.005.2 7170.5 1175
54443.011.1- ANLN NM_018685 7p15-p14 54443.011.1 54443.11 F_at 1176
29127.019.1- RACGAP1 NM_013277 12q13.13 29127.019.1 29127.19 T_at
1177 6288.004.1-T_at SAA1 NM_000333 11p15.1 6288.004.1 6288.4 1178
29997.008.1- GLTSCR2 NM_015710 19q13.3 29997.008.1 29997.8 C_at
1179 57447.039.1- NDRG2 NM_016331 14q11.2 57447.039.1 57447.39 B_at
1180 3872.007.1-B_at KRT17 NM_000422 17q12-q21 3872.007.1 3872.7
1181 57561.002.1- ARRDC3 NM_020801 5q14.3 57561.002.1 57561.2 T_at
1182 57451.002.3- ODZ2 NM_001080428 5q34-q35.1 57451.002.3 57451.2
B_at 1183 5213.024.1-B_at PFKM NM_000289 12q13.3 5213.024.1 5213.24
1184 2.005.1-T_at A2M NM_000014 12p13.3-p12.3 2.005.1 2.5 1185
11065.004.1- UBE2C NM_007025 20q13.12 11065.004.1 11065.4 C_at 1186
1410.006.1-C_at CRYAB NM_001885 11q22.3-q23.1 1410.006.1 1410.6
1187 6289.006.1-T_at SAA2 NM_030754 11p15.1-p14 6289.006.1 6289.6
1188 55366.001.1- LGR4 NM_018490 11p14-p13 55366.001.1 55366.1 T_at
1189 23284.007.1- LPHN3 NM_015236 4q13.1 23284.007.1 23284.7 F_at
1190 79971.009.1- GPR177 NM_001002294 1p31.3 79971.009.1 79971.9
T_at 1191 6288.004.1-E_at SAA1 NM_000334 11p15.1 6288.004.1 6288.4
1192 11065.004.1- UBE2C NM_007026 20q13.12 11065.004.1 11065.4 T_at
1193 51203.009.1- NUSAP1 NM_016362 15q15.1 51203.009.1 51203.9 T_at
1194 1410.010.1-E_at CRYAB NM_001885 11q22.3-q23.1 1410.010.1
1410.10 1195 57447.030.1- NDRG2 NM_016332 14q11.2 57447.030.1
57447.30 D_at 1196 1308.002.1-T_at COL17A1 NM_000507 10q24.3
1308.002.1 1308.2 1197 4288.007.1-C_at MKI67 NM_002417 10q25-qter
4288.007.1 4288.7 1198 244.011.1-T_at ANXA8L2 NM_001630 10q11.22
244.011.1 244.11 1199 94274.003.1- PPP1R14A NM_033256 19q13.1
94274.003.1 94274.3 B_at 1200 3178.003.1-E_at HNRNPA1 NM_002136
12q13.1 3178.003.1 3178.3 1201 7153.002.4-T_at TOP2A NM_001067
17q21-q22 7153.002.4 7153.2 1202 9055.012.1-D_at PRC1 NM_003987
15q26.1 9055.012.1 9055.12 1203 9232.001.1-E_at PTTG1 NM_004219
5q35.1 9232.001.1 9232.1 1204 79068.011.2- FTO NM_001080432 16q12.2
79068.011.2 79068.11 B_at 1205 120.005.2-F_at ADD3 NM_001122
10q24.2-q24.3 120.005.2 120.5 1206 7534.001.1-C_at YWHAZ NM_003406
8q23.1 7534.001.1 7534.1 1207 120.005.2-T_at ADD3 NM_001123
10q24.2-q24.3 120.005.2 120.5 1208 7373.003.3-C_at COL14A1
NM_021110 8q23 7373.003.3 7373.3 1209 57447.004.2- NDRG2 NM_016333
14q11.2 57447.004.2 57447.4 D_at 1210 2568.005.1-F_at GABRP
NM_014211 5q33-q34 2568.005.1 2568.5 1211 1308.001.1-E_at COL17A1
NM_000508 10q24.3 1308.001.1 1308.1 1212 6876.020.1-F_at TAGLN
NM_001001534 11q23.2 6876.020.1 6876.20 1213 79971.014.1- GPR177
NM_001002295 1p31.3 79971.014.1 79971.14 D_at 1214 5621.008.1-D_at
PRNP NM_000312 20p13 5621.008.1 5621.8 1215 55732.003.2- C1orf112
NM_018186 1q24.2 55732.003.2 55732.3 T_at 1216 221120.006.1-D
ALKBH3 NM_139178 11p11.2 221120.006.1 221120.6 1217 23266.008.1-
LPHN2 NM_012302 1p31.1 23266.008.1 23266.8 T_at 1218
2335.045.1-F_at FN1 NM_002052 2q34 2335.045.1 2335.45 1219
7170.007.1-F_at TPM3 NM_001043367 1q21.2 7170.007.1 7170.7 1220
10461.002.1- MERTK NM_006343 2q14.1 10461.002.1 10461.2 B_at 1221
59.031.2-F_at ACTA2 NM_001613 10q23.3 59.031.2 59.31 1222
9055.010.1-T_at PRC1 NM_003988 15q26.1 9055.010.1 9055.10 1223
58499.005.2- ZNF462 NM_021224 9q31.2 58499.005.2 58499.5 F_at 1224
54443.006.2- ANLN NM_018685 7p15-p14 54443.006.2 54443.6 F_at 1225
59.016.1-B_at ACTA2 NM_001613 10q23.3 59.016.1 59.16 1226
4288.004.1-C_at MKI67 NM_002417 10q25-qter 4288.004.1 4288.4 1227
7170.014.1-C_at TPM3 NM_001043368 1q21.2 7170.014.1 7170.14 1228
7170.007.1-D_at TPM3 NM_001043369 1q21.2 7170.007.1 7170.7
TABLE-US-00009 TABLE 5 Table 5. Average profiles of the preferred
1,228 signature probe set on the 24 benign and 70 malignant tissues
of the training set. NO Probeset_Id benign profile malignant
profile 1 1756.022.2-C_at 7.77577583 3.59039694 2 1756.029.1-D_at
7.04295703 3.513387741 3 1756.026.1-C_at 6.95161337 3.464276589 4
1756.022.4-T_at 6.48188081 3.420868252 5 1756.011.1-B_at 6.86417826
3.496864254 6 1308.008.1-C_at 7.57956334 3.687873002 7
1756.022.3-F_at 6.51097796 3.58405119 8 3861.020.1-D_at 6.22316661
3.499798722 9 1756.011.1-F_at 6.46286419 3.439670248 10
4629.007.1-F_at 7.83187958 4.047826786 11 1756.022.4-B_at
5.66870747 3.376207029 12 1756.024.1-F_at 5.6343038 3.538881886 13
3861.019.1-T_at 6.68378293 3.662794206 14 1756.026.1-T_at
5.75006153 3.403683849 15 1756.022.1-B_at 5.5659674 3.347255374 16
3861.001.1-T_at 8.03618493 4.233009236 17 1308.008.1-T_at
7.11931893 3.582324909 18 4629.020.1-C_at 5.83439993 3.404790946 19
1756.027.1-T_at 5.61961823 3.38354471 20 3861.013.1-T_at 6.54371337
3.606451019 21 4629.020.1-F_at 8.29507715 4.572815098 22
3861.001.1-B_at 6.22211499 3.452593672 23 1756.022.4-F_at
5.86145739 3.406465282 24 1756.026.1-F_at 5.60288028 3.360497686 25
1756.022.2-T_at 5.58253289 3.54186397 26 1756.022.2-F_at 5.61962239
3.502994928 27 3861.022.1-B_at 7.02845041 3.87855387 28
3868.004.1-D_at 7.74158414 4.319798082 29 4629.015.1-C_at
7.25657837 3.723809766 30 6422.002.1-E_at 8.94850792 4.159424522 31
3861.001.1-D_at 6.09123229 3.432322015 32 1756.022.1-F_at
5.69246198 3.544494185 33 1308.003.1-T_at 7.94010542 4.370493824 34
3868.005.1-B_at 8.74334588 5.189519553 35 1308.007.1-F_at
6.53872712 4.045429995 36 1308.009.1-F_at 6.89532626 4.071167435 37
3861.007.1-E_at 6.32900696 3.492862508 38 4629.016.1-D_at
6.54432919 3.640775643 39 3084.007.1-F_at 5.24077491 3.36157297 40
3861.007.1-F_at 8.80010947 5.27987695 41 26289.003.1-E_at
5.86287574 3.533159027 42 1756.028.1-T_at 5.51782565 3.40968711 43
4629.021.1-E_at 5.66627575 3.423025757 44 4629.020.1-D_at
6.44086194 3.546901356 45 5764.001.1-F_at 8.69561376 4.488059326 46
3815.002.3-F_at 7.51289238 3.849064631 47 3852.020.1-T_at
6.42797621 4.732898695 48 4629.007.1-E_at 6.02756027 3.473012819 49
128553.003.1-F 5.53321089 3.635562107 50 26289.003.1-F_at
7.91558754 4.209493355 51 3815.002.2-F_at 7.57464628 4.354458317 52
1756.029.1-B_at 5.14699565 3.349809112 53 4629.005.1-E_at
7.84091036 4.284271836 54 4629.010.1-B_at 6.24893878 4.055036115 55
6422.001.1-T_at 7.16633034 3.787746012 56 5764.001.1-E_at
7.41150914 3.725088834 57 3861.008.1-F_at 7.02710456 4.066582177 58
1756.030.2-T_at 4.94195769 3.327396148 59 3084.009.1-B_at
5.68938525 3.45247142 60 26289.002.1-T_at 7.40948494 4.099092499 61
1756.022.5-B_at 5.43279988 3.481330797 62 4629.007.1-D_at
6.12853852 3.536108886 63 23336.001.1-C_at 6.64495461 3.668475185
64 1308.003.1-D_at 5.60928126 3.379520915 65 1756.022.3-T_at
5.52680369 3.62832307 66 3861.020.1-T_at 7.58427914 5.411375294 67
3861.022.1-C_at 5.51190841 3.385538085 68 3852.012.2-B_at
8.68398341 6.89513729 69 26289.012.1-E_at 7.90570335 4.172489159 70
23336.003.1-T_at 7.08201667 4.814503945 71 26289.007.1-B_at
7.72470925 4.152306769 72 84417.001.1-T_at 5.09011844 3.400475459
73 3861.018.1-D_at 5.42966542 3.382067375 74 3852.004.1-B_at
6.45366587 4.048382242 75 90865.006.1-B_at 6.73968166 3.990889311
76 4629.021.1-F_at 7.91177883 5.2531203 77 3861.018.1-T_at
6.93768003 4.389579877 78 1756.022.1-T_at 5.49427991 3.678236167 79
1264.003.1-B_at 6.59427618 3.644806029 80 26289.010.1-E_at
7.89895995 4.173752776 81 3861.001.1-F_at 8.22227254 5.365451942 82
1908.002.1-T_at 5.89142159 3.76026543 83 4629.007.1-C_at 5.95159281
3.449026103 84 1756.022.5-T_at 7.41985492 5.430396438 85
3815.002.4-B_at 6.82005827 3.837481838 86 1756.022.2-B_at
5.20019167 3.394669911 87 1756.027.1-B_at 4.8537932 3.389107204 88
3852.008.2-T_at 6.48445207 3.985807972 89 6422.001.1-E_at
7.27907161 3.874506745 90 3861.022.1-F_at 6.81336417 5.057032572 91
4915.011.1-D_at 5.90431076 3.64199141 92 5288.001.1-F_at 5.44594693
3.485884155 93 3861.007.1-T_at 7.95368914 5.49032736 94
3852.006.1-C_at 6.13678531 3.559093796 95 9413.003.1-T_at
5.34538697 3.552156816 96 3861.020.1-C_at 5.55692471 3.41004352 97
1308.008.1-D_at 5.59542139 3.406938539 98 23336.001.1-T_at
6.50954711 4.440969009 99 3815.001.1-F_at 7.00089122 3.951400817
100 1756.022.5-F_at 6.87448959 4.663598998 101 79937.001.1-T_at
6.15393538 4.110481521 102 4915.012.1-E_at 8.0872096 4.146795298
103 3861.022.1-T_at 6.45943061 3.91885164 104 26289.005.1-T_at
6.42663922 4.148293882 105 3815.002.3-B_at 5.54627639 3.429691278
106 4311.009.1-F_at 7.16081204 4.100265304 107 26289.006.1-T_at
8.56062669 4.815103599 108 5288.003.1-F_at 5.50819433 3.507713463
109 4629.020.1-B_at 5.84433404 3.602970173 110 26289.007.1-D_at
8.97225664 4.739722032 111 3815.002.1-B_at 6.95057351 3.834713723
112 26289.004.1-T_at 6.34773713 4.19513007 113 79192.002.2-T_at
6.05826364 3.842242343 114 4638.006.1-D_at 7.26387248 4.23337548
115 3084.008.1-F_at 4.91747714 3.337620462 116 4311.001.2-T_at
7.0894017 4.083336035 117 3815.002.1-D_at 5.62489378 3.413633401
118 4629.020.1-T_at 6.54528254 4.292670552 119 1756.026.1-B_at
5.04408715 3.401481888 120 3852.022.1-T_at 6.17920917 3.949400375
121 4629.015.1-D_at 6.8794921 4.903440037 122 26289.007.1-C_at
7.11737708 3.991072006 123 23194.003.1-C_at 6.62756369 4.216361434
124 3815.002.1-F_at 5.96350065 3.577775017 125 26289.007.1-T_at
9.05284176 5.053614074 126 65983.009.1-B_at 4.92316734 3.543080498
127 23336.001.1-F_at 6.76043292 4.496928377 128 1410.007.2-B_at
6.13154201 3.800315965 129 1756.029.1-F_at 4.74778319 3.336087634
130 7373.003.6-C_at 6.42568489 3.893070602 131 10010.002.1-E_at
4.95595545 3.398356655 132 59.026.1-B_at 5.82098007 3.829661839 133
4915.011.1-F_at 6.93603667 3.88986704 134 3872.007.1-D_at
6.20605492 3.672782211 135 26289.002.1-D_at 4.95771354 3.437272763
136 84668.002.1-C_at 7.73745334 4.885593169 137 1756.002.2-T_at
7.42432799 4.334919851 138 57447.033.1-C_at 6.98508503 4.791930475
139 26289.009.1-E_at 8.95673913 4.746268267 140 3872.006.1-F_at
8.33069501 5.239623762 141 3861.022.1-D_at 4.91710968 3.325488578
142 3861.020.1-B_at 5.32314912 3.412709023 143 667.021.1-B_at
6.18631919 3.841433137 144 57447.027.1-F_at 7.08539045 4.241139039
145 56477.001.1-D_at 6.55969728 3.814097685 146 26289.008.1-F_at
8.97978495 4.925626071 147 59.024.2-D_at 7.22299753 4.423928704 148
4629.005.1-T_at 8.60305039 5.554148468 149 3815.002.1-T_at
8.34708459 4.557379602 150 23336.001.1-B_at 7.9283908 5.377785469
151 3084.004.2-F_at 4.90868361 3.371411318 152 27122.014.2-T_at
5.66296874 3.671915992 153 26289.008.1-C_at 6.19905784 3.792605417
154 286887.003.2-B 6.65960082 4.217906735 155 4629.005.1-F_at
7.92220509 5.827308726 156 3872.009.1-T_at 8.11749997 4.97186016
157 59.014.2-D_at 7.2803688 4.475411666 158 403340.001.2-B
6.5225278 3.953645308 159 3852.014.1-F_at 6.65504418 4.502352655
160 27122.001.1-T_at 6.70494956 4.219728495 161 3815.002.3-T_at
5.79983719 3.546807083 162 3852.008.1-E_at 7.70698375 4.778195426
163 26289.012.1-T_at 6.44372459 3.808594574 164 26289.007.1-F_at
6.33764826 3.835752254 165 4638.006.1-T_at 7.48416583 4.880628209
166 8626.005.1-B_at 6.0506832 3.689171001 167 3815.002.4-T_at
7.18867318 3.947318855 168 84668.004.1-F_at 6.36068084 4.024117755
169 3872.007.1-F_at 8.15990919 5.039544664 170 57447.031.1-E_at
6.98413461 4.847264949 171 3084.012.3-T_at 5.1724186 3.372130258
172 3852.005.1-T_at 6.15177089 3.953202014 173 84417.001.2-T_at
4.88905487 3.400666252 174 3866.003.2-T_at 7.33197079 4.76008241
175 3866.008.1-C_at 6.52361561 3.762190903 176 3852.009.1-F_at
7.29388376 4.138971389 177 59.015.1-B_at 5.98286286 3.912382525 178
79937.002.1-F_at 4.55998542 3.353847089 179 7153.002.6-F_at
5.25845229 8.105836861 180 4281.010.1-B_at 5.89302118 3.740600544
181 59.008.1-B_at 5.76124199 3.852970764 182 1264.007.1-T_at
5.63801742 3.838276262 183 3868.004.1-T_at 5.66410876 3.79017218
184 3084.002.1-F_at 4.98674566 3.360938629 185 5137.004.2-T_at
4.64089266 3.34890403 186 4629.022.1-T_at 4.75765246 3.480568786
187 4915.011.1-T_at 6.94354411 3.915112838 188 3852.013.1-E_at
6.01894366 3.617314683 189 59.012.2-T_at 8.08522667 5.172148648 190
59.015.1-F_at 6.50494881 4.765128611 191 4638.006.2-T_at 7.26086954
4.714147988 192 23336.002.1-B_at 5.95183375 3.957277561 193
3868.005.1-C_at 8.63446621 7.297975458 194 3866.011.2-D_at
8.77838405 4.522564109 195 56477.001.1-T_at 8.14939865 5.06922736
196 3815.001.1-T_at 6.03901568 3.756819456 197 4311.001.1-T_at
7.11420453 4.238075405 198 1264.003.1-D_at 5.1912565 3.354675255
199 59.031.1-T_at 7.4628458 4.949828067 200 57447.030.1-B_at
6.45843286 3.891549539 201 1410.003.2-B_at 6.05784067 3.779422009
202 3866.009.2-D_at 8.80361998 4.576378265 203 59.026.1-T_at
7.29639751 4.650053313 204 440421.001.1-T 9.24293713 6.596812139
205 1756.022.4-D_at 5.07768477 3.476314006 206 65983.009.1-D_at
6.39596028 4.086911291 207 57447.041.1-T_at 6.95593663 4.149259947
208 3872.010.2-D_at 8.56203536 5.425416269 209 4629.006.2-T_at
8.90925918 6.221775982 210 3861.018.1-F_at 6.8430596 5.185870988
211 3815.002.2-T_at 5.28733127 3.421518659 212 3866.012.2-D_at
8.67083494 4.478603969 213 57447.021.1-D_at 6.98727375 4.930757851
214 59.015.1-T_at 7.34935329 4.513251269 215 8626.007.1-F_at
7.17503293 5.028534466 216 5288.001.1-B_at 5.02652959 3.42608729
217 72.001.1-B_at 6.05804544 3.853258443 218 3866.006.2-D_at
8.65913916 4.490509023 219 3852.004.1-T_at 6.78881411 4.012650025
220 4629.016.1-F_at 5.16326314 3.700432446 221 4629.007.1-T_at
5.80150326 4.040994731 222 65983.008.1-T_at 6.32502917 4.219582217
223 65983.013.1-F_at 5.56252368 3.731459395 224 3084.004.1-F_at
4.93700193 3.399738343 225 27122.007.1-F_at 6.83642294 4.356100082
226 3866.008.1-D_at 8.70576582 4.517001787 227 26289.009.1-T_at
8.23631259 5.882347434 228 59.009.1-B_at 7.1080566 4.810790662 229
4629.010.1-D_at 5.14795762 3.377019173 230 59.023.1-B_at 5.9667058
4.241472412 231 26289.002.1-F_at 6.02532667 4.093116116 232
1908.001.1-T_at 5.67746805 3.733518249 233 4915.008.1-F_at
7.26142834 4.642285716 234 23336.002.1-T_at 6.49776495 4.343732056
235 3861.008.1-C_at 5.95153563 3.602851161 236 3861.008.1-D_at
5.29062466 3.396003998 237 57447.035.1-E_at 6.91652713 4.662107171
238 3861.018.1-C_at 5.20378802 3.40238733 239 1308.003.1-B_at
6.04491667 4.20754377 240 667.022.1-B_at 9.21855078 6.264675763 241
3866.011.2-T_at 9.26272502 4.964885149 242 2115.001.2-F_at
4.89563967 3.419126266 243 3866.011.2-B_at 8.90774202
5.955221725
244 26289.010.1-T_at 6.53182588 3.913556066 245 27303.004.1-E_at
5.37295265 3.543582523 246 59.003.1-B_at 7.93270751 4.980983024 247
4311.009.1-C_at 5.83645359 3.593262545 248 7373.003.6-B_at
5.10650551 3.591717587 249 65983.004.1-T_at 6.08803336 4.309048954
250 26289.013.1-D_at 6.4702967 4.168098993 251 3866.004.1-F_at
8.69085999 5.161823428 252 56477.001.1-F_at 6.84530786 4.144567561
253 57447.037.1-F_at 6.50794623 4.008371243 254 59.022.2-T_at
8.05648541 5.423260634 255 147495.008.1-F 4.79759981 3.504777229
256 2.018.1-T_at 6.94869173 4.521707124 257 140807.003.1-E
7.78013704 4.939516908 258 65983.009.1-T_at 5.82469201 4.038349093
259 84668.002.1-F_at 6.10679619 3.911726506 260 3872.007.1-C_at
6.89188543 4.236245481 261 2115.008.1-T_at 4.99544075 3.646690809
262 65983.004.2-T_at 6.08050374 4.312433521 263 57447.034.1-D_at
6.936035 4.801981821 264 3866.001.1-F_at 9.09052167 5.099093334 265
3866.008.1-T_at 9.07318081 5.048805174 266 1959.003.1-C_at
5.09323093 3.511681612 267 389432.002.1-T 5.08376017 3.428817257
268 389734.001.1-T 5.43078503 3.868151914 269 3855.001.2-D_at
7.00167453 4.478486691 270 3866.003.1-T_at 7.28560994 4.919439752
271 3084.006.1-F_at 4.88762029 3.435292071 272 4915.008.1-B_at
9.33812372 6.600441272 273 2115.011.1-T_at 4.96772945 3.573388451
274 65983.005.1-T_at 5.18666491 3.68451349 275 84668.004.1-T_at
5.6127121 3.643748216 276 59.015.2-T_at 7.37091506 4.589962999 277
2119.006.1-B_at 5.29804773 3.689885023 278 4638.006.2-F_at
6.94711133 4.982563544 279 3866.007.2-D_at 8.65600661 4.653097355
280 59.014.1-T_at 6.68646455 4.640934588 281 3866.001.2-F_at
8.99732872 5.069416275 282 1308.008.1-B_at 5.17775427 3.436187546
283 59.026.1-F_at 6.20953542 4.590760008 284 3866.013.1-T_at
8.10955622 4.736748894 285 1264.007.1-F_at 4.75311015 3.431422638
286 3866.007.2-T_at 9.11439411 5.094569305 287 27122.013.1-T_at
6.62548583 4.301605936 288 27122.006.2-T_at 6.55351463 4.265429835
289 3866.006.2-T_at 9.06546704 5.104948803 290 3866.009.2-T_at
9.95142456 5.435454431 291 4240.004.1-D_at 6.56591292 3.971193091
292 3866.010.1-C_at 9.93993743 5.314895513 293 3866.009.2-B_at
8.95840788 6.023022151 294 3866.009.1-T_at 9.94526994 5.403869315
295 4629.006.1-T_at 8.84832501 6.182536282 296 7018.029.1-B_at
7.60030878 4.306073488 297 1410.002.2-B_at 5.81431314 3.745409488
298 3866.012.1-T_at 9.90206544 5.308091577 299 59.034.2-D_at
7.86477089 5.080775226 300 27122.019.1-F_at 6.89881084 4.480037843
301 5156.001.1-T_at 4.81097854 3.473046125 302 389734.001.2-T
5.40328573 3.837281942 303 27122.014.1-T_at 5.51451528 3.660985743
304 57447.010.3-T_at 7.75144798 5.575239001 305 358.018.1-F_at
5.42702744 3.627847604 306 3866.006.1-T_at 9.0668668 5.139316838
307 7373.001.1-T_at 4.83532429 3.464644018 308 26289.012.1-B_at
6.41666504 4.261745027 309 57447.029.1-T_at 6.56314208 4.648604292
310 358.018.1-B_at 6.41651654 4.110814767 311 79068.010.1-B_at
5.46560699 3.70220541 312 59.024.1-B_at 5.86685124 4.334726645 313
59.004.1-B_at 7.7789734 4.946058533 314 3866.011.1-T_at 9.18073541
5.037406823 315 3866.013.1-E_at 9.93641299 5.489343529 316
3866.010.1-D_at 7.92735291 4.325351254 317 59.004.1-T_at 6.80411249
4.752679161 318 2115.012.1-T_at 4.90559701 3.671185668 319
2.018.1-D_at 7.56738794 4.906078362 320 2115.007.1-T_at 4.92205691
3.509530779 321 59.040.1-T_at 7.92500959 5.05284254 322
130497.001.2-T 5.99836959 4.482736911 323 140885.014.1-T 6.11906211
4.162154943 324 3866.005.1-F_at 10.0863709 6.759928131 325
7373.003.3-F_at 5.33919182 3.590603587 326 8404.028.1-F_at
7.04051836 4.637927072 327 3860.007.1-D_at 6.74551501 4.619163344
328 4638.003.1-C_at 6.92132293 4.308398188 329 3872.009.1-E_at
6.06310081 3.900207749 330 59.004.2-T_at 6.8944992 4.903788058 331
3872.006.1-C_at 5.96674849 3.642756113 332 3866.005.1-C_at
9.92269961 5.465682846 333 25925.008.1-T_at 5.69718285 3.927983551
334 23650.011.2-T_at 7.84409583 5.100253551 335 3866.012.2-T_at
9.91429542 5.489051755 336 3852.017.1-D_at 7.83835576 6.280406857
337 4915.005.1-T_at 6.46700411 3.841875247 338 4638.003.1-B_at
5.77600419 3.967963498 339 1756.003.1-B_at 5.78203385 3.613994813
340 4638.006.1-F_at 6.98679711 5.084511181 341 57447.035.1-F_at
8.86960129 6.679175491 342 4638.014.1-T_at 6.2093321 4.224843914
343 7373.003.4-T_at 5.85405082 3.941925452 344 27122.014.2-D_at
7.20343208 5.077601963 345 3866.007.1-T_at 8.98065251 5.096039971
346 2707.002.1-E_at 5.34630411 3.674524536 347 59.024.1-T_at
6.83542202 4.80269153 348 23650.011.1-T_at 7.77512705 5.141458081
349 4638.011.1-F_at 6.85698752 4.967669809 350 7373.002.1-F_at
5.47015821 3.55519593 351 3866.013.1-F_at 10.0353866 5.509128495
352 5608.002.1-T_at 5.59795956 4.054949846 353 3866.001.1-C_at
8.25309213 4.510684041 354 1756.013.1-B_at 5.65046199 3.958957471
355 2115.006.1-E_at 4.67003702 3.398574534 356 6376.001.2-F_at
6.76738419 4.594461954 357 3084.004.1-B_at 5.38510101 3.510068108
358 3815.002.4-F_at 5.6936983 3.530847279 359 8404.002.1-D_at
5.08914334 3.509495218 360 1264.006.1-T_at 4.78935745 3.400776827
361 59.022.2-D_at 7.5362729 4.574317348 362 25925.001.1-T_at
5.6505549 3.971262708 363 4638.006.2-B_at 10.2697846 7.926227045
364 7373.003.5-B_at 6.13588807 3.881763973 365 8404.035.1-B_at
4.89853755 3.542374505 366 59.012.1-T_at 5.29276653 3.730940958 367
3852.017.1-T_at 5.94439335 4.136178865 368 3866.012.2-B_at
8.89819048 6.139221978 369 2.022.1-B_at 6.71649373 4.755989653 370
27122.016.1-F_at 5.4913787 3.685454959 371 4311.009.1-B_at
5.80492787 3.970849589 372 59.031.2-T_at 7.28741747 5.073231596 373
4311.009.1-T_at 6.04715771 3.812370988 374 3866.006.2-B_at
8.87200336 6.165346275 375 57447.025.2-T_at 7.83901538 5.040091008
376 1717.007.1-F_at 8.47657921 6.307092709 377 59.004.2-D_at
5.77885906 4.201996709 378 3866.007.2-B_at 9.03444459 6.541756746
379 3866.010.1-F_at 10.0841138 6.76233538 380 9768.004.1-D_at
5.61546594 8.042566668 381 3084.012.2-T_at 4.98851121 3.374482117
382 1410.004.2-B_at 5.76955824 3.747418029 383 59.008.1-D_at
7.580525 4.705524193 384 57447.030.1-C_at 6.89544125 5.081510062
385 2327.002.1-D_at 5.9013749 3.706350575 386 1308.004.1-B_at
5.16195304 3.553648577 387 2568.005.2-B_at 6.91662284 3.904971891
388 2568.001.1-T_at 5.88553699 3.946862951 389 3084.004.2-T_at
4.94236295 3.3780596 390 7373.003.4-B_at 5.93233847 3.707708869 391
7153.002.2-D_at 4.68145177 7.624764565 392 2893.006.2-T_at
4.85081759 3.447008535 393 3872.016.1-D_at 11.1567975 8.699934006
394 9413.006.1-F_at 5.72231532 3.924184102 395 59.023.2-B_at
8.07001275 5.312063628 396 72.005.1-B_at 6.00386245 3.894301071 397
4915.011.1-C_at 6.67654504 3.909184112 398 27122.018.1-F_at
6.87829457 4.481518888 399 3852.006.1-B_at 6.41696793 4.385795959
400 4638.006.2-D_at 8.29420831 6.32375426 401 7153.005.1-E_at
4.77417213 7.640160109 402 7373.001.2-T_at 4.90613308 3.486605886
403 7018.026.1-B_at 7.57683708 4.643843211 404 7402.014.1-B_at
4.80489581 3.457197254 405 57447.010.3-D_at 6.06072901 3.842292369
406 140446.004.1-T 6.16231533 4.305325034 407 59.026.2-T_at
7.15005413 4.607592814 408 59.038.1-B_at 5.6494079 4.056218565 409
4240.009.1-C_at 6.78849961 4.026127894 410 57447.030.1-F_at
7.60148038 5.351594285 411 9768.004.1-B_at 8.05212792 10.06930458
412 57447.008.1-T_at 7.31095336 4.743544863 413 59.014.2-T_at
6.61391873 4.504144736 414 4915.012.1-T_at 5.09228311 3.51551028
415 3866.004.1-T_at 8.98279458 5.909305497 416 2582.007.2-C_at
5.8740549 3.779098879 417 7153.002.5-T_at 4.34207016 6.815675337
418 4638.009.1-T_at 6.73711208 4.705108768 419 3861.023.1-T_at
8.54451168 7.107258463 420 5858.003.3-C_at 7.42717125 4.805969254
421 3861.020.1-F_at 6.68913708 5.181784732 422 147495.005.1-T
4.88155983 3.636974481 423 4638.006.2-C_at 6.96393228 4.171935351
424 1308.004.1-F_at 4.77853486 3.492851328 425 4915.004.1-F_at
7.22504252 4.799719839 426 3866.008.1-B_at 10.1199429 6.470209973
427 8626.002.1-E_at 5.06121478 3.39085572 428 1264.003.1-T_at
5.58569266 3.581548983 429 59.042.1-F_at 7.27807331 4.623171279 430
4833.004.1-C_at 9.54827464 10.38615702 431 2568.006.1-B_at
6.6183729 3.976037452 432 57447.004.2-T_at 6.70536079 4.18281839
433 59.014.2-B_at 8.212195 5.378024412 434 3084.012.1-T_at
5.03022579 3.397719814 435 27122.017.1-T_at 6.51481084 4.366155325
436 3852.012.2-T_at 6.92067083 5.004410401 437 59.033.1-T_at
6.06486589 4.665665746 438 27122.002.1-C_at 7.19364005 5.202367669
439 3880.011.1-B_at 10.5071551 7.518624838 440 65983.013.1-T_at
7.70720875 5.536789935 441 3872.014.1-T_at 7.93552665 5.762824716
442 162605.001.4-C 7.30134493 4.179141958 443 59.031.2-B_at
5.4449077 3.782243257 444 3084.012.2-B_at 6.18353868 4.174289227
445 5858.001.2-C_at 7.44400374 4.932750742 446 65983.010.1-T_at
5.57005121 3.990871807 447 7373.003.5-F_at 5.34533867 3.627863939
448 3866.010.1-T_at 9.51219169 5.699587788 449 8404.005.1-B_at
7.38892631 4.907319634 450 3866.005.1-T_at 9.03709757 6.030628254
451 59.003.1-F_at 5.4356104 4.096508262 452 7153.002.5-F_at
5.25391475 7.80693684 453 2487.001.1-T_at 5.33828017 3.563654952
454 3866.010.1-B_at 9.6945434 7.292676871 455 147495.009.1-T
4.85966734 3.631522846 456 65983.003.2-T_at 6.05435123 4.377097045
457 59.040.1-D_at 7.44167751 4.584016558 458 59.024.2-T_at
6.73075195 4.593534348 459 1717.009.2-B_at 8.45360663 6.312163684
460 1756.027.1-F_at 4.75197052 3.358719581 461 59.042.1-B_at
8.72270213 5.878159021 462 7153.002.5-D_at 4.84971619 7.17366424
463 57447.031.1-F_at 6.49415294 4.65208765 464 140885.011.1-C
6.38820366 4.253831639 465 59.003.1-T_at 7.42538834 5.15557028 466
3832.002.1-D_at 3.75527723 5.95014323 467 3880.005.1-D_at
10.9942207 8.319628818 468 3084.012.1-F_at 5.28504089 3.485172312
469 6595.012.1-B_at 5.31888699 3.686393951 470 59.012.2-D_at
7.44955953 4.615757659 471 57447.034.1-C_at 8.57145373 6.706526296
472 56477.001.1-B_at 7.19333631 5.61196287 473 57447.041.1-D_at
6.52483208 4.131433849 474 9768.005.1-B_at 8.31090623 9.919835275
475 285203.001.2-C 5.76551543 4.033568669 476 147495.006.1-B
4.7178507 3.386397601 477 7018.029.1-D_at 7.49247458 4.695975326
478 3852.009.1-T_at 7.08281122 4.869630434 479 59.023.2-D_at
7.777198 5.151112126 480 1959.002.1-D_at 4.95918444 3.503378215 481
7018.014.1-D_at 7.44352827 4.557712011 482 5858.004.1-F_at
6.76116585 4.375553995 483 79192.002.2-D_at 5.63448533 3.51926817
484 59.008.2-B_at 8.69617919 5.779103612 485 8404.008.1-E_at
5.85502792 4.086526269 486 59.008.1-F_at 6.10922251 4.513619758 487
4240.011.1-B_at 6.01396547 3.771634645 488 94274.002.1-C_at
6.16939359 3.837512253 489 4638.015.1-T_at 5.62349541 3.911665402
490 6376.001.1-T_at 7.28348829 5.069341011 491 57447.043.1-F_at
6.82408835 4.362797669 492 59.039.1-T_at 6.75082374 4.916156262 493
4638.006.1-B_at 5.98299624 4.034678304 494 25802.003.1-F_at
8.44079836 5.782396909
495 57447.025.1-T_at 7.73646375 5.084216105 496 57447.017.1-T_at
6.65771959 4.273635182 497 7018.026.1-C_at 7.45984207 4.533286079
498 7018.028.1-E_at 7.40598333 4.550309687 499 4915.008.1-C_at
5.64881509 3.72422841 500 358.018.1-C_at 5.7267252 3.761286452 501
7153.002.6-B_at 4.11329877 6.373276857 502 57447.012.1-T_at
7.30791833 4.819204577 503 59.040.1-B_at 5.85498792 4.104163066 504
57447.006.1-T_at 7.76068288 5.150567998 505 9493.006.1-F_at
4.10577729 6.338245812 506 57447.004.1-T_at 7.33632129 4.896275995
507 57447.004.2-B_at 8.9127783 6.322143899 508 7373.001.2-D_at
5.3965566 3.844531388 509 9493.004.1-B_at 3.76399079 5.935350549
510 2568.005.2-C_at 6.84549764 3.843092863 511 7018.029.1-F_at
7.12490547 4.43476648 512 26289.013.1-B_at 6.90469249 5.370319984
513 7169.015.1-B_at 6.84318501 4.909744137 514 57451.001.3-F_at
4.90668348 3.471308523 515 2568.005.2-F_at 6.79093209 4.252137182
516 57447.004.2-F_at 8.06429543 5.612147867 517 8404.004.1-D_at
5.17131676 3.577119644 518 3855.004.2-D_at 6.85394835 4.458549061
519 3872.014.1-F_at 6.14273082 4.52366007 520 57447.033.1-F_at
7.64663376 5.439828214 521 9452.001.1-T_at 6.18030538 4.323283485
522 59.033.2-T_at 5.65222584 4.220481151 523 3084.009.1-T_at
5.35152557 3.607558469 524 57447.040.1-T_at 8.2897346 6.134921385
525 4833.004.1-T_at 9.46766291 10.42910615 526 3426.001.1-F_at
6.26649958 4.50478468 527 59.034.1-B_at 5.62313286 4.199853557 528
10253.001.1-E_at 5.11930015 3.602200848 529 9073.001.1-C_at
6.47130665 3.903135256 530 51201.005.1-T_at 6.31581082 4.43048891
531 9477.006.1-C_at 5.53969827 4.094283805 532 57447.028.1-T_at
7.15440543 4.718940054 533 25925.007.1-T_at 5.59498246 3.919647944
534 59.024.2-B_at 8.11536088 5.398824045 535 2.022.1-T_at 6.6607733
4.783988683 536 4281.008.2-B_at 6.31875113 4.027809365 537
90231.001.1-C_at 7.10807035 5.499098683 538 358.012.1-D_at
7.14590494 4.561944415 539 3852.021.1-T_at 6.09796458 4.733460989
540 7373.003.4-D_at 5.31871742 3.444341336 541 57447.048.1-T_at
7.77920047 5.301184204 542 358.012.1-B_at 6.31206962 4.291200634
543 7018.025.1-C_at 6.45586871 3.926355221 544 5608.004.1-T_at
5.49475117 4.000756586 545 3084.012.2-F_at 5.75533986 3.729134317
546 4306.002.1-C_at 4.88461568 3.537810553 547 4288.004.1-D_at
3.93407536 6.069531548 548 57447.002.1-F_at 7.74355125 5.160300501
549 4281.018.1-T_at 5.78771209 4.04473446 550 10144.020.2-B_at
5.47403735 3.883268971 551 6876.016.1-E_at 6.18917118 4.18306498
552 57447.008.2-T_at 7.34801416 4.979022114 553 51203.004.1-T_at
4.78407281 7.121996232 554 2335.028.1-B_at 4.21322617 6.985070244
555 7018.028.1-F_at 7.69070629 4.697084965 556 7373.003.5-T_at
4.92968881 3.413713427 557 81557.006.1-C_at 5.93949691 3.8795395
558 3866.002.1-D_at 8.13043421 4.563939496 559 3866.001.1-B_at
9.58995543 5.652717341 560 55107.006.2-T_at 5.84582122 4.291743766
561 79068.010.1-D_at 5.70046398 3.712391955 562 57447.009.1-T_at
8.2708267 6.230837008 563 2115.015.1-T_at 4.73030559 3.529706912
564 1756.013.1-C_at 5.56755741 3.498765701 565 7169.015.1-F_at
7.18617 5.481397093 566 65983.013.2-F_at 6.02311371 4.186716607 567
8404.001.1-B_at 7.99199458 5.467331229 568 4240.004.1-B_at
5.05165978 3.552351613 569 57447.012.2-T_at 7.26590502 4.745539951
570 57447.024.1-F_at 7.68629251 5.418867784 571 358.018.1-T_at
6.45498824 4.241533634 572 57447.048.2-T_at 7.78420544 5.160126545
573 59.031.1-C_at 7.49205582 4.903309981 574 3860.007.1-F_at
7.96260627 7.096659156 575 8404.028.1-C_at 8.62889588 6.246608834
576 4240.011.3-E_at 6.64966622 4.03055242 577 59.022.2-B_at
6.73772327 4.432555365 578 3866.002.1-F_at 9.25258448 5.192570901
579 3866.002.1-T_at 10.3199488 7.640256534 580 4915.005.1-B_at
5.32094122 3.959770809 581 8404.008.1-F_at 7.59063584 4.972790065
582 79608.002.1-F_at 6.76648623 4.436714154 583 8404.023.1-D_at
5.15683509 3.569085706 584 3426.002.1-D_at 5.89393001 3.867643288
585 2335.027.1-T_at 4.74881131 7.635920403 586 11065.009.1-T_at
4.30670491 6.277657291 587 140885.013.1-F 4.7450748 3.529107038 588
57447.021.1-B_at 8.92169251 6.883898006 589 25802.004.1-C_at
5.57673557 3.766890823 590 4638.014.1-F_at 6.07887669 4.28495326
591 9493.004.1-F_at 4.40101083 6.610015234 592 8404.004.1-B_at
5.26981439 3.864868573 593 8404.004.2-T_at 7.56316749 5.288443352
594 57447.010.2-T_at 8.91041497 6.730736236 595 57447.010.3-B_at
6.48036743 4.021664269 596 27122.006.1-T_at 6.45932378 4.338943765
597 5156.005.1-T_at 6.0454338 4.480368629 598 5858.004.1-E_at
7.37541332 5.015122988 599 25802.008.1-D_at 5.55466297 3.708835665
600 2327.002.2-T_at 5.75006787 3.952332834 601 3852.004.1-C_at
5.36673477 3.588173957 602 59.026.2-F_at 6.23946248 4.728060027 603
57447.029.1-C_at 6.81845329 4.22278911 604 7169.022.1-D_at
7.8722658 5.729424902 605 23266.001.3-B_at 6.46418041 4.203358555
606 3084.012.1-B_at 5.2276441 3.451592509 607 29127.019.2-T_at
4.21990379 6.173743362 608 10253.004.1-T_at 5.1662428 3.694488428
609 10124.002.1-D_at 4.89764097 3.541005706 610 3861.013.1-D_at
9.32851084 8.049530881 611 8404.032.1-T_at 7.52923111 5.000568707
612 84441.002.1-E_at 5.90012193 3.970885538 613 2.013.1-E_at
7.80547535 5.549361786 614 3084.004.1-T_at 4.81080947 3.346803546
615 5288.001.2-F_at 4.76245236 3.504782872 616 57447.017.1-F_at
8.0107637 5.541276327 617 3084.006.1-T_at 4.81532746 3.375970424
618 59.039.1-F_at 6.56572249 5.093494374 619 2.024.1-T_at
5.21957454 3.829912849 620 3815.002.2-E_at 4.63092258 3.36714837
621 1756.009.1-D_at 4.85499539 3.471377655 622 7091.014.1-B_at
7.40595585 5.56221435 623 4629.015.1-F_at 5.10691679 3.491137224
624 59.008.2-F_at 6.0929029 4.444669467 625 2568.005.2-T_at
8.95422916 5.14191273 626 115207.002.1-T 5.88924208 4.419602651 627
4281.001.1-T_at 5.35086765 3.640788304 628 84668.002.2-T_at
5.15028907 3.79042988 629 4240.004.1-F_at 5.66574104 3.720396854
630 8404.005.1-D_at 6.9401254 4.492872909 631 8404.032.1-B_at
7.44013836 5.095849595 632 57447.044.1-E_at 6.80906698 4.217089915
633 8626.006.2-F_at 7.23333868 4.510165054 634 57447.051.2-B_at
7.98328422 5.210860718 635 1063.001.1-T_at 3.65207754 5.460717647
636 3426.002.1-T_at 6.14481418 4.337714037 637 1308.001.1-T_at
4.49112544 3.366968911 638 389432.002.1-F 4.87416968 3.449919343
639 57447.017.1-B_at 7.4444592 4.927207265 640 2115.014.1-F_at
4.64920074 3.393814502 641 5284.004.1-T_at 5.42573909 3.644981157
642 57447.029.1-F_at 6.90955367 4.763872665 643 8626.006.1-F_at
7.10882986 4.577853419 644 2982.002.1-C_at 5.95650332 4.047393285
645 57447.047.1-T_at 8.49737877 6.301927816 646 5803.006.1-E_at
4.70860909 3.460139104 647 57447.021.1-F_at 6.99463667 4.787200512
648 57447.039.1-F_at 8.6752975 7.025558424 649 4281.008.2-F_at
5.78507528 3.786315944 650 57447.029.1-D_at 7.11241156 4.695681706
651 65983.013.1-B_at 6.06404247 4.544332621 652 5284.004.1-E_at
5.48521773 3.473351613 653 4240.011.1-D_at 6.58817281 4.028721269
654 57447.024.1-T_at 6.74179663 4.451590226 655 6876.011.1-B_at
6.30476658 4.18672283 656 7373.003.2-T_at 4.82544001 3.471146792
657 3852.014.1-D_at 5.18111457 3.45188203 658 4915.005.1-D_at
5.64408415 3.959617796 659 9768.002.2-B_at 5.37116829 7.073380688
660 140885.010.1-D 6.19842073 4.31967621 661 4638.020.1-E_at
5.02985387 3.533302553 662 57447.017.1-C_at 7.71365249 6.834906013
663 7373.004.1-T_at 5.09440176 3.576481268 664 3852.008.2-E_at
5.70467573 3.895814365 665 4281.015.1-E_at 5.86221529 3.827749855
666 8404.013.1-C_at 7.63052911 5.806566552 667 90293.001.3-T_at
5.16415646 3.590009024 668 57447.044.1-T_at 6.3521445 4.368444106
669 23650.011.2-D_at 5.16951309 3.620720053 670 2335.006.1-D_at
5.19038486 8.099850829 671 57447.022.1-T_at 8.16254038 6.240130159
672 8404.032.1-D_at 6.59024869 4.387778168 673 8404.030.1-F_at
6.20905072 4.160627809 674 5803.002.2-T_at 4.56393909 3.473197076
675 8404.004.2-C_at 5.26606619 3.620282123 676 84441.005.1-C_at
4.85915223 3.545415518 677 7091.015.1-F_at 6.21201003 4.478013561
678 2119.005.1-D_at 5.07146093 3.567763303 679 7373.003.6-F_at
6.24165607 4.086113068 680 79608.008.1-T_at 7.43049786 5.105020166
681 3852.008.1-T_at 6.84173919 4.788195739 682 8626.007.1-T_at
5.77669765 3.835835567 683 8404.022.1-T_at 6.96844417 4.561425115
684 8404.034.1-T_at 7.70565001 5.437963133 685 57447.049.1-T_at
8.19539372 6.244201139 686 5311.002.1-B_at 5.23153491 3.9379694 687
2335.025.3-T_at 4.97507454 7.552542415 688 4147.012.1-T_at
6.56476077 4.115527169 689 301.015.1-T_at 7.08671415 4.704911993
690 301.004.1-T_at 5.88285125 4.193540097 691 3426.002.2-F_at
6.42951667 4.610291858 692 7091.001.1-C_at 5.78834657 3.99782643
693 8404.021.1-D_at 7.13632332 4.668450897 694 7153.002.3-B_at
4.32680853 6.386139877 695 53335.002.1-E_at 6.97060249 4.349457276
696 5284.003.2-T_at 5.56357531 3.826429145 697 4306.002.1-F_at
5.12339023 3.619119014 698 5284.003.2-D_at 5.40634511 3.413836573
699 5803.002.1-T_at 4.46452818 3.454054461 700 10253.004.1-E_at
5.04005634 3.60976014 701 23650.020.1-T_at 4.5970193 3.540969462
702 57447.042.1-T_at 8.23732789 6.24305985 703 6876.023.1-F_at
6.0056721 4.219933741 704 7169.015.1-C_at 7.73240413 5.633948369
705 7153.002.4-F_at 4.29974508 6.250118979 706 4629.016.1-B_at
6.78440003 5.390110166 707 6876.002.1-C_at 6.05319952 3.996827256
708 65983.007.1-T_at 5.80300089 4.538161738 709 7373.003.2-F_at
4.94886483 3.638149496 710 152015.004.1-T 7.02090877 4.99281238 711
8404.004.2-B_at 9.10036043 6.953060695 712 6285.001.1-B_at
6.79781208 4.254547252 713 2115.007.1-E_at 4.60359502 3.455996501
714 2.013.1-T_at 7.4129596 5.313450804 715 6289.005.1-T_at
7.97416675 5.388443167 716 9232.002.1-T_at 4.43941526 6.671542368
717 59.014.1-B_at 5.61171235 4.093335038 718 59.031.1-F_at
6.05184505 4.804165615 719 3084.011.1-T_at 4.47393244 3.329487007
720 3872.005.1-F_at 7.08989626 4.850069536 721 3084.012.3-F_at
5.22568038 3.554479542 722 81704.008.1-F_at 6.21408125 4.397532613
723 140885.010.2-C 4.97071116 3.671401317 724 338707.006.1-E
5.98755333 4.509773447 725 23266.008.2-T_at 6.14954287 4.054145008
726 120.005.2-E_at 4.96398804 3.493809568 727 4281.009.1-E_at
5.85541642 3.780316615 728 4094.001.1-T_at 4.9006582 3.742133457
729 2995.001.1-T_at 5.43112669 4.074233155 730 4638.011.1-T_at
5.98438955 4.171529554 731 2335.017.1-T_at 4.62014922 7.477442043
732 5284.001.1-F_at 5.85070156 4.156065391 733 8404.026.1-D_at
5.85230036 3.946505653 734 2335.009.1-D_at 4.30571681 7.164817626
735 10461.002.2-F_at 4.63243519 3.535654634 736 84441.002.1-T_at
5.38195119 3.727915338 737 147495.006.1-T 5.03268944 3.722907652
738 7091.010.1-B_at 7.35452034 5.471123192 739 8404.008.1-C_at
8.16760292 5.675687385 740 6376.001.2-C_at 4.95398073 3.657520603
741 3832.002.1-B_at 5.6547708 7.337897553 742 59.034.2-T_at
7.1564008 5.827736739 743 147495.005.1-B 4.74136095 3.469591177 744
3872.005.1-T_at 7.59194046 5.105397146 745 79895.001.1-D_at
5.67879632 4.246832679
746 57447.038.1-T_at 6.69850781 4.473274428 747 7373.008.1-T_at
5.31202269 3.784685566 748 4744.004.1-C_at 6.56900249 4.507168025
749 140885.010.1-T 5.34750246 3.919015769 750 6876.016.2-E_at
5.93029441 3.912787487 751 8404.015.1-T_at 6.44737359 4.403676272
752 4281.014.1-T_at 5.78461168 4.11824695 753 4288.006.1-F_at
6.66901042 8.513403763 754 25925.009.1-E_at 5.28428858 3.73856992
755 4240.009.1-B_at 5.83089671 3.671481622 756 667.010.1-E_at
6.85392624 5.299481091 757 3866.005.1-B_at 7.15276909 4.263334499
758 57447.011.1-T_at 8.19368289 6.289649841 759 57447.034.1-B_at
5.65705009 3.831297336 760 25802.004.1-B_at 8.21857039 6.532464436
761 8404.024.1-T_at 6.97369157 4.587021041 762 57447.032.1-T_at
7.06280543 4.783190929 763 667.021.1-F_at 8.07963087 5.823822156
764 5858.001.2-F_at 5.1370254 3.721747178 765 51062.008.1-T_at
5.30551619 3.890620002 766 2335.013.1-F_at 6.15540646 8.86885363
767 2568.001.2-T_at 5.68238983 3.94629046 768 7170.005.2-D_at
8.99098118 9.775109373 769 57447.034.1-F_at 6.98073127 5.016025642
770 7153.002.6-C_at 5.57448334 7.592280416 771 2568.003.1-T_at
5.81249572 4.092333465 772 59.008.2-T_at 8.60581658 6.540879986 773
9898.015.2-B_at 3.9211311 5.201936253 774 7018.013.1-T_at
5.65007058 3.778570945 775 7170.034.2-D_at 9.01623909 9.815404878
776 3866.004.1-E_at 4.83901548 3.502240062 777 5284.001.1-T_at
8.49976792 6.07875714 778 2.002.1-C_at 6.12813044 4.193878475 779
57447.050.1-T_at 8.19795199 5.982437202 780 7018.014.1-F_at
6.97729458 4.681227687 781 2335.032.1-D_at 5.08653484 8.031106422
782 3866.002.1-C_at 6.91504668 4.200467449 783 57447.043.1-T_at
6.56411152 4.225208179 784 51201.005.1-D_at 5.11440976 3.64815718
785 51203.003.1-T_at 4.82041174 7.05990414 786 9493.001.1-F_at
3.98373277 6.007980938 787 57447.024.1-B_at 7.87321828 5.204843561
788 80034.003.4-B_at 5.58242913 4.421835696 789 7170.016.3-C_at
9.01883837 9.828229863 790 65983.003.1-T_at 5.92193731 4.324879597
791 57447.026.1-T_at 8.15874879 6.121827399 792 440421.001.1-F
7.16019583 5.432495648 793 301.008.1-D_at 5.48743448 3.703220782
794 80034.002.2-T_at 4.34845355 3.381277916 795 7153.002.5-B_at
5.10010536 7.50996728 796 3852.023.1-T_at 5.16770498 4.068449227
797 8404.013.1-F_at 6.3516361 4.31581135 798 2.018.1-C_at
4.79949735 3.600814702 799 10124.003.1-B_at 7.77141001 5.984762853
800 3852.008.2-F_at 5.25269037 3.555215368 801 4288.006.2-T_at
4.41269608 6.475089289 802 8404.026.1-C_at 7.87032712 5.309471428
803 23650.019.1-C_at 4.78127834 3.449585316 804 7170.027.1-T_at
10.1785633 10.86779555 805 54928.003.1-E_at 7.95793621 6.353966846
806 2335.025.1-B_at 6.59794162 8.83157397 807 3084.010.1-T_at
4.64480819 3.365397857 808 57447.051.1-T_at 7.94997082 5.870179931
809 80034.003.4-T_at 4.8124569 3.414443991 810 2568.005.1-D_at
5.60503766 3.638290306 811 8404.032.1-F_at 7.82269285 5.541014824
812 2115.003.1-E_at 4.60503701 3.463043796 813 57447.035.1-T_at
6.58609653 4.690569876 814 8404.009.1-T_at 8.30486375 5.75977584
815 8404.028.3-B_at 6.39814918 4.353137247 816 6289.003.1-B_at
8.85424542 5.981607568 817 7170.025.1-F_at 7.37697122 8.410726942
818 8404.030.1-D_at 4.68883661 3.480079758 819 8404.009.1-F_at
6.4288173 4.305937183 820 2335.009.1-T_at 5.3309114 8.084486221 821
22974.007.1-F_at 5.33852227 7.851513061 822 3426.002.1-B_at
5.18878725 3.666443854 823 4638.003.1-D_at 4.80794498 3.519315999
824 4147.011.1-T_at 5.5473121 3.770096298 825 6876.016.2-T_at
6.73562706 4.929179325 826 23650.003.1-F_at 5.36467738 3.8134759
827 4744.004.1-E_at 5.98052533 4.025288625 828 64168.010.1-F_at
4.47544044 3.464747266 829 9073.001.1-F_at 6.32607617 3.970691137
830 5288.001.3-B_at 5.80543381 4.395911298 831 3866.005.1-D_at
4.69976421 3.498394825 832 8404.021.1-T_at 7.61048125 5.126133895
833 25925.011.1-E_at 5.22009218 3.770296785 834 23266.001.3-F_at
6.97341376 4.950755879 835 9232.004.1-F_at 4.54899231 6.788996757
836 4147.005.2-F_at 6.46653951 4.116097107 837 2335.025.3-B_at
4.1218962 6.635944112 838 4638.006.1-C_at 4.60097436 3.386710346
839 147804.004.1-T 8.74204077 9.383412702 840 81704.013.1-D_at
5.74760963 4.078176314 841 54443.013.1-B_at 3.78713573 5.832999901
842 1410.005.1-T_at 7.99587494 5.02138884 843 25925.009.1-T_at
5.84441997 4.119796362 844 3204.001.1-T_at 6.21835333 4.25541633
845 29997.012.1-F_at 9.16397087 7.980650261 846 2.005.1-C_at
9.81288715 8.155872692 847 140885.011.1-F 6.19333879 4.903420797
848 7153.002.3-F_at 3.47065774 5.379571026 849 1063.002.1-F_at
4.818547 6.814140949 850 10144.021.1-F_at 5.41639448 3.918615816
851 8404.025.1-E_at 7.03203124 4.624818473 852 6876.020.1-B_at
6.533895 4.437030997 853 7170.006.1-C_at 9.05537796 9.822975281 854
10051.016.1-T_at 7.11146583 8.35678465 855 5288.001.2-D_at
4.36619367 3.362822607 856 7018.029.1-T_at 6.23394945 3.983824938
857 5627.002.1-B_at 5.10823783 3.887587419 858 57447.037.1-T_at
6.70751747 4.463904664 859 4147.005.2-D_at 6.41967658 4.010663201
860 8404.023.1-T_at 8.96871259 6.761468547 861 3872.006.1-D_at
7.20926464 5.468717646 862 399687.001.1-C 5.1094656 3.656879029 863
3815.002.4-D_at 4.48207839 3.345874495 864 59.034.2-B_at 7.86775534
5.305977855 865 8404.035.1-T_at 7.35557119 4.961673356 866
8404.030.1-T_at 9.22413584 7.338140147 867 54997.002.2-T_at
4.91413205 3.541335298 868 57561.001.1-F_at 7.63984954 5.681299176
869 8404.031.1-T_at 8.83771374 6.734753847 870 2.025.1-E_at
6.76479665 4.728179737 871 699.002.1-F_at 4.23691585 6.351343745
872 57447.041.1-F_at 8.01010166 5.655092904 873 9055.013.1-D_at
3.74232362 5.955553435 874 8404.008.1-D_at 7.31144196 4.840262527
875 7018.028.1-T_at 6.15805126 3.968077116 876 2568.005.1-T_at
5.80411431 3.692039293 877 10051.005.3-T_at 7.06136791 8.335822705
878 2568.002.2-T_at 5.39690112 3.699196299 879 4147.004.1-F_at
6.45719145 4.078127629 880 2938.001.1-T_at 5.28917706 3.569952051
881 1308.007.1-E_at 4.33353721 3.32285855 882 2982.012.1-T_at
6.69749373 4.397652902 883 8404.028.1-D_at 9.17080043 6.681120058
884 7373.001.2-B_at 5.50958781 3.91365763 885 2893.002.2-B_at
4.99194607 3.464698996 886 116369.006.4-C 7.33578706 5.780057699
887 6304.007.1-T_at 6.03651208 4.53887378 888 2335.035.1-T_at
3.84203808 6.550409853 889 4751.002.1-T_at 3.37070549 5.029578851
890 64151.001.2-T_at 4.47557646 6.324975406 891 29089.003.1-T_at
4.48056575 6.605198239 892 59.031.1-B_at 7.22996112 4.744191474 893
7018.025.1-T_at 5.84703558 3.746460765 894 3860.008.1-T_at
5.34250998 4.140007902 895 5858.003.3-F_at 5.09683569 3.735471384
896 8404.009.1-C_at 8.45510904 6.045801083 897 7169.022.1-T_at
6.97482167 4.826590592 898 25925.006.1-T_at 5.34961663 3.868058889
899 59.049.1-F_at 6.6091616 5.230817807 900 5284.003.1-T_at
5.4389606 3.820813601 901 2982.002.1-F_at 6.20754503 4.114933269
902 2568.002.1-T_at 5.18521978 3.672133283 903 301.004.1-B_at
6.4786296 4.407193121 904 25925.011.1-F_at 5.58763288 4.002507678
905 59.004.1-F_at 5.74336584 4.280036618 906 6289.002.1-B_at
8.87204796 6.038294234 907 244.003.1-C_at 5.36729328 3.596389122
908 11065.008.1-C_at 3.66496529 5.619449029 909 7091.006.1-T_at
6.70324989 4.896846915 910 79608.009.1-F_at 6.81856163 4.583013558
911 9413.002.1-T_at 5.78003165 4.176180652 912 7431.064.1-C_at
6.00790783 4.318847511 913 8404.029.1-E_at 7.5152716 5.026824891
914 6876.020.1-T_at 6.73708584 4.994785476 915 301.005.1-T_at
7.12173249 4.879038375 916 9055.014.1-T_at 5.9433395 8.161119674
917 4281.023.1-T_at 5.06611225 3.689556134 918 3868.005.1-D_at
5.81265413 4.356646518 919 1062.001.6-B_at 4.61979335 5.902124565
920 5858.005.1-T_at 6.62044043 5.019290814 921 51201.007.1-F_at
5.89798751 4.556162061 922 4240.001.1-B_at 7.04315913 5.225486532
923 8404.029.1-T_at 7.19061905 4.823349131 924 9413.001.1-T_at
5.85356534 4.184779715 925 9768.005.1-T_at 4.56065688 6.668381892
926 11197.001.1-T_at 5.497932 3.863349343 927 6285.002.1-T_at
7.15759953 4.38354551 928 2335.006.2-F_at 4.52057793 7.007712622
929 7169.001.1-C_at 9.97986289 8.443197393 930 9493.004.1-T_at
4.12782496 5.475321289 931 4601.014.1-T_at 7.11289499 5.834825527
932 51203.002.2-F_at 3.76957554 5.500135903 933 7018.022.1-F_at
5.24694116 3.916461778 934 4288.009.1-F_at 4.54685294 6.450101537
935 8321.004.1-D_at 5.28227566 3.892211156 936 8564.004.1-E_at
6.48035789 5.023116233 937 7169.022.1-C_at 8.24544042 5.873824132
938 29127.013.1-T_at 4.10561977 5.802203111 939 2.018.1-B_at
7.31981124 5.353818042 940 2.005.1-D_at 8.25561915 6.09796658 941
1058.004.2-T_at 3.7975226 5.865920911 942 2232.014.1-C_at
5.21644948 3.868088006 943 23650.005.1-E_at 6.06219649 4.127697497
944 5621.002.2-T_at 6.01313915 4.906824984 945 51201.005.1-B_at
6.93913414 5.202799498 946 667.022.1-F_at 8.42885166 6.36231857 947
54443.012.1-C_at 3.50725399 5.586709148 948 25802.003.1-C_at
7.43616073 5.067395951 949 3479.003.1-T_at 6.77825963 4.651724222
950 94274.003.1-D_at 5.91050731 3.846777655 951 84668.003.1-T_at
5.22078827 3.927647308 952 22974.008.1-E_at 4.27998201 6.244828978
953 55656.007.3-B_at 5.26745658 6.648785128 954 29127.002.1-T_at
4.18023368 5.884883109 955 4281.012.2-T_at 5.18559903 3.709369654
956 2335.013.1-B_at 4.24843254 6.768210889 957 79627.003.1-B_at
5.80046587 4.283731062 958 2982.014.1-T_at 6.70490207 4.400137878
959 2335.053.1-T_at 5.80672371 8.072794315 960 667.001.1-F_at
5.91836585 4.436185766 961 8404.030.1-B_at 8.7803817 6.762729417
962 2335.025.1-C_at 5.89016354 8.340545982 963 140885.010.3-D
5.64716726 3.935175019 964 55366.001.2-F_at 6.45584577 4.52968697
965 7169.015.1-D_at 9.10850076 7.746283286 966 57447.002.1-B_at
10.5154174 8.85406099 967 22974.008.1-T_at 4.68631855 6.537183038
968 6876.011.1-C_at 6.44837046 4.645016388 969 4281.008.2-D_at
5.85946061 3.878305283 970 59.008.1-T_at 8.48935505 6.63847471 971
23266.008.1-F_at 7.18072955 5.133107519 972 2568.003.2-T_at
5.85722739 4.051173411 973 5311.003.1-T_at 5.37168206 4.077343368
974 6304.011.1-T_at 5.92190291 4.37727733 975 3861.008.1-B_at
7.42551236 5.399716053 976 7018.013.1-B_at 5.26119189 3.69876029
977 8404.005.1-F_at 8.58438422 6.423269422 978 7170.027.1-C_at
9.03620668 9.824923692 979 8404.023.1-C_at 6.96271536 4.627460556
980 7373.007.1-C_at 5.21901652 3.512769797 981 1410.009.1-T_at
8.07507455 5.204140322 982 79745.004.3-D_at 5.57669121 4.147896702
983 24137.004.1-T_at 3.54526583 5.143662611 984 6241.013.1-B_at
5.32142819 7.577868116 985 1410.001.1-T_at 8.89756795 5.783554496
986 4781.015.2-B_at 7.82251501 5.588763483 987 72.002.1-T_at
5.49901408 3.657567415 988 4833.004.1-D_at 7.72478747 8.933008875
989 57447.024.1-D_at 8.39121333 5.734774748 990 2982.013.2-T_at
6.69829498 4.788664846 991 79971.012.1-T_at 7.86816422 5.097596928
992 8404.028.3-C_at 8.43509005 5.660339589 993 4638.011.1-E_at
4.54149983 3.401814228 994 7169.004.1-C_at 9.93319291 8.292756224
995 4288.004.1-F_at 5.48379306 7.569481427 996 59.012.2-C_at
7.35490878 6.158197444
997 301.008.1-B_at 7.75881704 5.561554031 998 4281.012.1-T_at
5.22990892 3.775893084 999 2335.016.1-F_at 5.72062946 8.271881228
1000 259266.003.1-C 3.74524657 5.64429601 1001 9055.020.1-T_at
4.54642664 6.710996898 1002 7091.016.1-T_at 6.32037409 4.628367394
1003 59.023.1-T_at 6.98702578 5.652733648 1004 57162.010.1-B_at
5.51558535 4.297033118 1005 4781.002.2-D_at 4.69751141 3.532094277
1006 6122.037.1-T_at 10.367148 9.581841169 1007 4240.015.1-B_at
5.58448718 3.769441906 1008 59.034.1-T_at 7.30028333 5.815069711
1009 8404.004.2-D_at 6.59680571 4.480908858 1010 9413.001.2-T_at
5.83173699 4.199417075 1011 2.005.1-F_at 9.23135004 7.463118008
1012 6304.002.1-T_at 6.22980998 4.691222262 1013 3852.005.1-C_at
5.1815999 3.540371293 1014 7170.027.1-B_at 8.61016621 9.330841255
1015 301.013.1-T_at 7.9831001 5.822883877 1016 6304.012.1-F_at
5.99863704 4.356895672 1017 57447.051.2-T_at 7.96085286 6.017184644
1018 11065.005.1-C_at 3.70869314 5.527276202 1019 6422.002.1-F_at
5.79053376 4.58677324 1020 6241.013.1-F_at 4.36486456 6.707728465
1021 2335.032.1-T_at 6.09077284 8.189655849 1022 11065.005.2-T_at
4.44502121 6.241724709 1023 2335.028.1-D_at 4.37811935 7.181272915
1024 29997.016.1-F_at 7.01231968 5.364391961 1025 7018.014.1-T_at
5.84447021 3.853791495 1026 1410.011.1-E_at 10.4572153 7.631013667
1027 7170.040.1-E_at 9.04381331 9.788601589 1028 6289.002.2-F_at
7.95331589 5.409835249 1029 7373.003.4-C_at 5.37900799 3.668049298
1030 7170.041.1-E_at 9.0780429 9.837001991 1031 128553.003.1-B
4.33787983 3.383127715 1032 4094.002.1-D_at 5.80489701 4.110942964
1033 7113.011.1-T_at 5.03380702 3.77489186 1034 7170.002.1-C_at
10.3310325 11.10058024 1035 8404.017.2-T_at 7.65991671 5.307045406
1036 59.029.1-T_at 6.00974416 4.740356024 1037 29089.001.1-T_at
4.60079781 6.714422405 1038 358.012.1-T_at 7.75384082 5.172139857
1039 9134.001.1-B_at 3.63113188 5.472113919 1040 2335.013.1-C_at
6.22416658 8.858188139 1041 1410.010.1-T_at 8.00194091 5.107287395
1042 2327.003.4-F_at 5.3147747 3.687201869 1043 59.042.1-T_at
8.33740211 6.337284559 1044 6304.007.2-T_at 6.10850875 4.532546697
1045 8404.031.1-B_at 7.42216219 5.19861614 1046 6289.001.1-F_at
8.9307375 6.034635624 1047 1410.006.1-T_at 9.12745661 6.076865916
1048 80034.004.1-T_at 4.30047326 3.355594342 1049 1410.008.1-T_at
7.99198784 5.116495458 1050 57447.051.2-D_at 6.09844409 4.536325155
1051 7170.016.3-B_at 8.29403671 9.288724852 1052 4240.001.1-C_at
9.00972003 7.16992054 1053 6288.001.1-T_at 8.96603543 6.273903027
1054 7018.014.1-C_at 5.99538964 3.822846066 1055 8404.020.1-T_at
7.54635493 5.312082632 1056 6289.001.2-F_at 8.8100063 5.866140365
1057 6876.011.1-F_at 6.08933324 4.374504349 1058 8404.031.1-C_at
6.08486742 4.373738904 1059 57447.010.1-T_at 8.82775044 6.339588309
1060 1410.007.2-C_at 8.33758962 5.131217413 1061 59.012.2-B_at
6.35775616 4.443173526 1062 3459.005.1-T_at 5.80207334 4.471777329
1063 301.013.1-C_at 4.76677119 3.59309712 1064 83539.001.1-D_at
5.41027098 3.741417748 1065 6288.004.1-F_at 7.89445249 5.613330538
1066 4781.016.1-E_at 6.59597542 4.602150459 1067 29997.012.1-E_at
8.53873537 7.295932688 1068 57447.021.1-T_at 6.81768585 5.034847695
1069 3426.002.1-C_at 5.23704842 3.641068359 1070 53829.001.2-T_at
5.15275541 3.943598064 1071 2115.001.2-B_at 4.85542703 3.530125932
1072 10051.008.1-T_at 4.4316929 5.920843577 1073 1033.002.1-T_at
3.63139162 5.34811339 1074 2335.005.1-D_at 3.91739921 6.295453643
1075 7113.009.1-T_at 5.43609158 3.994720867 1076 3866.002.1-B_at
9.19732873 6.293031612 1077 140885.014.1-D 7.59348333 5.605094004
1078 7168.003.1-T_at 5.64472419 4.457129076 1079 79608.001.1-T_at
5.30303748 3.935571553 1080 79608.008.2-F_at 6.74835004 4.557558664
1081 1410.001.1-B_at 6.75241131 4.22870793 1082 7113.010.1-T_at
5.85442041 4.280294556 1083 4781.014.2-B_at 7.86598754 5.705821081
1084 2335.016.1-E_at 4.77399968 7.375547826 1085 11065.003.1-T_at
4.37783851 6.306175214 1086 3872.006.1-T_at 7.85482665 6.124969921
1087 3084.005.1-F_at 4.51722715 3.439893991 1088 6285.003.1-T_at
6.40683627 4.093334173 1089 6876.016.2-F_at 6.53765126 5.03041211
1090 8404.004.1-T_at 7.29426573 5.24109976 1091 54829.001.1-F_at
4.55095384 7.099570517 1092 8404.001.1-T_at 8.00106035 5.742296291
1093 9055.011.1-E_at 5.20354473 7.152510552 1094 6289.003.2-F_at
7.95780418 5.56331609 1095 22974.007.1-T_at 4.55846251 6.477981817
1096 59.023.2-T_at 6.91216911 5.63439702 1097 7169.015.1-T_at
10.1958997 8.61185317 1098 6289.002.1-F_at 7.95223459 5.506509999
1099 4288.008.1-B_at 4.4490631 6.277435237 1100 4781.007.1-B_at
6.06074416 4.463013886 1101 6876.023.1-T_at 5.30318153 3.837265148
1102 9055.017.1-F_at 4.93875917 6.675610123 1103 7170.018.2-D_at
8.97464252 9.731315695 1104 4781.014.2-D_at 6.62173963 4.59382551
1105 7170.025.1-T_at 10.1528395 10.84778358 1106 7018.025.1-B_at
5.85576515 3.729848132 1107 10253.003.1-T_at 5.21328569 3.796731651
1108 57447.039.1-D_at 6.20353459 4.650979725 1109 59.022.1-T_at
5.01607936 3.66486644 1110 2982.015.1-F_at 6.52910873 4.398315488
1111 10124.004.2-F_at 5.65171957 4.395524581 1112 6289.001.1-B_at
8.84060005 6.026432745 1113 7091.005.1-F_at 6.22924785 4.644117845
1114 501.006.1-B_at 5.49535249 3.832258169 1115 1410.001.1-C_at
8.37978611 5.283357954 1116 57447.021.1-C_at 6.64989625 4.516711936
1117 244.012.1-B_at 4.57455863 3.452384416 1118 7018.026.1-F_at
7.02591455 4.884695118 1119 3872.018.1-T_at 5.9287371 4.536856978
1120 10144.017.3-T_at 5.24556385 3.811639459 1121 11197.001.1-F_at
5.1313114 3.685307479 1122 29127.007.1-B_at 3.92146605 5.671967353
1123 10010.004.1-F_at 6.85011832 5.471009514 1124 81704.013.1-C_at
7.00929626 5.228254202 1125 4781.006.2-B_at 7.95071123 5.849829769
1126 7373.003.1-F_at 4.96962295 3.466223281 1127 8404.009.1-D_at
7.25304506 5.54375843 1128 23092.004.1-T_at 5.63034915 4.135821153
1129 2335.002.1-F_at 4.95716635 7.470035933 1130 8404.031.1-F_at
8.49473661 6.266230481 1131 6304.006.2-T_at 6.19437915 4.664814203
1132 1410.008.1-E_at 8.35323964 5.23093246 1133 9055.019.1-F_at
5.08438207 6.749313988 1134 1398.001.1-D_at 6.62952 5.474846977
1135 57447.051.1-E_at 7.64975415 6.754949154 1136 339965.001.2-B
6.09281787 4.427445717 1137 7113.001.1-C_at 6.49441996 4.364555738
1138 4240.009.1-D_at 6.92405991 4.992040248 1139 7153.002.4-B_at
3.9192437 5.943978275 1140 7169.004.1-D_at 10.5243791 9.455104283
1141 1410.001.1-D_at 10.4537888 7.669238725 1142 59.015.2-B_at
4.65235051 3.439217599 1143 4833.010.1-T_at 7.67064462 8.499214874
1144 7169.022.1-B_at 8.88810535 7.392553599 1145 11065.005.1-T_at
4.40063594 6.264196367 1146 7170.018.2-T_at 9.1005517 9.929531193
1147 79971.013.2-F_at 7.81954831 5.197831093 1148 152015.005.2-F
5.50228015 3.631181096 1149 4288.005.1-D_at 3.58855622 5.41357555
1150 8404.002.1-T_at 7.82572709 5.654573319 1151 6441.004.1-E_at
7.06431123 5.1604289 1152 6122.046.1-B_at 10.4919703 9.7185156 1153
115908.002.1-T 3.8854167 5.716319219 1154 9481.001.1-F_at
4.56745873 3.48672793 1155 8404.008.1-T_at 7.67594705 5.231619593
1156 1410.007.1-D_at 8.38485465 5.254780902 1157 8404.030.1-C_at
8.36615125 6.003710685 1158 57447.039.1-T_at 6.16284998 4.598519131
1159 4147.004.1-E_at 6.5996408 4.306043014 1160 2335.024.2-F_at
4.14778676 6.724104869 1161 891.007.1-T_at 4.37836908 6.277454073
1162 2335.002.1-T_at 3.69677239 5.842235509 1163 8404.017.1-T_at
7.62129329 5.344108953 1164 57451.004.1-B_at 4.98513349 3.645263861
1165 8404.001.1-F_at 7.80115205 5.644594488 1166 8626.006.2-B_at
4.99013916 3.634011318 1167 2335.025.1-T_at 5.20342277 7.312790967
1168 6286.001.1-T_at 4.37066146 7.627611404 1169 10580.012.1-C_at
5.72236701 4.332788093 1170 23321.014.1-T_at 4.77278608 3.653834143
1171 2824.001.2-B_at 6.86512458 5.132614728 1172 29127.022.1-T_at
4.01626993 5.699644246 1173 6289.003.1-F_at 8.04884622 5.558117392
1174 7170.005.2-B_at 7.21902208 8.187290968 1175 54443.011.1-F_at
3.90847075 5.715840566 1176 29127.019.1-T_at 4.45515346 6.238930793
1177 6288.004.1-T_at 8.9163962 6.203405757 1178 29997.008.1-C_at
8.54806753 7.280192975 1179 57447.039.1-B_at 8.64953038 6.241324868
1180 3872.007.1-B_at 5.78319757 3.824950968 1181 57561.002.1-T_at
7.04642246 5.352091902 1182 57451.002.3-B_at 4.71308984 3.460721722
1183 5213.024.1-B_at 5.69666791 4.585191172 1184 2.005.1-T_at
9.54067496 7.938923018 1185 11065.004.1-C_at 3.58696224 5.482200678
1186 1410.006.1-C_at 8.38947588 5.204282844 1187 6289.006.1-T_at
6.36227497 4.331717996 1188 55366.001.1-T_at 5.81899126 4.357905799
1189 23284.007.1-F_at 5.22440061 3.837622352 1190 79971.009.1-T_at
7.81567707 5.261440799 1191 6288.004.1-E_at 6.55709998 4.810646704
1192 11065.004.1-T_at 4.59241158 6.359329521 1193 51203.009.1-T_at
4.74450869 6.362980434 1194 1410.010.1-E_at 8.32156036 5.167245484
1195 57447.030.1-D_at 7.16110591 5.926932144 1196 1308.002.1-T_at
4.50117394 3.487272397 1197 4288.007.1-C_at 4.97101233 7.189192841
1198 244.011.1-T_at 5.29003948 3.948200539 1199 94274.003.1-B_at
4.42148503 3.46060704 1200 3178.003.1-E_at 6.30358046 5.181900836
1201 7153.002.4-T_at 4.03542364 6.008249752 1202 9055.012.1-D_at
4.02757905 6.120371884 1203 9232.001.1-E_at 5.22181281 7.208579638
1204 79068.011.2-B_at 6.64417255 5.308326918 1205 120.005.2-F_at
9.06074824 6.73592483 1206 7534.001.1-C_at 8.71480548 9.492140995
1207 120.005.2-T_at 8.73626834 6.165418999 1208 7373.003.3-C_at
4.85399243 3.462673564 1209 57447.004.2-D_at 6.16627621 4.604091159
1210 2568.005.1-F_at 4.73444224 3.560755491 1211 1308.001.1-E_at
4.41347272 3.418435324 1212 6876.020.1-F_at 6.2728158 4.761356719
1213 79971.014.1-D_at 6.31129325 4.294251993 1214 5621.008.1-D_at
5.98900704 4.179299085 1215 55732.003.2-T_at 3.81867845 5.173615902
1216 221120.006.1-D 8.08525795 7.079961293 1217 23266.008.1-T_at
6.70366212 4.807135334 1218 2335.045.1-F_at 4.39135516 6.494344728
1219 7170.007.1-F_at 7.64167879 8.466704716 1220 10461.002.1-B_at
4.77990896 3.622574749 1221 59.031.2-F_at 5.912075 4.730239133 1222
9055.010.1-T_at 4.95064392 6.677393383 1223 58499.005.2-F_at
5.8908337 4.132220814 1224 54443.006.2-F_at 3.53549616 5.526168717
1225 59.016.1-B_at 5.96979167 4.589590519 1226 4288.004.1-C_at
4.97220803 6.791619005 1227 7170.014.1-C_at 10.3731633 11.0837507
1228 7170.007.1-D_at 10.3462783 11.09055128
EXAMPLE III
Molecular Prediction for Breast Cancer Diagnosis: Validation
Set
[0538] A validation set was carried-out that included overall 71
samples. Of these, 21 and 50 were benign lesions and breast cancer
respectively. Using this dataset, the inventors assessed the
performances of the 1228 signature probes to predict for breast
cancer as opposed to benign lesions. Overall 68 out of 71 samples
were accurately classified (96%). Sensitivity and specificity of
the tests were 96% (95% CI: 90.5-100) and 95% (95% CI: 86.1-100).
The correlation of each specimen with the malignant and benign
profile is reported in FIG. 6. Of the three misclassified specimen,
one corresponded to a benign tumor (inflammatory granulomatosis)
classified as malignant, and two were malignant tumors classified
as benign by molecular predictor. The inventors then evaluated the
add-value of molecular predictor to cytological exam, and to a
model that included classification of American College of Radiology
(ACR) and age. Cytological exam failed to provide a definitive
diagnosis in 5 out of 71 patients. Four out of these 5 patients
were accurately classified by the molecular predictor. The
proportion of explained variation (PEV) by Clinical model (age and
ACR) was 75%+-8%, while the PEV by molecular predictor was 81%
(+/-10%). When clinical model and molecular predictor were
combined, the PEV was 87% (+/-7%), suggesting that molecular
predictor presented an add-value of 12% (+/-7%) to the clinical
model. Using the top 50 polynucleotide probe sets: 1 out of 21
samples from patients with benign status were misclassified and 8
out of 50 samples from patients with malignant status. Using the
top 100 polynucleotide probe sets: 1 out of 21 samples from
patients with benign status were misclassified and 7 out of 50
samples from patients with malignant status. Using the top 150
polynucleotide probe sets: 1 out of 21 samples from patients with
benign status were misclassified and 10 out of 50 samples from
patients with malignant status. Using the top 200 polynucleotide
probe sets: 1 out of 21 samples from patients with benign status
were misclassified and 7 out of 50 samples from patients with
malignant status. These data demonstrate that top probe set, even
if some misclassifications occur, gives a good prognosis for a
breast tumor. Moreover, the use of the 1228, or 1640,
polynucleotide probe sets according to the invention allows,
without ambiguity, and misclassification, to determine if a breast
tumor is benign or malignant.
DISCUSSION
[0539] In the present study, the inventors have reported the exonic
portrait of breast malignancy. The analysis of differential exonic
events between malignant and benign lesions provides a complete
picture of genomic anomalies associated with breast malignancy. The
present study reveals a high level of genomic dysregulation between
malignant and benign breast lesions. The inventors found out that
56652 out of 703680 evidenced probes (8%) were different among the
two conditions. When the analysis focused on gene expression level
(geo mean of probe sets), 3733 out of 20649 genes (7%) were
differentially expressed between malignant and benign lesions.
Analysis of gene expression levels revealed overexpression of
candidate genes for further investigations. Pituitary Tumor
Transforming 1 (PTTG1) has been previously reported to be
overexpressed in pituitary tumors, thyroid cancer, colon cancer and
glioma and to mediate malignant transformation (Vlotides G, Eigler
T, Melmed S. Pituitary tumor-transforming gene: physiology and
implications for tumorigenesis. Endocr Rev. 2007 April;
28(2):165-86). Neuroepithelial cell transforming gene 1 (NET1) is a
guanine exchange factor that has been reported to mediate oncogenic
transformation through activation of RhoA (Chan A M, Takai S,
Yamada K, Miki T. Isolation of a novel oncogene, NET1, from
neuroepithelioma cells by expression cDNA cloning. Oncogene. 1996
Mar. 21; 12(6):1259-66). Pathway analysis revealed that genes
involved in spliceosome assemble were enriched in the malignant
condition. Spliceosome mediates alternative splicing, a phenomenon
involved in oncogenesis (Lonning PE, Knappskog S, Staalesen V,
Chrisanthar R, Lillehaug J R. Breast cancer prognostication and
prediction in the postgenomic era. Ann Oncol. 2007 August;
18(8):1293-306; Pajares M J, Ezponda T, Catena R, Calvo A, Pio R,
Montuenga L M. Alternative splicing: an emerging topic in molecular
and clinical oncology. Lancet Oncol. 2007 April; 8(4):349-57).
Present study suggests that alternative splicing could
significantly contribute to the molecular profile of breast cancer.
Based on this consideration, the inventors further evaluated to
what extent analyses at exonic level could provide additional
information to the ones provided by analyses at gene expression
level.
[0540] The inventors identified that 2675 exon-probes that did not
belong to genes identified as differentially expressed, actually
presented a significantly higher intensity in breast cancer. A high
proportion of these 2675 exon-probes presented a significantly
increased splice index in breast cancer as compared to benign
tumors. These exon-probes were considered to present a higher
difference of intensity between cancer and benign lesions, as
compared to the one of their relative genes. Several of these exons
are located within genes linked to cancer biology (casein kinase 1,
delta (Gao Z H, Seeling J M, Hill V, Yochum A, Virshup D M. Casein
kinase I phosphorylates and destabilizes the beta-catenin
degradation complex. Proc Natl Acad Sci U S A. 2002 Feb. 5;
99(3):1182-), retinoblastoma binding protein 9 (Woitach J T, Zhang
M, Niu C H, Thorgeirsson S S. A retinoblastoma-binding protein that
affects cell-cycle control and confers transforming ability. Nat
Genet. 1998 August; 19(4):371-4) and ERB2 interacting protein
(Jaulin-Bastard F, Arsanto J P, Le Bivic A, Navarro C, Vely F,
Saito H, Marchetto S, Hatzfeld M, Santoni M J, Birnbaum D, Borg J
P. Interaction between Erbin and a Catenin related protein in
epithelial cells. J Biol Chem. 2002 Jan. 25; 277(4):2869-75)).
These data point out the limits of analyses at gene expression
level to define the transcriptional profile of diseases, and
suggest that analysis at exon level could capture biological
information that is missed by analysis at gene expression
level.
[0541] Based on the finding that breast cancer presents a widely
different exonic profile as compared to benign tumors, the
inventors evaluated whether this technology could be used for
breast cancer diagnosis. Pathologic exam of tumor biopsy is the
gold standard for cancer diagnosis. Nevertheless, such approach
presents several limitations including the need for invasive
procedures and, in some tumor types, misdiagnosis. In the present
study, the inventors have shown that a large scale molecular
analysis based on fine needle aspiration could allow breast cancer
diagnosis. This finding opens new ways in the field of cancer
diagnosis. Applied to breast cancer, it could allow a more
effective post-screening pattern of care by increasing the metric
performances of fine needle aspiration. Although biopsy is the
current gold standard for breast cancer diagnosis, it is associated
with both morbidity and treatment delays (Meunier M, Clough K. Fine
needle aspiration cytology versus percutaneous biopsy of
nonpalpable breast lesions. Eur J Radiol. 2002 April; 42(1):10-6).
Fine needle aspiration is a safer and easier approach but is
associated with a high rate of false negative results. In the
present study, molecular diagnosis by a 1228-probe signature using
FNA samples was associated with 100% accuracy in a training set and
96% accuracy in a validation set. Interestingly, molecular
classifier provided accurate diagnosis in 4 out of 5 samples for
which the cytological exam was not conclusive. Altogether, these
data suggested that the 1228-probe signature could be a
complementary tool to cytological exam for the breast cancer
diagnosis. This tool could allow avoiding biopsies and unnecessary
surgery in patients with benign lesions of the breast. At the
opposite, for malignant lesions, this approach could speed-up the
diagnosis and could allow decreasing time to surgery. The
development of molecular assays for cancer diagnosis could be of
special interest in other tumor types. As illustration, the benign
nature of thyroid nodules is often difficult to be determined
preoperatively, leading to unnecessary surgeries (Poller D N,
Stelow E B, Yiangou C. Thyroid FNAC cytology: can we do it better?
Cytopathology. 2008 February; 19(1):4-10). A molecular assay could
dramatically decrease the need for surgery in this setting.
[0542] Overall, the present study reports the full description of
exons differentially expressed between breast malignant and benign
tumors. These data allowed the identification of candidate genes
(PTTG1, NET1) for further functional validation in breast cancer.
In addition it suggests that alternative splicing significantly
contributes the molecular profile of breast cancer, leading to the
identification of exons with a significantly higher splice index in
cancer, but located within unchanged gene.
[0543] Finally, the splice array technology allowed the development
of an exon signature for breast cancer diagnosis.
TABLE-US-00010 Lengthy table referenced here
US20120283132A1-20121108-T00001 Please refer to the end of the
specification for access instructions.
TABLE-US-00011 Lengthy table referenced here
US20120283132A1-20121108-T00002 Please refer to the end of the
specification for access instructions.
TABLE-US-LTS-00001 LENGTHY TABLES The patent application contains a
lengthy table section. A copy of the table is available in
electronic form from the USPTO web site
(http://seqdata.uspto.gov/?pageRequest=docDetail&DocID=US20120283132A1).
An electronic copy of the table will also be available from the
USPTO upon request and payment of the fee set forth in 37 CFR
1.19(b)(3).
Sequence CWU 0 SQTB SEQUENCE LISTING The patent application
contains a lengthy "Sequence Listing" section. A copy of the
"Sequence Listing" is available in electronic form from the USPTO
web site
(http://seqdata.uspto.gov/?pageRequest=docDetail&DocID=US20120283132A1).
An electronic copy of the "Sequence Listing" will also be available
from the USPTO upon request and payment of the fee set forth in 37
CFR 1.19(b)(3).
0 SQTB SEQUENCE LISTING The patent application contains a lengthy
"Sequence Listing" section. A copy of the "Sequence Listing" is
available in electronic form from the USPTO web site
(http://seqdata.uspto.gov/?pageRequest=docDetail&DocID=US20120283132A1).
An electronic copy of the "Sequence Listing" will also be available
from the USPTO upon request and payment of the fee set forth in 37
CFR 1.19(b)(3).
* * * * *
References